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ABSTRACT 
Reactive oxygen species (ROS) contribute to the pathogenesis of a number of common and 
important diseases which include atherosclerosis and skin cancer. Selenium (Se) 
supplementation can protect skin and the endothelium from oxidative damage possibly by 
increasing the synthesis of antioxidant selenoproteins such as the family of glutathione 
peroxidases (GPX) and thioredoxin reductase (TR). 
The relative importance of TR and GPX in protecting endothelial cells (EC) and skin cells 
from oxidative damage was studied using the EAhy926 and HaCaT cell lines as models of 
human endothelial cells and keratinocytes, respectively. 
[75Se]- labelled human umbilical vein EC (HUVEC) had a similar selenoprotein profile to 
EAhy926 cells. In HUVEC, human coronary artery EC (HCAEC), bovine aortic EC (BAEC) 
and EAhy926 cells, the expression of TR, cytoplasmic GPX (cyGPX) and phospholipid 
hydroperoxide GPX (PHGPX) was increased by incubating cells with increasing sodium 
selenite concentrations for 48 hr. Basal and Se- induced levels of these selenoproteins were 
similar in EAhy926 to HUVEC. BAEC differed considerably from HUVEC and EAhy926 cells 
in their selenoprotein expression. Therefore, EAhy926 cells appear to be a better model 
than BAEC for studies of selenoprotein function in humans. 
In EAhy926 cells TR, cyGPX and PHGPX activities were induced 1.9 -fold, 5.3 -fold, and 2.6- 
fold respectively by sodium selenite supplementation (40 nM for 48 hr). Se- deficient 
EAhy926 cells were susceptible to oxidative damage by tertiary butyl hydroperoxide (t- 
BuOOH) and oxidised low density lipoprotein (oxLDL), as assessed using percentage 
retention of LDH. Cytotoxicity was attenuated (p < 0.001) by pre- incubation with 40 nM 
sodium selenite, a concentration which maximally induced TR and cyGPX. 
Treatment of Se- deficient EAhy926 cells with gold thioglucose (GTG) (1 pM) significantly 
inhibited TR activity (74.8 % activity retained) (p < 0.01) but not cyGPX or PHGPX. Treated 
cells were more susceptible to oxidative damage by t -BuOOH (p < 0.05) or oxLDL (p < 0.05), 
suggesting that TR may provide antioxidant protection. Cells treated with 10 pM GTG 
showed inhibition of both TR and the GPXs (14.02 % TR activity (p < 0.001), 40.2 % cyGPX 
activity (p < 0.001), and 77.5 % PHGPX activity (p < 0.01) retained). Such cells were more 
susceptible to t -BuOOH toxicity than cells treated with 1 pM GTG (p < 0.05). Hence, both 
TR and the GPXs may be involved in the prevention of oxidative damage to human EC. 
In HaCaT cells, expression of TR and cyGPX was optimally induced by incubation with 
sodium selenite concentrations of 10 nM and 100 nM (increased activities of 2.8 -fold and 
3.8 -fold, respectively). Sodium selenite- treated HaCaT cells were significantly protected 
from oxidative damage mediated by UVB (p < 0.001) or menadione (p < 0.01). 
Using UVB as the oxidative agent, loss of protection occurred at sodium selenite 
concentrations greater than 100 nM. At 1000 nM no protective effect of selenite was 
observed. There was an accompanying loss of cyGPX activity (p < 0.05), but not of TR or 
PHGPX expression. No loss of protection was demonstrated at the higher sodium selenite 
concentrations using menadione as oxidative stressor. The concentration of Se used for 
protection against UVB thus appears crucial. 
Se- deficient HaCaT cells incubated with a GTG concentration (10 pM) that significantly 
inhibited TR activity (18.1 % activity retained) (p < 0.001) but not the GPXs were more 
susceptible to damage by menadione (p < 0.05), but showed no increase in susceptibility to 
UVB- mediated damage. Treatment with a GTG concentration (100 pM) which significantly 
inhibited both TR (3.18 % activity retained) (p < 0.001) and cyGPX activity (33.3 % activity 
retained) (p < 0.001) increased the susceptibility of HaCaT cells to UVB damage when 
compared to controls (p < 0.01). The data suggest that menadione, a model agent for UVB 
oxidative stress, may produce misleading results. TR appears to be important in protecting 
cells against damage mediated by menadione, but cyGPX to be more important in 
preventing damage caused by UVB. The two different oxidative stress agents may thus 
differ in their mechanism of toxicity. 
TR expression regulated by Se supply and the redox state of the cell may affect cell growth. 
Changes in TR and cyGPX activity were investigated in human foetal (16 -20 weeks 
gestation) and neonatal (1 day -15 weeks postnatal) liver cytosols. TR activity and 
concentration, and cyGPX activity in human foetal liver were approximately 3 -fold greater 
than in neonatal liver. These human findings contrast markedly with results in the rat where 
TR and cyGPX activities increase throughout the foetal, newborn and adult stages. These 
results cast doubt on the rat as a model for studying cyGPX and TR in human development. 
In conclusion, the data presented in this thesis suggest that both cyGPX and TR are 
important contributors to the antioxidant defence mechanisms of EAhy926 and HaCaT cells, 
and may therefore help to protect against atherogenesis and skin cancer formation 
respectively. 
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CHAPTER ONE 
INTRODUCTION 
1.1 OXIDATIVE STRESS 
1.1.1 Introduction 
Tissue damage mediated by reactive oxygen species (ROS) is believed to play an important 
pathogenic role in the development of various disorders and disease states including 
atherosclerosis and cancer (Halliwell, 1994; Halliwell and Gutteridge, 1999). Since the 
antioxidant capacity of tissues plays an important role in influencing their susceptibility to 
oxidative challenge, much research has focused on the assessment of antioxidant defence 
systems. This thesis examines the enzymatic antioxidant systems, in particular the 
thioredoxin and glutathione peroxidase systems, in relation to antioxidant protection of 
endothelial cell and skin cell models in vitro. 
The utilization of oxygen by aerobic organisms generates large amounts of reactive oxygen 
species, leading to either physiological concentrations required for normal cell function, or 
excessive quantities, leading to oxidative stress. The term `oxidative stress' denotes "a 
disturbance in the prooxidant- antioxidant balance in favour of the former, leading to potential 
damage" (Sies, 1991). In principle, oxidative stress may result from diminished antioxidants 
or increased production of ROS. Correspondingly, the consequences of oxidative stress 
may be either adaptation (e.g. ischaemic pre- conditioning), damage or stimulation (e.g. of 
proliferation of vascular smooth muscle cells). 
ROS can directly modify all major groups of biomolecules, DNA, lipids, and proteins, which 
results in mutations, strand breaks, aldehyde formation, lipid peroxidation, alterations in 
enzyme activities, and signal transduction pathways. Extracellular tissue components, 
including hyaluronic acid and collagen, are also vulnerable to injury by toxic oxidants. This 
may compromise the architectural integrity of tissues including the basement membrane of 
epithelia and blood vessels. The ubiquity of damage linked to ROS illustrates the vulnerable 
nature of cells and tissue to free radical attack. 
There are many intracellular sources of ROS (figure 1.01). These include electron leakage 
from the mixed -function oxidase cytochromes P450 and b5 in the endoplasmic reticulum, 
electron leakage from the mitochondrial electron transport chain, enzymatic reactions (e.g. 
xanthine oxidase), intracellular autooxidation of various compounds, arachidonic acid 
metabolism, transition metals (Fenton chemistry), and the activation of phagocytic cells 
(oxidative burst). ROS can also be formed in the skin directly or indirectly through 
endogenous photosensitization reactions. 
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1.1.2 Reactive oxygen species (ROS) 
A group of related terms is used in the scientific literature to refer to free radicals; these 
include oxyradicals and oxygen free radicals. The term reactive oxygen species (ROS) is 
generally preferred because singlet oxygen, hydrogen peroxide, hypochlorous acid and 
peroxide, and hydroperoxide and epoxide metabolites of endogenous lipids and xenobiotics 
contain chemically reactive oxygen- containing functional groups, but are not radicals and do 
not necessarily interact with tissues through radical reactions. Examples of ROS are listed in 
table 1.01. ROS include a number of chemically reactive molecules derived from oxygen. 
Some of these molecules are extremely reactive, such as the hydroxyl radical, while some 
are less reactive (superoxide and hydrogen peroxide). Free radicals and ROS can readily 
react with most biomolecules, starting a chain reaction of free radical formation. In order to 
stop this chain reaction, a newly formed radical must either react with another free radical, 
eliminating the unpaired electrons, or react with a free radical scavenger _ a chain -breaking 
or primary antioxidant. 
Table 1.01 Reactive oxygen species 
Radicals Non -radicals 
Superoxide (02. ) 




Hydrogen peroxide, (H2O2) 
Hypochlorous acid, (HOCI) 
Ozone (03) 
Singlet oxygen (102) 
Peroxynitrite, (ONOO-) 
The step -wise reduction of molecular oxygen via 1- electron transfers produces superoxide, 
hydrogen peroxide and the hydroxyl radical, with the eventual four -electron reduction product 
water, which may be outlined as detailed below in reaction 1: 
é é + 2H+ é é + 2H+ 
02 H202 'OH + OH 2H20 
(reaction 1) 
The cellular sources of ROS formation are summarised in figure 1.01, and their metabolism 
by cellular antioxidant systems is summarised in figure 1.02. Table 1.02 lists the most 
common intracellular forms of ROS, their main cellular sources of production, and the 
enzymatic antioxidant systems which scavenge these ROS molecules. 
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mixed -function oxidase electron transport 

























NADPH oxidase (oxidative burst: 
phagocytes) 
Figure 1.01 Cellular sources of reactive oxygen species. Many constituents of the cell 
are subject to oxidative attack. A frequent target is the cell membrane, resulting in lipid 
peroxidation. Proteins and DNA are also prone to attack. Sources of ROS include leakage 
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1.1.3 Physiological functions of ROS 
Neutrophils, eosinophils, and mononuclear phagocytes possess a flavoprotein NADPH 
oxidase system that converts 02 to 02.-. During phagocytosis, cells consume increased 
amounts of oxygen ('oxidative' or 'respiratory burst') to generate 02'-, H202 (from 02.- via 
SOD), OH., and hypochlorous acid (HOCI) (from H202 via myeloperoxidase) which are highly 
toxic to bacteria ingested by the phagocyte. 
ROS also have crucial, advantageous physiological use in cellular functions including 
intracellular signalling (Go et al., 1999; Pani et al., 2000; Peus et al., 1999; Thannickal and 
Fanburg, 2000) and redox regulation of transcription factor activity (Gupta et al., 1999; 
Lakshiminarayanan et al., 1998; Sun and Oberley, 1996). Several cytokines, growth factors, 
hormones, and neurotransmitters use ROS as secondary messengers in intracellular signal 
transduction (Bae et al., 1997; Finkel, 1998; Pani et al., 2000; Peus et al., 1999; Thannickal 
and Fanburg, 2000). ROS can directly affect the structure and /or activities of all sulphydryl- 
containing molecules by oxidation of their thiol groups. Such redox regulation affects many 
proteins which are important in signal transduction and carcinogenesis, such as protein 
kinase C, collagenase, and tyrosine. 
1.1.4 ROS as cause of oxidative damage 
ROS are mutagenic (Marnett, 2000), due to chemical modification of DNA. Alterations to 
DNA, such as DNA cleavage, DNA -protein cross links, and oxidation of purine /pyrimidine 
bases (Halliwell and Gutteridge, 1999), are due to reactions with ROS. ROS may also 
damage DNA indirectly by activating Cae + -dependent endonucleases as a consequence of 
rises in intracellular free Cae +, or by a variety of aldehyde derivatives formed during the 
oxidation of lipids, proteins or amino acids. 
Polyunsaturated fatty acids (PUFA) of membranes and lipoproteins are prime targets for free 
radical attacks. Generation of peroxyl and alkoxyl radicals, aldehydes (especially 4- hydroxy- 
2-nonenal; 4 -HNE), and other products of lipid peroxidation in membranes and lipoproteins 
can cause severe damage to the proteins present by reacting with thiol groups of GSH or 
cysteine in proteins, altering their functions. Aldehydes can also react with amino groups. 
ROS react with several amino acid residues in vitro, generating modified and less active 
enzymes, cross -linked, denatured, or inactive proteins (Halliwell and Gutteridge, 1999). 
Damage to proteins can occur by direct attack by ROS, or by secondary damage by lipid 
peroxidation end -products such as malondialdehyde (MDA) and 4 -HNE. General antioxidant 
systems such as Trx, Grx, or GSH, or specific systems, such as methionine sulphoxide 
reductase, maintain the protection of proteins from such attack and modification. 
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1.1.5 Cellular antioxidant systems 
The cellular antioxidant systems can be divided into two major groups, enzymatic and 
nonenzymatic. The antioxidant enzyme systems of the cell are illustrated in figure 1.02. 
a) Enzymatic antioxidants 
i) Superoxide dismutases (SOD) 
Superoxide dismutase (SOD) catalyses the dismutation of 02- to oxygen and H2O2. Human 
tissue contains three isoenzymes of SOD: an 80kDa tetrameric mitochondrial manganese - 
containing SOD (Mn -SOD), a 32 -kDa dimeric cytosolic copper -zinc SOD (Cu /Zn -SOD) and a 
larger Cu /Zn -SOD, distinct from the cytosolic type, is found extracellularly. 
Catalases 
Catalases of mammalian origin are mainly haem- containing enzymes of four subunits, each 
with a ferric haem group and NADPH bound. The predominant subcellular localization is in 
peroxisomes, where the enzyme catalyzes the dismutation of H2O2 to water and molecular 
oxygen. Mammalian catalases also have some peroxidase -like activity. 
Peroxiredoxins (Prx) 
The thioredoxin peroxidases belong to a conserved family of proteins, the peroxiredoxins 
(Prx). Prx catalyze reduction of peroxides, e.g. H2O2 and alkyl hydroperoxides (Berggren et 
al., 2001; Chae et al., 1999) using Trx as their source of reducing equivalents in mammalian 
cells (Chae et al., 1999). Prx I and I I are abundant in the cytosol (Kim et al., 2001 a). 
iv) Glutathione peroxidases (GPX) 
There are four different selenocysteine- containing GPXs in mammalian cells. The GPX 
family of enzymes is described in detail in section 1.2.7. 
v) Glutathione S- transferase (GST) 
Many xenobiotics are metabolised by conjugation with GSH, catalysed by the glutathione S- 
transferase (GST) enzymes. Eukaryotes have multiple cytosolic and membrane -bound GST 
isoenzymes, each with distinct substrate specificities (Halliwell and Gutteridge, 1999). Some 
GSTs metabolise cytotoxic aldehyde products of lipid peroxidation, or show GPX -like activity, 
reducing organic peroxides (but not H2O2) 
vi) The mammalian thioredoxin system (Trx -TR) 
The Trx -TR system is described in detail in section 1.2.7. 
vii) Haem -oxygenase -1 (hsp32/HO -1) 
Haem -oxygenase (HO) is the rate -limiting enzyme in haem catabolism, which degrades 
haem to carbon monoxide and biliverdin with the release of iron (Otterbein and Choi, 2000). 
Iron is then sequestered by ferritin, preventing ROS production. The HO -1 isoform is a 
stress protein that is induced by oxidative stress (Clark et al., 2000; Otterbein and Choi, 
2000; Vile et al., 1994). 
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Figure 1.02 The endogenous antioxidant enzyme systems of the cell. CAT, catalase; 
cyGPX, cytoplasmic glutathione peroxidase; PHGPX, phospholipid hydroperoxide 
glutathione peroxidase; GR, glutathione reductase; GSH, reduced glutathione, GSSG, 
glutathione disulphide; H202, hydrogen peroxide; L -Arg, L- Arginine; L -Cit, L- Citrulline; 02-, 
superoxide anion; ONNO-, peroxynitrite; NO, nitric oxide; NOS, nitric oxide synthase; TR, 
thioredoxin reductase. Also of importance are the peroxiredoxins (not included in the 
diagram), which can reduce H202. Non -enzymatic antioxidants are also importance for 
defence against oxidative damage. Low molecular weight compounds considered to be 
antioxidants of biological importance include vitamins C and E, different selenium 
compounds, lipoic acid, and ubiquinones. 
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b) Non -enzymatic antioxidants 
i) Glutathione (GSH) 
Glutathione (GSH), an endogenous tripeptide (glutamate, cysteine, glycine), is the most 
abundant intracellular thiol- containing antioxidant (Meister, 1994; Valencia et al., 2001). Two 
molecules of reduced GSH react non -enzymatically to form one molecule of glutathione 
disulphide (oxidised glutathione) (GSSG). Its function is primarily as a sulphydryl buffer, but 
GSH also detoxifies compounds either via conjugation reactions catalyzed by GSTs or 
directly by donating a hydrogen atom. It protects cell membranes and maintains enzymes in 
bioactive forms (Valencia et al., 2001). GSSG is recycled by glutathione reductase (Deneke 
and Fanburg, 1989) and by human and E.coli thioredoxins (Holmgren, 2000a). GSH is a 
hydrogen donor for GPX and ascorbate. 
ii) Glutaredoxins (Grx) 
The glutaredoxins (Grx), or thioltransferases, closely related to GSH, have functions 
overlapping those of thioredoxins. Grx's are largely located in the cytosol, but, unlike Trx, 
can be directly reduced by GSH. Grx's are possibly involved in catalysing thiol- disulphide 
interchange with cytosolic proteins, but also have dehydroascorbate reductase activity 
(Halliwell and Gutteridge, 1999). 
Low molecular weight antioxidant compounds 
Low molecular weight compounds important in antioxidant defence can be divided into 
compounds obtained from the diet, e.g. vitamins C and E, carotenoids, different selenium 
compounds, and compounds made in vivo, e.g. bilirubin, melanins, ubiquinones and lipoic 
acid. Melanins are discussed in section 1.7.1. Vitamins C and E and selenium compounds 
in relation to atherosclerosis and skin damage by UV are discussed in sections 1.5.6 and 
1.6, and 1.10 and 1.11.4, respectively. 
i) a- tocopherol 
a- tocopherol (Vitamin E) is a lipophilic, chain -breaking antioxidant. Attached to the 
hydrophobic structure of a- tocopherol is an -OH group whose hydrogen atom is easily 
donated (Halliwell and Gutteridge, 1999). Peroxyl and alkoxyl radicals generated during lipid 
peroxidation combine with a- tocopherol instead of the PUFA, terminating the chain reaction. 
The a- tocopherol is converted to the a- tocopheryl radical which is poorly reactive and unable 
to attack PUFA. Vitamin C is involved in regenerating a- tocopherol from the a- tocopheryl 
radical, as are ubiquinol and GSH to a lesser extent (Halliwell and Gutteridge, 1999). 
ii) Ascorbate 
Ascorbic acid (vitamin C) is a water -soluble vitamin that cannot be manufactured in the 
human body, and so needs to be present in the diet. It is the major antioxidant in protection 
of cells and human plasma from oxidative stress. Ascorbic acid has two ionisable -OH 
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groups, and is a reducing agent (Halliwell and Gutteridge, 1999). Donation of one electron 
by ascorbate gives the ascorbyl radical which can be oxidised to dehydroascorbate (DHA). 
The ascorbyl radical is relatively unreactive, and DHA is unstable and breaks down rapidly. 
Reduction of the ascorbyl radical and DHA is carried out by mammalian thioredoxin 
reductase (May et al., 1998a; May et al., 1997) as well as GSH- dependent 
dehydroascorbate reductase. 
Carotenoids 
The carotenoids are a group of coloured pigments (orange, red or yellow) that are 
widespread in plant tissues, and include lycopene, 6-carotene, a- carotene, and lutein. 
Carotenoids are the hydrophobic precursors of the fat -soluble vitamin A (retinol). Radicals 
can react with carotenoids by electron transfer, since the carotenoid molecule is a long 
alternating single- and double -bond structure, allowing electron delocalisation. 
iv) Ubiquinone 
Coenzyme Q (ubiquinone) forms part of the electron transport chain in mammals, and 
functions as an antioxidant in mitochondria, and to a lesser extent in the plasma and plasma 
membranes. The coenzyme accepts one electron to form a semiquinone radical, or two 
electrons to form a fully- reduced ubiquinol form (Halliwell and Gutteridge, 1999). Ubiquinine 
also accepts electrons from reduced flavoproteins and 6-oxidation of fatty acids. 
1.1.6 Antioxidant synergy 
Antioxidant defences operate as a balanced and coordinated system, and each relies on the 
action of the others. Antioxidant enzymes cooperate with antioxidants to defend against 
oxidative stress -induced cellular damage. The survival time of rats exposed to pure 02 is 
increased by . 70 % when liposomes containing both catalase and SOD are intravenously 
injected before and during 02 exposure; liposomes containing catalase or SOD alone are 
much less protective (Turrens et al., 1984). Increased Cu /Zn -SOD levels in stable 
transfectants results in sensitization to oxidative DNA damage, which can be counteracted or 
overcome by co- transfection with GPX or catalase (Amstad et al., 1994). 
Ascorbate and GSH interact in vivo (Meister, 1994). Treatment of newborn rats with 
buthionine sulphoximine (BSO), a GSH -depleting agent, results in marked depletion of tissue 
ascorbate in liver, kidney, eye, lung and brain. When ascorbate is given to newborn rats, the 
levels of tissue and mitochondrial GSH increase, suggesting that ascorbate can spare GSH. 
Some vitamins show synergistic effect if they exist simultaneously as antioxidants (May et 
al., 1998b; Nègre- Salvayre et al., 1995; Pryor, 2000b). This sort of synergy may be 
expressed as the beneficial effect on blood lipids. A full complement of multi- vitamins and 
multi -minerals taken orally can favourably modify lipid profiles and plasma peroxide levels 
and reduce the risk of cardiovascular diseases (Morcos, 1999; Morcos and Tornita, 1996). 
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1.2 Selenium 
1.2.1 Introduction 
Since the discovery that selenium (Se) is essential to animals and that it is necessary for the 
prevention of various disease states, research on the metabolism and the effects of this 
element has grown rapidly. Discovered by Berzelius in 1817, it was the 1950s before Se 
was first appreciated for its practical role in prevention of vascular disorders and nutritional 
myopathies in livestock. The true nutritional significance of this element was brought to the 
fore when, in 1973, it was identified as the biologically active component of the enzyme 
cytosolic glutathione peroxidase (GPX) ( Rotruck et al., 1973), preceded by the perception of 
its fundamental role in the prevention of liver necrosis in vitamin E- deficient rats in 1957 
(Schwartz and Foltz, 1957). Reports highlighting the importance of Se in human nutrition 
appeared in 1979 describing the Se- responsive cardiomyopathy of Keshan disease in China 
(Group, 1979). Since then a considerable amount of subsequent research has 
demonstrated that Se is essential to human nutrition through the expression of a wide, and 
growing range of selenoproteins which have multiple and diverse roles. 
1.2.2 The chemistry of selenium 
Se is an essential element for the growth of humans and animals. However, its role in the 
mammalian diet is somewhat ambivalent since at lower concentrations it is essential for 
growth, but it exhibits toxicological properties at higher doses. Se lies between sulphur and 
tellurium in Group VI of the periodic table, with an atomic weight of 78.96. It is classed as a 
metalloid by virtue of sharing properties of both metal and non -metals. The element exists 
naturally in a range of oxidation states, combining with other elements to form inorganic 
selenides, selenites and selenates. Se also forms organic selenoamino acids, which include 
selenocysteine and selenomethionine. Despite sharing some physical and chemical 
properties, Se and sulphur are not interchangeable in biological systems (Foster and Sumar, 
1997). 
1.2.3 Se Metabolism and Bioavailability 
a) Introduction 
The metabolism of Se in animals and humans, i.e. its absorption, transport, distribution, 
excretion, retention and transformation to the active selenide form is dependent on its 
chemical form and the overall Se status of the individual. Animals normally receive dietary 
Se as organic selenoamino acids such as selenomethionine and selenocysteine and as 
methylated and non -methylated Se, though inorganic forms, such as sodium selenite and 
sodium selenate, are used in experimental diets and as supplements. Se is contained in 
association with tissue proteins throughout the body. Proteins that incorporate Se 
endogenously in stoichiometric amounts are referred to as selenoproteins and are 
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metabolically active, whereas proteins that bind Se non -specifically are termed Se- containing 
proteins. 
The only reductive metabolic pathway for Se that has been well characterized is that based 
on the metabolism of most forms of Se to selenite and further reduction to selenide. Figure 
1.03 shows a hypothetical scheme of Se metabolism adapted from Ip (Ip, 1998). 
b) Absorption 
Se is readily absorbed from the intestine and extracted rapidly by the liver and erythrocytes. 
Under normal feeding conditions absorption is not the limiting factor to Se bioavailability 
(Mutanen, 1986). L- Selenomethionine and L- methionine share the same active transport 
mechanism (McConnell and Cho, 1965), and absorption of inorganic forms such as selenite 
and selenate is via a passive mechanism (Thomson, 1998). Virtually complete absorption 
occurs when Se is supplied as selenomethionine (Swanson et al., 1991) and other forms are 
generally well absorbed. Although different forms of Se are absorbed through different 
mechanisms, most forms are absorbed through the duodenum (Thomson, 1998). 
Absorption is unaffected by Se status which would suggest that no homeostatic regulation of 
absorption exists. The bioavailability of Se can be dependent on the levels of methionine 
and vitamins in the diet, total protein content, restricted diet intake, and the presence of 
heavy metals. 
c) Transport 
Se is transported in plasma bound to protein. Selenoprotein P (Self) has been identified in 
the plasma of both rats and humans (Burk and Hill, 1994), accounting for over half of the Se 
content of mammalian plasma. It has been proposed to have a Se transport function 
(Motsenbocker and Tappel, 1982), and new data from a self knockout mouse confirms this 
(Hill et al., 2002). 
d) Metabolism and distribution 
The metabolism of Se is a complex process and varies according to the particular chemical 
form ingested (figure 1.03). Most forms of Se are metabolized to selenite, further reduced to 
selenides, or both. The bioavailability of these forms differs however. Se retention is greater 
when introduced as selenomethionine, which relates to non -specific incorporation of 
selenomethionine into proteins via the usual method of methionine incorporation (Nève, 
1998), especially into skeletal muscle protein. However, selenomethionine in place of 
methionine confers no additional catalytic activity within a protein (Rayman, 2000; 
Waschulewski and Sunde, 1988). 
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e.g. GPX, selenoprotein P 
Figure 1.03 A diagram illustrating the pathways of Se metabolism. Adapted from Ip (Ip, 
1998). The figure shows the pathway through which most forms of Se are metabolised and 
the precursors for the synthesis of different forms of selenoproteins and Se- containing 
proteins. Selenide is a precursor of selenophosphate, the universal Se donor in vivo. 
Selenomethionine (SeMeth) is not directly available for utilisation in specific Se pathways 
until it has been catabolized to selenocysteine (SeCys) by trans -sulphuration. The resulting 
SeCys does not accumulate; instead it is reduced to selenide to enable its Se to be made 
available for selenoprotein synthesis. Trimethyl selenide in urine can be sequentially 
demethylated to methyl selenol, which is then returned to the selenide pool where it may be 
used in selenoprotein manufacture. 
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Absorbed Se will go primarily into one of two distinct metabolic pools or compartments in 
mammalian tissues (Levander and Burk, 1992). The first incorporates all forms of Se 
derived from inorganic Se, including endogenously synthesised selenoproteins. This pool 
provides the metabolically active seleno- compounds. Other forms of Se will chiefly go into a 
second pool which consists of Se- containing proteins that do not require Se for catalytic 
activity and incorporate Se by substitution of methionine with selenomethionine. This non - 
active Se pool makes up a large proportion of the total body Se and does not appear to be 
under homeostatic control. 
e) Excretion 
Se is principally excreted through the urine. Homeostatic balance of Se in animals is 
primarily controlled through the regulation of its excretion through urine. Se is excreted to a 
small extent through dermal loss (Daniels, 1996). Tri- methyl Se is excreted through urine, 
the dimethyl form is exhaled, and the monomethylated form is usually discharged by 
metabolism of selenomethionine (Daniels, 1996). 
f) Dietary requirement for Se 
The average daily intake of Se varies depending on the Se levels in general food products, 
in turn reflecting the Se concentration in soil. The average daily intake of Se in the UK has 
decreased over the last 30 years from approximately 60 pg/day in the 1970s (Rayman, 
1997) to approximately 30 pg /day (Combs, 2001). The recommended daily intake in 
different countries varies between 50 and 70 pg/day (Rayman, 2000). This level is aimed to 
be sufficient to increase the level of GPX in the plasma to plateau levels. However this may 
be an underestimate of how much Se is required for optimal health and for other 
selenoproteins to attain maximal expression (Combs, 2001; McKenzie et al., 2002a; Nève, 
1995; Rayman, 2000). The highest levels of Se in the diet are found in Brazil nuts, kidney 
and fish, whereas levels in dairy products are much lower. In response to the requirement 
for Se to sustain human health, several types of Se- enriched foods have been developed in 
recent years, including Se- fortified cereal, margarine, salt, and beverages, as well as foods 
grown in Se- enriched soil (Combs, 2001). Se supplements are sold in the form of both 
selenomethionine and sodium selenite (Schrauzer, 2001; Whanger, 2002), but the 
recommended dietary daily allowance is irrespective of the chemical compound consumed 
(Brigelius -Flohé et al., 1995). 
1.2.4 Se- Related Human Diseases and Se Toxicity 
Health conditions associated with selenium deficiency 
Low dietary Se intake has been implicated in the development of numerous health disorders 
in humans. These include, Kashin -Beck disease, cancer, cardiovascular disease (including 
Keshan disease), atherosclerosis (detailed in section 1.6), muscular dystrophy, malaria, 
arthritis, alopecia areata, pregnancy hypertension syndrome, altered immune function, male 
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infertility, spontaneous abortions, pre -eclampsia, and AIDS (Baum et al., 1997; Combs, 
2001; Combs and Clark, 1999; Foster and Sumar, 1997; Levander, 1987; Robinson and 
Thomson, 1983; Ximin et al., 1998). Patients administered total parenteral nutrition 
(intravenous feeding) or enteral nutrition (tube feeding) long -term without Se- 
supplementation in their formulation run the risk of Se deficiency (Hatfield, 2001; Levander, 
1987) which has been linked with myopathy (Brown et al., 1986; Kien and Ganther, 1983) 
and cardiomyopathy (Fleming et al., 1982; Johnson et al., 1981). The relationship between 
the symptoms and Se- deficiency is supported by data showing that supplementation with Se 
alleviates many symptoms (Abrams et al., 1992; Saito et al., 1998; Yagi et al., 1996b). 
Among the diseases associated with severe endemic Se deficiency in humans, the most 
convincing data for an etiological role of Se- deficiency exists for Keshan and Kashin -Beck 
diseases. The occurrence of each of these two diseases is in rural areas of China and 
Russia (Eastern Siberia) where food systems have an exceedingly low Se supply. 
Keshan disease 
Keshan disease is a multifocal myocarditis occurring in children and females of child- bearing 
age. Supplementation of the diets of over one million rural -dwelling individuals with Se- 
enriched salt has reduced the incidence of Keshan disease, thereby confirming the causal 
relationship between Se- deficiency and the disease (Hatfield, 2001). Certain features of the 
disease cannot be explained by Se- deficiency alone, including the seasonal variation. The 
low Se status may be an underlying, pre- disposing factor, but Se supplementation works 
prophylactically only; Se cannot reverse the cardiac failure once it has occurred. The 
involvement of other cofactors, such as the viral agent coxsackie B3 virus in the 
development of the cardiomyopathy has been suggested from studies in mice. In a Se- 
deficient host the coxsackie virus can mutate into a cardiotoxic form (Beck et al., 1995). 
Coxsackie virus has been isolated from tissues of some Keshan disease victims (Li et al., 
2000). Coxsackie virus recovered from cyGPX knockout mice undergoes mutation, and 
such knockout mice develop myocarditis, while virus from wild -type mice is unchanged, and 
wild -type mice are resistant to myocarditis (Beck et al., 1998). 
Kashin -Beck disease 
Kashin -Beck disease is a Se- responsive endemic osteoarthropy (deforming arthritis), 
affecting preadolescent and adolescent children (Combs, 2001; Levander, 1987). The 
principal pathological feature of this disease is the necrosis of the chondrocytes during bone 
growth. The Se- enrichment of table salt for a Chinese population of 5 million individuals 
resulted in dramatic decreases in new cases, with the incidence rate decreasing to almost 
zero in communities which were formerly endemic (Hatfield, 2001). However, the complete 
absence of this disease in Se- and iodine -deficient central Africa suggests multiple 
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etiological factors, which may include poisoning by mycotoxins, fulvic acids in drinking water, 
and nutritional mineral imbalances (Combs, 2001; Hatfield, 2001; Levander, 1987; 
Tomlinson, 1999). 
Cancer 
Evidence from animal experiments and epidemiological studies suggests that Se can 
diminish cancer risk (Combs and Clark, 1999). Epidemiological studies have provided 
evidence of an inverse relation between Se intake (or Se status) and cancer risk (Clark et al., 
1991; Combs and Clark, 1999; Fex et al., 1987; Knekt et al., 1998; Salonen et al., 1984; 
Virtamo et al., 1987). The potency of Se is illustrated by a meta -analysis of the combined 
data from several studies (Ip, 1998) comparing the significance of serum Se, retinol, 13- 
carotene, and vitamin E with respect to cancer risk (Comstock et al., 1992). Se was the 
factor with the most consistently protective effect. 
The most convincing evidence for the inverse relationship between Se and certain forms of 
cancer to date comes from a randomised double blind, placebo -controlled intervention study 
carried out by Clark et al. (Clark et al., 1996; Clark et al., 1998). 1312 subjects with a history 
of at least 2 skin cancers, from the (Se -poor) South -Eastern region of the USA received 
either 200 pg Se (as Se yeast) or a placebo daily. The results reported in 1996, 13 years 
after the initiation of the trial, showed no effect on the primary endpoint of non -melanoma 
skin cancers. However, those receiving Se showed secondary endpoint effects of 50 
lower total cancer mortality (p = 0.002) and 37 % lower total cancer incidence (p = 0.001) 
with 63 % fewer cancers of the prostate, 58 % fewer cancers of the colon, and 46 % fewer 
cancers of the lung. This study has however been criticised (Colditz, 1996; Ip, 1998; Parker, 
1997; Pocock and Hughes, 1990). 
The PRECISE (Prevention of Cancer by Intervention with Selenium) trial is the most recent 
Se supplementation trial, and has been designed to confirm /refute the results of Clark's trial. 
It has recently commenced with cohorts in the UK, Denmark, Sweden, Finland and the USA. 
A total of 33,000 patients will receive 100, 200 or 300 pg of Se a day, the trial will last for 5 
years and will study the mortality rate in all of the groups. 
In addition, the US National Cancer Institute is to fund a 12 year study, SELECT (Selenium 
and Vitamin E Cancer Prevention Trial), in which 32,000 men will be recruited to determine 
the effect of Se supplementation (200 pg per day as selenomethionine) and vitamin E on the 
risk of prostate cancer. 
Another large scale supplementation trial was started in 1994 in France (SUVIMAX trial). 
The trial is to be carried out for 8 years on 15,000 individuals to investigate whether Se and 
zinc supplementation reduces the incidence of cancer and heart disease. The results will be 
published in 2003. 
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1.2.5 Selenium toxicity 
Although Se is an essential element, it can become toxic at high concentrations. Se toxicity 
is dependent on the chemical form of Se administered, animal species, and quality of dietary 
protein (Spallholz, 1994). 
The toxicity of Se at high concentration is thought to be due to its prooxidant ability to 
catalyse oxidation of thiols and generate H2O2 and other ROS (Spallholz, 1994; 
Spallholz, 1997). Cytotoxic Se compounds include selenite and selenocystine, which can 
generate 02- and lead to an increase in oxidative DNA damage in the cell leading to 
apoptosis (Stewart et al., 1999). Selenite can also react with GSH to produce 
selenodiglutathione, a very reactive compound which has apoptosis -inducing and 
carcinostatic properties (Ip, 1998; Spallholz, 1994). Mitochondria appear to be the main 
target of Se- induced oxidative stress (Spallholz, 2001). Documented cytotoxic effects of 
selenite (1 - 5 pM) include cytoplasmic vacuolisation, cell detachment, and membrane 
damage (Ip, 1998). Selenomethionine is not cytotoxic to cells even at high concentrations 
since it does not undergo redoxing -cycling and does not produce 02- (Stewart et al., 1999). 
The tolerable upper intake level for Se, i.e. the highest level of daily intake that is likely to 
pose no risk of adverse health effects, was set at 400 Ng /day for adults in the year 2000 
(Hatfield, 2001). The `Lowest Adverse Effect Level', defined as the `average daily selenium 
intake causing individuals within a population to develop overt signs of toxicity' is thought to 
be in the order of 1540 ± 653 pg /day (Schrauzer, 2001). 
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1.2.6 Selenoprotein synthesis 
Se is incorporated specifically into selenoproteins as selenocysteine (SeCys) residues 
through a co- translational event directed by the UGA codon (Heider et al., 1992). This UGA 
codon has a dual role in the genetic code; in selenoprotein synthesis the UGA codon 
indicates the site of SeCys incorporation, whilst the alternative interpretation of the UGA 
codon recognises it as a termination codon. 
The mechanism for the synthesis of selenoproteins was characterised in E. coli mutants 
(Bermano et al., 1996a; Heider et al., 1992). The synthesis of SeCys and its insertion into 
specific selenoproteins in prokaryotes involves the products of four genes (selA, selB, selC, 
and selD) (Allan et al., 1999). The products are; a selenocysteine- specific tRNA species 
(tRNA$80) (se1C) which carries the anticodon for UGA, the enzymes, selenocysteine 
synthase (selA) and selenophosphate synthetase (selD) that are essential for the formation 
of selenocysteine- tRNA$B0 from seryl- tRNAsec and the elongation factor that specifically 
recognises the selenocysteine -tRNA (selB). The selB product is similar to the elongation 
factor -Tu (Hatfield, 2001) which transports amino acid tRNAs to the ribosome. The major 
steps of selenocysteine insertion are illustrated in figure 1.04. 
In eukaryotes, the process of selenoprotein synthesis differs in some features from the 
mechanism in E.coli. At least two forms of the tRNA$B0 have been isolated in eukaryotes 
and both contain the UGA anticodon which is functional in E. coli (Kollmus et al., 1996; Low 
and Berry, 1996). Like bacterial tRNAsBO in eukaryotes tRNAsBO is esterified with serine and 
is subsequently converted to seryl- tRNASeO 
The nature of the mRNA selenocysteine insertion sequence (SECIS) elements which are 
responsible for the recognition of the UGA as a selenocysteine insertion codon differs 
between prokaryotes and eukaryotes (Kollmus et al., 1996). In prokaryotes the SECIS stem - 
loop structure is immediately downstream (3') from the UGA codon in the open reading 
frame. In contrast eukaryotic SECIS elements are located in the 3'- untranslated region 
(UTR) of the mRNA (Berry et al., 1993). The SECIS sequences vary for different 
selenoproteins, but serve a common purpose. Differences in stem -loop function may permit 
the translation machinery of the cell to express some selenoproteins selectively in 
preference over others (Berry et al., 1993). 
Two selenophosphate synthetases have been identified in eukaryotes, Spsl and Sps2 (see 
section 1.2.7). In addition to Sps 1 and 2, two proteins have been identified in eukaryotes 
that carry out the functions equivalent to Se/B. These proteins, one of which binds to the 
SECIS sequence (SBP2) and a second that is a selenocysteyl- tRNA[ser]sec_ specific 
elongation factor (eEFSec), allow the translation of UGA as SeCys instead of a termination 
codon. 
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Figure 1.04 A proposed model of the incorporation of selenocysteine into 
selenoproteins in prokaryotes. The selenocysteine specific tRNA (tRNA ec) is initially 
esterified with t-- serine, catalysed by seryl -tRNA synthetase. Once charged with L -serine 
the seryl- tRNAsec can bind to selenocysteine synthase. Selenocysteine synthase is a 
pyridoxyl phosphate- containing enzyme which catalyses the conversion of seryl- tRNAsec to 
selenocysteyl- tRNA$B0. The initial step involves elimination of a water molecule to form a 
dehydroalanyl- tRNAsec intermediate. The second step involves the addition of a reactive 
selenium derivative; monoselenophosphate acts as the Se donor. It is produced from 
selenide and ATP by selenophosphate synthetase. The selenocysteyl- tRNAsec (sec - 
tRNAs80) is then released from the selenocysteine synthase and binds an elongation factor 
selB which delivers the sec- tRNAsec complex to a stem loop structure on the mRNA. In 
order to recognize the UGA codon as an insertion sequence for selenocysteine as opposed 
to a stop codon the stem loop structure has a specific sequence downstream from the UGA 
codon. The stem loop structure binds the se /B- tRNA$B0- selenocysteine complex aiding its 
interaction with the UGA codon and the subsequent incorporation of selenocysteine into the 
protein. SeIB is represented by the circle, with the selenocysteyl- tRNAsec the stem -loop and 
the ribosome approaching the UGA codon. 
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1.2.7 Mammalian selenoproteins and Se- containing proteins 
The many biochemical roles of Se and the large number of diseases with which Se 
deficiency has been associated are reflected in the number of selenoproteins that have been 
identified. Approximately 30 -40 selenoproteins can be demonstrated by [75Se]- labelling of 
mammals in vivo or cultured cells in vitro (Behne et al., 1988; Evenson and Sunde, 1988; Wu 
et al., 1995). Up to 21 of these proteins have been further characterised by purification 
and /or cloning (Arthur and Beckett, 1994; Hatfield, 2001). Bioinformatic techniques have 
also been used to search published nucleotide sequences for SECIS elements to identify 
potential sequences for selenoproteins (Kryukov et al., 1999; Lescure et al., 1999; Martin - 
Romero et al., 2001). Some potential selenoproteins identified in this manner have been 
expressed, although in most cases their enzyme activities or functions have not been 
identified. On the basis of abundant and non -abundant proteins in the genome, it has been 
suggested that there may be up to 100 selenoproteins (Burk and Hill, 1993). 
Of the mammalian selenoproteins that have been characterised (Table 1.03) four are GPXs, 
three are iodothyronine deiodinases and three are thioredoxin reductases (TRs). All 
mammalian selenoproteins with known functions are redox enzymes with an active site that 
contains SeCys (Gasdaska et al., 1999a). 
a) Glutathione peroxidases 
The family of glutathione peroxidases includes five distinct selenoproteins. Each of these 
peroxidases arise from distinct gene products which are homologous with one another but 
structurally and phytogenetically unrelated to the Se- containing bacterial oxidoreductases 
and the other mammalian selenoproteins. Distinct biological roles of the individual GPX 
types are suggested from differences in catalytic efficiency, substrate specificity, tissue 
distribution, subcellular compartmentalisation, and Se- dependency of biosynthesis. 
As is common to most known selenoproteins, Se is an essential requirement for the 
synthesis of all the GPXs. The elimination of the SeCys residue or carboxymethylation of 
SeCys by iodoacetate inactivates the GPX (Ursini et al., 1995). One of the common features 
of the GPX family is a strictly conserved catalytic triad of selenocysteine, glutamine and 
tryptophan residues (Hatfield, 2001). 
A novel form of GPX in the skin (Frank et al., 1997) is upregulated by keratinocyte growth 
factor and produced by fibroblasts and keratinocytes. The protein is putitatively involved in 
wound repair; however it is not a selenoenzyme (Munz et al., 1997), and the gene has only 
slight homology to other GPX genes. 
Cytoplasmic glutathione peroxidase (cyGPX) 
cyGPX comprises four identical subunits, each with a molecular weight between 19 -25 kDa. 
Each subunit contains a glutathione binding site and an active site comprising of a single 
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SeCys residue which is located at approximately the fortieth residue from the N- terminal end, 
the exact location depending on the tissue and species (Sunde, 1994; Zachara, 1992). 
cyGPX is expressed in virtually all cells although its specific activity is known to vary 
between different species and tissues. The tissue distribution of cyGPX largely parallels 
oxidative metabolism, being present at high levels in liver, kidney, lung, red blood cells and 
placenta. Within the cell, it is present as a soluble enzyme of the cytosol and mitochondrial 
matrix. The antioxidant function of the GPXs is well documented. CyGPX, as well as the 
other tetrameric GPXs (pIGPX and GIGPX), is able to catalyse the reduction of a variety of 
hydroperoxides, including H2O2, tert-butyl hydroperoxide, cumene hydroperoxide and fatty 
acid hydroperoxides (Flohé, 1989), according to the following reactions. 
H2O2 + 2GSH 
ROOH + 2GSH 
GPX 
GPX 
2H2O + GSSG 
ROH + GSSG + H2O 
Ganther proposed that the first step involves the oxidation of the GPX active site selenol (E- 
SeH) to selenenic acid (E -SeOH) by the peroxide substrate (Ganther, 1999). This is 
followed by the reaction of selenenic acid with the first GSH molecule to form the 
sulfoselenide adduct (E- Se -SG) and water (or alcohol in the case of organic 
hydroperoxides). The final step involves the cleavage of the sulfoselenide link by a second 
GSH molecule, releasing GSSG and restoring GPX to its selenol form (Zachara, 1992). 
The importance of cyGPX in the physiological regulation of intracellular hydroperoxide 
concentrations is in doubt as Se deficiency, resulting in a loss of cyGPX activity to less than 
1% of control values in the rat liver, resulted in no obvious adverse clinical effects (Arthur et 
al., 1987; Burk and Hill, 1993). In addition cyGPX knock -out mice displayed no clinical 
abnormalities under normal physiological conditions and no increased sensitivity to 
hyperoxia (Ho et al., 1997). Therefore, as losses of cyGPX appear to be well tolerated and 
because cyGPX appears to contain a large fraction of the total body Se, it has been 
postulated that cyGPX serves as a Se store which can be mobilised for the synthesis of 
selenoproteins more critical for survival (Arthur and Beckett, 1994; Burk and Hill, 1993; 
Sunde, 1990). In the situation of Se deficiency, the loss of cyGPX activity may be 
compensated for by increased levels of GST isoenzymes, which have non -Se dependent 
peroxidase activity (Coursin and Cihla, 1996). 
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Table 1.03 Mammalian selenoproteins and their postulated functions 
Selenoprotein Proposed functions 
Glutathione peroxidase (GPX) 
Cytosolic GPX 
Phospholipid hydroperoxide GPX 
Plasma GPX 
Gastrointestinal GPX 
Sperm nuclei GPX 
lodothyronine deiodinase 
Types I & Il 
Types I & Ill 
Selenoprotein P 
Selenoprotein W 
Thioredoxin reductase (TR) 
TR 1, TR2/TR3, TR3 
Selenophosphate synthetase 2 
Selenoproteins (R, X), T, N 
15-kDa selenoprotein 
15-kDa selenoprotein 
18-kDa mitochondrial selenoprotein 
34-kDa nuclear selenoprotein 
Intracellular antioxidant, Se store? 
Intracellular antioxidant, structural role in 
spermatozoa 
Plasma antioxidant 
Gastrointestinal tract antioxidant 
Sperm maturation and male fertility 
Catalyses the conversion of thyroxine (T4) to 
active 3,5,3' triiodothyronine (T3) 
Catalyses the conversion of T4 to 3,3',5' 
reverse triiodothyronine 
Transport? Antioxidant role? 
Antioxidant role? 
Multiple roles associated with its role as part 
of a dithiol- disulphide oxidoreductase system 
Catalyses the production of 
selenophosphate, required for selenoprotein 
synthesis 
SeIR is methionine sulphoxide reductase (R 
and X same protein). T and N unknown role 
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However, the role of cyGPX as a potential antioxidant against the pathogenic effect of ROS 
in other conditions has not been ruled out. For example, oxidative stress induced by 30 
mg /kg of paraquat, which is approximately LD20 for mice, killed all the cyGPX knock -out 
mice, whereas control mice showed no signs of toxicity at this dose (de Haan et al., 1998). 
In the same study neurons from cyGPX knock -out mice were more sensitive to toxicity from 
H2O2 (de Haan et al., 1998). In another study cyGPX knock -out mice, mice over -expressing 
cyGPX, or control mice received an intraperitoneal injection of paraquat (12.5, 50, or 125 
mg /kg body weight) (Cheng et al., 1998). Survival time was greatly reduced in cyGPX 
knock -out mice compared to control mice, but only in the presence of adequate dietary Se 
(0.3 mg /kg). The mean survival time of mice over -expressing cyGPX was 10 -fold longer 
than control mice. The cyGPX knockout mouse ( -/ -) is also more susceptible to diquat- 
induced oxidative stress (Fu et al., 1999), and myocardial ischaemia reperfusion (Yoshida et 
al., 1997) than WT mice. The GPX overexpressing mouse is more resistant to damage by 
paraquat or diquat than WT mice (Lei, 2001). 
Levels of cyGPX, as well as PHGPX, increase after excisional wounding of skin in mice, 
suggesting a role for the GPXs in detoxification of ROS during cutaneous wound repair 
(Steiling et al., 1999). 
Phospholipid hydroperoxide glutathione peroxidase (PHGPX) 
PHGPX is a monomeric selenoprotein with a molecular mass of approximately 19 kDa 
(Ursini et al., 1985). cDNA sequencing of PHGPX shows 45 % homology to cyGPX, 
although the location of the SeCys residue is in a region of high homology to cyGPX 
(Zachara, 1992). PHGPX is present in the cytosol of different tissues as well as being 
associated with membranes (Roveri et al., 1994). It exhibits a different distribution pattern to 
cyGPX with a relatively high abundance in rat testis (Burk and Hill, 1993). PHGPX also 
appears to account for the majority of GPX activity in the brain (Hatfield, 2001); however 
activities do not consistently match protein measurements, suggesting the occurrence of 
enzymatically inactive forms. 
PHGPX, like cyGPX, can function as an antioxidant with the ability to reduce fatty acid 
hydroperoxides as well as cholesterol hydroperoxides (Ursini et al., 1985). As a monomer, 
the active site of PHGPX is much more accessible. This may help to explain the broad 
specificity of PHGPX for hydroperoxides comprising H2O2, phosphatidyl choline 
hydroperoxide and cholesterol ester hydroperoxides even when these are integrated into 
lipoproteins or cell membranes (Ursini et al., 1995). Transfection of PHGPX into cells 
provides protection from injury mediated by lipid hydroperoxides (Yagi et al., 1996a) and 
cholesterol hydroperoxides (Arai et al., 1999; Hurst et al., 2001; Imai et al., 1996). It has 
been estimated by kinetic modelling that PHGPX is far more efficient than cyGPX in 
inactivating lipid hydroperoxides (Girotti, 2001). 
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PHGPX plays an important role in spermatogenesis. In spermatids PHGPX exists as a 
soluble peroxidase exhibiting high activity (Ursini et al., 1999). However during 
spermatogenesis PHGPX polymerises to become an enzymatically inactive, oxidatively 
cross -linked insoluble protein which is tightly bound to the mitochondrial capsule (Ursini et 
al., 1999). This may explain the increased fragility of the mitochondrial mid -piece observed 
in Se- deficiency. 
Protection of membranes from oxidative damage is only one, and possibly not the most 
important, role of PHGPX. PHGPX may also be an important biological regulator, reducing 
lipoxygenases, inhibiting apoptosis, and suppressing cytokine- induced NFKB activation (as 
with the other members of the GPX family). PHGPX may have a role in modulating 
leukotriene biosynthesis (Huang et al., 1998; Imai et al., 1998; Weitzel and Wendel, 1993). 
Plasma glutathione peroxidase (pIGPX) 
pIGPX is an extracellular enzyme, and is distinct enzymatically and structurally from cyGPX. 
PIGPX is a glycoprotein with subunits of between 21.5 -23 kDa (Zachara, 1992). The main 
site of synthesis is the proximal tubules of the kidney (Whitin et al., 1998; Yoshimura et al., 
1991). PIGPX is found in the plasma, chamber water of the eye, and amniotic fluid 
(Takahashi et al., 1990). PIGPX has been implicated in the reduction of lipid hydroperoxides 
in LDL (Saito et al., 1999; Yamamoto and Takahashi, 1993); however the substrate 
specificity of pIGPX is not ideal for reduction of peroxidised LDL since it does not reduce 
peroxidised cholesterol esters (Yamamoto and Takahashi, 1993). 
Gastrointestinal glutathione peroxidase (GI -GPX) 
GI -GPX is closely related to cyGPX in terms of its sequence homology, tetrameric structure 
and substrate specificity (Chu et al., 1993) and is found in the epithelium lining the 
gastrointestinal tract (Chu et al., 1993; Esworthy et al., 1998). GI -GPX has been proposed 
to be responsible for the protection of the gastrointestinal tract from the adverse effects of 
ingested hydroperoxides (Chu et al., 1993; Esworthy et al., 1998), and may be of importance 
in the prevention of colon cancer (Chu et al., 1997). 
Sperm nuclei glutathione peroxidase (snGPX) 
This 34kDa selenoprotein is present in spermatozoa and testis (Behne et al., 1988; Behne et 
al., 1997; Pfeifer et al., 2001). Its sequence at the N- terminus includes a signal for 
localization within the nuclei, where it is the only selenoenzyme present (Pfeifer et al., 2001). 
The concentration of snGPX in Se- deficient rats is depleted to one third of control levels, and 
there is resulting severe disruption of chromation condensation (Behne and Kyriakopoulos, 
2001; Pfeifer et al., 2001). snGPX is essential for maturation of sperm and male fertility 
(Pfeifer et al., 2001). 
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b) Thioredoxin reductases 
The thioredoxin reductases (TRs) belong to the flavoprotein family of pyridine nucleotide - 
disulphide oxidoreductases that includes lipoamide dehydrogenase, glutathione reductase 
and mercuric ion reductase. However the other members of this family lack the SeCys 
residue which characterises TR as a selenoprotein (Gladyshev et al., 1996; Tamura and 
Stadtman, 1996). TR, in conjunction with its substrate thioredoxin (Trx) and NADPH as a 
cofactor, forms a powerful dithiol- disulphide oxidoreductase system (the ` thioredoxin 
system') which has multiple functions and is ubiquitous. 
Mammalian TR has different characteristics from the enzyme of bacteria, yeast or plants, 
exhibiting a much broader substrate specificity, and having subunits of 55 kDa instead of 35 
kDa (Arnér et al., 1999). The bacterial TR does not have the SeCys- containing redox- active 
motif of the mammalian enzyme. 
Isoforms of Human TR 
TR1 
The most abundant TR isozyme in mammalian cells is the ubiquitous cytoplasmic form, TR1 
(Sun et al., 1999); TR1 was only shown to be a selenoenzyme fairly recently (Tamura et al., 
1995; Tamura and Stadtman, 1996). TR1 is located largely in the cytosol and rarely in the 
nucleus, and is also secreted from granules of endocrine and exocrine cells (Rozell et al., 
1985). The highest levels of TR1 are found in testis, ovary, and placenta (Koishi et al., 1997; 
Miranda -Vizuete et al., 1999b; Sun et al., 1999). Human enzyme preparations have given 
Mr ranging from 54.6 kDa for purified placental TR1, which lacks Met and Asn residues at 
the N- terminal (Mustacich and Powis, 2000), to 56 kDa for TR1 isolated from T cells 
(Gladyshev et al., 1996). Potential variants of this isoenzyme have been described which 
are due to alternative splicing of the first exons of the TR1 gene (Rundlöf et al., 2000; Sun et 
al., 2001). 
TR2 
A second TR isoform, variously referred to as TRß (Gasdaska et al., 1999b) and TrxR2 (Lee 
et al., 1999), has also been identified and characterized, and shown to be a mitochondrial 
enzyme (Lee et al., 1999; Miranda -Vizuete et al., 1999a; Miranda -Vizuete et al., 1999b; 
Rigobello et al., 1998). This isoform of human TR, differs in molecular mass (56.2 - 56.5 
kDa) from TR1 and exhibits a distinct pattern of tissue expression, with high levels of 
TRß/TR2 mRNA found in the prostate, testis, liver, uterus and small intestine, and only low 
levels in placenta, kidney, pancreas, thymus and peripheral blood leukocytes (Gasdaska et 
al., 1999b; Miranda -Vizuete et al., 1999b). The cDNA sequence of TIRO is identical to that of 
TR2 from human adrenal except that the former possesses a Met -Ala -Ala extension at its N- 
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terminus (Gorlatov and Stadtman, 1999). TR0 has been identified in both the cytosolic and 
microsomal subcellular fractions of MCF -7 human breast cancer cells (Gasdaska et al., 
1999b). 
TR2 has 84 % similarity at the protein level, and - 55 % sequence similarity to TR1 
(Gasdaska et al., 1999b; Miranda -Vizuete et al., 1999a). TR2 has a 33 amino acid N- 
terminal extension, which is recognised as a mitochondrial import sequence. Localisation of 
TR2 in mitochondria is eliminated upon removal of the N- terminal extension (Miranda - 
Vizuete et al., 1999b). The TR2 isoform is postulated to provide mitochondria -specific 
defence against ROS produced by the mitochondrial respiratory chain, thus maintaining a 
redox balance critical for cell survival (Lee et al., 1999). This theory is furthered by the 
recent identification of a unique mitochondrial form of Trx (Spyrou et al., 1997) and by the 
discovery of a mitochondrial thioredoxin peroxidase (Watabe et al., 1997), the induction of 
Trx in mitochondria by oxidative stress (Gauntt et al., 1994), and also the Trx- mediated 
regulation of SOD synthesis (Das et al., 1997). Substrates of TR can induce mitochondria) 
swelling in vitro (Wudarczyk et al., 1996). The mitochondrial Trx system could also 
conceivably act as an electron donor for mitochondria) GPX (Miranda -Vizuete et al., 1999a). 
TR3 
A third Secys- containing TR, referred to as TR3 (Sun et al., 1999), was purified from [75Se]- 
labelled mouse testis, where it is preferentially expressed (Sun et al., 1999). The deduced 
sequence of the human enzyme shows > 50 % identity to that of TR1. It contains a long N- 
terminal extension, and has a higher molecular mass (- 65kDa) than the other two 
isoenzymes. 
Common properties of the isoforms of human TR 
All three homodimeric isoforms of TR share considerable sequence homology, including a 
conserved -Cys- Val -Asn- Val -Gly -Cys redox- active (residues Cys59 and Cys64) catalytic site 
at the N- terminal, FAD -binding and NADPH- binding domains, and a dimer interface domain 
(Miranda -Vizuete et al., 1999b; Sun et al., 1999). This conserved active -site sequence motif 
is also found in human glutathione reductase, and is located in the FAD domain of the 
enzymes, whereas in the TR of E. coli the catalytic site, -Cys -Ala -Thr -Cys -, is part of the 
NADPH domain (Zhong et al., 1998). 
The C- terminal end of mammalian TR contains an extension of 16 amino acid residues with 
a SeCys as the penultimate residue within the sequence -Gly- Cys -SeCys -Gly- (Cys497- 
SeCys498). This sequence is conserved in all mammalian TR isoforms reported to date 
(Zhong et al., 1998) (Gasdaska et al., 1999b; Gladyshev et al., 1996; Lee et al., 1999; 
Miranda -Vizuete et al., 1999b). The SeCys residue is essential for the catalytic activity of 
TR; its removal by carboxypeptidase digestion (Zhong et al., 1998), trypsin digestion 
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(Gromer et al., 1998b) or modification by alkylation (Gorlatov and Stadtman, 1998; Zhong et 
al., 1998) leads to inactivation. A Cys497 /Cys498 mutant of TR1 and a truncated mutant 
lacking residues 498 and 499 had decreased or no catalytic activity, respectively, compared 
with native enzyme (Gasdaska et al., 1999a). The replacement of SeCys with Cys in the rat 
TR results in about 1 % of the activity seen in the native enzyme with Trx as substrate, and 
major loss in kyat (Zhong and Holmgren, 2000). Mutant enzymes (SECIS removal, SeCys 
substitution, and truncated enzyme) also lack hydroperoxidase activity (Zhong and 
Holmgren, 2000). 
Distribution of TR in vivo 
The principal site of TR activity is the cytosol, with some localisation of the enzyme in the 
perimembraneous area of the plasma membrane (Hansson et al., 1986; Rozell et al., 1985) 
as well as the granular endoplasmic reticulum and cisternae of the Golgi body (Rozell et al., 
1988) in the rat cell. The localisation of TR to these areas may be vital for maintaining Trx in 
its reduced form. All TR isoforms are synthesized in the cytosol (Gromer et al., 1999). The 
mitochondrial form is then translocated into mitochondria. TR in human liver is detected in 
nuclei, mitochondria, lysosomes, microsomes, and cytosol (Chen et al., 2002). 
Structure 
Each monomer of TR includes a tightly -bound FAD group, an NADPH- binding site and an 
active site containing a redox- active disulphide. The three -dimensional structure of rat TR 
has been elucidated (Sandalova et al., 2001). The C- terminal extension of amino acid 
residues containing SeCys is proposed to fold in such a way as to be able to advance toward 
the disulphide at the active site of the other subunit of the TR dimer. The active sites are 
situated at the interface between the subunits, thus the dimer is the 'functional unit' of TR. 
Mechanism 
The enzyme mechanism of reduction of a substrate by TR involves the transfer of electrons 
from NADPH, via FAD, to the active -site disulphide formed by the cysteine residues in 
positions 59 and 64 within the sequence -Cys -Ala -Thr -Cys -, which then goes on to reduce 
the substrate (Arscott et al., 1997; Gromer et al., 1998b; Lee et al., 2000b; Zhong et al., 
2000). Overall, the thiol -redox control is a stepwise reduction whereby TR catalyses the 
transfer of an electron from NADPH to Trx, which then reduces a number of protein thiol 
acceptors. 
The C- terminal end of human TR may be flexible, allowing the -Cys -SeCys -Gly moiety to 
carry reducing equivalents from the conserved active -site Cys residues to the substrate 
(Gromer et al., 1999; Gromer et al., 1998b). The extension at the C- terminus of TR may 
lengthen the electron transport pathway from the catalytic disulphide to the surface of the 
enzyme, where it can react with Trx (Sandalova et al., 2001). 
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NADPH domain 
16 aa elongation 
Interface with Cys -SeCys 
domain 
16 aa elongation 





Figure 1.05 Proposed model of mammalian TR (from (Zhong et al., 2000)). The C- 
terminal elongation of 16 amino acid residues extends from the interface, positioning 
residues SeCys498 and Cys497 in one subunit adjacent to Cys59 and Cys64 (redox- active 
disulphide /dithiol) of the other subunit. Electrons can then be transferred out from the redox- 
active disulphide /dithiol to the SeCys and Cys residues, which make up the active site of the 
enzyme. The active sites of TR are located at the interface between the two subunits, and 
the dimer is therefore the functional unit of the enzyme. The redox- active disulphide is 
located in the FAD domain. 
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Substrates 
Trx is a ubiquitous low molecular weight (10 -12 kDa) multifunctional protein (Holmgren, 
1985; Holmgren, 1989; Holmgren and Björnstedt, 1995). It comprises a redox- active 
disulphide (Trx -S2)/ dithiol (Trx -(SH)2 within the conserved active site sequence -Cys -Gly- 
Pro -Cys -Lys- (Holmgren, 1989; Holmgren and Björnstedt, 1995). The redox state and 
activity of Trx is regulated by TR, whereby TR converts oxidised Trx back to its reduced form 
(Holmgren, 2000b; Holmgren and Björnstedt, 1995). 
Mammalian TRs have a broad substrate specificity and, in addition to reducing Trx from 
many species (Holmgren, 1977), catalyze reduction of L- cystine (Luthman and Holmgren, 
1982), protein disulphide isomerase (Lundström and Holmgren, 1990), NK -lysin (Andersson 
et al., 1996), lipoic acid (Tamura and Stadtman, 1996), and 5,5'- dithiobis (2- nitrobenzoic 
acid) (DTNB) (Gromer et al., 1999). TR will also interact with non -disulphide components 
such as alloxan (Holmgren and Lyckeborg, 1980), menadione (a synthetic vitamin K) 
(Holmgren, 1999; Holmgren and Björnstedt, 1995; Luthman and Holmgren, 1982), Cue+ 
(Holmgren and Lyckeborg, 1980), selenite (Björnstedt et al., 1995b; Björnstedt et al., 1996; 
Holmgren, 1999), selenodiglutathione (Björnstedt et al., 1995b; Ganther, 1999), 
methylseleninate (Gromer and Gross, 2002), lipid hydroperoxides (Björnstedt et al., 1995a), 
hydrogen peroxide (Björnstedt et al., 1995a; Gromer et al., 1999; Zhong and Holmgren, 
2000) and the SeCys residue at the active site of plasma glutathione peroxidase (Björnstedt 
et al., 1994; Holmgren, 1999). S- Nitrosoglutathione (GSNO), an important metabolite and 
transport form of nitric oxide (NO), is also a substrate of mammalian TR (Becker et al., 
2000). The ability of TR to reduce dehydroascorbic acid as well as the ascorbyl radical has 
also been reported (May et al., 1998a; May et al., 1997). The majority of studies 
investigating substrates of TR have used TR purified according to the method of Holmgren 
(Holmgren, 1977). This method uses a primary centrifugation step of 16,000 x g, after which 
the supernatant is saved and further purified. Since mitochondria spin down at 6,500 x g in 
rat liver homogenate (Rice and Lindsay, 1997), it is likely that the majority of the studies 
quoted have investigated the cytosolic form of TR alone. 
The C- terminal catalytic SeCys may provide an explanation for the broad substrate 
specificity of mammalian TR, allowing the enzyme to reduce bulky proteins as well as small 
molecules. 
Regulation of Expression 
The expression of TR1 appears to be regulated through a number of factors including Se 
supply (Berggren et al., 1997; Berggren et al., 1999; Gallegos et al., 1997; Marcocci et al., 
1997; Yarimizu et al., 2000), redox state of the cell (Sun et al., 1999), oxidative stress (Das 
et al., 1999; Didier et al., 2001; Eftekharpour et al., 2000; Ejima et al., 1999a; Lechner et al., 
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2002) including ONOO- (Park et aL, 2002), calcium (Gitler et al., 2002), and also through 
activation of protein kinase C (PKC) (Anema et al., 1999; Kumar and Holmgren, 1999). 
Increases in Se supply (Berggren et al., 1997; Berggren et aL, 1999; Gallegos et al., 1997; 
Yarimizu et al., 2000) and oxidative stress (Didier et al., 2001; Eftekharpour et al., 2000; 
Ejima et al., 1999a; Lechner et al., 2002) lead to increased expression of TR, whilst 
activation of PKC may decrease (Anema et al., 1999) or increase (Kumar and Holmgren, 
1999) the expression of the enzyme. The GPX -mimic ebselen promotes the 
hydroperoxidase activity of TR. Using H2O2 as a substrate, ebselen stimulates TR activity 
(Holmgren, 2000a). 
TR1 levels are well maintained when Se supply is low, but protein levels do not increase 
dramatically under conditions of Se excess (Berggren et al., 1999; Gasdaska et al., 1999a). 
In cell culture studies both TR expression and activity are dependent on Se availability, due 
in part to enhanced mRNA stabilisation by Se (Gallegos et al., 1997). The degree of change 
in TR activity and TR protein levels is not always directly related (Berggren et al., 1999; 
Gallegos et al., 1997). In specific rat tissues increases in TR activity did not directly correlate 
with increases in protein levels; instead they paralleled increases in specific activity, possibly 
due to an increased SeCys incorporation (Berggren et al., 1999). These findings are 
consistent with the possibility that in Se- deficiency a truncated protein is formed in which 
translation is terminated at the UGA codon where SeCys is normally inserted (Gladyshev et 
al., 1996). 
Biological Roles of TR 
The reduction of Trx (Trx -S2) to Trx -(SH)2 catalysed by TR (reaction a) provides a powerful 
protein disulphide reductase (reaction b) which has multiple roles. Interest in the TR/Trx 
system increased after the initial discovery that TR provides reduced Trx which serves as a 
hydrogen donor for ribonucleotide reductase in the initial and rate limiting step in DNA 
synthesis (Thelander and Reichard, 1979). 
TR 
NADPH + W + Trx-S2 NADP+ + Trx-(SH)2 
Trx -(SH)2 + protein -S2 
spontaneous 
Trx -S2 + protein -(SH)2 
(a) 
(b) 
The TR/ Trx system has subsequently been associated with a multitude of disparate cellular 
functions including the regulation of cell growth in both normal and cancer cells (possibly by 
increasing the sensitivity of the cell to endogenous growth factors) (Berggren et al., 1996; 
Freemerman et al., 1999; Gallegos et al., 1996; Oblong et al., 1994) and the inhibition of 
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apoptosis (regulation of apoptosis signalling kinase -1) (Fujiwara et al., 1999). The TR/ Trx 
system is thought to regulate gene expression through activation of DNA -binding activity of 
transcription factors (Berggren et al., 1996; Gallegos et al., 1997; Holmgren, 2000b; 
McKenzie et al., 2002a), including NF -KB (Matthews et al., 1992) and the glucocorticoid 
receptor (Makino et al., 1996), and the modulation of activator protein 1 (AP -1) activity 
(Karimpour et al., 2002) indirectly through a nuclear redox factor ref -1 /HAPE (Hirota et al., 
1997). The TR/Trx system can regulate the cellular redox state (Holmgren, 2000b) (for 
example, TR can serve as a redox regulator of cellular antioxidant systems by acting as an 
electron donor for methionine sulphoxide reductase (Holmgren, 1985), peroxiredoxin (Chae 
et al., 1999), protein disulphide isomerase (Holmgren and Björnstedt, 1995), and vitamin K 
epoxide reductase (Silverman and Nandi, 1988), and protect against oxidative stress 
(Holmgren, 1985; Holmgren, 1989; Holmgren, 2000a; Holmgren and Björnstedt, 1995), 
including chemotherapeutic agents (see below). The TR/Trx system also facilitates the 
refolding of disulphide- containing proteins (Lundström and Holmgren, 1990) and modifies the 
structure of export proteins. Oxidation of the redox- active SeCys residue of TR contributes 
to redox signalling and to mediating responses to oxidative stress (Sun et al., 1999). 
Detoxification and Antioxidant Functions of TR 
TR can reduce and detoxify lipid hydroperoxides, H2O2, and organic hydroperoxides directly 
using NADPH as a cofactor in a cell -free system (Björnstedt et al., 1995a). The 
accumulation of these compounds in tissues exerts deleterious effects, e.g. the 
hydroperoxide (15S)- hydroperoxy -(5Z), (8Z), 11(Z), 13(E)- eicosatetranoic acid ((15S)- 
HPETE) oxidises LDL to a cytotoxic form, with implications in atherogenesis (Ylä- Herttuala et 
al., 1990). Detoxification of (15S) -HPETE and other LOOH is through a GPX- mediated 
reduction. However, the TR pathway operating together with catalytic amounts of SeCys 
has a high capacity to detoxify such compounds and may provide an important alternative to 
the Se- dependent GPXs for detoxification (Björnstedt et al., 1995a). To serve as an efficient 
peroxidase in the cell, continued regeneration of the selenol ( -SeH) form of the SeCys 
residue in TR from the oxidised -SeOH form is necessary to permit enzyme turnover 
(Gorlatov and Stadtman, 1999). The rate of peroxide reduction in vitro, with H2O2 as 
substrate, has been calculated to be much lower than that of an effective peroxidase such as 
cyGPX (Gorlatov and Stadtman, 1999). However, studies by Zhong et al. (Zhong and 
Holmgren, 2000) have calculated a high apparent Km of TR for H2O2 (2.5 mM), which would 
suggest a role for TR only when there is an elevated H2O2 level. TR reduces H2O2 and 15- 
HPETE at approximately the same rate (Björnstedt et al., 1995a). 
TR can replace GSH as an electron donor to regenerate the active site SeCys residue in 
GPXs, which is oxidised during the peroxidase reaction (Björnstedt et al., 1994). TR can 
regenerate bioactivity in proteins inactivated by oxidative stress, such as glyceraldehdye -3- 
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phosphate dehydrogenase (Fernando et al., 1992), phosphotyrosine phosphatase (McCarty, 
1999) and nitric oxide synthase (Ejima et al., 1999b; Patel et al., 1996). TR can also function 
as a peroxynitrite reductase (Arteel et al., 1999a), and efficiently reduce ebselen selenoxide 
back to ebselen. NK -lysin is a pore- forming peptide secreted by natural killer cells, which is 
efficiently reduced and inactivated by human TR, confining the effects of the highly toxic 
substances to invading microorganisms (Andersson et al., 1996). TR in conjunction with Trx 
is important in antioxidant protection of the human placenta (Ejima et al., 1999b), and 
protects mouse placentae from oxidative damage (Ejima et al., 1999a). TR is reported to be 
highly expressed on the surface of human keratinocytes and melanocytes, where it is 
suggested to provide the first line of defence in the skin against ROS generated in response 
to UV light (Schallreuter and Wood, 1986) (see section 1.11.1 for details of TR in the skin). 
The TR system as well as Trx or TR alone can protect against oxidative stress. Up- 
regulation of the thioredoxin system has been associated with the development of cellular 
resistance to the chemotherapeutic agent cis- diamminedichloroplatinum (II) (Sasada et al., 
2000; Sasada et al., 1999). Human Trx protects murine endothelial cells from injury induced 
by H2O2 (Nakamura et al., 1994) and reperfusion injury (lsowa et al., 2000). Human 
hepatoma cells with increased Trx show decreased sensitivity to cell kill by cisplatin 
(Kawahara et al., 1996), and adult -T cell leukemia cell lines with higher Trx levels show 
lower resistance to doxorubicin (Wang et al., 1997). Recombinant human Trx protects 
against H2O2- and tumour necrosis factor -alpha (TNFa)- induced cytoxicity (Matsuda et al., 
1991; Nakamura et al., 1994). Trx can prevent oxidative stress -induced apoptosis in cells 
(Andoh et al., 2002). Trx is also a specific electron donor for many peroxiredoxins (Berggren 
et al., 2001; Chae et al., 1999), which are crucial for the reduction of peroxides. Trx protects 
the lens from oxidative stress and cataract formation (Reddy et al., 1999), helps protect the 
intestinal epithelium from oxidative stress (Higashikubo et al., 1999), may protect the 
developing fertilized egg and placental trophoblasts from oxidative damage in the uterus 
(Kobayashi et al., 1995), and prevents reperfusion- induced arrhythmias in an isolated rat 
heart model (Aota et al., 1996). In in vivo animal models of ischaemia reperfusion, Trx can 
protect the lung (Yagi et al., 1994; Yokomise et al., 1994) and brain (Takagi et al., 1999) 
from damage. Extracellularly, increased levels of Trx in plasma have been found in a 
collection of diseases including hepatocellular carcinoma, pancreatic ductal carcinoma, 
AIDS, Sjögrens Syndrome, and rheumatoid arthritis (Powis and Montford, 2001). 
In baboon lung, Trx and TR are expressed constitutively at low levels in the foetus, and 
increase rapidly with the onset of 02 or air breathing at birth in a possible protective role (Das 
et al., 1999). Increases in TR and Trx mRNA are also observed in adult baboon lung 
explants exposed to 95 % 02. 
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Interaction with other antioxidant systems 
TR also has effects on other antioxidant systems, e.g. TR in the presence of Trx leads to a 
specific induction of Mn -SOD (Das et al., 1997). The Trx system can reduce a variety of 
protein disulphide groups and other substrates important in maintaining the redox balance in 
cells. The TrxITR system is capable of directly regenerating ascorbate from 
dehydroascorbate (DHA) (May et al., 1997) and the ascorbyl free radical (May et al., 1998a). 
TR can reduce the ascorbyl free radical to ascorbate with a Km of 2.8 NM, which is in the 
physiological range for this free radical in cells sustaining oxidative stress (Buettner and 
Jurkiewicz, 1993; May et al., 1998a). Since the a- tocopherol radical is reduced non - 
enzymatically by ascorbate (Liebler, 1993), coupling of these reactions provides a theoretical 
mechanism for the in -vivo regeneration of a- tocopherol from the oxidized form via TR and 
protein disulphide isomerase (Tamura et al., 1995). Se and vitamin E have mutual sparing 
effects, and TR could be the link explaining this phenomenon (Tamura et al., 1995). Se can 
spare ascorbate and a- tocopherol in liver cell lines exposed to oxidative stress (Li et al., 
2001). Trx also contributes to the induction of HO -1 by inflammatory mediators (Wiesel et 
al., 2000). Production of excessive amounts of NO in the cell is counteracted by its 
conjugation with GSH, resulting in formation of GSNO. GSNO can subsequently be directly 
cleaved by TR or by the TR/Trx system, releasing GSH and NO (Nikitovic and Holmgren, 
1996). TR may also reduce the antioxidants lipoic acid (Arnér et al., 1996; Watabe et al., 
1999) and ubiquinone (Xia et al., 2001). 
TR inhibitor studies and implications for TR in pathophysiology 
TR activity is inhibited by gold compounds (Cromer et al., 1998a; Hill et al., 1997), which are 
used to treat some autoimmune diseases such as rheumatoid arthritis (Van Riel et al., 1986). 
Similarly, the anti -tumour drugs quinones, doxorubicin and diaziquone also inhibit TR activity 
(Mau and Powis, 1992). Treatment with gold drugs increases oxidative stress (Reglinski et 
al., 1997). Rheumatoid arthritis, a common chronic disease characterized by persistent 
inflammation in the synovial membranes of peripheral joints (Kerimova et al., 2000), may 
involve secretion of ROS and cytokines (e.g. tumour necrosis factor -a). The synovial fluid 
from inflamed joints of patients with rheumatoid arthritis have significantly increased levels of 
Trx compared with levels in patients with other rheumatic diseases (osteoarthritis, gout and 
reactive arthritis) (Maurice et al., 1999). In -situ mRNA hybridisation confirmed the presence 
of TR in rheumatoid synovium also. Trx levels were found to be higher in erosive joints than 
in non -erosive joints. Stimulation of synovial synoviocytes with H2O2 led to an induction of 
increased Trx, suggesting a role for local oxidative stress in upregulated Trx production in 
the inflamed joints of patients of rheumatoid arthritis. However, contrasting results of down - 
regulation of antioxidant enzymes in rheumatoid arthritis are reported (Kerimova et al., 
1 -32 
Introduction Chapter one 
2000), and the pathogenic mechanisms are far from clear. Severe rheumatoid arthritis has 
also been associated with Se deficiency (Tarp et al., 1985). 
c) lodothyronine deiodinases (IDI) 
The iodothyronine deiodinases (IDI) are a family of three selenoproteins, all of which 
possess a single SeCys residue at the active site, and are involved in the metabolism of 
thyroid hormones by removal of iodine from iodothyronine substrates (St Germain and 
Galton, 1997). The TrxITR system can reduce the IDIs to an active form (Bhat et al., 1989; 
Sharifi and St Germain, 1992). The deiodinases are thought to be important in regulating 
foetal development as well as regulating thyroid hormone metabolism in the adult. 
d) Selenoprotein P (SeIP) 
Selenoprotein P (SeIP) is an extracellular glycoprotein, and is the major plasma 
selenoprotein, accounting for most of the Se in human plasma (Mostert et al., 1998). SeIP 
contains up to ten SeCys residues per 43 kDa polypeptide chain, nine of which are situated 
at the carboxyl terminus (Burk and Hill, 1994; Hill and Burk, 1994). It has been proposed to 
have a Se transport function (Motsenbocker and Tappel, 1982), and new data from a self 
knockout mouse confirms this (Hill et al., 2002). 
Selenoprotein P is also associated with endothelial cells in the liver, where it may provide the 
endothelium with important defence against oxidative damage (Burk et al., 1997). 
e) Selenoprotein W 
Selenoprotein W is a small intracellular selenoprotein containing one SeCys residue per 
polypeptide chain (Burk and Hill, 1999), and four different isoforms of selenoprotein W have 
been isolated from rat muscle, with molecular masses between 9.5 -10 kDa (Allan et al., 
1999). The brain, muscle, testis and spleen contain the greatest amounts of selenoprotein 
W (Burk and Hill, 1999). The catalytic activity of selenoprotein W is at present unknown 
although an antioxidant role has been postulated (Burk and Hill, 1999). A possible 
antioxidant function is further strengthened by the discovery that glutathione is bound to the 
major selenoprotein W species (Beilstein et al., 1996; Gu et al., 1999), and that 
overexpression of selenoprotein W in cultured cell lines reduces their sensitivity to H2O2 
cytotoxicity (Jeong et al., 2002). 
f) Selenophosphate synthetase 
Sps2 is a selenoprotein (Guimaraes et al., 1996). The requirement of Sps2 synthesis for Se 
would suggest that this protein is involved in the regulation of selenoprotein synthesis per se, 
such that Se- deficiency would be reflected by a down -regulation of Sps2 expression 
subsequently with a parallel decrease in the expression of other selenoproteins, possibly 
providing auto -regulation of selenoprotein synthesis. 
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g) Other selenoproteins and Se- containing proteins, and novel proteins 
Selenoproteins 
Investigation using SDS -PAGE and two -dimensional electrophoresis of [75Se]- labelled 
animal tissue has identified approximately 35 Se- containing proteins or protein subunits with 
molecular masses ranging between 6 and 116 kDa, five of which contain Se as a SeCys 
residue (Behne et al., 1988; Behne and Kyriakopoulos, 2001; Behne et al., 1999). Some of 
these proteins may represent as yet uncharacterized SeCys- containing selenoproteins. The 
selenoproteins S, T, (R or X), Z and a 15 kDa protein from prostate and a more ubiquitous 
15 kDa protein, a 34 kDa nuclear protein and a further 18 kDa mitochondria) protein have all 
been either purified or identified by bioinformatic methods (Hatfield, 2001; Kyriakopoulos et 
al., 2000; Lescure et al., 1999). Their functions have yet to be described in totality, but their 
existence further emphasises the wide range of metabolic processes that can potentially be 
influenced by changes in Se status. The 15 kDa selenoprotein that has been isolated and 
characterized in human T cells, with high expression in prostate tissue (Gladyshev et al., 
1998b), has been linked with the protective role of Se against prostate cancer (Gladyshev et 
al., 1998b; Kumaraswamy et al., 2000). Selenoprotein R has been identified as a zinc - 
containing methionine sulphoxide reductase (Kryukov et al., 2002). 
Se- containing proteins 
Several Se- containing proteins have been characterized in which Se is bound covalently in a 
form which is not SeCys. The biological significance of the Se in these proteins is unknown 
and the activity of these proteins is not regulated by Se status. Fatty acid -binding proteins 
(FABP) are involved in the regulation of intracellular levels of fatty acids (Masouyé et al., 
1997). A 14 kDa mouse liver Se- binding protein identified as an FABP (Bansal et al., 1989) 
is proposed to be involved in regulation of cell growth. Protein disulphide isomerase (PDI), a 
Se- containing protein, is involved in protein folding. Se is tightly bound to PDI, but is not 
incorporated as a SeCys residue (Sinha et al., 1993). The role of Se in this protein is 
unclear since PDI activity is not regulated by Se in either cultured cells or rats (Arthur et al., 
1991; Sinha et al., 1993). 
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1.2.8 Regulation of selenoprotein expression 
Hierarchy of selenium supply 
Se supply regulates selenoprotein translation, mediated by Sec -tRNA availability. Se 
deficiency results in a decrease in all selenoproteins, unlike other modulators of 
selenoprotein expression which may be specific for certain selenoproteins. The extent to 
which Se availability effects selenoprotein expression differs between tissues and between 
individual selenoproteins within a tissue (Behne et al., 1988; Bermano et al., 1996a; 
Bermano et al., 1995; Burk and Hill, 1993; Hill et al., 1997; Weitzel et al., 1990) 
There is a distinct hierarchy in the Se supply to different tissues during Se deficiency. 
Regulatory mechanisms exist to ensure that in Se deficiency, Se levels are maintained in 
certain priority organs. Se is generally retained by organs such as the brain, endocrine and 
reproductive organs, indicating the relative importance of the element for the biological 
functions of these organs, whilst it is rapidly lost from liver, kidneys and muscle (Behne et al., 
1988; Bermano et al., 1995). This differential regulation is not achieved by a decrease in the 
turnover of Se in deficient tissues alone; re- distribution of the metabolised element and 
priority supply to these tissues are also involved. 
In addition there is an important hierarchy of Se supply to different selenoenzymes within 
tissues in Se deficiency (Behne et al., 1988; Bermano et al., 1996a; Burk and Hill, 1993; Hill 
et al., 1997; Weitzel et al., 1990), such that Se supply to selenoproteins other than GPX has 
priority (i.e. loss of cyGPX expression occurs before most other selenoproteins) (Bermano et 
al., 1995). 
All selenoproteins are regulated by Se at the level of translation. Se status does not affect 
the transcription rate of genes for any selenoproteins characterised (Burk and Hill, 1993; 
Wingler et al., 1999). However, changes in the expression and /or the activity of 
selenoproteins in Se deficiency are accompanied by changes in mRNA levels which may 
result from alterations in mRNA translation and/ or stability (Bermano et al., 1996a; Bermano 
et al., 1995; Gallegos et al., 1997; Saedi et al., 1988; Sunde et al., 1993). CyGPX 
expression is uniquely regulated significantly by Se at the levels of translation and mRNA 
stability; the regulation of mRNA stability involves nonsense -mediated mRNA decay 
(Hatfield, 2001). The hierarchy of Se regulation of selenoprotein mRNA quantity is (most to 
least regulation): cyGPX » IDI -1 > TR1 > SelP, PHGPX (Hatfield, 2001). The hierarchy of 
Se regulation of selenoprotein translation is (most to least regulation): cyGPX > IDI -1 > SeIP, 
TR1 > PHGPX. The overall hierarchy of the GPXs is: GI -GPX > PHGPX > pIGPX > cyGPX 
(Brigelius -Flohé, 1999). 
In addition, Se deficiency may also result in premature polypeptide chain termination due to 
recognition of the UGA codon as a normal stop codon (Burk and Hill, 1993). Se- deficiency 
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can lead to a decrease in the levels of mRNA for TR and to incorporation of cysteine instead 
of SeCys into the protein, resulting in a less active form of the protein (Gallegos et al., 1997). 
Se depletion in some cell types leads to a decreased half -life of cyGPX mRNA but not 
PHGPX mRNA (Bermano et al., 1995; Bermano et al., 1996b). Sequences in the 3' UTRs of 
mRNA allow regulation of expression by a variety of mechanisms, including alterations in 
mRNA turnover, translation initiation, subcellular localization and by controlling the choice 
between SeCys insertion or termination of protein synthesis (Berry et al., 1994). 
Other modulators of selenoprotein expression 
Factors other than Se status modulate individual selenoprotein expression. For example, 
the expression of TR is increased by PMA, the calcium ionophore A23187 and ROS(Howie 
et al., 1998; Kumar and Holmgren, 1999; Sun et al., 1999). Iodine -deficiency in adult rats 
increases cyGPX activity in the thyroid (Mitchell et al., 1996). The cyGPX activity is also 
increased in vascular endothelial cells by fatty acids and interleukin -113 (Crosby et al., 1996). 
p53 expression results in elevated cyGPX expression, but down -regulation of TR expression 
(Gladyshev et al., 1998a). p53- induced activation of transcription of GPX has been shown in 
other studies (Tan et al., 1999), as has the down -regulation of TR ( Polyak et al., 1997). 
These studies suggest that regulation of selenoprotein expression can be p53- dependent, 
and that TR and cyGPX can be regulated independently. Expression of selenoproteins in 
vivo is also subject to transcriptional control by hormones such as gonadotropin (Brigelius- 
Flohé et al., 1994). 
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1.3 ATHEROSCLEROSIS 
1.3.1 Introduction 
Atherosclerosis (Gr. "porridge -like hardening ") is a highly complex vascular disease which 
leads to myocardial and cerebral infarction, gangrene and loss of function of the extremities 
(Ross, 1993b). It is the principal cause of morbidity and mortality in the United States, 
Europe, and much of Asia (Ross, 1999). The mechanisms involved in the development of 
the atheromatous lesion have been established. 
1.3.2 `Response to injury' hypothesis 
The most widely accepted model of atherogenesis is the 'response -to- injury' hypothesis 
formulated by Ross and Glomset (Ross, 1993b; Ross, 1993a; Ross and Glomset, 1973). 
Briefly, the theory proposes that injury to the endothelium (for example, by local disturbances 
of blood flow at certain branch points of the arterial tree) coupled with major risk factors 
(such as hypercholesterolemia, hyperglycemia, cigarette smoking, and microbial infections) 
can initiate a protective, inflammatory -fibroproliferative response. This response results in a 
series of compensatory cellular and molecular events leading to the formation and 
development of the atherosclerotic lesion. Multiple interactions of monocytes, T- 
lymphocytes and platelets together with the endothelium and smooth muscle of the arterial 
wall are involved in the process. 
1.3.3 The `Oxidative- Modification' Hypothesis 
This hypothesis suggests that in addition to endothelial activation, oxidative modification of 
low density lipoprotein (LDL) plays a pivotal role in atherogenesis (Esterbauer et al., 1992; 
Heinecke, 1998; Steinberg et al., 1989). Hessler et al. observed that LDL could injure cells 
in culture (Hessler et al., 1979), and that the injury depended upon oxidative modification of 
LDL (Hessler et al., 1983; Morel et al., 1984; Morel et al., 1983). The oxidative modification 
hypothesis of atherosclerosis (Steinberg et al., 1989) originated with the observation by 
Goldstein et al. (Goldstein et al., 1979) that cultured macrophages are converted to lipid - 
laden foam cells in the presence of chemically- modified LDL, but not native LDL. 
Subsequent work revealed that all the major cell types of the arterial wall (endothelial cells, 
smooth muscle cells, and macrophages) oxidatively modify LDL (Chisolm and Steinberg, 
2000) to a form that is recognised by scavenger receptors on macrophages (Henriksen et 
al., 1981; Henriksen et al., 1983). 
The LDL oxidative modification hypothesis itemizes on one hand the lipid peroxidation 
theory, and incorporates the need for the inflammatory cell -cell interactions proposed in 
Ross' 'response -to- injury' hypothesis. 
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1.3.4 The lesions of atherosclerosis 
The lesions of atherosclerosis are principally found in large and medium -sized elastic and 
muscular arteries such as the femoral artery, cerebral arteries, aorta and coronary arteries. 
The more classical nomenclature of atherosclerotic lesions, the fatty streak, intermediate 
lesion and fibrous plaque (Ross, 1995), has been superseded by `Stary's classification' 
(Yutani et al., 1999). The 'Stary classification' embraces the more recent morphological and 
biochemical details of atherogenesis. 
Stary's classification 
Stary's classification characterises atherosclerotic lesions by categorising their progression 
into five phases, each being defined by its histological characteristics (table 1.04) (Stary et 
al., 1995). The initial type I lesion consists of macrophage- derived foam cells containing lipid 
droplets. The location of these and subsequent lesions is more evident in locations such as 
branches, bifurcations and curvatures, and regions of arterial narrowing which are subject to 
alterations in blood flow (Ross, 1999). These 'adaptive thickenings' do not cause substantial 
morphological alteration. Type Il lesions (formerly 'fatty streaks') consist of layers of 
macrophage foam cells and SMC with intracellular lipid droplets. In the type Ill lesion pools 
of extracellular lipids also occur, which serve as the precursor to the core of lipid that typifies 
type IV lesions. The lipid core may now also contain thick layers of fibrous connective tissue 
and /or lipid or calcium (type V lesion). The morbidity and mortality associated with 
atherosclerosis are predominantly due to the rupture of types IV and V lesions, with ensuing 
hematoma and thrombus formation occluding the vessel lumen. 
1.3.5 Cellular interactions of atherosclerosis 
One of the earliest events in atherogenesis is a change in the endothelial surface phenotype. 
The expression of molecules on the endothelium responsible for the adherence, 
accumulation and migration of monocytes and T -cells markedly increases at specific 
locations within the artery wall. Adhesion molecules expressed, including L- E- and P- 
selectin, intracellular adhesion molecule -1 (ICAM -1) and vascular cell adhesion molecule -1 
(VCAM -1) (Gimbrone, 1995; Ross, 1999), allow adherence of monocytes and T- lymphocytes 
to the endothelium. An increase in permeability in the endothelium, mediated by factors 
such as oxidised low density lipoprotein (oxLDL), monocyte chemotactic protein -1 (MCP -1), 
and platelet derived growth factor (PDGF), aids the migration of these inflammatory cells into 
the sub -endothelial intima. Expression of growth- regulatory molecules (e.g. PDGF, fibroblast 
growth factor -2, transforming growth factor -ß), and cytokines (e.g. TNFa and interleukin -2), 
which may activate EC and SMC of the lesion, can be modified by the presence of 
macrophages and T lymphocytes in the intima. Ultimately the release of various growth 
factors and cytokines from cells in the lesion leads to progression of the fatty streak into a 
more advanced, complicated lesion involving formation of a fibrous plaque. 
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Table 1.04 Stary's classification of atherosclerotic lesions. The flow diagram indicates 
the sequence of progression of human atherosclerotic lesions. The Roman numerals 
represent the different classification of lesion as defined in the left hand column and the 
direction of the arrows indicate the sequence in which characteristic morphologies may 
change. Cycling between stages V and VI may represent the natural progression or growth 
of the atherosclerotic lesion. Adapted from Stary et al. (Stary et al., 1995). 
nomenclature & sequence in main 
main histology progression growth 
mechanism 
type I (initial lesion) 
isolated macrophage 
foam cells 
type ll (fatty streak lesion) 
mainly intracellular 
lipid accumulation 
type III (intermediate) 
lesion 
type II changes & small 
extracellular lipid pools 
type IV (atheroma) lesion 
type II changes & core 
of extracellular lipid 
type V (fibroatheroma) 
lesion 
lipid core & fibrotic layer, or 
multiple lipid cores & fibrotic 
layers, or mainly calcific, or 
mainly fibrotic 
type VI (complicated) 
lesion 
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1.4 THE ENDOTHELIUM 
1.4.1 Structure and function 
Arterial vessels exhibit a layered structure of tissues and cells (figure 1.06). The outermost 
layer (tunica adventitia) comprises connective tissue rich in elastic and collagen fibres, whilst 
the middle layer (tunica media) consists of connective tissue and SMC. Adjacent to the 
lumen is the tunica intima consisting of lamina propria and a basement membrane upon 
which lies the endothelium. 
The vascular endothelium is a continuous monolayer of cells that lines the inner surface of 
all blood vessels, providing a barrier between blood and the underlying SMC of the vessel. 
The endothelium is a highly dynamic, metabolically active structure with numerous 
endocrine, paracrine and autocrine functions. Owing to its positioning at the interface 
between the blood and tunica intima the endothelium has a vital role in the maintenance of 
vascular homeostasis, with functions ranging from the regulation of the mass transport of 
solutes or macromolecules across vessel walls to immune responses and control of vascular 
tone. The principal functions of the endothelium are listed in table 1.05. 
1.4.2 Endothelium -derived factors 
The functions of the endothelium are mainly mediated directly or indirectly by endothelium - 
derived autacoids such as NO', prostacyclin (PGI2) (a member of the prostaglandin family), 
an endothelium- derived hyperpolarizing factor (EDHF), thromboxane A2 (TXA2), endothelin -1 
(ET -1), 02-, and possibly prostaglandin H2. These factors modulate the functions of SMC 
and platelets as well as the EC from which they were derived. Endothelium- derived factors 
are secreted in response to autonomic and sensory nerves (e.g. acetylcholine, noradrenalin, 
substance P), circulating hormones (e.g. catecholamines, angiotensin II), products of 
coagulation (e.g. serotonin, adenosine diphosphate, thrombin), autocoids produced by EC or 
SMC (e.g. bradykinin, angiotensins, ET -1) and to changes in shear stress exerted on the 
endothelium by the circulation. 
ROS are released in response to shear stress and some agonists (e.g. bradykinin) 
(Mombouli and Vanhoutte, 1999), and can inactivate NO', favouring vasoconstriction. ROS 
may also mediate vasoconstriction by facilitating the mobilisation of Cae+ in vascular SMC 
and /or by enhancement of Cae+ sensitivity of contractile elements. 
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and lamina propria) 
Tunica 
externa 
Figure 1.06 Structure of arterial vessel wall. From Carola et al. (Carola et al., 
1992). The outermost layer (tunica externa or adventitia) consists of connective 
tissue abundant in elastic and collagen fibres, whilst the middle layer (tunica media) 
consists of connective tissue and smooth muscle cells. Adjacent to the lumen is the 
tunica intima consisting of lamina propria and a basement membrane upon which 
lies the endothelium. 
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Table 1.05 Functions of the vascular endothelium 
Functions of the vascular endothelium 
Maintenance of vascular tone through release of vasoactive compounds, e.g. NO', PGI2, 
EDHF, ET -1, 02 PGH2 
Provision of a selective permeability barrier 
Provision of a non -adherent surface for leukocytes and platelets 
Formation and secretion of a variety of growth -regulatory molecules and cytokines, e.g. 
PDGF, bFGF and TNFa 
Modification of plasma- derived compounds, e.g. oxidation of lipoprotein 
Formation and maintenance of the extracellular matrix e.g. basement membrane, 
collagen, elastic fibres and proteoglycans 
Maintenance of a non -thrombogenic surface through the formation of molecules such as 
NO', PGI2, thrombomodulin and heparan sulphate 
Provision of anticoagulant and procoagulant properties through the production of 
molecules such as NO', vWF and PGI2, as well as thrombomodulin and t- PA /u -PA 
Regulation of the inflammatory response by production of several proinflammatory 
agents, e.g. IL -6, IL -8 and PAF, and by CAM expression 
Abbreviations: BFGF, basic fibroblast growth factor; CAM, cell adhesion molecule; EDHF, 
endothelium- derived hyperpolarizing factor; ET -1, endothelin -1; IL, interleukin; NO, nitric 
oxide; 02 superoxide anion; PAF, platelet activating factor; PDGF, platelet- derived growth 
factor; PGH2, prostaglandin H2; PGI2, prostacyclin; t -PA, tissue type plasminogen activator; 
TNFa, tissue necrosis factor alpha; u -PA, urokinase type plasminogen activator, vWF; von 
Willebrand factor. 
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1.5 ENDOTHELIAL DYSFUNCTION IN ATHEROSCLEROSIS 
1.5.1 Introduction 
There is an abundance of evidence demonstrating that although the endothelium in 
atherosclerotic vessels from animals and humans is physically intact, there are a number of 
apparent functional modifications. In healthy arteries, the endothelium generally performs an 
inhibitory role, inhibiting SMC contraction, monocyte adhesion, oxidation of LDL, platelet 
adherence and aggregation, synthesis of inflammatory cytokines, vascular smooth muscle 
proliferation and thrombosis (Shimokawa, 1999). However the endothelium also plays an 
important role in the pathophysiology of several vascular diseases including atherosclerosis. 
Due to its anatomical position the endothelial surface is a primary target for attack from 
damaging stimuli from the earliest stages of atherogenesis. Endothelial dysfunction, i.e. `the 
shut -down or inactivation of certain intrinsic anti -atherogenic mechanisms' (Busse and 
Fleming, 1996), is a primary step in atherogenesis. (Ross and Glomset, 1973) and is 
observed prior to the development of overt atheroma, suggesting a principal role for 
endothelial dysfunction in the initiation of atherogenesis. Endothelial dysfunction is 
detectable in patients with a family history of atherosclerosis prior to the manifestation of 
atherogenesis (Busse and Fleming, 1996). 
A number of risk factors, alone or in combination, can bring about `endothelial dysfunction'. 
Risk factors which promote atherogenesis (e.g. elevated and modified LDL; cigarette 
smoking; ageing; gender; menopause; physical inactivity; hypertension; ischemia; diabetes 
mellitus; elevated plasma homocysteine levels and infectious organisms such as herpes 
virus or Chlamydia pneumoniae) (Ross, 1999; Shimokawa, 1999) are strongly associated 
with endothelial dysfunction in that the modification or removal of the risk factor (e.g., 
cholesterol lowering, cessation of smoking, exercise) improves endothelial dysfunction and 
may prevent further disease progression (Vogel, 1997; Vogel, 1999). 
1.5.2 Features and mechanisms of endothelial dysfunction 
The endothelial dysfunction that results from injury caused by one or more risk factors alters 
the normal homeostatic properties of the endothelium (table 1.05), thus promoting 
atherogenesis (Vogel, 1997). There is considerable evidence to suggest that endothelial 
dysfunction is associated with the loss of NO' production and /or its bioavailability (Busse and 
Fleming, 1996; Harrison, 1997a). Recent evidence suggests that endothelial dysfunction is 
characterised not simply by a loss of NO' production by endothelial nitric oxide synthase 
(eNOS), but by dysregulation of this enzyme, which may involve perturbations in subcellular 
trafficking, phosphorylation, cofactor availability, and /or interactions with other proteins. NO. 
plays a crucial role in the maintenance of vascular homeostasis under normal conditions 
such that the loss of production and /or bioavailability of NO. from the endothelium should 
lessen the protective effects and predispose the vessel to atherogenesis. 
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Tetrahydropbiopterin (BH4), an essential cofactor for all NOS enzymes, is thought to 
determine whether electron flow within the enzyme can be directed to L- arginine. In intact 
blood vessels depleted of BH4, eNOS transfers electrons to the now preferred substrate 
molecular oxygen to produce 02`, (Cosentino and Katusic, 1995; Kinoshita et al., 1997). 
The addition of BH4 to recombinant eNOS increases NO' production whilst decreasing 02- 
production (Weyer et al., 1998). Depletion of BH4 is associated with vascular pathology 
(Cosentino et al., 1998). In hypercholesterolemic patients supplementation with BH4 can 
improve endothelium- dependent vasodilation (Shimokawa, 1999; Weyer et al., 1998). 
Oxidation of BH4, by H2O2, is reversible by TR (Schallreuter and Wood, 2001) (see section 
1.11). 
The reduction in NO' bioavailability is proposed to be linked with its increased inactivation. 
The interaction between NO' and 02- effectively reduces the biological activity of NO' due to 
formation of ONOO- (figure 1.07). The presence of ONOO-- modified protein in human 
atherosclerotic lesions and early subintimal streaks has been demonstrated (Beckmann et 
al., 1994). A two- to three -fold increase in the release of total nitrogen oxides from 
atherosclerosed rabbit aortas compared to normal controls has been detected, despite a 
decrease in the bioavailability of NO', implying that the NO' has sustained oxidative 
destruction (Minor et al., 1990). The reaction of NO' with 02'- to form ONOO- (figure 1.08) 
(Beckmann et al., 1994; Harrison, 1997a; Harrison, 1997b) is approximately three times 
faster than that of scavenging of 02- by SOD (Harrison, 1997b). This suggests that under 
oxidative stress the functions of NO' are inhibited by its conversion to ONOO -, promoting 
atherogenesis. The Cu /Zn -SOD plays an important role in protecting NO' in the endothelium 
(Harrison, 1997b; Lynch et al., 1997), maintaining endothelial function. In a rat model of 
SOD deficiency, a 58 % increase in vascular 02- production compared to control rats, and 
10 -fold less sensitivity of thoracic aorta to relaxation by acetylcholine was reported (Lynch et 
al., 1997). Pharmacologic inhibition of SOD results in release of NO from the endothelium in 
an oxidatively inactive form (Harrison, 1997b). 
In cultured EC exposure to hypoxia and high concentrations of oxLDL decrease eNOS 
expression (Busse and Fleming, 1996; Harrison, 1997a). Oxidised LDL destabilises the 
mRNA encoding eNOS, decreasing its expression (Liao et al., 1995). 
In summary, the findings from animal and human studies suggest that the inactivation of NO 
by 02. and other ROS observed under pathophysiological conditions contributes to 
endothelial dysfunction (Busse and Fleming, 1996; Harrison, 1997a). The involvement of 
ROS in atherogenesis is discussed in further detail in section 1.5.3. 
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regulation of vascular antiatherogenic effects on platelets; 
tone; inhibition of suppression of gene expression of 
inflammatory cytokine adhesion molecules; inhibition of smooth 
synthesis muscle cell proliferation and migration 
xanthine oxidase; 
smooth muscle cells 
Figure 1.07 Schematic diagram of some of the interacting factors involved in the 
decreased bioavailability of nitric oxide in the process of endothelial dysfunction. 
ENOS expression may be decreased by oxidised LDL (oxLDL), hypoxia, shear stress or 
decreased tetrahydropbiopterin (BH4) levels. Increases in - mediate decreased 
bioavailability of NO', by oxidative destruction and conversion to ON00 -. 02' - is generated 
by the endothelium, SMC and intimal macrophages in response to injury, ischemia, oxLDL 
and activated leukocytes. Both NO' and 02- are produced constitutively, so changes in the 
relative flux of either species will modulate NO- dependent endothelial function. 
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Figure 1.08 The interaction of the superoxide anion and nitric oxide in endothelial 
dysfunction. Endothelial dysfunction may be associated with the loss of NO' production or 
inactivation, and thereby its essential role in the maintenance of vascular homeostasis. 02 
is generated by the endothelium, smooth muscle cells (SMC) and macrophages, ischaemia, 
oxLDL, activated leukocytes, and xanthine oxidase (XO) among other factors. NO' reacts 
rapidly with 02 at a rate of approximately 6.7 x 10-9 Ms-1, to form peroxynitrite (0N00-), 
which is approximately three times faster than the reaction of 02 - with SOD and ríearly thirty 
times faster than the reaction of NO with haem proteins. Under conditions of oxidative 
stress the physiological functions of NO are inhibited by its conversion to ON00- thus 
promoting atherogenesis. 02 - has several pro -atherogenic features including the oxidation 
of LDL and lipid accumulation in the vessel wall. 02- can also provide a source of other ROS 
(H2O2, OH-, singlet oxygen, hypochlorous acid and ON00-) which may participate in lipid 
peroxidation and influence endothelial function. The altered ratio of NO /02 - production has 
been proposed to diminish the intrinsic inhibition of the transcription factor NFKB, leading to 
an enhanced expression of endothelial adhesion molecules and chemotactic factors. 
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1.5.3 Reactive oxygen species and the endothelium 
a) Reactive oxygen species and the endothelium 
The EC in vivo is constantly exposed to the high partial pressure of molecular oxygen in the 
blood as well as ROS ( Schuppe- Koistinen et al., 1994). Metabolic trauma 
(hypercholesterolemia, diabetes mellitus, smoking, viral infection, ischaemia/ ischaemia- 
reperfusion) and physical trauma (coronary angioplasty, hypertension) all increase vascular 
oxidative stress (McGorisk and Treasure, 1996). Cyclical stretch also increases the 
production of 02- by EC (Hishikawa and Löscher, 1997; Kojda and Harrison, 1999). The 
ROS relevant to vascular biology include 02. , H2O2, OH., hydroperoxy radicals, O0N0- and 
lipid hydroperoxides (Hennig and Chow, 1988; Kojda and Harrison, 1999). The major source 
of ROS in the normal endothelium and adventitia is principally the NADH and NADPH 
oxidases (Kojda and Harrison, 1999; Somers et al., 2000; Sorescu et al., 2001). Potential 
sources of vascular 02- are more numerous in pathological conditions, and xanthine oxidase 
is implicated as a significant source of 02- in hypercholesterolemia (Ohara et al., 1993). 
b) Reactive oxygen species and endothelial dysfunction 
Damage to the endothelium by ROS, free radicals and oxidised lipids and lipoproteins has 
been shown to favour atherogenesis (Hennig and Chow, 1988; Hennig et al., 2001). 
Oxidative stress can disrupt several important physiological functions of the endothelium, 
including flow, inhibition of leukocyte adhesion and platelet aggregation. 
Oxidative stress may also alter the expression of other genes associated with atherogenesis 
such as eNOS, ICAM -1, E- selectin, PDGF and FGF -2. The increased presence of 02- and 
loss of NO. bioavailability in hypercholesterolemia results in the activation of genes 
controlling mechanisms such as monocyte adhesion (Maxwell et al., 1998; Ohara et al., 
1993). 
Both atherosclerosis and hypercholesterolemia are associated with increased flux of 02- 
within the vascular wall. Excess generation of 02- within vessels from hypercholesterolemic 
subjects may lead to endothelial dysfunction (Mügge et al., 1991; Ohara et al., 1993). In 
hypercholesterolemic rabbits a three -fold increase in aortic 02- production was measured 
compared to normal rabbits (Maxwell et al., 1998; Ohara et al., 1993). The increased 
steady -state flux of O2.- was abolished by endothelial denudation and inhibited by oxypurinol 
(a non -competitive inhibitor of xanthine oxidase) inferring that the endothelium provides the 
major source of abnormal 02- production in early atherosclerosis through the activation of 
xanthine oxidase. Hypercholesterolemic patients treated with oxypurinol demonstrate a 
partial improvement in NO.- mediated arterial vasodilation (Cardillo et al., 1997). In 
hypercholesterolemic rabbits, dietary treatment normalizes vascular 02- production, and the 
bioactivity of endothelium- derived NO. (Ohara et al., 1995). Hypercholesterolemia may also 
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be associated with increased circulating levels of xanthine oxidase that may bind to the 
vascular endothelium (White et al., 1996). In the later stages of atherosclerosis activated 
macrophages in the intima and SMC are also likely to contribute to the production of 
vascular 02.- as well as other ROS (Kojda and Harrison, 1999). 
Lipid radicals and 02- are detected in suspensions of cultured EC treated with chemical 
oxidative stressors (Rosen and Freeman, 1984). The generation of lipid radicals markedly 
decreases upon addition of SOD into the system, suggesting that 02.- radicals make a 
significant contribution to the production of lipid free radicals, and to EC membrane damage 
(Rosen and Freeman, 1984). The 02- anion has several pro -atherogenic features including 
the oxidation of LDL and lipid accumulation in the vessel wall. 02- can also provide a source 
of other ROS (H2O2, OH -, singlet oxygen, HOCI and ON00 -) which may participate in lipid 
peroxidation and impact upon endothelial function. At neutral pH the peroxynitrite radical is 
protonated and can form cytotoxic peroxynitrous acid which can spontaneously yield the 
hydroxyl radical and nitrite (NO2-) (Harrison and Ohara, 1995; Wever et al., 1998). The 
oxidation of LDL, protein fragmentation by nitration of proteins, DNA damage, modification of 
iron -sulphur clusters, zinc -fingers, protein thiols and membrane lipids are all effects of 
ON00-, and may be important in the pathophysiology of atherosclerosis (Graham et al., 
1993; Harrison and Ohara, 1995; Heinecke, 1998; Wever et al., 1998). 
1.5.4 Oxidised LDL - a promoter of atherosclerosis 
Introduction 
LDLs are roughly spherical particles with an average diameter of 19 -25 nm, and a relative 
molecular mass of between 1.8 and 2.8 million (Esterbauer et al., 1992). In humans, the 
hydrophobic core of each particle comprises triglyceride and cholesterol ester, and the 
surface monolayer consists of phospholipid molecules and a single copy of apoB -100 
embedded in the outer layer (Esterbauer et al., 1992; Halliwell and Gutteridge, 1999) (Figure 
1.09). In addition, the particles contain unesterified cholesterol. The principal oxidizable 
lipid, cholesteryl linoleate, is situated in the lipoprotein core (Denicola et al., 2002). LDL also 
contains several lipophilic antioxidants such as a- tocopherol, and minute amounts of y- 
tocopherol, carotenoids, oxycarotenoids and ubiquinol -10 (Esterbauer et al., 1992). Several 
plant- derived antioxidant pigments such as lycopene and lutein are also contained in LDL 
(Halliwell and Gutteridge, 1999). 
LDL particles are in a dynamic state, their structure and function being dependent on their 
lipid composition as well as the conformation of apoB -100. LDL particles are defined within 
the density limits of 1.019 - 1.063 g /ml. Thus, LDL forms a heterogeneous group of particles 
varying widely in size, composition and structure. Variability in the chemical and structural 
composition of LDL may in part mediate the differences in susceptibility between LDL 
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samples to oxidation (Esterbauer et al., 1992). The LDL composition of a given individual 
will depend to a considerable extent on diet. LDL particles are the main carriers of 
cholesterol in the human circulation and are thus key players in cholesterol transfer and 
metabolism (Olson, 1998). LDLs bind to receptors on the surface of cholesterol- requiring 
cells, and are internalized, releasing cholesterol within the cells. 
Oxidation of LDL 
Oxidation of LDL is believed to be crucial to initiation of atherogenesis (Heinecke, 1998; 
Steinberg et al., 1989; Witzum and Steinberg, 1991). LDL stays in the circulation for several 
days, during which time it may enter the vascular wall. While in plasma, LDL is relatively 
protected against oxidation by antioxidants in the plasma such as vitamins C and E, f3- 
carotene, and also by antioxidants contained in the LDL particles themselves. However, the 
levels of antioxidants in the extracellular space are much lower, so once LDL enters the 
intima, its phospholipids and fatty acids are susceptible to oxidation. The cells of the artery 
wall secrete various oxidative products that can seed the LDL trapped in the sub -endothelial 
space and initiate oxidation (Parthasarathy et al., 1999; Witzum and Steinberg, 1991). 
Oxidative modification of LDL has been demonstrated in vivo, and LDL extracted from the 
intima includes oxLDL, and antibodies to oxLDL also occur (Hörkkö et al., 2000; Rosenfeld, 
1991; Steinberg, 1991; Ylä- Herttuala et al., 1989). Such autoantibodies are found in 
plaques, complexed with oxLDL (Ylä- Herttuala et al., 1994). There are increases in both 
oxLDL and circulating antibodies to oxLDL in atherosclerotic patients (Esterbauer et al., 
1992; McGorisk and Treasure, 1996; Ylä- Herttuala et al., 1989). 
Oxidation of LDL enhances its atherogenicity (Hörkkö et al., 2000) whilst inhibition of such 
oxidation by antioxidant therapy decreases the progression of atherosclerotic lesions in 
Watanabe heritable hyperlipidemic rabbits (Ylä- Herttuala et al., 1990). Antioxidants also 
reduce the autoantibody titre to modified LDL in hypercholesterolemic rabbits (Schwenke 
and Behr, 2001). Antioxidants and atherosclerosis are further detailed in section 1.5.6. 
In -vivo, it is likely that there are many mechanisms by which LDL is oxidised within the artery 
wall (Heinecke, 1997). Under conditions of increased oxidative stress, enhanced interaction 
of 02- and NO. may lead to peroxidation of lipids, including LDL via ONOO- as an 
intermediate (Graham et al., 1993). In vitro studies suggest the formation of oxLDL is 
mediated in part by the enhanced production of ROS by the cells of the arterial wall. 
Lipoxygenases (12/15 lipoxygenase), cyclooxygenases and peroxidases (including 
myeloperoxidase) are postulated to act as enzymatic catalysts for generation of bioactive 
lipid- oxidation products at sites of inflammation and vascular disease (Benz et al., 1995; 
Cathcart and Folcik, 2000; Gaut and Heinecke, 2001; Hazen and Heinecke, 1997; 
Leeuwenburgh et al., 1997; Podrez et al., 2000). 
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Figure 1.09 The lipoprotein particle. From (Baynes and Dominiczak, 
1999). The surface monolayer of the lipoprotein particle comprises 
unesterified (free) cholesterol (-10%), phospholipids (-20%), and a single 
copy of apoproteinB -100. Cholesterol esters (-40 %), unesterified 
cholesterol, and triglycerides (-5 %) are located in the core of the particle. 
The quoted percentages are of the whole LDL particle. Protein comprises 
-20% of the particle. 
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The mechanisms by which EC oxidise LDL remain unresolved, with some reports attributing 
a role to O2- alone (Steinbrecher, 1988), lipoxygenase alone (Derian and Lewis, 1992; 
Parthasarathy et al., 1989), or neither 02- nor lipoxyganse (van Hinsberg et al., 1986). 
Arterial SMC oxidise LDL by releasing 02. (Heinecke et al., 1986), while activated human 
monocytes oxidise LDL by way of a dual superoxide and lipoxygenase- mediated pathway 
(Cathcart et al., 1989). 
The role of oxLDL in atherogenesis 
Oxidised LDL affects numerous cellular functions, each of which could contribute to each 
stage of atherosclerosis. The more established pro -atherogenic properties of oxLDL are 
summarised in table 1.06. In addition to oxLDL, mmLDL may also elicit biological responses 
implicated in the pathogenesis of atherosclerosis (Drake et al., 1991). 
At higher concentrations oxLDL is directly cytotoxic to several different cell types including 
endothelial, fibroblasts and SMC in culture (Hessler et al., 1979; Kosugi et al., 1987; Kuzuya 
et al., 1991; Thomas et al., 1993). This effect is possibly mediated by polar sterols (e.g. 
oxysterols) generated in the process of LDL oxidation. The mechanism of vascular cell 
death by oxLDL appears to include both necrosis, secondary to induction of peroxidation of 
cellular lipids by cholesterol hydroperoxides (Coffey et al., 1995; Thomas et al., 1993), and 
apoptosis induced by other oxysterols (Lizard et al., 1999). 
The principal toxic lipids of oxLDL are present in human lesions (Breuer et al., 1996; Brown 
et al., 1997; Carpenter et al., 1993; Chisolm et al., 1994) and oxidised forms of lipoproteins 
from in vivo sources are cytotoxic to cultured cells (Hodis et al., 1994; Morel and Chisolm, 
1989). Exogenous oxLDL, or its toxic lipids, induce endothelial dysfunction and damage in 
vivo (Harrison and Ohara, 1995; Rangaswamy et al., 1997; Rong et al., 1998). 
Biological properties of oxLDL (some of which contribute to the pro -atherogenic properties of 
this molecule) are summarised in table 1.06. 
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Table 1.06 Summary of the biological properties of oxLDL. These properties are 
characteristic of LDL oxidised in vitro either by Cu"" or endothelial cells for 24 hr. Adapted 
from (Esterbauer et al., 1992) and (Parthasarathy et al., 1999). Not all the biological 
properties of oxLDL have been suggested to be atherogenic. Those properties proposed to 
be pro -atherogenic are marked ( *). 
Biological properties 
Recognition by macrophage scavenger receptor, resulting in increased uptake and 
degradation by macrophages; may lead to foam cell formation 
Recognition by unknown proteins (e.g. LOX -1) on cell surface; may account for signalling 
pathways activated by components of oxLDL 
Possible ceroid (lipid -protein complexes) accumulation in degenerated tissues including 
macrophage foam cells 
Cytotoxic to several cell types e.g. endothelial, fibroblasts, macrophages and smooth 
muscle cells (by both necrotic and apoptotic pathways)* 
Chemotactic for monocytes /macrophages, T cells and smooth muscle cells* 
Inhibition of monocyte- macrophage motility and endothelial cell migration* 
Inhibition of NO activation of guanylate cyclase 
Inhibition of relaxation of isolated smooth muscle strips induced by ACh, NO* 
Alteration of the vasoactive compounds released by the endothelium e.g. ET -1 * 
Highly antigenic and able to elicit generation of autoantibodies* 
Inhibition of protein C (increases thromboresistance) activity in cultured endothelial cells* 
Suppression of PDGF secretion by monocyte- macrophages 
Increase in macrophage glutathione concentration (approximately two -fold) 
Induction of endothelial -leukocyte adhesion molecules (e.g. VCAM -1, ICAM -1, P- 
selectin)* 
Induction of chemotactic MCP -1 and colony -stimulating factors 
Induction of DNA synthesis and enhancement of the proliferative response to M -CSF and 
GM -CSF by macrophages 
Enhancement of pro -coagulant pathways, e.g. by induction of tissue factor and platelet 
aggregation* 
Stimulation of nuclear transcription factor (NF(B) to increase monocyte adherence* 
Induction of interleukin -1 expression by foam cell macrophages 
Induction of pro -inflammatory genes 
Increase expression of macrophage scavenger receptors, enhancing its own uptake* 
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Figure 1.10 Schematic representation of the role that oxidation of LDL might play in 
the development of atherosclerosis (from (Schwenke, 1998)). Thick arrows and dotted 
lines indicate direct effects of oxidised LDL. Unfilled crosses indicate processes that are 
inhibited by antioxidants. Abbreviations: LDL, low density lipoprotein; HDL, high density 
lipoprotein; PAI -1, plasminogen activator inhibitor -1; TF, tissue factor; CAM, cell adhesion 
molecule; MCP -1, monocyte chemotactic protein -1; M -CSF, monocyte colony stimulating 
factor; PDGF, platelet- derived growth factor; IL -1, interleukin -1; PGs, proteoglycans; SMC, 
smooth muscle cell; MMP, matrix metalloproteinase; TIMP, tissue inhibitor of 
metalloproteinase; EC, endothelial cell; ROS, reactive oxygen species. 
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Receptors for oxLDL on the endothelial cell 
Vascular EC internalise and degrade oxLDL through a unique receptor- mediated pathway, 
independent of the classic macrophage scavenger receptor (Kume et al., 1991). A novel 
cell- surface receptor for LDL, the lectin -like oxidised LDL receptor (LOX -1), is predominantly 
expressed in EC (Kakutani et al., 2001), has a different biochemical structure from the 
scavenger receptor (Kume et al., 1991), and is putitatively involved in atherosclerosis. In- 
vivo, LOX -1 exhibits enhanced expression in hypertension and hyperlipidaemia, and 
accumulates in atherosclerotic lesions (Chen et al., 2000). The presence of LOX -1 provides 
a molecular basis for linking oxLDL to EC, and resultant cellular activation, dysfunction and 
injury (Kakutani et al., 2001). 
The role of oxLDL receptors in atherogenesis 
The uptake of oxLDL by EC is mediated by LOX -1 (Li and Mehta, 1999; Li and Mehta, 
2000a; Sawamura et al., 1997). OxLDL also upregulates the expression of LOX -1 mRNA in 
a concentration -dependent manner (Mehta and Li, 1998). Endothelial activation, dysfunction 
and loss of integrity, and alterations in cell secretory functions are all induced by uptake of 
oxLDL (Li and Mehta, 2000b; Mehta et al., 1995; Vieira et al., 2000). Expression of LOX -1 is 
elevated in the initial atherosclerotic lesions of the Watanabe hyperlipidemic rabbit (Chen et 
al., 2000) and in human atherosclerotic tissues (Kataoka et al., 1999). In vascular EC LOX -1 
is induced by fluid shear stress (Murase et al., 1998). The binding of oxLDL to LOX -1 
induces a decrease in NO concentration and induction of 02- production (Cominacini et al., 
2001), induction of ROS production resulting in activation of NF -kß (Cominacini et al., 2000), 
the expression of monocyte chemoattractant proteins, and LOX -1 itself (Aoyama et al., 1999; 
Li and Mehta, 2000b). 
Antioxidants and oxidation of LDL 
Antioxidants that inhibit oxidation of LDL in vitro may have the potential to inhibit 
atherogenesis and disease progression in vivo. A great number of chemicals inhibit the 
oxidation of LDL in vitro, but the efficacy of such compounds has, in most cases, not been 
tested in vivo (Parthasarathy et al., 1999). Inhibition of endothelial cell- mediated oxidation of 
LDL in vitro is further described in chapter three. Antioxidants and atherosclerosis are 
discussed in section 1.5.6. 
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1.5.5 Enzymatic antioxidant defence systems in the endothelium 
The EC possesses several intracellular enzymatic antioxidant systems, including the 
glutathione redox system, catalase and SOD (figure 1.02) (Hennig and Chow, 1988). More 
recently HO and the Trx/TR system have also been implicated in roles of antioxidant defence 
of the EC (Pohlman and Harlan, 2000). 
Whilst both GPX and catalase reduce H2O2, catalase has a much lower intracellular 
concentration in most cells, with the exception of hepatocytes and erythrocytes, and the Km 
for H2O2 is higher than that of GPX (Asahi et al., 1995). Impairment of the glutathione redox 
cycle, but not catalase, by pharmacologic manipulation increases the susceptibility of 
pulmonary artery EC to damage by H2O2 (Suttorp et al., 1986). 
1.5.6 Antioxidants and atherosclerosis 
An important implication of the oxidative modification hypothesis of atherosclerosis is that 
antioxidants may inhibit atherogenesis. The proposed mechanisms for such anti - 
atherogenic effects are an LDL- specific antioxidant action, i.e. the protection of LDL against 
oxidative modification, or a tissue- or cell- specific antioxidant action, i.e. increased 
antioxidant uptake by vascular cells, leading to an elevated antioxidant status (Diaz et al., 
1997). The antioxidants may additionally enhance the resistance of vascular cells to the 
damaging effects mediated by oxLDL. 
The most convincing evidence to support hypothesis of 
atherosclerosis is the direct demonstration that treatment with a variety of antioxidants (e.g. 
[3-carotene, a- tocopherol, vitamin C, probucol) of hypercholesterolemic animal models 
results in suppression of atherogenesis (lesion formation) (Diaz et al., 1997; Meagher and 
Rader, 2001; Schwenke and Behr, 2001). 
Basic science and epidemiology are currently strongly supportive of a protective role for 
vitamin E. Despite the promising results of epidemiological studies, data from the limited 
number of large prospective clinical trials of antioxidants, in particular vitamin E, in 
secondary prevention of coronary artery disease have been mixed. The GISSI (1999) and 
HOPE (2000) trials found no benefit of vitamin E supplementation on cardiovascular disease 
risk, whilst the SPACE trial (2000) found a 46 % reduction (p = 0.005) in the composite 
primary outcome measure that was primarily attributable to 70 % reduction in acute 
myocardial infarction in subjects taking vitamin E. The CHAOS study (1996) reported 77% 
reduction (p = 0.014) in non -fatal myocardial infarction in subjects taking vitamin E as 
compared with those taking placebo (Diaz et al., 1997; Gaziano, 1999; Meagher and Rader, 
2001; Tribble, 2001; Witzum and Steinberg, 2001). 
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Observational studies can only show associations and not causal relationships. Clinical 
trials also have a number of limitations, including the fact that antioxidant treatment of 
patients with advanced disease (secondary prevention) may not provide information relevant 
to disease prevention in healthy individuals (primary prevention). For example, both the 
GISSI and HOPE trials were secondary prevention trials in which > 75 % of all participants 
were treated with aspirin or other antiplatelet agents, and many received 13-blockers, lipid - 
lowering drugs, and calcium channel blockers also (Pryor, 2000b). Other possibilities to 
explain the discrepancies include differences in patient characteristics, degree of depletion of 
endogenous antioxidant defence mechanisms, the dietary antioxidant content, and potential 
pro- oxidant effects of vitamins E and C (Meagher and Rader, 2001). It has not yet been 
conclusively proven that vitamin E acts as an antioxidant in vivo (Gaut and Heinecke, 2001; 
Thomas and Stocker, 2000). 
The difficulties in reproducible effects between trials may also be attributed to several 
causes, among which are: the trials begin too late, involve cure rather than prevention, last 
too short a time period, and generally involve a single dose of a single antioxidant (Pryor, 
2000a), whereas antioxidants act in a synergistic fashion (Pryor, 2000b). 
In summary, descriptive, case -controlled and prospective cohort studies have found inverse 
associations between the frequency of coronary artery disease and dietary intake of 
antioxidant vitamins. Randomized therapeutic trials have thus far shown no benefit with (3- 




1.6 SE AND CARDIOVASCULAR DISEASE 
1.6.1 Se deficiency and cardiovascular disease 
The contribution of Se deficiency to the pathogenesis of cardiovascular disease was 
originally suggested from epidemiological studies that correlated low Se content of forage 
crops, drinking water and blood levels with regional mortality rates from cardiovascular 
disease (Schamberger et al., 1979). Such associations are difficult to interpret since it is not 
possible to exclude the effects of other factors such as interactions of other nutrients, 
smoking, exercise, alcohol and fat intake, and genetics. Whilst epidemiological studies have 
provided some evidence for the role of low Se intake in the aetiology of cardiovascular heart 
disease and ischaemic heart disease, the results of studies within populations have often 
produced conflicting results. Atherosclerosis is an inflammatory condition, which will provoke 
the acute -phase response to a degree related to its severity. Being an acute -phase reactant, 
(Nichol et al., 1998) some decrease in plasma Se concentration may be expected in 
atherosclerosis patients, even before the occurrence of an event. 
An inverse correlation between low plasma Se and the severity of atherosclerosis was found 
in 91 subjects examined by coronary angioplasty (Moore et al., 1984). In a similar study the 
ratio of Se to PUFA levels in serum was negatively correlated to the degree of 
atherosclerosis (Kok et al., 1991). However, Aro et al. found no such correlation in a group 
of Finnish subjects (Aro et al., 1986). The results from eight prospective studies had been 
published by 1997 which attempted to correlate Se status with risk of coronary vascular 
disease and myocardial infarction (table 1.07). The results were mixed findings. From the 
prospective studies of the 1980s, only one found an inverse correlation between Se and the 
risk of death from cardiovascular death and myocardial infarction, two were equivocal, and 
no association was demonstrated in the other studies (Levander, 1987; Rayman, 2000). In 
the 1990s, the results from the Copenhagen Male Study (1992) found that, after adjustments 
to account for age, cholesterol, social class and smoking, individuals whose Se level was 
below 1 pmol/L had an increased risk of coronary heart disease (Suadicani et al., 1992). 
The study carried out by Simonetta et al. concluded that there was no association between 
serum Se and risk of myocardial infarction (Simonetta et al., 1995). 
To date, the prospective epidemiological studies linking Se deficiency to cardiovascular 
disease are inconclusive. Huttunen has postulated that the conflicting data from these 
studies can be explained by "the threshold effect" of Se intake on the risk of cardiovascular 
disease (Huttunen, 1997). That is, only populations with a low Se status (serum Se < 45 
pg /L), are at risk of cardiovascular disease (Korpela, 1993). The "threshold" is approximately 
half of that required to maximally express serum GPX. A study of the association between 
toenail Se and the risk of myocardial infarction in ten centres across nine European countries 
(Kardinaal et al., 1997) found no overall significant association. However, Germany, with an 
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average 20 % lower Se concentration than the other countries, demonstrated that men with 
low toenail Se levels were at increased risk of myocardial infarction. The disparity between 
studies may also be explained to some extent by the status of other antioxidants such as 
vitamin E, which may compensate for a deficiency in Se in protection against 
atherosclerosis. Until results are available from controlled trials such as SUVIMAX 
(Hercberg et al., 1998), any effects of Se on cardiovascular disease remain unsubstantiated. 
From 1984 up until 1990, Finland embarked on a nationwide Se supplementation 
programme in the form of Se- supplemented fertilizers. The plasma Se levels in the Finnish 
population were very low in the 1970s and the prevalence of cancer and heart disease was 
high. In 1986 the Se intake in Finland was 80 -100 pg /day, which is 3 - 4 fold higher than 
intakes in the mid 1970s (Varo et al., 1988). In 1970, the Se content of plasma in Finland 
was between 0.63 -0.76 NM and has risen to 1.40 pM (Varo et al., 1994). During the 1980s 
the decline in mortality from ischemic events was almost linear, and the Se supplementation 
programme did not alter this. Thus the improvement in mortality rates from ischemic heart 
disease could not be attributed to increased dietary Se, and was likely the result of other 
factors such as increased exercise, reduction in smoking, better health care and improved 
diets (Varo et al., 1994). 
1.6.2 Selenium and endothelial dysfunction 
Se- deficiency is associated with an increased severity of atherosclerosis in experimental 
animals, e.g. a 37 % decrease was measured in the percentage of aortic intima covered by 
atherosclerotic lesions in hypercholesterolemic rabbits supplemented with Se compared to 
controls (Wójcicki et al., 1991). Formation of 0NOO- may contribute to endothelial 
dysfunction (section 1.5.2). The GPX's and SelP in human plasma act as peroxynitrite 
reductases (Arteel et al., 1999b; Sies and Arteel, 2000; Sies et al., 1997). The TR/Trx 
system also has peroxynitrite reductase activity (Arteel et al., 1999a; Sies and Arteel, 2000). 
Impaired endothelium- dependent vasodilation and increased oxidative stress is seen in GPX 
( -/ -) knockout mice (Forgione et al., 2002). 
Se supplementation has beneficial effects on several different aspects of endothelial 
dysfunction. For example, Se supplementation enhances endothelium- dependent relaxation 
in response to acetylcholine in rat aortic rings (Lu et al., 1994). The mechanism may be 
through increased NO' production mediated either directly by Se or through selenoproteins. 
Se may also exert other effects in the endothelium, including the regulation of prostacyclin 
and platelet activating factor (Hampel et al., 1989). Neutrophil adherence to bovine 
mammary artery EC in response to TNFa is increased in cells cultured in Se- deficient media 
compared to those cultured in Se- sufficient media (Maddox et al., 1999). 
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Table 1.07 The association of cardiovascular disease mortality and incidence with 
low serum Se in prospective case -control studies 
Study reference Study population Major findings 
(Salonen et al., 1982) Case -control study with 
283 cases, men and 
women aged 35 -59 yrs, 7 
yr follow -up 
Serum Se below 45 pg /L was 
associated with the increased risk of 
death by CHD and CVD, as well as 
the risk of fatal and non -fatal MI 
(Miettinen et al., 
1983) 
Case -control study of 33 
middle -aged male patients 
with 1 or more risk factors 
for CHD 
5 -7 yr follow -up 
Serum Se (50 -105 pg /L) was not 
associated with the development of 
clinical CHD 
(Virtamo et al., 1985) Cohort study of 1110 male 
subjects aged between 
55 -74 yrs 
5 yr follow -up 
Serum Se below 45 pg /L was 
negatively correlated to CVD death 
but not in subjects initially free of CHD 
No significant association between low 
serum Se (< 45 pg /L) and the risk 
of coronary death or MI 
(Salonen et al., 1985) Case -control study of 92 
subjects, men and women 
aged 30 -64 yrs 
5 yr follow -up 
No significant association between low 
serum Se (< 45 pg /L) and the risk 
of death from CAD 
The Tromso Heart 
Study 
(Ringstad et al., 
1987) 
Case -control study of 59 
male subjects initially free 
of disease, aged 28 -54 
yrs, 6 yr follow -up 
Low serum Se is not associated with an 
excess risk of MI 
(Kok et al., 1987) Case -control study of 84 
subjects, men and women 
aged 37 -87 yrs, 6 -9 yr 
follow -up 
No significant association between low 
serum Se (< 105 pg /L) and the risk of 
subsequent death from CVD or CHD 
Copenhagen Male 
Study (Suadicani et 
al., 1992) 
Case -control study of 107 
males aged 53 -74 yrs, 3 yr 
follow -up 
Individuals whose Se level was below 1 
pmol /L had an increased risk in ischemic 
heart disease 
US Physicians Health 
Study 
(Simonetta et al., 
1995) 
Case -control study on 251 
male subjects aged 
between 40 -84 yrs, 4 -6 yr 
follow -up 
No association between serum Se and 
risk of myocardial infarction 
Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; MI, myocardial 
infarction 
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1.7 THE SKIN 
1.7.1 Structure and function 
The skin is directly exposed to a prooxidant environment, including ultraviolet (UV) radiation, 
ambient levels of 02, and air pollutants such as sulphur dioxide (SO2), ozone (03) and 
nitrogen dioxide (NO2) (Halliwell and Gutteridge, 1999). The important role of ROS in UV- 
induced skin damage is well documented. UV- induced skin damage includes acute 
reactions, such as erythema, oedema, followed by exfoliation, tanning and epidermal 
thickening (Diffey, 1998). Premature skin ageing (`photoaging) and carcinogenesis are 
believed to be consequences of chronic UV exposure. The skin provides the first line of 
defence against oxidative damage induced by environmental factors. 
Skin tissue consists of numerous cell layers that may be anatomically divided into the cellular 
epidermis, fibroelastic connective tissue of the dermis, and the underlying subcutaneous fat 
layer. The epidermis, the outermost skin tissue layer, consists of stratified squamous 
epithelial cells, separated from the dermis by a basal lamina (figure 1.11). 
The epidermis is mainly composed of keratinocytes, which are rich in enzymes such as 
superoxide dismutase, catalase, TR, and glutathione reductase, and in low molecular mass 
anti -oxidant molecules such as tocopherol, glutathione and ascorbic acid, and thus provides 
an efficient protective system against ROS (Maccarrone et al., 1997). Keratinocytes 
constitute 92 % of the cells in the epidermis forming a stratified multi -layered epithelium. 
Keratinocytes provide the physical barrier properties of the epidermis and accomplish its 
repair and regeneration. The keratinocytes situated adjacent to the basement membrane 
are predominately undifferentiated, rapidly proliferating stem cells. The cells mature as they 
detach from the basal layer by successive divisions, lose their capacity to proliferate, and 
undergo keratinisation, becoming more flattened as they approach the surface. Different 
stratified layers of the epidermis correspond to progressive stages of differentiation. The 
names of the layers in order of increasing differentiation are the stratum germinativum 
(basale), stratum spinosum, stratum granulosum, and stratum corneum. The stratum 
corneum consists of dead, terminally differentiated keratinocytes; the keratinocytes of all 
other layers are viable. 
In addition to keratinocytes, the other components of the skin include melanocytes, 
Langerhans' cells, leukocytes, mast cells, fibroblasts, and endothelial cells. 
1 -60 









Papillary capillary loops 
Superficial or 
sub -papillary plexus 
of blood vessels 
Sebaceous gland 
Dermal duct 
of eccrine sweat gland 
Arrector pili muscle 
Ha' follCle 
Deep plexus 
of blood vessels 
Loose connective tissue 
of subcutaneous fat layer 
!connective tissue septum 
Lobules of adipose tissue 
Figure 1.11 Diagrammatic representation of the architecture of human skin, and 
penetration of UVA and UVB (adapted from (Geras, 1990)). The skin consists of many 
cell layers that may be anatomically divided into the cellular epidermis and underlying 
fibroelastic dermis. The epidermis consists of stratified squamous epithelial cells, separated 
from the dermis by a basal lamina. Keratinocytes make up 92 % of the cells in the epidermis 
and provide the physical barrier properties of the epidermis, and accomplish its repair 
and 
regeneration. Most of the UVB reaching the skin is absorbed by the epidermis, causing 
epidermal cell damage, while UVA primarily causes dermal injury. 
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Melanocytes are highly differentiated cells which are present in the basal layer of the 
epidermis. Melanocytes are responsible for basal skin pigmentation and for tanning. Their 
primary function is to protect the skin from UV irradiation, achieving this by the production 
and transfer of melanin to keratinocytes (Gilchrest and Eller, 1999). Melanin consists of two 
types, eumelanin (brown /black) and phaeomelanin (red /brown). Melanin is produced in 
specialised intracellular organelles called melanosomes. Following synthesis (from tyrosine) 
the melanin is transported through the dendritic processes of the melanocytes to the 
surrounding keratinocytes. The melanin pigment is carried upwards with the keratinocytes to 
the stratum corneum. Following exposure to UV radiation, the number of melanosomes and 
their production of melanin greatly increases (Yaar and Gilchrest, 1991), resulting in tanning. 
Acute exposure of human skin to UV irradiation induces immediate pigment- darkening, due 
to photo- oxidation of preformed melanin by UVA, followed by a delayed, persistent tanning 
reaction caused by UVB (Ortonne, 1990; Porges et al., 1988). Melanin can directly absorb 
UV, thereby dissipating the otherwise injurious energy as heat (Soter and Baden, 1991), as 
well as scatter UV. Melanin can also absorb free radical species generated by the 
interaction of UV photons with cellular lipids. 
The dermis lies on a layer of subcutaneous fatty tissue. This layer contains hair follicles, 
sebaceous glands and apocrine (sweat) glands, and consists of dense collagen bundles and 
elastin fibres. Dermal collagen is capable of being replenished by scattered resting 
fibrocytes, which are capable of activation into collagen- synthesizing fibroblasts if the need 
arises, as in scar formation. A network of small blood vessels comprises the skin 
microcirculation which maintains tissue nutrition, gas tensions, and provides a route for 
immunological responses. 
Functions of the skin include temperature regulation, pH and osmotic control, as well as 
offering mechanical protection (e.g. insect bites), and protection from UV light, viruses, 
bacteria, fungi, and thermal stimuli. The skin also provides a nociceptory function. It is the 
largest organ of the body, being both active and multifunctional. Human skin also produces 
hormones which are released into the circulation, and which are important for functions of 
the whole organism. Human skin cells produce insulin -like growth factors, proprio- 
melanocortin derivatives, neuropeptides, catecholamines (adrenaline and noradrenaline), 
steroid hormones and vitamin D (from cholesterol), retinoids (from dietary carotenoids), and 
eicosanoids (from fatty acids) (Zouboulis, 2000). 
1.8 ULTRAVIOLET RADIATION AND THE SKIN 
1.8.1 Ultraviolet radiation - an introduction 
In the ultraviolet (UV) region of the solar spectrum (figure 1.12), only UVA (320 - 400 nm) 
and UVB (290 - 320 nm) reach the earth's surface. The UVC component (100 -290 nm), 
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which is even more damaging, is completely filtered out by the ozone (03) layer of the 
stratosphere. UVB is also filtered out to some extent by the ozone layer. However, 
depletion of this ozone layer, by photochemical reactions involving chlorofluorocarbons, has 
resulted in more UVB reaching the surface of the earth, with the corresponding increase in 
photochemical damage to organisms including man (Coldiron, 1992; de Gruijl and Leun, 
2000; Slaper et al., 1996). It has been estimated that each 5 % depletion of stratospheric 03 
will raise UVB flux at ground level by 10 %. Ultraviolet light is likely to be the largest toxic 
insult that the skin receives. Chronic exposure to sunlight is postulated to be a major risk 
factor for basal- and squamous -cell carcinomas, and malignant melanoma (de Gruijl, 1999). 
Optical penetration into the skin is governed by a combination of scattering and absorption, 
but only the latter promotes specific chemical reactions. In the normal epidermis, absorption 
is the dominant process across most of the optical spectrum. 
Different wavelengths of solar radiation have different biological effects. The time course 
and reaction pattern of UV- mediated sunburn (an acute inflammatory reaction) is 
wavelength- dependent, as are the effects of UV on cell- mediated immunity and 
photocarcinogenesis (Fuchs, 1998). This may be accounted for by differences in penetration 
of UV into the different skin layers (UVA >UVB >UVC), and /or from particular reaction 
cascades initiated by a specific wavelength (figure 1.13). Most of the UVB is absorbed in the 
epidermis, causing epidermal cell injury, while UVA causes mainly dermal injury (Pearse et 
al., 1987). Up to 10 % of UVB light falling on the skin can penetrate through the epidermis to 
the dermis (Halliwell and Gutteridge, 1999). UVB is much more damaging to the skin than 
UVA if equal exposures are carried out, but the deeper penetration of UVA and its greater 
abundance in sunlight suggest that UVA is a major contributor to photodamage. Generally, 
UVB acts mainly in the epidermis, while UVA injury causes necrosis of the endothelial cells, 
damaging dermal blood vessels (Clydesdale et al., 2001). UVA comprises a major part of 
the spectral output of tanning lamps, which are becoming increasingly popular (Freeman et 
aL, 1987). 
UVA light is the main source of photo- oxidative stress in skin, but UVB also has an oxidative 
element (Darr and Fridovich, 1994). Some studies have suggested that UVA- induced 
cytotoxicity may be just as important as cytotoxicity mediated by UVB (Tyrrell and Pidoux, 
1987). Humans are exposed to much less UVB irradiation in comparison to UVA since 
summer daylight comprises - 5 % UVB and 95 % UVA (Obermüller -Jevic et aL, 2001). 
However, many biological effects of exposure to UV are much greater at shorter 
wavelengths, and UVA radiation is predicted to contribute only 20 % to the harmful effects of 
sun exposure (Diffey, 1998). 
1 -63 
Introduction Chapter one 
Generation of ROS by UV Exposure 
Direct evidence for free radical formation in skin has been obtained by EPR spectroscopy 
and Fourier Transform Raman spectroscopy (FT- Raman). UV exposure of human and 
animal skin induced formation of EPR signals, indicating formation of ROS (Nishi et al., 
1991; Pathak and Stratton, 1968). 
Some of these free radical species are derived from melanin (Chedekel and Zeise, 1988; 
Collins et al., 1995) (see further information below). Irradiation of human skin with UVB 
demonstrated a dose -dependent production of H2O2 (in the mM range) as measured by FT- 
Raman (Schallreuter and Wood, 2001). Indirect evidence for the formation of ROS (OH',02- 
, RO2') by UV irradiation is supplied by spin trapping studies in human (Jurkiewicz and 
Buettner, 1996) and animal skin (Jurkiewicz and Buettner, 1994; Jurkiewicz and Buettner, 
1996; Taira et al., 1992). 
Chronic exposure of human skin to increasing doses of UV radiation causes erythema, 
chronic hyperplasia, mutation, accelerated photo- ageing and photocarcinogenesis. Damage 
to the skin by UV light produces the characteristic inflammatory response, including 
recruitment of free radical -generating (02' , H2O2, HOCI and possibly NO') neutrophils (Afaq 
and Mukhtar, 2001; Halliwell and Gutteridge, 1999). Photochemical reactions with UV light 
produce ROS such as 02'-, peroxide (02-) and OH'. Increased production of H2O2 induced 
by UVA irradiation has been measured in HaCaT cells using fluorescent probes (Petersen et 
al., 2000). Singlet oxygen can be produced in the skin as a result of photosensitization 
reactions triggered by exogenous sensitizers such as drugs (e.g. nonsteroidal antipyretics 
and phenothiazines), cosmetics, food additives, plant toxins or by the endogenous 
porphyrins that amass in some forms of porphyria (Maccarrone et al., 1997; Wlaschek et al., 
1995). Numerous sensitizing dyes and pigments (natural and synthetic) are activated by 
visible light. The pigmentation of human skin also appears to have a role in generation of 
02- from photosensitizers (natural and synthetic) that are activated by visible light; this 
property has been harnessed for therapeutic use in the development of agents for 
photodynamic therapy for in vivo eradication of malignant tumours (Krutmann and Morita, 
1999). The pigmentation of human skin also appears to have a role in generation of O2'- and 
02- from molecular oxygen upon irradiation with UV light. For example, pheomelanin 
extracted from human red hair produces more 02- and 02= upon irradiation with UV light than 
eumelanin from black hair. However, the UV- absorbing polymers eumelanin and 
pheomelanin themselves contain intrinsic free radicals which might trap available soluble 
radicals by coupling reactions (Schallreuter and Wood, 1989). 
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Figure 1.12 The spectrum of electromagnetic radiation (adapted from Soter & Baden, 
1991). Solar radiation with wavelengths between 290 and 320 nm (UVB) reaches the earth's 
surface in relatively small quantities, but these are sufficient to cause sunburn in human skin. 
Epidemiological evidence strongly suggests that UVB causes most skin cancers in humans. 
Longer UV wavelengths between 320 and 400 nm (UVA) are also melanogenic and 
erythemogenic, but the amount of energy required to produce either effect is much greater 
than for UVB. 
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Melanins act as free radical scavengers (Rózanowska et al., 1999). Some of the biological 
effects of UVA irradiation on the skin are connected with the formation of lipid 
hydroperoxides from PUFA (Girotti, 1998). UVA exposure induces iron -catalyzed lipid 
peroxidation in fibroblasts, as evidenced by LOOH and 4- hydroxynonenal accumulation 
(Basu -Modak et al., 1996; Girotti, 1998). Lipid metabolites such as arachidonate and 
diacylglycerol have been implicated in the upregulation of haem oxygenase -1, suggesting a 
role for eicosanoids and protein kinase C in the induction process (Basu -Modak et al., 1996). 
1.8.2 Chromophores present in the skin 
Chromophores in the skin absorb the UV radiation and are altered or damaged by the 
energy they absorb. Following excitation of the chromophore, energy or an electron is 
transferred to oxygen, forming singlet oxygen or superoxide. Alternatively, the chromophore 
may be converted to a photoproduct, which then reacts with a biological substrate. The 
major chromophores present in the skin are melanin, DNA, proteins (peptide bonds) and 
urocanic acid. Absorption of photons by proteins can lead to the formation of protein -protein 
cross -links and protein -DNA cross links. The absorption of UV radiation by proteins and 
DNA increases dramatically towards the shorter wavelengths in the UVB range, as do the 
resultant damaging effects on these target molecules (de Gruijl and Forbes, 1995). 
Constitutive melanin has a broad absorption spectrum across the UVB to visible ranges (290 
- 800 nm) (Maccarrone et al., 1997). Melanin is induced by UVB, with a peak at 360 nm. 
Urocanic acid (UCA) is synthesized from the essential amino acid histidine using the enzyme 
histidase. The skin does not contain the enzyme urocanase to catabolize UCA, so the skin 
contains a high level of accumulated UCA. In the epidermis, UCA exists as a trans -form. 
Exposure to UV radiation isomerises UCA from the trans -form to the cis -form, which is 
thought to be an important mediator of UV- induced regulation of cellular responses in the 
skin (Duthie et al., 1999). 
Absorption of UV photons by DNA molecules produces an excited state that is followed by 
rearrangement of electrons to form a variety of photoproducts; DNA absorbs UV radiation in 
the wavebands 230 - 300 nm. DNA absorbs UVB radiation more strongly than UVA 
(Freeman et al., 1987). The main mechanisms of UV radiation- induced DNA damage are 
wavelength- dependent. Ultraviolet radiation may damage DNA directly as occurs with 
shorter wavelengths of UVC or UVB, or indirectly as with longer wavelength UVA, acting via 
a photosensitiser or through the formation of ROS. 
Endogenous, intracellular UVA- absorbing sensitizers in the skin include the tetrapyrroles 
(e.g. protoporphyrin IX, uroporphyrin Ill), flavins (FMN, FAD), and reduced pyridine 
nucleotides (NADH, NADPH) (Girotti, 2001). 
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Figure 1.13 The spectrum of solar radiation, and its penetration into the layers of the skin, 
with resultant activation of various genes. From (Tyrrell, 1995). The longer the wavelength of 
light, the deeper into the skin it can penetrate. From 2 % to 10 % of UVB radiation will reach the 
basal layer of the epidermis, whilst 20 % of UVA radiation will penetrate to this depth. Genes 
which have been demonstrated to be up- regulated by UV irradiation, which include ferritin and 
collagenase, are marked by a surrounding white box. Abbreviations: ODC, ornithine 
decarboxylase; PLA2, phospholipase 2; CSF, colony stimulating factor; TNF, tumour necrosis 
factor; ICAM -1, intracellular adhesion molecule 1; HO -1, haem oxygenase 1; MAPK phosphatase, 
mitogen activated protein kinase phosphatase. 
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1.8.3 Deleterious effects of UV Irradiation on skin 
Acute effects of exposure to sunlight include erythema resulting from vasodilatation of the 
blood vessels in the skin, sunburn, blistering, and photokeratitis. Chronic effects include 
premature photoaging, malignant and benign tumours, and immunosuppression. The effects 
of UV on the skin are summarised in table 1.08. 
Oxidative damage and cytotoxicity 
The cytotoxic effects of UV radiation on the skin are well documented. UVB radiation can 
damage cells by numerous means and is far more efficient at causing cell death than UVA. 
Both epidermal and dermal cells are targets for UV- induced oxidative stress, and their 
antioxidant defences can be overwhelmed. Exposure to UVB can provoke DNA damage, 
protein cross -linking and oxidation, and the production of free radicals which can damage 
DNA and induce lipid peroxidation (Fuchs, 1998; Soter and Baden, 1991). UVB- induced 
cytotoxicity may be mediated by a different mechanism than that for genotoxicity including 
single strand breaks in DNA (Sugiyama et al., 1992). 
Cells in vitro which are exposed to high doses of UVB radiation receive a high level of 
damage, and exhibit necrotic cell death. However at lower doses of UVB radiation cultured 
cells undergo apoptotic cell death (Mammone et al., 2000). Sunburn cells are dyskeratotic 
cells induced by acute exposure to UV (Young, 1998). They represent the morphological 
ultimate stage of apoptotic cell death induced when the amount of DNA damage is too 
extensive to be repaired (Bayer) et al., 1995; Young, 1987). The effects of UVB to DNA may 
be direct (e.g. pyrimidine dimer formation due to energy deposition on thymine = thymine 
bonds) or may be mediated by ROS. Indirect, radical- mediated damage to DNA becomes 
relatively more important with UVA radiation, and such processes are highly dependent upon 
other factors such as oxygen level (de Gruijl and Forbes, 1995). Pyrimidine dimers are 
induced in DNA by irradiation of human skin in situ with UVA (Freeman et al., 1987). 
Melanocytes, keratinocytes and fibroblasts are all susceptible to UVB- mediated cell death 
(Dissanayake et al., 1993). Based on their anatomical site and their metabolic and functional 
characteristics, keratinocytes and fibroblasts may have different responses to UV radiation. 
Fibroblasts are more sensitive to UVA irradiation -induced damage than keratinocytes (Leccia 
et al., 1998; Moysan et al., 1995a). PK have lower cyGPX than fibroblasts, but similar levels 
of GSH, SOD and catalase (Moysan et al., 1995a). Applegate et al. attributed the difference 
in sensitivity of keratinocytes and fibroblasts to UV- induced damage to a higher activity of 
HO and ferritin in keratinocytes (Applegate and Frenk, 1995; Applegate et al., 1995). 
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Activation of transcription factors, metalloproteinases and other factors 
UVA or UVB can induce activation of a wide range of transcription factors in skin cells, 
including AP -1 and NF -KB (Tyrrell, 1995). UVB also induces synthesis of metalloprotease 
enzymes, which can degrade dermal interstitial collagen and other connective tissue 
components (Brenneisen et al., 1998; Wlaschek et al., 1995). Induction of these enzymes 
may be mediated by NF -KB and AP -1, whose activation may be promoted by ROS. 
Human keratinocytes produce NO' (Heck et al., 1992) generated by iNOS, the calcium - 
independent inducible isoform of NOS, in response to UVA and UVB irradiation 
(Deliconstantinos et al., 1995). NO' may participate in the deleterious effect of UV irradiation 
in conjunction with other ROS produced during the photo- oxidation of intracellular 
components (Didier et al., 1999), but may also play a role in both UVA- and UVB- induced 
melanogenesis (Roméro -Graillet et al., 1997). 
UV exposure increases the expression of integrins (Neitmann et al., 1999), and induces 
synthesis of ICAM -1 (a known binding site for leukocyte function) and several cytokines, 
including interleukin -1 (IL -1), IL -6, IL -8, IL -10, IL -12 and tumour necrosis factor alpha 
(TNFa). Induction of apoptosis, and formation of sunburn cells may involve TNFa (Schwarz 
et al., 1995). When the skin is exposed to UV radiation there is a dose -dependent increase 
in the release of arachidonic acid from membrane bound phospholipids through the 
activation of phospholipase A2 and phospholipase C (De Leo et al., 1984). The subsequent 
increase in prostaglandin is thought to be involved in the erythema reaction following 
exposure to UV. 
Transition metal ion mobilisation 
Mobilisation of iron ions following UV exposure makes them available for participation in 
catalysis of ROS, which may be a mechanism for oxidative skin damage (Trenam et al., 
1992). UVA causes release of free iron in skin fibroblasts via proteolysis of ferritin 
(Pourzand et al., 1999). Chronic exposure of hairless mice to low levels of UVB increases 
the iron content of the skin (Bissett et al., 1991). Human skin chronically exposed to UV 
accumulates iron (Jurkiewicz and Buettner, 1994) and has an increased ferritin content when 
compared with unexposed areas (Morlière et al., 1997). The ferritin content of keratinocytes, 
which are exposed to more UV than fibroblasts, is much higher when compared with 
fibroblasts (Applegate and Frenk, 1995). Topical application of the iron chelator Desferal to 
human skin decreases ROS production by - 50 % ( Jurkiewicz and Buettner, 1996). Amino 
acid -based iron chelators reduce UVB- induced oxidative stress in murine dermal fibroblasts 
(Kitazawa and Iwasaki, 1999). In iron -loaded human fibroblasts, UVA photocytotoxicity 
increases in a dose -dependent manner with the iron load (Morlière et al., 1997). 
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Table 1.08 A summary of the effects of UV irradiation on the skin 
Effects of UV irradiation on the skin 
Vasodilation of cutaneous blood vessels, resulting in erythema (prostaglandin release) 
Increase in epidermal and stratum corneum thickness 
Increased NO' , histamine and PGE2 production and release from keratinocytes, 
leading to increased vascular permeability 
Direct cytotoxic damage to epidermal cells; decrease in keratinosomes; formation of 
dyskeratotic (sunburn) cells; intracellular oedema 
Penetration to the dermis (10 - 15 % of UVB), leading to a direct effect on 
microvascular EC 
Initiation, promotion and progression of photocarcinogenesis 
DNA damage, leading to lesions (pyrimidine dimers; thymidine dimers; pyrimidine- 
pyrimidone photoproducts), and oxidative damage leading to 8- hydroxyguanine 
formation 
Increase in the proto -oncogene c -fos, and induction of mutations in the p53 anti - 
oncogene 
Induction of nuclear factor KB (NFKB), leading to production of pro -inflammatory 
cytokines IL -1, IL -6 and TNF -a 
Induction of IL -8, which is a chemoattractant for neutrophils, and IL -10, which 
mediates systemic immune suppression 
Increased expression of ICAM -1 on keratinocytes 
Modification of integrin expression on melanocytes 
Induction of protective metallothionein genes in keratinocytes and fibroblasts 
Induction of metalloproteases which can degrade collagen and other tissue 
components 
Release of transition metal ions, leading to ROS formation 
Immunosuppression: depletion of immunocompetent cells, and release of 
immunosuppressive mediators (IL -10, C -UCA, PGE2) 
Modulation of antioxidants, depleting and inactivating some (GPX; GSH; SOD; GR; a- 
toc; ascorbate; ubiquinol /ubiquinone; CAT; 3-carotene) , and inducing others (ferritin; 
HO; SOD; Trx and TR) 
Abbreviations: CAT, catalase; C -UCA, cis -urocanic acid; GPX, glutathione peroxidase; GR, 
glutathione reductase; GSH, glutathione; HO, Haem oxygenase; a -toc, a- tocopherol; TR, 
thioredoxin reductase; Trx, thioredoxin; TNF -a, tumour necrosis factor -alpha; PGE2, 
prostaglandin E2 
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Immune suppression 
In addition to causing neoplastic changes, UVB irradiation also causes systemic immune 
suppression which may impair defence reactions permitting abnormal cells to proliferate and 
develop into skin tumours. The immunosuppressive events induced by UVB radiation are 
mediated by several pathways involving DNA damage, photoisomerisation of urocanic acid, 
or cell membrane damage, and release of interleukin -10 and TNF -a from degranulated mast 
cells (Black et al., 1997; Clydesdale et al., 2001; Duthie et al., 1999; Kripke et al., 1992; 
McKenzie and Sauder, 1994). 
Antioxidant inactivation 
Small molecular antioxidants and antioxidant enzymes can be directly depleted or 
inactivated by UV in cell -free systems. This has been demonstrated for a- tocopherol 
(Boguth and Niemann, 1971; Mehlhorn et al., 1990), ascorbate (Bors and Buettner, 1997), 
and catalase (Cheng and Packer, 1979; Feierabend and Engel, 1986; Zigman et al., 1996). 
Moreover, ROS produced by UV can directly use up small molecular antioxidants and inhibit 
enzymic antioxidants in cell -free systems. Glutathione reductase (Tabatabaie and Floyd, 
1994), GPX (Blum and Fridovich, 1985), SOD (Bray et al., 1974; Pigeolet et al., 1990; 
Whiteside and Hassan, 1988), and catalase (Kono and Fridovich, 1982; Sun and Oberley, 
1989; Whiteside and Hassan, 1988) are inactivated by ROS. Irradiation of skin cells and 
murine skin also causes inactivation of antioxidant enzymes and depletion of non -enzymic 
antioxidants immediately following irradiation; ascorbate (Jurkiewicz and Buettner, 1994; 
Jurkiewicz and Buettner, 1996; Kagan et al., 1992), a- tocopherol (Fuchs et al., 1989a; 
Kagan et al., 1992; Shindo et al., 1993), retinol (vitamin A) (Sorg et al., 2002), GSH (Emonet 
et al., 1997; Fuchs et al., 1989a; Shindo et al., 1993), and ubiquinol /ubiquinone (Fuchs et al., 
1989a; Shindo et al., 1993) are depleted, whilst catalase (Miyachi et al., 1987; Pence and 
Naylor, 1990; Punnonen et al., 1991), GPX (Maisuradze et al., 1987), and glutathione 
reductase (Fuchs et al., 1989a; Maisuradze et al., 1987) are inactivated. The immediate 
antioxidant inhibition is of a higher magnitude in the epidermis than the dermis (Shindo et al., 
1993). UV exposure can also deplete the levels of a- tocopherol (Thiele et al., 1998), ß- 
carotene and lycopene (Ribaya- Mercado et al., 1995) in human skin. 
However, some studies have shown GPX activity (Fuchs et al., 1989a; Moysan et al., 1993; 
Shindo and Hashimoto, 1997; Sugiyama et al., 1992), SOD activity (Fuchs et al., 1989a), or 
GR activity (Shindo and Hashimoto, 1997) to be resistant to inactivation by UV, and catalase 
to increase rather than decrease upon irradiation (Afaq and Mukhtar, 2001). These 
disparities may be due to different doses of UV, varying times between irradiation and assay, 
or differing irradiation protocols (single exposure versus repeated, multiple exposures). 
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Increases in catalase activity may be due to UV- induced infiltration of leukocytes in the 
epidermis (Afaq and Mukhtar, 2001). 
Carcinogenesis 
UVB radiation is a major cause of human skin cancer (de Gruijl, 1999). Natural sunlight is a 
complete human skin carcinogen, affecting all three stages of photocarcinogenesis: initiation, 
promotion and progression (Black et al., 1997; McKenzie and Sauder, 1994). The peak of 
UV- induced carcinogenicity lies within the UVB portion of the spectrum (de Gruijl, 1996). 
There is increasing evidence to link DNA damage to skin carcinogenesis, the most 
compelling evidence being that patients with the genetic disorder xeroderma pigmentosum 
are 2000 times more likely than unaffected individuals to develop skin carcinomas (Brash et 
al., 1991; McKenzie and Sauder, 1994). Patients with xeroderma pigmentosum are 
characteristically defective in the mechanisms to repair direct DNA damage; such defects 
are proposed to predispose cells to a higher frequency of mutation, which may lead to 
induction of carcinogenesis (Soter and Baden, 1991). 
Since UV radiation is a potent DNA -damaging and mutagenic agent, it can initiate 
carcinogenesis by damaging DNA and inducing mutations in one or more genes (Black et 
al., 1997). The importance of UVB as an initiator of tumourogenesis is thought to result from 
its ability to cause mutations in genes controlling the cell cycle, e.g. proto- oncogenes, such 
as ras, and tumour suppressor genes, such as p53 (Burns and EI- Deiry, 1999; Pruitt and 
Der, 2001), allowing aberrant cells to proliferate, and ultimately to local tumour invasion. 
Cells in the epidermis accumulate mutations over years of exposure to sunlight and the 
resulting dysfunctional genes can eventually lead to a malignant transformation. The p53 
tumour suppressor gene is mutated in the majority of human cancers, including basal cell 
carcinoma and squamous cell carcinoma (Brash et al., 1991). Most of the mutations in p53 
are located in the DNA binding region of the protein, which contains cysteine residues 
important for its function. Once activated, p53 can directly bind to single stranded DNA and 
interact with the DNA replication machinery to regulate the transcription of genes involved in 
cell cycle arrest (Liu and Pelling, 1995) and apoptosis (Polyak et al., 1997). Confirmation 
that the P53 tumour suppressor gene is a target in UV carcinogenesis has been confirmed in 
mouse experiments (Dumaz et al., 1997; van Kranen et al., 1995). 
If the intensity of UV radiation is low, then there is limited DNA damage, expression of p53 in 
the nucleus is increased and activates cell cycle arrest (late G1 and G2 /m), apoptosis and 
nucleotide excision repair (de Gruijl et al., 2001). The cell is then allowed to advance 
through the cell cycle. If the UV intensity is high then a considerable level of DNA damage 
occurs, and p53 signals the cell to undergo apoptosis, which will prevent the mutated DNA 
from being passed on to subsequent generations of daughter cells. The mutated p53 is 
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thought to have an extended half -life, preventing cells from halting in cycle arrest (to repair 
their DNA) and proceeding through apoptosis (Liu et al., 1994). Section 1.9 details the 
epidemiology of skin cancers. 
Induction of cell death pathways 
Cell death in skin cells can occur by one of three paths, termed necrosis, apoptosis, and 
terminal differentiation. UVB irradiation can induce both the apoptosis and necrosis 
pathways in normal human keratinocytes. Necrotic cell death is caused by a period of acute 
and severe physical trauma to a cell, resulting in the disruption of cell organelles and 
membrane integrity, and ultimately cell death. Necrosis is characterized by random DNA 
fragmentation, cell swelling and lysis. 
Apoptosis, in comparison, is an active form of cell death with specific morphological features 
which differ from necrosis (Kulms and Schwarz, 2000). Apoptotic death is characterised by 
cell shrinkage, plasma membrane blebbing, condensation of chromatin, protease and 
endonuclease activation, fragmentation of the nucleus, and cell fragmentation into apoptotic 
bodies that are phagocytosed by neighbouring cells (Kulms and Schwarz, 2000). As the 
cells are removed quickly and do not lyse, no cellular contents leak and there is no release 
of inflammatory mediators, unlike necrotic cell death. However, in the absence of 
macrophages, apoptotic cells will eventually necrose. 
The extent of peroxidative injury in a photodynamically -stressed cell may ultimately 
determine whether it survives or yields to apoptosis or necrosis (Girotti, 1998). The possible 
outcomes may be viewed as a graded pattern of responses to membrane damage that 
increases in the proceeding order: (a) no net damage when constitutive antioxidant capacity 
is sufficient to prevent or repair peroxidative damage; (b) sublethal /mild oxidative damage, 
possibly triggering induction of antioxidant proteins for enhanced cytoprotection; (c) more 
extensive damage, which triggers apoptosis, beyond which any constitutive or inducible 
antioxidant protection is overwhelmed; and (d) very extensive damage with membrane lysis, 
which abolishes any programmed cell death response, and leads to necrotic cell death. 
When normal human skin is exposed to UVB, some of the keratinocytes in the epidermal 
layer develop into apoptotic cells, referred to as sunburn cells. Low doses of UVB (5 -20 
mJ /cm2) induce apoptosis, whereas increasing doses ( >20 mJ /cm2) of UVB produce direct 
necrosis in HaCaT cells (Mammone et al., 2000). Such a threshold of stimulus for necrotic 
cell death has also been demonstrated for H202 (Lennon et al., 1991). 
Many studies have reported that mammalian cells overexpress particular cytoprotective 
enzymes in response to sub -lethal oxidative stress. Haem -oxygenase -1 (HO -1) and ferritin 
are induced in fibroblasts irradiated with UVA (Basu -Modak et al., 1996; Vile et al., 1994; Vile 
1 -73 
Introduction Chapter one 
and Tyrrell, 1993). Such induction is though to be a defensive tactic against haem- and iron - 
amplified oxidative damage triggered by UVA- generated singlet oxygen. 
1.8.4 Cellular signalling in the skin in response to UV 
NF -KB is an oxidative stress -sensitive transcriptional activator which activates multiple target 
genes, many of which have proinflammatory effects in common (Rahman and MacNee, 
2000). In human keratinocytes, a variety of stimuli, including ozone, UVA and UVB, and 
cytokines activate NF -KB (Fuchs, 1998; Tyrrell, 1995). Induction of NF -KB is an early 
response to oxidative stress, and the NF -KB signalling pathway appears to be a natural 
protective mechanism against injury. Certain proteins related to oxidative stress, such as 
Mn -SOD (Rahman and MacNee, 2000), inducible NO (Spink et al., 1995), and ferritin (Shi et 
al., 1994) are induced after activation of NF -KB. 
Activation of AP -1 results in the expression of downstream target genes such as y- glutamyl- 
cysteine synthetase, glutathione S- transferase, and quinone reductase (Bergelson et al., 
1994; Sekhar et al., 1997). AP -1 responsive genes induced by irradiation with UV include 
genes encoding HO and matrix proteases (Maccarrone et al., 1997; Petersen et al., 1992). 
Ascorbate may mediate cellular responses to counteract UV- mediated damage and death by 
adjusting the activity of the AP -1 pathway, and modulating the expression of AP- 1- regulated 
genes in HaCaT and normal human keratinocytes (Catani et al., 2001). 
Mitogen- activated protein (MAP) kinases (e.g. extracellular signal -regulated protein kinases 
(Erks) and c -Jun N- terminal kinases (JNKs)) are tyrosine phosphoproteins which are 
important mediators of the cellular stress response. MAP kinases are phosphorylated and 
activated by ROS (Gupta et al., 1999). Distinct signalling cascades involving either oxidative 
stress or GTPase -coupled pathways are triggered by different forms of cellular stress, 
implying that antioxidants may only affect MAP kinase activation induced by oxidative stress. 
1.9 Epidemiology of skin cancer 
It is widely accepted that UV radiation is carcinogenic in humans and can produce 
photochemical changes in superficial tissues resulting in acute and chronic adverse health 
effects. 
The wavelength dependence (action spectrum) of UV- induced skin cancers has been 
estimated (de Gruijl, 1996). The UVA contribution to the carcinogenicity of sunlight is 
approximately 20 %, with UVB causing about 80 %. Factors that influence induction of skin 
cancer by UV irradiation include physical factors such as dose response, dose rate, dose 
fractionation, radiation quality (wavelength) (Black et al., 1997), and biological factors such 
as skin type, genetic constitution, age, and anatomical site. 
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The incidence of the three main types of skin cancer, basal cell carcinoma (BCC), squamous 
cell carcinoma (SCC), and cutaneous malignant melanoma (CMM), almost doubled between 
1980 and 1990 (Devesa et al., 1995). The number of skin cancer -related deaths in the UK 
has increased from 1040 cases in 1986 to 1522 cases in 1997 (Murphy, 2002). 
Non -melanoma skin cancers (NMSC), comprising BCC and SCC, the most common type of 
skin tumours to occur, are generally curable, and death is uncommon. The occurrence of 
NMSC is related to chronic UV exposure and is therefore more common in fair skinned 
individuals (Stern and Momtaz, 1984), albinos and individuals with xeroderma pigmentosum. 
Some of the apparent increased incidence of skin cancers may be to due to better reporting. 
1.9.1 Basal cell carcinoma 
BCCs are slow -growing, locally invasive malignant epidermal skin tumours. BCC is the most 
common type of skin cancer (Diepgen and Mahler, 2002). It is estimated that 4,000 are 
currently diagnosed annually in the UK (Murphy, 2002). The most significant etiologic factor 
is chronic exposure to UV radiation; consequently the head and neck are the most 
commonly involved sites (Armstrong and Kricker, 2001; de Gruijl, 1999). The incidence of 
BCC rises with increasing age up to middle age (English et al., 1997; Buettner et al., 1998), 
but such tumours are seldom fatal and metastasize rarely. 
1.9.2 Squamous cell carcinoma (SCC) 
SCCs are malignant tumours arising from keratinocytes in the epidermis or from mucous 
membranes. SCCs are also locally invasive and more aggressive than BCCs, which makes 
them more likely to metastasize. SCCs represent the second most common type of skin 
cancer in the USA, Australia and Europe (Diepgen and Mahler, 2002). 
1.9.3 Cutaneous malignant melanoma (CMM) 
CMM are malignant tumours stemming from melanocytes. Although it is less common than 
BCC or SCC, CMM accounts for the majority of deaths from skin cancer. This is the most 
aggressive type of skin cancer, and can metastasise very rapidly. The 1980's saw an 
increase in mortality from malignant melanomas in England and Wales. The incidence and 
mortality rates of melanoma are now falling in Australia and Hawaii (Rigel, 2002). It is 
thought that the risk of melanoma may be associated with short periods of intense exposure 
to UV radiation and possibly acute episodes of sunburn, particularly in childhood (de Gruijl, 
1996; Elwood, 1992). 
1.10 Selenium, UV and the skin 
Se appears to have an important role in protecting the skin from the injurious effects of UVB, 
and against UV- induced skin cancers (McKenzie, 2000). Se prevents oxidative damage 
caused by UV, but fails to stop dimer formation, which is the predominant carcinogenic 
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photoproduct. The production of inflammatory and immunosuppressive cytokines is 
prevented by Se, which would otherwise impair immune responses following UV exposure. 
Se also raises cellular and humoral immunity. In several disease states, including 
melanoma and NMSC (Deffuant et al., 1994), plasma levels of Se are low, but this may be 
due to an acute phase response with concomitant decrease in selenoproteins in plasma. 
Se supplementation in mice substantially decreases the level of skin damage, tumour 
formation and overall mortality following UVB exposure (Overvad et al., 1985; Pence et al., 
1994; Stewart et al., 1996). In man Se- deficiency is associated with up to a 4 -fold increase 
in the risk of developing skin cancer (Clark et al., 1984; Deffuant et al., 1994; Reinhold et al., 
1989). Topical application of Se in the form of selenomethionine can protect humans and 
mice from acute skin damage and decrease sunburn cell formation following exposure to 
UVB (Burke et al., 1992a; la Ruche and Césarini, 1991; Thorling et al., 1983). In Se- 
deficiency there is increased lipid peroxidation in UVA- exposed cultured fibroblasts (Moysan 
et al., 1995b). In cultured murine keratinocytes, sodium selenite decreases UV- induced 
oxidative damage to DNA when added to the growth medium (Stewart et al., 1996). Sodium 
selenite prevents oxidative DNA damage to HaCaT cells induced by irradiation with UVA 
(Petersen et al., 2000). Selenomethionine induces DNA repair enzymes in human 
fibroblasts exposed to UV (Seo et al., 2002). Incubation with sodium selenite increases GPX 
activity and decreases UVA- induced lipid peroxidation in human skin fibroblasts (Emonet- 
Piccardi et al., 1998; Leccia et al., 1993). In addition, dietary supplementation in mice with 
sodium selenite increases GPX levels and decreases the incidence of chemically- induced 
skin carcinogenesis (Perchellet et al., 1987). Topically applied thermal water from natural 
spas containing a high level of Se decreases the level of UVB- induced lipid peroxidation and 
skin carcinogenesis in hairless mice (Overvad et al., 1985). Similarly, Se supplementation in 
patients for 14 days diminishes the level of lipid peroxidation induced by exposure to UVB 
(Pietschmann et al., 1992). Supplementation of primary keratinocytes with Se prevents 
UVB- induced apoptosis, but does not decrease the levels of UVB- induced p53. This 
suggests that Se prevents UVB- induced cell death by inhibiting p53- independent pathways 
(Rafferty et al., 2003a). 
Both selenomethionine and sodium selenite can protect keratinocytes (Rafferty et al., 1998a; 
Rafferty et al., 1998b; Stewart et al., 1996) and melanocytes (Rafferty et al., 1998a; Rafferty 
et al., 1998b) from UV- induced cell death at nanomolar concentrations. These studies are 
described in further detail in chapter 5. Seleno- compounds do not absorb in the UVA/UVB 
wavelengths (McKenzie, 2000), and so cannot act as sunscreens. Sodium selenite can 
inhibit caspase -3 (an essential enzyme in the induction of apoptotic pathways) activation in 
vitro (Park et al., 2000). Selenite, unlike other seleno- compounds, does not induce 
activation of caspase -3 in HL -60 cells, suggesting that selenite- induced cell death could be 
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due to necrosis rather than apoptosis (Kim et al., 2001 b). Caspase -3 also increases 
oxidative stress, and thereby damage, by decreasing catalase, GPX, and SOD activities 
(Pence et al., 1994). 
UV irradiation is well documented in its immunosuppressive effects (Clydesdale et al., 2001; 
Duthie et al., 1999). An adequate intake of Se is essential for both humoral (antibody - 
mediated) and cell- mediated immunity. Se- deficiency impairs synthesis of complement and 
immunoglobulins (McKenzie et al., 2002b), and causes defective neutrophil function and 
decreased neutrophil numbers, increases H2O2 release during neutrophil phagocytosis, and 
reduces natural killer cell activity (McKenzie et al., 2001). Conversely, Se supplementation 
augments host antibody and complement responses to tetanus and typhoid toxins, sheep 
erythrocytes, and immunoglobulins. Supplementation with Se also increases the number of 
antibody -producing B- cells, increases T -cell- dependent antibody production (T -cell help), 
and increases in neutrophils (McKenzie et al., 2001). The immunomodulatory effects of Se 
occur chiefly through the following mechanisms: (1) anti -inflammatory effects of 
selenocompounds or selenoproteins; (2) selenocompounds or selenoproteins modulating the 
redox state of the cell through antioxidant action; (3) through the production of cytostatic and 
anticancer compounds as products of metabolism of Se. The principal mechanisms 
stimulated by Se may be summarised as follows: (a) detoxification of organic hydroperoxides 
and H2O2; (b) regulation of the balance of activity in the pathways of eicosanoid synthesis, 
resulting in preferential synthesis of leukotrienes and prostacyclins over thromboxanes and 
prostaglandins; (c) down -regulation of the expression of cytokines and adhesion molecules; 
(d) up- regulation of the expression of interleukin -2, resulting in enhanced lymphocyte, natural 
killer and lymphocyte activated killer cell activity. 
In the skin, Se supplementation protects keratinocytes from UV- induced release of IL -10, 
which would otherwise inhibit antigen presentation and cell- mediated immune responses. 
Inhibition of UVB- induction of the proinflammatory cytokines IL -6 and IL -8 has also been 
shown for Se- supplemented keratinocytes (McKenzie et al., 2002b). 
Selenoenzymes in the skin are discussed below in section 1.11.1. 
1.10.1 Selenium and skin cancer 
The major trial of Se in chemoprevention carried out by Clark et al. (described in detail in 
section 1.2.4) initially used the primary endpoint of NMSC in subjects with a history of at 
least 2 skin cancers receiving either 200 Ng Se or placebo daily (Clark et al., 1996; Clark et 
al., 1998). The results reported 13 years after the initiation of the trial showed no effect of Se 
on NMSC, but showed secondary endpoint effects of 50 % lower total cancer mortality and 
37 % lower total cancer incidence (section 1.2.4). It is conceivable that this study used too 
low a dose of Se to achieve the protection required from the damage mediated by UV 
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irradiation. Although Se can prevent UVB- induced skin tumours in hairless mice (Burke et 
al., 1992b; Overvad et al., 1985; Pence et al., 1994), the doses of Se used in such studies 
are often too high to be applicable to the human situation, and definitive evidence of 
protection against UVB- mediated skin carcinogenesis in humans by Se is lacking. Case - 
control studies of internal human cancers are difficult to interpret since neoplastic tissue 
sequesters Se (Clark et al., 1984), but this may not apply in the case of skin cancers. 
1.11 Antioxidant systems in the skin 
A complex antioxidant defence system has evolved in the skin to protect against ROS. The 
individual antioxidant enzymes are located in specific subcellular sites and are substrate 
specific. Several antioxidant defence mechanisms have been identified in skin. Water - 
soluble antioxidants include ascorbic acid, glutathione, and enzymes such as SOD, catalase, 
GR and GPX. The individual antioxidants and selenoproteins are described in detail in 
sections 1.1.5 and 1.2.7, respectively. The epidermal TR/Trx system may be important in an 
antioxidant defence role (Schallreuter and Wood, 1986; Schallreuter and Wood, 1989; 
Schallreuter and Wood, 2001). Lipid soluble antioxidants in the skin include a- tocopherol 
and ubiquinones (Leccia et al., 1998). 
Sunlight induces the synthesis of melanin, which has a broad absorbance spectrum that 
ranges through the UVB, UVA and visible ranges. Eumelanin may be highly protective, but 
this is not necessarily true of pheomelanin (Halliwell and Gutteridge, 1999). ROS, such as 
the superoxide anion, can affect tyrosinase activity (Wood et al., 1995). Furthermore, H2O2 
and UVB have been shown to oxidise BH4 (tetrahydrobiopterin), an essential cofactor for 
phenylalanine hydroxylase, to 6 biopterin (Schallreuter et al., 1999; Wood et al., 1995). This 
oxidation is reversible by TR (Schallreuter and Wood, 2001) (see below). 
Whereas high UV doses and ROS levels are known to overwhelm the antioxidant enzymatic 
defence system, repetitive low -dose UV exposures prevent phototoxicity upon subsequent 
higher UV doses (Meewes et al., 2001), indirectly suggesting that the skin, apart from other 
principal protective strategies like inducible melanogenesis, is equipped with an inducible 
adaptive antioxidant defence mechanism. Up- regulation of antioxidants by UV exposure is 
described in section 1.11.3. 
1.11.1 Antioxidant enzymes in the skin 
Catalase 
Catalase is thought to be a less important antioxidant enzyme than GPX in the skin, since 
catalase- deficient fibroblasts do not show decreased viability following exposure to UV 
compared with fibroblasts exhibiting the enzyme (Shindo and Hashimoto, 1995). However, 
catalase can decrease the damage to other antioxidant enzymes during chronic UV 
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exposure (Shindo and Hashimoto, 1995), and when added exogenously to culture media can 
decrease the formation of sunburn cells in mouse skin expiants following exposure to UVB 
(Miyachi et al., 1983). Following exposure to UVA and UVB the level of catalase present in 
the skin is greatly reduced (Fuchs et al., 1989a; Pence and Naylor, 1990; Punnonen et al., 
1991). The decrease in catalase is probably due to the irreversible oxidative damage of the 
enzyme. 
Superoxide dismutase (SOD) 
SOD is present in the skin in both the Cu /Zn (Cu /Zn -SOD) and Mn (Mn -SOD) forms (Carraro 
and Pathak, 1988; Schallreuter and Wood, 1989). In mice given a single injection of SOD 
either just before or immediately following UV exposure, formation of sunburn cells was 
significantly decreased (Danno et al., 1984). The level of SOD in the skin decreases 
following UVB exposure (Fuchs et al., 1989a; Fuchs et al., 1989b; Miyachi et al., 1987) (see 
section 1.8.3 above). As seen with catalase, the damage to SOD is probably a result of 
direct oxidative damage to the enzyme. Such a decrease in SOD activity following UV 
irradiation can be prevented by treating mice with SOD in liposomes (Miyachi et al., 1987). 
Human dermal fibroblasts in vitro irradiated with single and repetitive low doses of UVA show 
significant increases in MnSOD protein and mRNA, and this induction offered substantial 
protection against the cytotoxic effect of UVA exposure (Poswig et al., 1999). When added 
exogenously to tissue culture media, SOD prevents the formation of sunburn cells (Miyachi 
et al., 1983). However the H2O2 formed by the action of SOD is damaging to cells in itself, 
so to be protective any increase in SOD should ideally occur in unison with an increase in 
catalase or GPX. 
Peroxiredoxin (Prx) 
At least three isoforms of Prx are differentially expressed in rat skin, in the epidermis, hair 
follicles, and sebaceous glands, where TR and Trx are also present (Lee et al., 2000a); this 
is expected since Prx can only function when TR and Trx are present as an electron donor 
system. Expression of at least one Prx can be increased by UV irradiation, suggesting a 
protective role (Lee et al., 2000a). 
Selenoenzymes 
In humans, the concentration of Se in the epidermis is higher than in the dermis (Molokhia et 
al., 1979). The corresponding expression of selenoproteins may reflect this. The epidermis 
has a significantly higher cyGPX activity than the dermis in human skin (Shindo et al., 1994). 
In mice, levels of catalase, GPX, glutathione reductase, and GSH (but not SOD) are higher 
in epidermis than in dermis (Shindo et al., 1993). In human skin there are higher activity 
levels of catalase, SOD, cyGPX, and GR than in the dermis (Shindo et a/., 1994). This 
presumably reflects the higher level of damaging UV that the epidermis is exposed to. 
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Keratinocytes express lower levels of TR and PHGPX than melanocytes, but are more 
resistant to UVB- induced cell death than melanocytes (Rafferty et al., 1998b). TR and 
PHGPX expression were greater in melanocytes than keratinocytes, but not as great as in 
fibroblasts. Clearly, the susceptibility of a cell to UVB- mediated damage will be dependent 
upon an extensive range of enzymatic and non -enzymatic antioxidant systems, and DNA 
repair mechanisms, rather than selenoproteins in isolation. This is supported by studies 
showing that keratinocytes have twice the specific activity of GPX of fibroblasts, and that the 
50 % toxic dose for cell death by UVA is 48 J /cm2 for keratinocytes, and only 5.8 J /cm2 for 
fibroblasts (Leccia et al., 1998). 
Normal skin shows Trx immunohistochemical staining in the sebaceous glands, secretory 
components of sweat glands, and the outer root sheath of the hair follicle, but not in the 
interfollicular epidermis (Wakita et al., 1992). TR and Trx are expressed in the hair follicles 
and basal cell layer of the epidermis in the rat (Lee et al., 2000a). In another report, Trx was 
present in the hair follicle, sebaceous and sweat glands, but not in normal epidermis (Sachi 
et al., 1995). However, enhanced expression of Trx has been demonstrated in the 
epidermal cells of skin exposed to UV (Sachi et al., 1995), and this may be a protective 
response to oxidative stress insult. UVB irradiation of keratinocytes increases Trx levels in 
the cytosol, followed by its translocation into the nucleus (Schallreuter et al., 1994b). Such 
translocation of Trx to the nucleus upon irradiation is also true for UVA- treated human skin 
fibroblasts (Didier et al., 2001), and for phorbol acetate -treated HeLa cells (Hirota et al., 
1997). These data suggest an important role for Trx in the protection of DNA against 
oxidative damage. Both Trx and TR, and also glutaredoxin, are induced in mouse skin upon 
application of the phorbol ester 12- O- tetradecanoylphorbol -13- acetate (TPA), a PKC 
activator and (non- carcinogenic) tumour promoter (Kumar and Holmgren, 1999). 
Schallreuter and Wood have proposed that TR is an extremely active free radical reducing 
enzyme on the plasma membrane (Schallreuter and Wood, 1986). They developed a 
bioassay for TR: using electron spin resonance spectroscopy (ESR), the decrease in ESR 
amplitude of a cationic nitroxide (free radical; spin label) is monitored. The spin labelled 
nitroxide is reduced in the epidermis to an ESR silent product. Schallreuter and Wood 
suggested that this reduction is specific for TR in epidermis. Reduction of spin label on skin, 
on keratinocytes, melanocytes and purified E. coli TR was inhibited by thioprotein inhibitors, 
NADP +, anthralin, azelaic acid and other saturated dicarboxylic acids, and Trx (competitive 
substrate) (Schallreuter et al., 1986; Schallreuter and Wood, 1987). However these studies 
have been justifiably criticized because of the non -specific nature of the assay employed for 
measuring TR (Fuchs, 1988) (this is further discussed in section 4.3). Studies by Fuchs et 
al. have suggested that the main reducing activity for piperidinoxyl -type nitroxides in mouse 
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skin homogenates is ascorbate, and pyrroline -type nitroxides are reduced by a non - 
ascorbate method, possibly GSH (Fuchs et al., 1989b). 
There is a link between reduction of free radicals by TR and melanin biosynthesis by 
melanocytes (Schallreuter et al., 1994b; Schallreuter and Wood, 1986). Schallreuter and 
Wood reported a direct correlation between TR activity and skin pigmentation. TR activity in 
patients with skin type VI (highly pigmented) is 5 -fold higher than that found in patients with 
skin type I (fair skin) (Schallreuter et al., 1987). Tyrosinase is essential to the first 2 steps of 
melanin synthesis (Yaar and Gilchrest, 1991). Oxidised thioredoxin stimulates, whereas 
reduced thioredoxin inhibits tyrosinase activity (Schallreuter and Wood, 1989). The oxidation 
of the cofactor 6BH4, by H2O2, to cytotoxic 6 biopterin is reversible by TR (Schallreuter et al., 
1994a; Schallreuter and Wood, 2001). 
1.11.2 Non -enzymatic antioxidants in the skin 
Keratinocytes and fibroblasts contain millimolar levels of GSH, ascorbate and DNA repair 
enzymes. Amongst the photoprotection systems in the skin, the availability of a sufficient 
supply of reduced GSH is essential (Maccarrone et al., 1997). GR activity is extremely high 
in the skin, and it is predicted that the amount is sufficient to recycle all cutaneous GSH in 
under 1 min (Connor and Wheeler, 1987). This apparent excess capacity is an indication of 
the importance of high GSH levels. At wavelengths corresponding to UVA, GSH is 
particularly important as the unique hydrogen donor in the quenching of H2O2 by GPX (Afaq 
and Mukhtar, 2001). Cellular GSH also has an important role in regulating HO -1 activity by 
via thiol /disulphide redox control (Basu -Modak et al., 1996). 
a- tocopherol is effective against UV- induced, immunosuppression (Clement- Lacroix et al., 
1996; Gensler and Magdaleno, 1991; Yuen and Halliday, 1997), lipid peroxidation (Sarai et 
al., 2002; Yuen and Halliday, 1997), sunburn cell formation (la Ruche and Césarini, 1991), 
and oxidative DNA damage (Stewart et al., 1996). 
In comparison to a- tocopherol, the basal concentration of [3-carotene in human keratinocytes 
is several -fold lower (Shindo et al., 1994; Vahlquist et al., 1982). However, [3-carotene 
accumulation in keratinocytes can reach tissue concentrations far greater than those of a- 
tocopherol. [3-carotene administration is protective against light- induced skin damage in 
patients with porphyria (Mathews -Roth, 1987). Sunlight depletes [3-carotene in the skin, 
consistent with a protective role in normal subjects (Biesalski et al., 1996). 
1.11.3 Antioxidant upregulation by UV exposure 
UV radiation may exert opposing effects on the activities of antioxidants in the skin, 
depending on dose and sequence of radiation exposures. Commonly, high dose acute UV 
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exposure may inhibit, and low dose chronic UV exposure induce particular antioxidants. 
Chronic UVA exposure elevates GPX activity in mouse skin (Maeda et al., 1991). In cultured 
human skin fibroblasts, UVA induces `heat- shock' proteins, including haem oxygenase -1 
(Hsp32 /HO -1), co- upregulated with ferritin (Tyrrell, 1995). The induction of HO by UVA is 
thought to be a protective response to oxidative stress since bilirubin and biliverdin have 
antioxidant activities (Clark et al., 2000). 
Keratinocytes have higher basal levels of haem oxygenase (HO -2), but little inducible (HO -1) 
activity. This may be explained by the fact that considerable UV radiation reaches the 
keratinocytes at the base of the epidermis, whereas higher exposures are needed to reach 
the dermal fibroblasts. Upregulation of HO -1 by UVA has been shown in human fibroblasts 
however (Basu -Modak et al., 1996). 
Upon UVA irradiation of human fibroblasts, the expression of both Trx and TR is increased 
(Didier et al., 2001). A UV insult to skin increases peroxiredoxin II expression in rat skin 
within 15 min of irradiation (Lee et al., 2000a). Repetitive and chronic exposure of hairless 
mice to UVB results in an increase of SOD activity after 36 wk (Okada et al., 1994). In 
chronically UVB- exposed sun -exposed human skin, SOD activity (Punnonen et al., 1995), 
tocopherol and ubiquinone concentrations are elevated (de Simone et al., 1987). 
1.11.4 Antioxidant photoprotection 
Studies in cell culture systems and animals 
The protective effects of antioxidants have been displayed in several studies in which they 
were administered to animals or cells in culture prior to UV irradiation. a- tocopherol, 
administered in liposomes to human keratinocytes in culture, provided protection from UV 
radiation -induced cell death (Werninghaus et al., 1991), and protected human skin 
fibroblasts in vitro from UVB- mediated cytotoxicity, while MDA production was unaltered 
(Kondo et al., 1990). In HaCaT cells, pre- incubation with ascorbate or a- tocopherol protects 
against UVB- mediated peroxide formation, but cannot protect against UVB- mediated 
cytotoxicity, suggesting that the mechanism of toxicity may not be mediated by ROS alone 
(Podhaisky et al., 2000). Chinese hamster V -79 cells incubated with a- tocopherol succinate 
are protected from UVB- induced cytotoxicity (Sugiyama et al., 1992), but the amount of DNA 
single strand breaks and induction of chromosomal mutations induced by UVB are not 
altered, perhaps suggesting that UVB- induced DNA damage does not directly correlate with 
the cytotoxic mechanism of UVB. Indeed, Se protects against UVB- mediated cytotoxicity 
(Rafferty et al., 1998a; Rafferty et al., 1998b) and oxidative damage to DNA (8- hydroxy -2- 
deoxyguanosine formation), but not against DNA lesion damage (cyclopyrimidine dimers; 
excision repair sites) induced by UVB irradiation in keratinocytes (Rafferty, 2000; Rafferty et 
al., 2003b). Studies utilising Se in photoprotection are described in section 1.10. 
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Topically applied a- tocopherol solution or 3- carotene solution, or ascorbic acid delivered 
intraperitoneally before UV exposure significantly reduced TBARS formation in mouse skin 
(Khettab et al., 1988; Kobayashi et al., 1996a; Pugliese and Lampley, 1985). UVB- induced 
(Jurkiewicz et al., 1995) or UVA- induced (Sorg et al., 2002) formation of lipid- derived radicals 
was significantly reduced by topical application of a- tocopherol to hairless mice, or guinea 
pigs (Sara) et al., 2002). These results suggest that a- tocopherol protects against UV- 
induced lipid peroxidation in the skin. Apart from scavenging ROS, a- tocopherol may act as 
a sunscreen, since it absorbs UV light (with maximum absorption at 295 nm), or a cellular 
response moderator, for example altering inflammatory cascades. 3- carotene absorbs 
radiation in the near violet and visible spectrum (360 - 550 nm) (Pathak, 1982). Vitamin E 
also possesses an anti -inflammatory effect via the inhibition of phospholipase. 
Murine skin can be protected from UVB- induced erythema by topical application of a- 
tocopherol or ascorbate prior to exposure to UV (Khettab et al., 1988; Möller et al., 1989; 
Roshchupkin et al., 1979). Inhibition of photocarcinogenesis in mice has been demonstrated 
using topical application of a- tocopherol (Gensler and Magdaleno, 1991) or glutathione 
derivatives (Kobayashi et al., 1996b), as well as dietary a- tocopherol (Gerrish and Gensler, 
1993; Pathak, 1982) or 3- carotene (Bissett et al., 1990). 
Trials of antioxidants in photoprotection in humans 
The results of randomised trials of antioxidants in the prevention of UV- induced damage 
have been largely ineffective, or minimally protective (table 1.09). There is no convincing 
evidence in the literature that a- tocopherol alone is clinically useful in prevention or treatment 
of normal skin reactions to UV irradiation (Fuchs, 1998). However, tocopherol is 
regenerated from the tocopheryl radical by ascorbate (section 1.1.5), so the two dietary 
components may act synergistically to provide protection. It has been suggested that 3- 
carotene supplementation is unlikely to modify the severity of cutaneous photodamage in 
normal individuals to any meaningful extent in clinical terms (Garmyn et al., 1995). The 
effectiveness of systemic ascorbate in protection against sunburn is regarded as poor and 
questionable (Fuchs, 1998). It remains to be seen whether antioxidants /combinations will 
prove beneficial in protection against photodamage in human skin. 
The ultimate objective in photoprotection is prevention of chronic skin damage, such as skin 
cancer. The molecular pathways leading to UV- induced inflammation are presumably 
different to those biochemical cascades resulting in immunosuppression, photo -aging and 
cancer (Fuchs, 1998). UV- induced erythema may be an inappropriate endpoint and invalid 
indicator for assessing the efficacy of protection of antioxidants in prevention of photoageing, 
photoimmunosuppression, and photocarcinogenesis (Fuchs, 1998). 
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Table 1.09 Trials of Antioxidants as Photoprotective Agents 
Study Study Population Major Findings 
(Mathews -Roth et al., 
1972) 
30 healthy male volunteers; 
21 - 49 years of age (180 
mg 6-carotene/day for 10 
weeks) 
Small but significant effect in 
increasing MED with 6-carotene (p 
< 0.025) 
(Wolf et al., 1988) 23 healthy volunteers (150 
mg 6-carotene/day for 4 
weeks) 
No effect of 6-carotene on 
UVA /UVB- induced erythema, or 
UVB- mediated DNA damage 
(Greenberg et al., 1990) 1805 patients with recent 
non -melanoma skin cancer, 
followed for 5 years 
No effect of beta carotene on 
either number or time of 
occurrence of new NMSC 
(Msika et al., 1990) 6 volunteers (topical a- 
tocopherol 1 %) 
Topical a- tocopherol reduced 
sunburn cell formation, but had no 
effect on UVB /A- induced erythema 
(Murray et al., 1991) 10 healthy volunteers 
(topical 10 % ascorbic acid 
(w /v) for 5 days) 
Topical ascorbate reduced UVB - 
induced erythema (p < 0.001) 
(Murray et al., 1992) 10 individuals (topical 
ascorbate) 
Topical ascorbate significantly 
attenuated UVA- induced 
immediate pigment response (p < 
0.001) and increased MED (p < 
0.05) 
(Werninghaus et al., 
1994) 
12 healthy volunteers; 2 
women and 12 men, aged 
25 - 84 years (oral a- 
tocopherol /day 6 
months) 
No clinical (MED) or histological 
(sunburn cell number) difference in 
acute UVB response with a- 
(Garmyn et al., 1995) Healthy volunteers (single 
120 mg dose, or daily 90 
mg 6-carotene for 23 days) 
No significant photoprotection, 
clinically (MED) or histologically, of 
6-carotene against SSR 
(Biesalski et al., 1996) Healthy young females (30 
mg 6-carotene/day for 10 
weeks) 
Slight but significant protection 
against solar radiation -induced 
skin inflammation with 6-carotene 
(Boffa et al., 1996) 12 EPP patients (oral 
ascorbate 1 g /daily for 4 
weeks) 
Slight but non -significant 
photoprotection (sunlight 
tolerance) 
(Eberlein -König et al., 
1998) 
10 subjects (either 2 g 
ascorbic acid combined 
with 1000 IU of a- 
tocopherol or placebo per 
day, for 8 days) 
Slight but significant protection (p 
< 0.01) by ascorbic acid and a- 
tocopherol in combination against 
UVA /UVB- induced erythema 
(Fuchs and Kern, 1998) 40 healthy volunteers (20 - 
47 years of age; ascorbic 
acid and /or a- tocopherol for 
50 days; varying dosages) 
Significant protection from solar - 
simulated light- induced erythema 
of combined ascorbic acid and a- 
tocopherol (p < 0.004) 
$ Photoprotection is variously measured as reduced sunburn cell formation, reduced 
erythema, reduction of non -melanoma skin cancer. 
Abbreviations: EPP, erythropoietic protoporphyria; MED, minimal erythema) dose; NMSC, 
non -melanoma skin cancer; SSR, solar -simulated radiation 
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1.12 Aims of the thesis 
The relative importance of TR and the GPXs has not been previously studied regarding their 
role in antioxidant defence of the endothelium and the skin. Therefore this thesis examines 
the participation of these selenoproteins in the protection against physiological- and non - 
physiologically mediated oxidative stress in in vitro models of the endothelium and the skin. 
The modification of selenoprotein expression through Se supply and through selenoprotein 
inhibitors is also studied. 
Previous studies demonstrate that Se supplementation, through the modulation of 
selenoprotein expression, causes BAEC to be resistant to the cytotoxicity of ROS- mediated 
damage (Geiger et al., 1993; Ochi et al., 1992; Thomas et al., 1993). These investigations 
attribute the protection observed to modification of GPX expression. Other selenoenzymes 
such as TR were not considered. Studies have also shown skin cells, primary keratinocytes, 
HaCaT cells, and fibroblasts, more resistant to UV- induced cytotoxic damage when pre- 
treated with Se (Emonet et al., 1997; Rafferty et al., 1998a; Rafferty et al., 1998b; Stewart et 
al., 1996). Although other studies in skin cells have demonstrated the modulation of 
selenoprotein expression by Se supplementation, the protective effect of Se has not been 
correlated to the expression of the individual selenoproteins. 
Thus, the experiments in this thesis were constructed to answer the following questions: 
What effect does Se deficiency have on the ability of cells in culture to withstand oxidative 
stress? 
Can Se supplementation, in the form of sodium selenite, protect EAhy926 cells from 
cytotoxicity resulting from exposure to oxidised lipids? 
Can sodium selenite supplementation protect HaCaT cells from cytotoxicity mediated by 
menadione or irradiation with UVB? 
If sodium selenite supplementation does provide protection, do the concentrations that 
provide protection maximally upregulate TR, cyGPX and PHGPX in these cell types? 
Does sodium selenite directly detoxify t -BuOOH or menadione, or is the protection 
through modification of selenoenzyme expression? 
Does gold thioglucose- mediated inhibition of selenoenzyme activity render the cells more 
susceptible to oxidative stress? Is the magnitude of susceptibility equal for different 
oxidative stressors? Are the activities of the GPXs and TR equally modulated by gold 
thioglucose treatment? 
Do any other components of the cell culture systems influence the level of cytotoxicity? 
Are the EAhy926 and HaCaT cell lines suitable models in which to investigate the role of 
Se and selenoproteins in human endothelial cells and keratinocytes (respectively)? 
Do TR inhibitors quoted in the literature modulate TR activity equally in the DTNB and 
insulin reduction assay systems for TR activity? 
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CHAPTER TWO 
MATERIALS AND GENERAL METHODS 
2.1 Materials: Chemical Suppliers 
Cell Culture Reagents and Equipment 
Amphotericin B solution; Dulbecco's modified Eagle's medium (DMEM) (25 mM HEPES) with 
4.5 g/L glucose; DMEM with glutamax (4.5 g/L glucose); Earle's balanced salt solution 
(EBSS); Ham's F -12 medium; Hank's balanced salt solution (HBSS) (Ca2 +- and Mgt + -free); 
hypoxanthine, aminopterin, thymidine (HAT) medium supplement; Keratinocyte -SFM 
medium; Medium 199 (M199); foetal bovine serum (FBS); penicillin /streptomycin solution; 
phosphate buffered saline (PBS); soyabean trypsin inhibitor; trypsin -EDTA were supplied by 
Invitrogen Ltd, Paisley, UK. 
Bovine aortic endothelial cells (BAEC); endothelial growth medium kit (EGM); endothelial 
growth medium -2 bulletkit (EGM -2); endothelial growth medium -2 supplements (i.e. HEPES 
buffered saline solution, trypsin /EDTA solution, trypsin neutralising solution); human coronary 
artery endothelial cells (HCAEC); human umbilical vein endothelial cells (HUVEC) (certain 
experiments); were supplied by Biowhittaker UK Ltd., Wokingham, Berkshire, UK. 
Tissue culture plastics were supplied by Iwaki, Japan, and Bibby Sterilin, Stone, 
Staffordshire, UK. 
Radioisotopes 
Bolton & Hunter reagent for protein iodination (18.5 MBq, 500 pCi) and Iodine -125 (37 MBq, 
1 mCi, specific radioactivity 16 MBq/ nmol) were supplied by Amersham International plc, 
Buckinghamshire, UK. 
[75Se] selenite (specific activity, 16 MBq/ nmol) was supplied by Reactor Center, Columbia, 
MO, USA. 
General materials 
Acetic acid; Aquamount; copper (II) sulphate; ethanol; ethylenediaminetetraacetic acid 
(EDTA); hydrochloric acid; methanol; microcrystalline cellulose; orthophosphoric acid; nitric 
acid; perchloric acid were supplied by MERCK, Leicester, UK. 
Acrylamide solution; 2'S'- ADP -agarose columns; ammonium persulphate; anthralin 
(dithranol); aurothioglucose (gold thioglucose); azelaic acid; bovine serum albumin powder 
(BSA); Brij solution; butylated hydroxytoluene (BHT); Coomassie brilliant blue (R -250 and G- 
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250); cytoplasmic glutathione peroxidase purified from human erythrocytes; DEAE 
Sepharose CL -6B anion exchange column; 5,5'- dithiobis(2- nitrobenzoate) (DTNB); 
dithiothreitol (DTT); N -ethyl maleimide (NEM); insulin; G -100 gel filtration column; 
glutathione; glutathione reductase; lactate dehydrogenase (LDH) kit (Sigma Diagnostics); 
lauryl sulfate (sodium dodecylsulfate; SDS); menadione sodium bisulphite (2- methyl -1,4- 
napthoquinone); NADPH; p- chloromercuri- benzoic acid (PCMB); phorbol -12- myristate 13- 
acetate (PMA); radiographic film Kodak X -OMAT XAR -5; reactive blue affinity column; 13 -cis 
retinoic acid; sulphosalicylic acid; sodium azide; sodium selenite; thioredoxin; ,N,N',N'- 
tetramethylethylene diamine (TEMED); trypan blue solution were supplied by Sigma Aldrich 
Company Ltd, Poole, Dorset, UK. 
Lipoprotein Electrophoresis kit was supplied by Beckman Coulter UK Ltd, Buckinghamshire, 
UK. 
Donkey anti -rabbit serum; normal rabbit serum; normal swine serum were supplied by the 
Scottish Antibody Production Unit, Carluke, Lanarkshire, UK. 
Centricon -10 concentrator tubes; polyethersulfone filters; Amicon 52 filtration units were 
supplied by Amicon Millipore, Bedford, MA, USA. 
Avidin- Biotin Complex Alkaline Phospahatase was supplied by Dako Ltd, Buckinghamshire, 
UK. 
Nitro -Blue tetrazolium chloride; BLIP (5- Bromo -4- chloro- 3- indolyl phosphate); `Complete' 
Protease Inhibitor; Precinorm ®U Universal control serum were supplied by Boehringer 
Mannheim. 
Sephadex G25M columns (PD -10) were supplied by Amersham Pharmacia Bio- Technics, 
Uppsala, Sweden. 
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2.2 SOURCES OF NON -COMMERCIAL MATERIAL 
2.2.1 Cell lines 
2.2.1.1 EAhy926 Endothelial Cell Line 
The human endothelial cell line, EAhy926 was a kind donation from Professor Cora -Jean 
Edgell, the University of North Carolina, North Carolina, USA. 
2.2.1.2 Human Keratinocyte HaCaT Cell Line 
Cultures of the spontaneously transformed human keratinocyte cell line HaCaT were a kind 
gift from Professor N E Fusenig, German Cancer Research Centre, Heidelberg, Germany. 
2.2.2 Antibodies 
Antisera to both rat liver and human placental thioredoxin reductase (TR) were raised in 
rabbits to cytosolic proteins purified to homogeneity. Rat TR antisera was supplied by 
Professor John Arthur, Rowett Research Institute, Bucksburn, Aberdeen, UK. Dr Forbes 
Howie of this department supplied the antisera to human TR. 
Antisera to rat PHGPX were raised in rabbits against PHGPX purified from rat testis. This 
antisera was also kindly donated by Professor John Arthur and Mr Fergus Nicol of the Rowett 
Research Institute. 
2.2.3 Lipoprotein 
Normal and oxidised low density lipoprotein was prepared by Mrs Margaret Millar and 
Professor Rudolph Riemersma of the Cardiovascular Research Department, University of 
Edinburgh. Donations of plasma were obtained from the National Scottish Blood Transfusion 
Service, Lauriston Place, Edinburgh. 
2.2.4 Human tissue samples 
Human placentas, for cytosol preparation, and umbilical cords, for preparation of HUVEC, 
were obtained from the Simpson Maternity Pavilion, Royal Infirmary of Edinburgh. 
Neonatal foreskins, for preparation of primary keratinocytes, were obtained from the Sick 
Kids Hospital, Edinburgh. 
Human foetal and neonatal liver cytosols, for selenoenzyme activity measurements, were 
obtained from Professor R. Hume of Ninewells Hospital and Medical School, Dundee. The 
collection of these tissues was approved by the Paediatric -Reproductive Medicine Ethics of 
Medical Research Sub -Committee of Lothian Health Board and the Ethics Committee of 
Tayside Health Board. 
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2.3 GENERAL METHODS 
2.3.1 Introduction 
The experimental methods and protocols described below are those used throughout this 
thesis. They include primary cell culture, maintenance of cell lines, selenoprotein 
determination, cell viability measurements, and selenoprotein expression and activity 
measurements. Where the methods differ from those detailed here, the modifications are 
described in the respective chapters. 
2.3.2 Cell Culture Conditions for Cell Lines 
a) Maintenance of EAhy926 Cell Line 
EAhy926 cells were maintained, unless otherwise stated, in high glucose (4.5 g /L) DMEM 
(containing 25 mM HEPES) supplemented with 10 % FBS, 5 mM hypoxanthine, 0.02 mM 
aminopterin, 0.8 mM thymidine, in a humidified atmosphere of 5 % CO2, 95 % air at 37 °C. 
The cells were passaged weekly using 0.25 % trypsin- 0.02 % EDTA solution. 
EAhy926 cells display the characteristic morphology of endothelial cells in culture, 
distinguished by an appearance (via light microscopy) of non -overlapping large polygonal 
cells, which after 3 -7 days in culture became a confluent single monolayer of contact - 
inhibited cells with a cobblestone appearance. The EAhy926 cell line has previously been 
shown to stain positive for von Willebrand Factor (former designation Factor VIII -related 
antigen, vWF) (Edgell et al., 1983). The presence of the glycoprotein vWF was also 
confirmed by this laboratory (figure 2.01). 
Figure 2.01 Immunofluorescence of the glycoprotein von Willebrand Factor (vWF) in a non - 
confluent monolayer of EAhy926 cells. x 400 magnification. 
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b) Maintenance of HaCaT Cell Line 
The cell line was maintained, unless otherwise stated, in high glucose (4.5 g /L) DMEM 
supplemented with 5 % FBS, in a humidified atmosphere of 5 % CO2, 95 % air at 37 °C. The 
cells were passaged weekly using 0.25 % trypsin -0.02 % EDTA solution. 
HaCaT cells in culture display the characteristic morphology of ovoid keratinocytes under the 
light microscope. HaCaT cells have been shown to behave phenotypically like normal 
keratinocytes in terms of growth and differentiation, maintaining full epidermal differentiation 
capacity (Boukamp et al., 1988). This cell line is a spontaneously transformed human 
epithelial cell line from adult skin, which possesses an enzymatic pattern similar to normal, 
non -transformed human keratinocytes. 
2.3.3 Isolation and /or maintenance of primary cells 
a) Isolation and culture of human umbilical vein endothelial cells 
Human umbilical cords ( >100 mm in length) were obtained at normal deliveries or Caesarean 
section from non -smoking females. Immediately after delivery the cords were placed into 
sterile Earle's Balanced Salt Solution (EBSS) containing penicillin (100 units /ml), 
streptomycin (100 µg /ml) and amphotericin B (2.5 µg /ml) at 4 °C. Endothelial cells were 
isolated within 20 hr of delivery using a method adapted from that described previously by 
Jaffe et al. (Jaffe et al., 1973). The vein of the umbilical cord was located and cannulated 
with a Venflon (gauge 17/ 45 mm), which was then clamped into place. The vein was flushed 
through with 100 ml of EBSS (pre- warmed to 37 °C) to remove any blood clots and the 
outside wiped using sterile gauze. One end of the cord was clamped shut, and the opposite 
end infused with 0.07 % collagenase (type IV) in EBSS (5 -15 ml). The cord was then 
incubated at 37 °C in a humidified atmosphere of 5 % CO2, 95 % air. 
After 10 min the cord was removed and massaged gently. The contents of the cord were 
flushed out with 30 ml of HBSS (Ca 2 +and Mg 2 +- free). The resulting cell suspension was 
collected and centrifuged at 450 x g for 10 min and the cell pellet washed once with EGM -2 
containing penicillin (100 units /ml), streptomycin (100 µg /ml) and amphotericin B (2.5 µg /ml). 
The cells were resuspended in 15 ml EGM -2 and seeded into one 75 cm2 flask. This flask 
was then incubated at 37 °C in a humidified atmosphere of 5 % CO2, 95 % air. 
After approximately 5 hr the HUVEC were washed with 2 x 10 ml EGM -2 to remove any 
blood, contaminant cells and cell debris. The medium was then changed and replaced with a 
further 15 ml of EGM -2 on alternate days. 
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The cells reached confluence within 3 -7 days. When the cells were approximately 90 
confluent the HUVEC were subcultured as required. To subculture the HUVEC the overlying 
medium was aspirated from the flask and the flask rinsed with approximately 9 ml HBSS. 
The HBSS was then aspirated from the flask and replaced with 9 ml trypsin (0.025 %) / 
EDTA (0.01 %) solution. The flask was then placed in the incubator at 37 °C for 
approximately 1.5 min. Cell detachment was checked by light microscope, and if necessary 
the flask was given a rap to detach any cells remaining attached to the surface of the flask. 
The trypsin/ EDTA solution was then neutralised with a trypsin -neutralising solution and the 
cell suspension transferred to a centrifuge tube. The cells were pelleted by centrifugation at 
450 x g for 10 min. The supernatant was aspirated and the cells gently resuspended in 5 ml 
EGM -2. The number of cells were counted using a haemocytometer, and were seeded at a 
density of approximately 3000 cells /cm2 in a 75 cm2 flask. 
b) Maintenance of human coronary arterial endothelial cells 
Human coronary arterial endothelial cells (HCAEC) were maintained in endothelial growth 
medium -2 bulletkit (EGM -2) containing penicillin (100 units /ml), streptomycin (100 µg /ml) and 
amphotericin B (2.5 pg /ml). The cells were incubated at 37 °C in a humidified atmosphere of 
5 % CO2, 95 % air. Passaging of the cells took place every 7 -9 days as described in section 
2.3.3. 
HCAEC were purchased from Biowhittaker UK Ltd. The certificate of analysis supplied with 
the cells stated that the HCAEC tested positive for the presence of vWF and acetylated LDL 
(an alternative method for the specific identification of endothelial cells in culture) (Voyta et 
al., 1984). HCAEC also displayed the characteristic morphology of endothelial cells as 
described above and cultures where non -endothelial contaminants were observed were 
discarded. 
c) Maintenance of bovine aortic endothelial cells 
Bovine aortic endothelial cells (BAEC) were maintained in endothelial growth medium 
bulletkit (EGM) containing penicillin (100 units /ml), streptomycin (100 µg /ml) and 
amphotericin B (2.5 µg /ml). The cells were incubated at 37 °C in a humidified atmosphere of 
5 % CO2, 95 % air. The cells were passaged every 7 -9 days as described in section 2.3.3. 
BAEC were purchased from Biowhittaker UK Ltd. The certificate of analysis supplied with the 
cells stated that the BAEC tested positive for acetylated LDL. In culture BAEC displayed the 
characteristic morphology of endothelial cells as described above and cultures where non - 
endothelial contaminants were observed were discarded. 
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d) Isolation and culture of epidermal keratinocytes from neonatal 
foreskins 
At circumcision, neonatal foreskins were placed into DMEM. The tissue was then 
transported on ice, and kept at between 2 and 8 °C until use. The foreskins were cut into 3 or 
4 pieces of equal size, and then rinsed in sterile petri dishes in 3 x 25 ml PBS (Ca2+ -and 
Mgt+ -free) containing antibiotics, fungizone (25 pg /ml) and penicillin (1000 U /ml) / 
streptomycin (40 pg /ml). The pieces of tissue were returned to a petri dish containing PBS 
where fat, blood vessels and as much dermis as possible were removed. The pieces of 
tissue were then placed into a 1 % dispase solution (10 ml) overnight, at 4 °C. 
Following incubation in dispase, the tissue was removed into a petri dish containing PBS. 
The epidermal layer was carefully lifted from the dermis using forceps, cut into smaller 
pieces, and placed into a centrifuge tube containing 50 ml trypsin -EDTA (0.025 %/0.01 
EDTA) solution. The epidermal tissue was incubated with the trypsin -EDTA at 37 °C for 10 to 
15 min, with occasional vortexing. Once the incubation time had finished, the action of the 
trypsin was stopped by the addition of 5 % foetal calf serum (v /v). The cell suspension was 
passed through a cell strainer (70 pm pore size) into a universal tube. 
The cells were centrifuged at 500 x g for 10 min at RT to gently pellet the cells. The cell 
pellet was gently resuspended in 5 ml DMEM and placed in a 25 cm2 tissue culture flask 
coated with fibronectin. After 1 to 2 days, the DMEM was replaced with Keratinocyte -SFM 
(GibcoBRL Life Technologies) containing bovine pituitary extract (BPE) (25 Ng /ml), 
recombinant epidermal growth factor (rEGF) (0.1 -0.2 ng /ml), fungizone (25 pg /ml) and 
penicillin (100 U /ml) / streptomycin (100 pg /ml). The cells were maintained in a humidified 
atmosphere of 5 % CO2, 95 % air at 37 °C. 
Upon reaching 60 - 75 % confluency, the keratinocytes were passaged. Since primary 
keratinocytes show variability donor to donor variability in their growth characteristics, the 
flasks of cells may take between 10 and 20 days to reach the required 60 - 75 % confluency 
following the isolation. To subculture the keratinocytes, the overlying medium was aspirated 
from the flask and the flask washed with approximately 10 ml PBS (Ca2+ -and Mgt + -free). 
The PBS was then aspirated from the flask and replaced with 2 ml trypsin (0.025 °/0/EDTA 
0.01 %) solution. The flask was then placed in the incubator at 37 °C for 5 - 10 min. Cell 
detachment was assessed under by light microscope. When approximately 90 % of the cells 
had detached, the trypsin/ EDTA solution was neutralised with 10 ml soyabean trypsin 
inhibitor, and the cell suspension transferred to a centrifuge tube. The cells were pelleted by 
centrifugation at 500 x g for 10 min at RT. The supernatant was then aspirated and the cells 
gently resuspended in 5 ml Keratinocyte -SFM. The number of cells were counted using a 
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haemocytometer and seeded at a density of approximately 1 -3 x 106 cells per 75 cm2 flask 
in 10 ml Keratinocyte -SFM. Cells were used between passage numbers 2 and 5. 
2.3.4 Preparation of Human Placental Cytosol 
Normal 40 -wk full -term placentas obtained within 2 hr of delivery were used, and all 
procedures were performed at 4 °C or on ice. The placenta ( -550 g) was cut into pieces 4 
cm3. Following removal of the umbilical cord and amniotic membrane, the pieces of placenta 
were washed with 2 L of 50 mmol Tris /HCI, pH 7.4, at RT, containing 1 mmol EDTA, 0.5 
mmol DTT (buffer A), and centrifuged at 30,000 x g for 1 hr. 
2.3.5 Assays for Thioredoxin Reductase (TR) Activity 
2.3.5.1 DTNB Assay 
a) Sample Preparation 
Cell pellets were stored at - 80 °C immediately following harvesting. Prior to assay, samples 
were removed from the freezer, thawed, resuspended in 200 pl (pellets from 75 cm2 flasks) 
or 250 pl (pellets from 225 cm2 flasks) 0.125 M phosphate buffer containing 1 mM EDTA and 
peroxide -free and carbonyl -free Triton X -100 (0.1 %) and lysed by sonication (three pulses of 
10 sec using a Soniprep 150 Sonicator) on ice. The lysates were centrifuged at 500 x g, and 
kept on ice until assay took place. The lysates were diluted 1 in 5 in assay buffer (10 mM 
EDTA, 0.2 mg /ml BSA in 100 mM potassium phosphate /50 mM potassium chloride buffer, 
pH 7.0) prior to assay. 
Samples were divided into two portions of 180 NI each. One portion was treated with 20 pl of 
gold thioglucose (GTG) to give a final concentration of 720 nM whilst the other portion was 
treated with 20 NI of assay buffer. The GTG was freshly prepared on the day of use using 
assay buffer as diluent, and incubation of sample with fresh GTG was at RT for 
approximately 10 minutes. The GTG solution was stored in the dark prior to use. 
b) Assay Conditions 
This assay is based on the conversion of the acceptor substrate DTNB to a yellow 
chromophore with an absorption max at 412 nm, according to the equation: 
DTNB (5, 5 "- dithiobis 2- nitrobenzoate) + NADPH + H+ - 2 TNB (thiolate thionitrobenzoate) 
+ NADP+ 
30 NI of sample was pipetted into a cuvette with 30 pl diluent (distilled H2O) and 190 pl of 
reagent. All samples were warmed to 37 °C prior to being read. The assay reagent 
comprised 5 mM DTNB, 0.24 mM NADPH, 10 mM EDTA, 0.2 mg /ml BSA in 100 mM 
potassium phosphate /50 mM potassium chloride buffer, pH 7.0. EDTA is necessary since 
mammalian TR is inhibited by heavy metal ions. Assay reagent was stored in the dark prior 
to use. The assay was performed on a Cobas FARA centrifugal analyser (Roche 
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Diagnostics, Welwyn Garden City, UK) with absorbance measurement at 412 nm over a 
period of 0.5 to 290.5 seconds. The absorbance was read once every 10 seconds following 
an initial reading at 0.5 sec, and the rate read by kinetic analysis over the linear portion of the 
curve (100.5 to 250.5 seconds). A GTG blank was run in parallel with the samples. The TR 
activity was calculated as the difference of the reaction rate in the presence and absence of 
GTG. Results were corrected for protein measured by the Bradford method (section 2.3.9) 
using BSA as standard. 
The extinction coefficient of TNB at 412 nm is 13.6 mM -1 cm-1 (Holmgren, 1977). TR activity 
is expressed in units per gram protein (U /g). One unit of mammalian TR activity is defined as 
1 µmol TNB formed per minute (Holmgren and Björnstedt, 1995). 
c) Quality control 
Four internal controls were prepared by diluting a pooled stock solution of human placental 
cytosol with FBS at two -fold, four -fold, sixteen -fold and thirty two -fold dilutions. The controls 
were constructed to cover the range of activities given by the different cell types in the assay, 
as assessed by historical data (- 0.25 to 5.0 U/g protein). The controls were dispensed into 
180 pl aliquots and frozen at - 80 °C. Good linearity was demonstrated for dilutions of human 
placental cytosol in the assay. 
d) Optimisation of gold thioglucose concentration in the DTNB assay 
In the original DTNB assay method described by Hill et al. (Hill et al., 1997), a concentration 
of 20 pM GTG was used to selectively inhibit TR activity to increase the specificity of the 
assay. Sample (TR source) is run in the presence and absence of GTG, with the difference 
between the two values of DTNB reduction (A412) being the activity due to TR. The 
concentration of GTG can be tailored to inhibit certain selenoenzymes by virtue of the fact 
that different selenoenzymes have differing sensitivities to inhibition by GTG (table 2.01). 
The GPXs are relatively resistant to inhibition whilst TR is very sensitive, having an IC50 -- 
1000 -fold lower than that of the GPXs (Gromer et al., 1998). Dose -response studies with 
GTG and human placental cytosol suggested that a final concentration of 727 nM GTG was 
optimal for maximal TR inhibition (figure 2.02). The apparent disparity between TR activity of 
the control cytosol (minus GTG) and the cytosol containing very low GTG concentrations may 
be due to a dilution effect in the cytosol containing GTG, which was not accounted for in the 
control cytosol. 
The final GTG concentration required to inhibit cyGPX activity in human placental cytosol was 
1000 pM, which inhibited cyGPX activity by 90 % in human placental cytosol (section 2.3.7) 
(figure 2.03). 
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Our studies revealed that GTG degrades if stored frozen in solution. In all studies GTG 
solutions were prepared fresh on the day of use, and used immediately. Dithiothreitol (DTT) 
was observed to give high background values in this assay system, requiring some samples 
to be treated to remove DTT prior to assay for TR. 
Table 2.01 IC50 values for the inhibition of human selenoenzymes by the gold 
compounds aurothioglucose (gold thioglucose) and auranofin (from Gromer et 
al.,1998). 
1050 value 










f) Intra -assay precision data 
Precision data for the intra -assay variation from one assay (3 duplicates of each pool were 
read during one assay run), is shown in table 2.02. 
Table 2.02 Intra -assay variation for four QC pools run in one assay for TR activity (CV 
denotes the Coefficient of variation) 
QC pool n Mean TR activity 
(U /g protein) 
SD CV ( %) 
1 3 4.992 0.936 18.8 
2 3 2.652 0.156 5.9 
3 3 1.560 0.078 5.0 
4 3 0.298 0.037 12.5 
g) Inter -assay precision data 
Inter -assay precision data was determined by running the controls in each assay for 11 
consecutive assays. The results are shown in table 2.03. 
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Table 2.03 Inter -assay variation for four QC pools run in eleven consecutive assays 
for TR activity (CV denotes the Coefficient of variation) 
QC pool n Mean TR activity 
(U /g protein) 
SD CV ( %) 
1 11 5.078 1.042 20.5 
2 11 2.338 0.492 21.1 
3 11 1.280 0.274 21.4 










-2.7 -2 -1.3 -0.6 0.07 0.76 1.46 2.16 2.86 3.56 4.26 
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--e-- Final activity 
Figure 2.02 The effect of gold thioglucose (GTG) on thioredoxin reductase (TR) 
activity in human placental cytosol. The GTG was added to the cytosol at final 
concentrations of 0.00186, 0.0093, 0.047, 0.233, 1.16, 5.8, 29, 145, 727, 3636, and 18,181 
nM. The arrow indicates the GTG concentration chosen to give optimal TR inhibition (> 90 
%) whilst giving the lowest possible GTG blank rate (727 nM GTG). Results shown are those 
of the mean of two experiments, where each GTG concentration added to cytosol was read 
in duplicate. Where the error bars are not visible, they lie within the symbol. The same 
preparation of human placental cytosol, and same preparation of GTG was used for each of 
the two experiments. 
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2.3.5.2 Insulin Assay for TR 
a) Sample preparation 
Sample preparation was as described in section 2.3.2.1 for the DTNB assay, except that 
GTG was not added to samples. 
b) Assay conditions 
20 pl of sample was pipetted into a cuvette with 180 pl of assay reagent. The samples were 
warmed to 37 °C for 120 sec prior to being read. The assay reagent comprised 0.8 mM 
insulin, 27 mM NADPH, and 0.4 mM oxidised thioredoxin in 50 mM sodium phosphate buffer, 
pH 7.0, containing 1 mM EDTA. Assay reagent was stored in the dark prior to use. The 
assay was performed on a Cobas FARA centrifugal analyser (Roche Diagnostics, Welwyn 
Garden City, UK) with absorbance measurement at 340 nm over the period 0.5 to 250 sec. 
The absorbance was read once every 5 sec following an initial reading at 0.5 sec, and the 
rate read by kinetic analysis. 
The thioredoxin system promotes the reduction of insulin using NADPH through a 
combination of the following reactions: 
Trx -S2 (oxidised thioredoxin) + NADPH + H+ -> Trx -(SH)2 (reduced thioredoxin) + NADP 
Trx -(SH)2 + oxidised insulin Trx -S2 + reduced insulin 
The thioredoxin system catalyses efficient reduction of the two interchain disulphides of 
insulin which is used in this thioredoxin -coupled assay system for TR. The assay monitors 
the oxidation of NADPH to NADP at 340 nm. The NADPH extinction coefficient used in the 
calculation is 6200 M -1 cm -1 (Arnér et al., 1999). 
2.3.6 Radioimmunoassay (RIA) of TR 
Thioredoxin reductase (TR) was measured using an 'in- house' radioimmunoassay developed 
in this laboratory by Dr. Forbes Howie, which has been described previously (Lewin et al., 
2001; Miller et al., 2001). 
a) Preparation of antisera 
Antisera were raised in rabbits to an immunogen of human TR purified from placenta. The 
secondary antibody was prepared by adding 25 ml of donkey anti -rabbit serum to 1.5 ml 
normal rabbit serum and mixing overnight at RT to precipitate out the immunoglobulins. 
Following centrifugation (230 x g, 5 min), the supernatant was discarded and the precipitate 
washed four times with 0.05 M phosphate buffer (pH 7.4) containing 0.1 % BSA and 0.02 
sodium azide. After the final wash the supernatant was removed and the pellet was 
resuspended in the same 0.05 M phosphate buffer as described above, to give a final volume 
of 100 ml. 
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b) Preparation of the assay diluent 
The assay was performed using a diluent of 25 mmol /L potassium phosphate buffer, pH 7.5, 
containing BSA 1 g /L, NaN3 0.2 g /L, and 10 mmol /L dithiothreitol. This diluent was used for 
both the antibody and the tracer. 
c) Preparation of 1251 -TR tracer, standards, controls and samples 
Purified human placental TR1 was iodinated by Dr Forbes Howie using the Bolton- Hunter 
iodination procedure (Bolton and Hunter, 1973). The 1251 -TR tracer was immediately diluted 
1:2 with FBS and stored at -20 °C for up to three months. For use in the radioimmunoassay 
the 1251 -TR tracer was diluted with assay diluent such that approximately 10,000 cpm was 
added to each tube (mass approximately 50 -100 pg TR/ tube). 
Standards were prepared by diluting a stock solution of purified placental human TR1 (1 mg 
TR /L) with FBS to give the following concentrations: 0.5, 1, 2, 5, 10, 25, 50 pg TR /L. Two 
controls were made by diluting a stock solution of human placental cytosol with FBS to give 
values of approximately 5 and 25 pg TR/ L. Both standards and controls were dispensed into 
aliquots and frozen at - 80 °C. 
Cell pellets were stored at - 80 °C immediately following harvesting. Prior to assay, samples 
were removed from the freezer, thawed, lysed by sonication, centrifuged and kept on ice until 
assay took place. Each sample was diluted with radioimmunoassay buffer between 1:50 and 
1:200. 
d) TR radioimmunoassay 
Antibodies, tracer, standards, controls and samples were all warmed to RT prior to set up of 
the assay. All samples, standards and controls were assayed in duplicate. For the assay 
100 pl of 1251 -TR tracer (15,000 cpm) was pipetted with 100 pl standard, control or sample. 
Primary anti -TR1 antibody (100 pl; final dilution 1 : 30,000) was then added to all tubes, with 
the exception of the total counts, which were vortexed and incubated at 4 °C overnight. 
The following day, pre -precipitated second antibody (donkey anti -rabbit serum) prepared as 
described above (section 2.3.6 a) was added to each tube (except the total counts), vortexed, 
and incubated at RT with shaking for 1 hour. Following this, 1.5 ml wash solution (0.05 % v/v 
Brij 35 and 0.001 % w/v microcrystalline cellulose) was added (except to the total counts 
tubes) and the tubes centrifuged at 3000 x g for 30 min at 4 °C. The supernatants were then 
removed by decanting and the radioactivity in the pellet counted on a 1261 MULTIGAMMA 
Gamma Counter (Wallac, Gaithersburg, MD, USA). The standard curve was plotted and 
results interpolated using a multicalc data processessing package (Wallac, Gaithersburg, 
MD, USA). 
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Results were corrected for protein measured by the Bradford method (section 2.3.9). The 
intra -assay precision of the TR radioimmunoassay was < 10 % coefficient variation over the 
range of concentrations measured. Controls were run as 9 replicates within a single assay to 
determine intra -assay precision. To determine the inter -assay precision, controls were 
included at the beginning and end of each assay. 
e) Infra -assay precision data 
The intra -assay variation was calculated from one assay (in which 9 duplicates of each pool 
(5 and 25 pg TR/ L) were read from a single standard curve, is shown in table 2.04. 
Table 2.04 Intra -assay variation for two pools run in one assay for TR concentration 
(CV denotes the Coefficient of variation) 
pools n Mean TR concentration SD CV ( %) 
(pg /protein) 
5pg TR/ L 9 5.062 0.733 14.473 
25,ug TR/ L 9 24.391 0.963 3.949 
f) Inter -assay precision data 
The inter -assay precision data was determined by running the controls in each assay for 12 
consecutive assays. The results are shown in table 2.05. 
Table 2.05 Inter -assay variation for two pools run in twelve consecutive assays for TR 
concentration (CV denotes the Coefficient of variation) 
pools n Mean TR concentration SD CV ( %) 
(pg /g protein) 
5,ug TR/ L 12 5.569 0.446 8.009 
25pgTR /L 12 25.151 2.811 11.176 
g) Detection range of TR radioimmunoassay 
A precision profile was constructed to determine the functional sensitivity of the assay, 
calculated from 9 consecutive assays. The minimum detection limit of the TR RIA was 
calculated as 1.50 pg TR /L which represented the TR concentration which had a CV of 22.5 
%. The working range of this assay was 3.50 - 50.0 Ng TR /L and was defined as the 
concentration range which had a CV of less than 10 %. 
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2.3.7 Cytosolic glutathione peroxidase (cyGPX) assay 
Cell pellets were stored at - 80 °C immediately following harvesting. Samples were then 
transported on dry ice to the Rowett Research Institute, Aberdeen, UK where cytosolic 
glutathione peroxidase (cyGPX) activities were measured by Miss Karen Pickering or Mr 
Fergus Nicol of the Rowett Research Institute using a method previously described by 
Beckett et al. (Beckett et al., 1990). Some cyGPX assays were carried out by the author at 
the Rowett Research Institute. 
cyGPX activity in human placental cytosols was measured in -house using an assay method 
adapted for use on the Cobas Fara centrifugal analyser. 
cyGPX activity was determined by following the rate at which NADPH2 is converted to NADP+ 
measured as a change in absorbance at 340 nm in the presence of the substrate hydrogen 
peroxide (detailed in equation below), using a Unicam UVNis spectrometer (UV4) linked to a 
computer installed with `Vision' software in the case of cell lysates, or using a Cobas Fara 
centrifugal analyser. 
The reaction catalysed by cyGPX utilised for its assay is as follows: 
2GSH (reduced glutathione) + H2O2 (hydrogen peroxide) -> GSSG (oxidised glutathione) + 
2H2O 
Reduced glutathione, hydrogen peroxide, glutathione reductase and NADPH2 are added in 
excess such that the rate limiting step is glutathione peroxidase. The GPX activity is directly 
related to the rate of change of NADPH2 to NADP+ which is followed at 340 nm. 
A unit of cyGPX is defined as that which oxidises 1 Nmole of NADPH per min. The molar 
extinction coefficient of NADPH is 6200 M-1 cm-1. The blank rate was subtracted from the 
rate obtained after substrate addition. The conversion factor for the assay when a 20 pl 
sample was used was 8.0385. 
a) Preparation of samples and standards 
The homogenisation buffer was prepared as follows. 50 pl aliquots of peroxide -free, 
carbonyl -free Triton X -100 were stored under argon in HPLC vials. 50 pl of Triton X -100 was 
removed from a vial with a syringe into an Eppendorf tube, and kept on ice. 50 ml of buffer 
(0.125M KPO4; 1 mM EDTA; pH 7.4) was placed in a beaker and kept on ice. The Triton X- 
100, to solubilise cell membranes, was added to the buffer, which was thoroughly stirred. 
Cell pellets were thawed and resuspended in 200 pl (pellets from 75 cm2 flasks) or 250 pl 
(pellets from 225 cm2 flasks) 0.125 M phosphate buffer containing 1 mM EDTA and 
peroxide -free and carbonyl -free Triton X -100 (0.1 %) as described above. The cell pellets 
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were lysed by sonication (three pulses of 10 sec) on ice. Purified cyGPX was used as a 
positive control. 
b) Preparation of the reaction mix 
A reaction mix was made up of the following: 5 mg NADPH2, 46 mg reduced glutathione, 3 
ml distilled H20, 24 ml PBS (pH 7.6), 1 ml sodium azide (112.5 mM), 20 U glutathione 
reductase and 0.1 % peroxide- and carbonyl -free Triton X -100. The reaction mix was placed 
in a water bath at 37 °C. 
To measure cyGPX activity using a Unicam UVNis spectrometer, 990 pl reaction mix was 
added to 10 pl sample in a 1 ml glass cuvette. The blank rate was followed for 5 cycles at 
340 nm for approximately 3 min. To start the reaction 20 pl of the substrate hydrogen 
peroxide solution (2.2 mM) was added, and the subsequent reaction rate was followed for a 
further five cycles at 340 nm. 
To measure cyGPX activity in human placental cytosol using a Cobas Fara centrifugal 
analyser, 15 pl sample was automatically pipetted along with 30 pl diluent (distilled H20) and 
180 pl reaction mix into a cuvette. The blank rate with H2O in place of the substrate was also 
measured. The reaction was started by addition of 5 pl of the hydrogen peroxide substrate 
solution, and the subsequent reaction rate was followed for 100.5 sec at 340 nm. The first 
reading was taken at 0.5 sec, with each subsequent reading at 5 sec intervals. 
The concentration of gold thioglucose (GTG) required to inhibit cyGPX activity in human 
placental and human liver cytosols was investigated to compare to results for inhibition of TR 
activity in human placental cytosol. Inhibition of cyGPX activity in human placental and liver 
cytosols by GTG concentrations of 1, 10 and 100 pM GTG did not produce any loss of 
cyGPX activity in human placental or liver cytosol (figure 2.03 a). The IC50 of GTG for cyGPX 
activity in human placental cytosol and liver cytosol was - 150 pM and 300 pM, respectively. 
In comparison, the IC50 of GTG for TR activity in human placental cytosol was - 87 nM 
(figure 2.02). These data are comparable to those of Gromer et al. (Gromer et a/.,1998) 
(table 2.01). 
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Figure 2.03 Inhibition of cytoplasmic glutathione peroxidase (cyGPX) activity in 
human placental and liver cytosols by gold thioglucose (GTG). GTG was added at a 
final concentration of (a) 1 to 10,000 pM or (b) 150 to 900 pM. Results shown are those of 
the mean of duplicate samples + SD. The basal level of activity in control cytosols is 
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2.3.8 Phospholipid hydroperoxide glutathione peroxidase (PHGPX) 
assay 
Cell pellets for measurement of phospholipid hydroperoxide glutathione peroxidase (PHGPX) 
activities were stored and transported as described for cyGPX activity measurement (section 
2.3.5). 
The same protocol was used for the measurement of PHGPX activity as for cyGPX activity 
measurement described in section 2.3.5 with the only exception being an alternative 
substrate of phosphatidyl choline hydroperoxide (PCOOH), and purified PHGPX was used as 
a control to quantify this substrate. The conversion factor for the calculation of the results 
was the same as that used in the cyGPX activity assay which was 8.0385. 
a) Substrate synthesis 
Substrate synthesis was performed at least the day before the assay. The substrate PCOOH 
was prepared by dissolving 20 mg phospatidyl choline in 3 ml of 3 % deoxycholate. This was 
then diluted with 21 ml of 0.2 M sodium borate buffer, pH 9.0, to which 100 pl of lipoxidase 
was added. The solution was placed in a water bath at 37 °C for 1 hr with oxygen passed 
through the mixture every 15 min. 
After the incubation step, the substrate was passed through a SepPak C18 cartridge which 
had been previously washed with 50 ml methanol and equilibrated with 50 ml distilled H2O. 
The column was than washed with 50 ml distilled H2O and all the air flushed out all with a 20 
ml syringe. The PCOOH substrate was eluted into a clean tube with 2 ml methanol. The 
substrate could be stored at -40 °C for up to 2 months. A unit of PHGPX is defined as that 
which oxidises 1 pmole of NADPH per min. 
2.3.9 Bradford Assay 
Protein measurements were carried out utilising the dye- binding assay of Bradford (1976) 
(Bradford, 1976) adapted for use on the Cobas Fara centrifugal analyser (Roche Diagnostics, 
Welwyn Garden City, UK). 
The Bradford reagent was prepared by dissolving 100 mg Coomassie Brilliant Blue G -250 in 
50 ml 95 % ethanol. To this solution was added 100 ml 85 % (w /v) phosphoric acid, and the 
mixture stirred for 30 min. The resulting solution was diluted with distilled H2O to a final 
volume of 1000 ml, filtered through Whatman grade 1 filter paper and stored at RT in a 
closed bottle. 
Bradford reagent (256 pl) was added to each cuvette, which was incubated for 100 sec at 
37 °C prior to sample addition, with an initial absorbance reading (595 nm) taken at 95 sec. 
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Following the addition of 25 pl of sample plus 50 pl distilled H2O (diluent) to the cuvettes, a 
further incubation took place for 180 sec at 37 °C. A final absorbance was then read at 595 
nm. 
A standard curve was constructed using bovine serum albumin (BSA) as standard, and 
distilled H2O as the diluent, covering the range 0 to 100 mg /L. The difference between the 
final and initial absorbances was calculated, and a standard curve plotted. The protein 
concentrations of samples were interpolated from the standard curve. Samples were diluted 
with distilled H2O to fall in the middle portion of the standard curve. A quality control (QC) 
was run with every rotor to assess the reproducibility of the results. 
2.3.10 Sodium -dodecyl sulphate- polyacrylamide gel electrophoresis 
The [75Se]- selenoproteins in cell lysates were separated by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS- PAGE). Samples were prepared for 
electrophoresis by diluting each sample to a common protein concentration with 60 mM Tris 
buffer, pH 7.8 at RT, containing 1 mM EDTA and 1 mM dithiothreitol. The diluted samples 
were further diluted 2:1 (sample: "boiling mix ") with "boiling mix" (SDS 35 mM, glycerol 1.4 
mM, 2- mercaptoethanol 0.3 mM and bromophenol blue 15 mM) and heat -treated at 90 °C for 
10 min. 
One -dimensional electrophoresis was carried out at RT using a Protean Il electrophoresis 
system (Bio -Rad Laboratories Ltd, Watford, Herts, UK). The discontinuous gel (0.1 cm x 
16.5 cm x 18 cm) was cast as two separate gels sandwiched between two glass plates, set in 
a casting stand. The lower 12 % resolving gel (14 cm long) was made up of 17 ml distilled 
H2O; 32 ml acrylamide solution (30 % acrylamide, 0.8 % bis- acrylamide); 30 ml 1M Tris/ HCI, 
pH 8.85; 0.8 ml 10 % SDS; 0.15 ml N,N,N',N' -tetramethylethylene diamine (TEMED); 0.15 ml 
0.1 % ammonium persulphate. The upper stacking gel (approximately 4 cm long) consisted 
of 32 ml distilled H2O; 7.2 ml acrylamide; 20 ml 0.375 M Tris/ HCI, pH 6.8; 0.6 ml 10 % SDS; 
0.2 ml TEMED; 0.2 ml 0.1 % ammonium persulphate. Once set the gel sandwiches were 
removed from the casting stand and transferred to the buffer chamber. The upper and lower 
buffer chambers were filled with SDS -electrophoresis buffer (0.3 % (w /v) Tris; 1.44 % glycine; 
0.1 % SDS); low range molecular weight markers (14.4 kDa - 97.4 kDa) and samples were 
loaded into the wells. The gel was run at 200 volts (V), 35 milliamperes (mA), 50 watts 
through the stacking gel until the bromophenol blue tracking dye entered the resolving gel, 
when the voltage and current was increased to 300 V and 50 mA respectively. The power 
supply was disconnected once the tracking dye had reached the bottom of the resolving gel. 
The gels were stained in 0.2 % (w /v) Coomassie Brilliant Blue R in a methanol: acetic acid: 
distilled H2O solution (50: 7: 50 ratio) for 30 min, and then destained in two changes of a 
methanol: acetic acid: distilled H2O solution (5: 7: 88 ratio) overnight. 
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The gels were then dried under vacuum in a Bio -Rad gel drier (model 583) at 80 °C for 2 hr, 
sandwiched between two layers of pre- soaked cellophane. 
2.3.11 Autoradiography of SDS -PAGE gels 
[75Se]- labelled selenoproteins were visualised by autoradiography using Kodak X -OMAT 
XAR -5 film. The dried gels were placed next to film within an exposure cassette at - 80 °C for 
between 12 hr and 4 days. Films were developed by the Department of Radiology, The 
Royal Infirmary of Edinburgh. The molecular weights of the standard protein molecular 
weight markers were plotted against the distance travelled, and a curve fitted using the 
program Fig P (Fig P Software Incorporation, Durham, NC, USA), which was used to 
determine the molecular weights of selenoproteins. 
2.3.12 Preparation of low- density lipoprotein 
Low density lipoprotein (LDL) was isolated from 300 -450 ml outdated human citrate plasma 
(Blood Transfusion Service, Edinburgh) by ultracentrifugation using a Ti 45 rotor in a 
Beckman instrument (L8.55 ultracentrifuge, Beckman, Glenrothes, UK). 
Plasma (45 ml) was overlayered with 15 ml of a buffered saline solution (p1.019 g /ml) 
containing EDTA (10 mg /L) and centrifuged for 18 hr at 186,000 x g max at 4 °C. The very low 
density lipoproteins were discarded. The density of the infranatant was adjusted to 1.063 
g /ml by addition of 14.7 ml of buffered saline (p 1.182 g /ml), overlayered with 5.3 ml of saline 
solution (p 1.063 g /ml) and re- centrifuged for 18 hr at 186,000 x g. The LDL fraction was 
removed and transferred into a 30 cm long dialysis tube (7.5 mm diameter, Spectra/Por, MW 
cut -off 300,000; Medicel, London) and dialysed overnight against 5L PBS (pH 7.4, 0.2 g/L 
chelex resin). The combined dialysates of known protein concentration were divided, one 
part was kept as native LDL (control experiments) and the other was used to prepare 
oxidised LDL (oxLDL) as follows. Approximately 25 ml native LDL was oxidised at 37 °C 
using 20 pM CuC12 (Cu- protein ratio 0.16 pmoles /mg protein), and the formation of 
conjugated dienes monitored at 234 nm. A Pye Unicam SP8 -100 UV Spectrophotometer, 
equipped with a Techne Circulator C400 set at 37 °C, was used to monitor diene formation at 
234 nm, using matched quartz cuvettes (1 cm path length). At peak absorbance (usually 60- 
90 min after initiation), 10 % excess EDTA was added to stop lipid peroxidation and the 
volume of the lipoprotein fraction was reduced to - 5 -10 ml using a 30,000 MW cut -off 
polyethersulfone filter and an Amicon 52 filtration unit (Amicon Millipore, Bedford, MA, USA). 
Traces of Cue+ were then removed by chromatography over a Sephadex G25M column (PD- 
10; Amersham Pharmacia Bio- Technics, Uppsala, Sweden) using PBS as the eluent (one 
pass). The tube containing oxLDL was flushed with a 0.22 p- filtered stream of argon and 
2 -20 
Materials and methods Chapter two 
stored at 4 °C until required. Native LDL was treated in an identical manner (filtration, 
chromatography, storage under argon) except the fraction was never exposed to Cue +. 
Both native and oxidised LDL were stored under argon, at 4 °C, prior to use. LDL was used 
for toxicity experiments within 3 weeks of preparation. 
2.3.13 Lactate dehydrogenase activity assay for cell damage 
measurements 
Cell damage was assessed as the percentage retention of lactate dehydrogenase (LDH) by 
the cell layer. Intracellular and extracellular LDH activity, in the cell lysates and culture 
medium respectively, was determined by following the rate at which NADH is oxidised to 
NAD+ measured as a decrease in absorbance at 340 nm in the presence of pyruvate using 
an LDH kit method (Sigma Diagnostics Ltd, Poole, UK) modified for use on the Cobas Fara 
centrifugal analyser (Roche Diagnositcs, Welwyn Garden City, U.K.). The rate of decrease in 
absorbance at 340 nm, measured at 37 °C, is directly proportional to LDH activity in the 
sample. The results were expressed as % LDH activity retained, calculated as follows: 
intracellular LDH activity /(extracellular LDH activity + intracellular LDH activity) x 100 
a) Preparation of reagents 
LDH reagent A, when reconstituted, contained NADH (0.194 mM) in phosphate buffer, pH7.5 
(54 mM). LDH reagent B, when reconstituted, comprised a solution of pyruvate (16.2 mM) to 
which non -reactive stabilisers and filler had been added. Both reagents were reconstituted by 
the addition of deionized H2O as indicated on the vial. After addition of H2O, the vial was 
stoppered and mixed by gentle inversion several times. 
b) Sample Preparation 
All cells for cell viability studies were plated into 24 well plates at a density of 5 x 105 cells /cm2 
for EAhy926 cells, 2 x 105 cells /cm2 for HaCaT cells, and 3,000 cells /cm2 for HUVEC. 
Immediately after treatment with t- BuOOH, menadione or oxidised LDL the culture medium 
(1 ml) was removed from the cells and placed into pre -labelled Eppendorfs tubes. Cells were 
then washed twice with 1 ml phosphate buffered saline (PBS, pH 7.4) and the cells lysed in 
0.5 ml of 0.5 % Triton X -100 (in PBS, pH 7.4). After 15 min the cell lysates were collected 
into pre -labelled Eppendorfs tubes. The wells were washed with a further 0.5 ml PBS and 
the washings combined with the respective lysates. Cell debris in the culture medium and 
cell lysates was removed by micro -centrifugation of all samples at 11,000 x g for 10 min prior 
to assay for LDH activity. 
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c) LDH activity assay 
Samples (100 pl) were transferred into Cobas cups for LDH activity measurement. The 
change in absorbance at a wavelength of 340 nm was measured in 10 pl of sample in a final 
volume of 290 pl (250 pl reagent A and 10 pl reagent B, and 20 pl of distilled H2O as diluent). 
The sample, diluent and reagent A were pipetted into the cuvettes and incubated at 37 °C for 
60 sec before addition of reagent B and diluent. The change in absorbance of the reaction 
mixture was read at 0.5 sec, and was then read every 5 sec for a total of 20 readings. The 
LDH activity was expressed as units per litre (U /L) as determined by kinetic analysis. 
The LDH activity was also measured in culture media that had not been in contact with cells 
as a measure of endogenous LDH in the culture medium, as well as Triton X -100 and PBS 
(lysis conditions). These blank values were subsequently subtracted from each extracellular 
and intracellular LDH activity. The LDH activity in both the medium and cell lysates was then 
calculated as described above. Precinorm® U (a commercially produced `universal control 
serum'; Boehringer Mannheim) was used for quality control for every run of the assay. 
2.3.14 Trypan Blue Assay for cell damage measurements 
a) Sample Preparation 
As detailed in section 2.3.13, all HaCaT cells for viability studies were passaged into 24 well 
plates. Immediately after the respective treatment period with menadione, or following 48 hr 
after UVB treatment, the culture medium (1 ml) was removed from the cells and placed into 
pre -labelled Universal tubes and put aside. The cells were then washed twice with 1 ml 
EBSS, and all the cells except the first two wells of the 24 well plate received fresh medium. 
The cells from the first two wells were trypsinised with 0.25 % trypsin -EDTA (0.5 ml). Cell 
detachment was checked by light microscope, and the trypsin neutralised with FBS- 
containing medium (0.5 ml). The cell suspension was then added to the medium that had 
previously been put aside, and centrifuged at 500 x g for 10 min. The trypsin- medium was 
aspirated from the cells, and the cell pellet gently re- suspended in 100 pl EBSS. 
b) Assessment of cell damage 
10N1 of the cell suspension was mixed with 10 pl of 0.4 % trypan blue solution, and 10p1 of 
the resultant mixture added to a haemocytometer. The suspension was then left for 1 min to 
allow the cells to settle; the cells remained uncounted for no longer than 2 min since viable 
cells begin to take up the trypan blue stain after this time. 
One hundred cells were counted, noting the proportion of these cells that had taken up the 
dye. The number of cells that had taken up the dye gave a measurement of the percentage 
of damaged /non -viable cells, calculated as follows: (N° blue cells/Total cells counted) x 100. 
The scoring of cells was by two independent observers, one reading blind. 
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For experiments in which cell viability assessments were being compared for both LDH 
release and trypan blue uptake for the same cells, the culture medium (1 ml) that had been 
removed from the cells and placed into pre -labelled Universal tubes was centrifuged at 500 x 
g for 10 min. The medium was removed into Eppendorf tubes for LDH analysis (being re- 
centrifuged at 11,000 x g for 10 min prior to LDH assay), while the cell pellet was treated as 
described above for trypan blue analysis. 
2.3.15 Assay of total glutathione 
The total glutathione (oxidised plus reduced) concentration of cell lysates was determined 
using the method of Tietze (Tietze, 1969) adapted for use on the Cobas Fara centrifugal 
analyser (Roche Diagnositcs, Welwyn Garden City, UK). 
The assay reagent was prepared by dissolving 0.007 g NADPH and 0.010 g DTNB in 25 ml 
assay buffer (150 mM NAPO4; 7.5 mM EDTA, pH 7.5). The start reagent was prepared by 
diluting glutathione reductase to a final concentration of 10 U /ml with assay buffer (150 mM 
NAPO4; 7.5 mM EDTA, pH 7.5). 
a) Sample preparation 
Cell lysates were deproteinised using 3.3 % sulphosalicylic acid. The cells in each well of the 
24 well culture plate were washed twice with 1 ml PBS. The 3.3 % sulphosalicylic acid (100 
pl /well) was then added to each well, and the plate was placed in a - 80 °C freezer for 15 min. 
The plate was then removed from the freezer to allow to defrost, and the freeze /thaw cycle 
repeated. The cell lysates were centrifuged at 13,500 x g for 5 min prior to assay for total 
glutathione. 
b) Assay conditions 
Sample (10 pl), diluent (25 pl H2O), and assay reagent (150 pl) were pipetted into each 
cuvette and incubated for 60 sec at 37 °C. The start reagent (50 pl) was then added to each 
cuvette, and reading commenced. The initial absorbance reading (412 nm), was taken at 0.5 
sec; after this readings were taken every 5 sec for a total of 50 sec. The rate was then 
determined by kinetic analysis. 
c) Preparation of standard curve 
Glutathione (GSH) standards were used at a concentration range of between 0 -100 pmol/L. 
Unless otherwise stated GSH standards were dissolved in 3.3 % sulphosalicylic acid. The 
change in absorbance reading resulting from the addition of the standard was used to 
construct a standard curve. Samples with unknown GSH concentrations were then 
interpolated from this curve. 
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2.3.16 Measurement of Se content of individual cell culture media 
The Se contents of cell culture media were determined by acid digestion followed by 
fluorimetric analysis (Boyne and Arthur, 1986; Olsen et al., 1975). The method used is 
based on the formation of piazselenol between Se and 2,3- diaminonaphthalene, followed by 
extraction with cyclohexane and fluorometry. The samples were read from a standard curve, 
prepared from 1 mg /ml selenious acid. A dried blood standard was used as a control. These 
analyses were performed by Mr Fergus Nicol of the Rowett Research Institute, Aberdeen, 
UK. 
2.3.17 Measurement of HDL cholesterol in foetal bovine serum 
The foetal bovine serum (FBS) used to supplement cell culture media was measured for its 
LDL content since several experiments involved adding exogenous oxLDL as a cytotoxic 
agent. The endogenous LDL in FBS was estimated by measurement of the HDL cholesterol, 
using an assay system based on formation of HDL -polymer and LDL -polyanion complexes, 
followed by destruction of HDL particles by detergent, and initiation of an enzyme reaction 
with HDL- derived cholesterol. Only the HDL in cholesterol is subject to cholesterol 
measurement. The N- geneousTM HDL Cholesterol Reagent used was supplied by the 
Genzyme Corporation, Cambridge, Massachusetts, USA. 
2.3.18 Electrophoresis of Lipoproteins 
Lipoprotein samples were separated by electrophoresis at low voltage using agarose gels 
according to their net charge at pH 8.6. A Lipoprotein Electrophoresis kit was used 
(Beckman, CA) in conjunction with a Paragon Electrophoresis System (Beckman 
Instruments, Palo Alto, USA). Increased electrophoretic mobility was used as a measure of 
oxidation of the LDL protein moiety. 
Lipoprotein samples were loaded onto pre -cast agarose (0.5 %) gels at a volume of 5 pl. 
The samples were left for 5 min to diffuse into the gel. Excess sample was then removed 
with a gel blotter, and the gel was placed into a Gel Bridge Assembly. The Gel Bridge 
Assembly was then placed into a Paragon Electrophoresis cell containing 45 ml B -2 barbital 
buffer (50 mmol /L 5,5- Diethylbarbituric acid sodium salt, pH 8.6). This was covered with a 
lid, and the complete Electrophoresis cell inserted into a Paragon power supply unit. The gel 
was electrophoresed at 100 V for 30 min. Upon completion of electrophoresis, the gel was 
removed from the Electrophoresis cell and placed into a Gel frame to facilitate staining. The 
gel was placed into fixative solution (60 % ethanol v /v, 30 % distilled H2O v /v, 10 % glacial 
acetic acid v /v) for 5 min. After fixing, the back of the gel was wiped to remove excess 
fixative, and the gel was dried in an incubator at 40 °C until completely dry (- 30 min). The 
dried gel was then processed in the following solutions in order: Lipoprotein working stain 
(Sudan Black B stain, 0.07 (3/0) for 5 min; Destain solution I (45 % v/v ethanol, 55 % v/v 
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distilled H2O) for 3 dips; Destain solution II (as Destain I) for 3 dips; Destain solution Ill (as 
Destain I) for 5 min. The gel was rinsed in distilled H2O, and placed in an incubator until fully 
dried, as detailed above. 
Results are expressed as relative electrophoretic mobility (REM), the migration of sample 
LDL relative to the mobility of the LDL band in normal serum. Normal control serum was 
electrophoresed in conjunction with sample LDL on each individual gel. 
2.3.19 Immunohistochemistry 
For the studies investigating the cellular localisation of TR (section 3.2.5 and 4.2.3), 
immunohistochemistry was employed. Briefly, HaCaT cells, human primary keratinocytes, 
EAhy926 cells, and HUVEC were grown to approximately 70 % confluence on 22 x 22 cm 
sterile glass coverslips in 6- well culture plates. Each respective culture medium was 'Se- 
deficient `unless stated. The medium was aspirated from the cells, and each well washed 
twice with 4 ml PBS. The glass coverslips were then removed from the culture plates into a 
shallow dish of acetone for 2 -3 min to fix the cells. After fixing, the glass coverslips were 
rinsed with fresh PBS, and placed back into the wells of the original culture plates which had 
been filled with absolute ethanol. The cells remained preserved in this state at 4 °C until 
immunohistochemistry took place. 
Immunohistochemistry for TR was carried out by Mr Craig Walker, Department of 
Dermatology, University of Edinburgh. Staining took place in a humidity chamber, with the 
coverslips placed `cell side down' onto a microscope slide primed with 100 pl of the 
respective reagent. 
The fixed coverslips were transferred into a coverslip staining rack and rinsed via immersion 
in two changes of Tris buffer containing 0.1 % BSA. The coverslips were placed in a 
humidity chamber at RT, where they were treated with 20 % normal swine serum (NSS) for 
10 min. The NSS was then drained from the coverslips and replaced with rabbit anti -human 
TR antibody at a dilution of 1:200. Incubation with the TR antibody was for 16 hr at 4 °C. 
Non -immune rabbit serum was used as a negative control in place of the primary antibody. 
The coverslips were then washed twice for 5 min in Tris buffer. The secondary antibody 
used was biotinylated swine anti -rabbit immunoglobulins, diluted 1:400. Treatment with the 
secondary antibody was for 30 min at RT, after which the coverslips were washed twice for 5 
min in Tris buffer. Avidin- Biotin Complex Alkaline Phosphatase was applied to the coverslips 
for 30 min, after which the coverslips were again washed twice for 5 min in Tris buffer. 
Visualisation was with freshly -prepared NBT /BCIP (Nitro -Blue tetrazolium chloride/5- Bromo- 
4-chloro-3-indolyl phosphate) at a 1:50 dilution (in 0.1 M Tris, pH 9.5; 50 mM MgCl2; 0.1 M 
NaCI) for 1 hr at RT. After this time, the coverslips were washed thoroughly in tap H2O and 
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mounted onto microscope slides using a small drop of Aquamount. The slides were 
examined under a Leitz Ortholux 2 microscope fitted with a Leica HBO 50W mercury vapour 
lamp using a Kodak Wratten No. 47B excitation filter and a Kodak Wratten No.12 barrier 
filter. The cells were photographed with a Leitz Vario Orthomat 2 camera using an 
Ektachrome 400 film. 
2.3.20 Ultraviolet irradiation of cells in vitro 
Prior to irradiation with UVB, HaCaT cells were grown to 70 % confluence in 24 well culture 
plates. Before irradiation the medium was removed from the wells into sterile containers to 
be replaced after irradiation. The cells in each well were then washed twice with 1 ml PBS, 
and covered with 0.5 ml PBS per well for the irradiation procedure. Cells were irradiated in 
their tissue culture plates without the lids on, with broadband UVB from a bank of two TL- 
20W/12 lamps (Philips, Croydon, UK) with an output range of 270 -350 nm (peak at 308 nm). 
The irradiation dose was 80 mW /cm2 at a vertical distance of 30 cm from the tubes (Kondo et 
al., 1993). An IL -1400A radiometer with a SEL240 /UVB 1/TD UVB detector (International 
Light Inc., Montreal, Canada) with a spectral sensitivity range of 280 -320 nm was used to 
quantify the UVB dose in Joules per square metre (J /m2) output that the cells received. 
The output of the lamps was determined by Dr Neil Gibbs of the Photobiology Unit, Ninewells 
Hospital, Dundee, using a spectroradiometer (model 742, Optronic Laboratories) across the 
spectral range 250 - 400 nm. The tube target distance was 16 cm. The spectral output is 
shown in figure 2.04. 
Cell viability following UVB irradiation was assessed either by trypan blue assay (section 
2.3.14) or LDH assay (section 2.3.13). 
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Figure 2.04 Emission spectrum for TL- 20W/12 UVB lamps. The output of the lamps was 
determined using a spectroradiometer (model 742, Optronics Laboratories) across the 
spectral range 250 - 400 nm. The tube target distance was 16 cm. 
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CHAPTER THREE 
THE ROLE OF THIOREDOXIN REDUCTASE IN THE 
PREVENTION OF OXIDATIVE DAMAGE TO THE 
ENDOTHELIUM BY SELENIUM 
3.1 INTRODUCTION 
3.1.1 Endothelial cells and oxidative stress 
Endothelial cells (EC), because of their unique location, are continually exposed to a pro - 
oxidant environment in the vasculature, and thus to the possibility of oxidative stress and 
damage by reactive oxygen species (ROS) such as O2'-, hydroxyl radicals, H202, lipid 
peroxides and hydroperoxides, and singlet oxygen. For example, when neutrophils are 
activated by various kinds of stimuli, they produce and release H202 and lipid 
hydroperoxides. The activation of EC themselves generates ROS and may therefore make 
a contribution to the oxidant -rich environment. Shear stress and turbulent blood flow can 
produce oxidative damage (Hishikawa and Löscher, 1997) by induction of O2'- (De 
Keulenaer et al., 1998) and ONOO- (Go et al., 1999) formation. Shear stress, created by the 
dragging force generated by blood flow, can also induce LOX -1 (Murase et al., 1998), which 
can produce ROS upon binding of oxLDL (Cominacini et al., 2000). Shear stress is a critical 
mechanism for eNOS activation, producing NO' (Patel et al., 2000). Oxidative stress is 
documented to increase vascular endothelial permeability, thereby causing barrier 
dysfunction (Lum and Roebuck, 2001). 
3.1.2 Selenium and cardiovascular disease 
Oxidative damage to the endothelium is one of the principle mechanisms in the 
pathogenesis of atherosclerosis (Gimbrone, 1995; McGorisk and Treasure, 1996; Ross, 
1993). Cytoprotection against oxidative damage is accomplished by an array of enzymatic 
and non -enzymatic antioxidant systems. In the endothelial cell these systems consist 
principally of antioxidant vitamins, superoxide dismutase (SOD), catalase and selenoproteins 
such as the glutathione peroxidases (GPX) and possibly thioredoxin reductase (TR). 
Low plasma Se levels in humans have been associated with an increased risk of 
cardiovascular disease, including coronary atherosclerosis (Kok et al., 1991; Nève, 1996; 
Salonen et al., 1982; Suadicani et al., 1992). Se deficiency can result in an accumulation of 
fatty acid peroxides in the heart and lead to the formation of substances that enhance 
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formation of clots (Masukawa et al., 1983). Cells cultured under Se- deficient conditions 
accumulate LOOHs more rapidly under conditions of oxidative stress than control cells, and 
die more rapidly (Geiger et al., 1993; Lin et al., 1992). Se- deficiency increases the 
susceptibility of BAEC to cytotoxic damage by tert -butylhydroperoxide - (t- BuOOH) (Hara et 
al., 2001). 
Resistance to oxidative damage is conferred on EC in vitro that receive Se supplementation 
(Ochi et al., 1992; Thomas et al., 1993). Ochi et al. demonstrated a dramatic decrease in the 
toxicity of the hydroperoxide (15S)- hydroperoxy -(5Z), (8Z), 11(Z), 13(E)- eicosatetraenoic 
acid ((15S)- HPETE) (which occurs in vivo by oxygenation of arachidonic acid by arachidonic 
acid 15- lipoxygenase) (Björnstedt et al., 1995) using sodium selenite and ebselen (a 
synthetic glutathione peroxidase mimic) pre- incubations (Ochi et al., 1992). These findings, 
and subsequent investigations manipulating the glutathione redox cycle, suggest that (15S)- 
HPETE- induced cytotoxicity could be attributed to decreased GPX activity. 
In agreement with Ochi et al., Thomas et al. proposed that an observed decrease in both t- 
BuOOH and photogenerated oxidized low density lipoprotein (oxLDL)- mediated cytotoxicity 
to Se- supplemented BAEC resulted from an increased expression of both cytoplasmic 
glutathione peroxidase (cyGPX) and phospholipid hydroperoxide glutathione peroxidase 
(PHGPX) (Thomas et al., 1993). 
3.1.3 Selenoenzymes and the cardiovascular system 
The involvement of other selenoenzymes such as TR has yet to be fully investigated in such 
a protective role, but human EC express very high concentrations of TR. The above - 
mentioned studies used bovine EC; there have been some studies of cytotoxicity and 
protection in human EC (Cho et al., 1999; Harlan et al., 1984; Varani and Dame, 1995), but 
none using Se. Bovine cells may be a poor model for human EC, however, since TR may 
not be as important for antioxidant protection as it is in human EC. 
Differences in the expression of intracellular selenoproteins occur between EC isolated from 
different vascular beds, and clear differences exist in selenoprotein expression in EC of 
different species. It is possible, therefore, that the antioxidant systems of EC may vary 
between cells isolated from different vascular beds and different species. Extracellular SOD 
in the aortic wall is known to vary widely between species (Stràlin et al., 1995). BAEC 
contain significantly higher activity of SOD and catalase than rabbit aortic EC (Steinbrecher, 
1988). 
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The GPXs are considered to exert powerful antioxidant function in the cell cytoplasm 
(Brigelius -Flohé, 1999), and the expression of the GPXs can be increased in situations of 
oxidative stress (de Haan et al., 1998; Mitchell et al., 1996). cyGPX catalyses the reduction 
of a variety of hydroperoxides including hydrogen peroxide, cumene hydroperoxide, t- 
BuOOH, and fatty acid hydroperoxides (Flohé, 1989; Rotruck et al., 1973). In contrast, 
PHGPX has been shown to catalyse the reduction of fatty acid hydroperoxides and 
cholesterol hydroperoxides (Ursini et al., 1985). In its role of reducing hydroperoxo -groups in 
complex lipids, PHGPX is synergistically supported by tocopherols, which reduce lipid 
peroxy radicals to lipid hydroperoxides. The latter, if not reduced by PHGPX, would re- 
initiate lipid peroxidation. A tumour cell line that over -expresses PHGPX has been found to 
be more resistant to cell death induced by photochemically -generated cholesterol 
hydroperoxides than wild -type or null -transfected cells (Hurst et al., 2001). 
The effect of Se supplementation on the heart is primarily reflected in an increase of PHGPX 
activity, and not of cyGPX (Jotti et al., 1994). This finding supports the concept that the 
physiological response to the cytotoxic action of ROS generated during redox -cycling of 
quinone- containing compounds such as doxorubicin (adriamycin) is directed towards 
maintenance of cell membrane integrity and prevention of lipid peroxidation. 
cyGPX knockout mice have been developed as a model to study the role of cyGPX in normal 
physiology and in the pathogenesis of a number of disease states. Using this model, mice 
deficient in cyGPX develop normally and show no increased sensitivity to pulmonary 
hyperoxia (Ho et al., 1997). The lack of any overt phenotype in these knockout mice is 
unsurprising considering the clinical phenotype associated with patients having deficiencies 
in GSH regeneration. Such patients are normal so long as they are unchallenged with 
hydroperoxides (Beutler, 1983). 
However, the contribution of cyGPX as an antioxidant defence mechanism against the 
pathogenic effect of ROS in other conditions has not been ruled out. For example, oxidative 
stress induced by 30 mg /kg of paraquat, which is approximately LD20 for mice, killed 100 
of cyGPX knock -out mice, whereas control mice showed no signs of toxicity at this dose (de 
Haan et al., 1998). In the same study neurons from cyGPX knock -out mice were more 
sensitive to oxidative stress induced by H2O2. 
Despite ongoing attempts to produce a PHGPX knockout mouse, a successful model has 
not yet been obtained. Such a model would be useful to provide further information on the 
role of PHGPX. 
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TR is a dominantly expressed selenoprotein in both HUVEC and HCAEC. TR acts as an 
antioxidant either directly or through the action of thioredoxin, and can reduce and detoxify 
lipid hydroperoxides, H202 and organic hydroperoxides, and peroxynitrite directly using 
NADPH as a cofactor (Arteel et al., 1999; Björnstedt et al., 1995; May et al., 2002). In 
addition, TR is able to regenerate bioactivity in proteins inactivated by oxidative stress 
(Spector et al., 1988) (Ejima et al., 1999), can regenerate ascorbic acid from 
dehyroascorbate (May et al., 1997), and can induce manganese superoxide dismutase (Das 
et al., 1997). TR is reported to have a superior capacity for detoxifying H202 and lipid 
peroxides over that of the GPXs (Björnstedt et al., 1995). This, together with the high 
expression of TR in human EC, suggests that TR may be more important than the GPXs at 
protecting cells from oxidative damage. TR may also contribute to the protective effects of 
Se against oxidative damage to the endothelium since the TR/Trx system can maintain NOS 
in a reduced configuration potentially overcoming the hypothesised oxidative deactivation of 
NOS (Patel et al., 1996). 
The upregulation of selenoprotein expression in cultured cells through Se- supplementation is 
widely reported (Buckman et al., 1993; Dreher et al., 1998; Fujiwara et al., 1999; Ricetti et 
al., 1994; Stewart et al., 1999; Takahashi et al., 1986; Thomas et al., 1993; Yarimizu et al., 
2000). It is therefore possible that decreased expression and activity of these selenoproteins 
in Se- deficiency in man may increase the susceptibility of the endothelium to oxidative 
damage. 
Labelling with [75Se] -selenite provides a reliable, precise and sensitive method to assess 
selenoprotein expression in tissues and cells. The [75Se] is specifically directed to and 
incorporated into selenocysteine residues via a UGA codon. However, since equilibration of 
exogenous [75Se] -selenite with the endogenous pool of Se and selenoproteins can take 
within excess of 27 hr (Beech et al., 1994), cells are usually labelled for between 32 and 48 
hr to ensure that a steady state of labelling has been achieved. 
3.1.4 Oxidised LDL and the endothelium 
OxLDL is an important mediator of oxidative damage to the endothelium in vivo (Nielson, 
1999; Steinberg, 1991; Witzum and Steinberg, 1991; Witzum and Steinberg, 2001), and 
oxidative modification of LDL cholesterol plays a central role in atherogenesis (Berliner et al., 
1995; Diaz et al., 1997; Steinberg, 1999; Steinberg et al., 1989). OxLDL activates PKC in 
HCAEC in vitro (Li et al., 1998); activation of PKC, by the phorbol ester PMA, in HUVEC 
decreases TR expression as assessed by [75Se]- labelling of cells and Western blot analysis 
(Anema et al., 1999). The activation of PKC through oxLDL has been implicated in vascular 
disease (Ohgushi et al., 1993). Since TR may provide essential antioxidant defence to the 
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EC, down -regulation of TR by this mechanism may diminish the antioxidant capacity of the 
EC, leaving the cell vulnerable to oxidative damage and to development of atheroma. a- 
Tocopherol provides resistance to PKC stimulation by oxLDL and PMA in cultured human 
aortic EC (Keaney et al., 1996). However treatment of HUVEC with the phorbol ester 
phorbol 12, 13- dibutyrate induced a 2 -fold increase in cyGPX mRNA levels (Jornot and 
Junod, 1997), and treatment with PMA increases cyGPX expression (Miller, 2000). 
Upon oxidation by metal ions or by cells in vitro, a variety of oxidation products are formed 
from the peroxidation of the lipid constituents of LDL, and the oxidative deterioration of 
apoprotein B (Rosenfeld, 1991). Each of the lipid classes can be oxidised, including sterols, 
fatty acids in phospholipids, cholesterol esters, and triglycerides. During oxidation of LDL, 
the various lipid classes undergo modification. This includes the oxidation of cholesterol to 
oxysterols, oxidation of PUFA to form various aldehydes, including 4- hydroxynonenal, and 
the conversion of phospholipids to lysophospholipids by a phospholipase A2 -like activity 
(Colles et al., 1996). The cytotoxicity of oxLDL to EC has been demonstrated in numerous 
studies (Claise et al., 1997; Thérond et al., 2000; Thomas et al., 1993). OxLDL shows 
cytotoxic effects on EC affecting several functions (Coffey et al., 1995; Escargueil -Blanc et 
al., 1997; Thomas et al., 1993). However previous studies in human EC have not explored 
the ability of Se to prevent oxLDL cytotoxicity. 
Endothelial cells in vitro are documented to oxidise LDL (Dugas et al., 1998; Fernando et al., 
1993; Henriksen et al., 1981; Nagelkerke et al., 1984a; Nagelkerke et al., 1984b; 
Parthasarathy et al., 1989; Steinbrecher, 1988; Steinbrecher et al., 1984; van Hinsberg et al., 
1986; Wilkins and Leake, 1994). Few studies have investigated the role of cell- associated 
antioxidants in LDL modification, as opposed to LDL- associated or extracellular antioxidants. 
These studies have shown that cultured vascular cells supplemented with ascorbate, a- 
tocopherol, f3-carotene, or probucol exhibit a lowered capacity to modify LDL (Martin and 
Frei, 1997; Navab et al., 1991; Parthasarathy, 1992; Reaven et al., 1994; Steinbrecher et al., 
1984). 
Assessment of the effect of Se supplementation of EC on their ability to promote LDL 
oxidation has not been studied to date. Ebselen has been shown to prevent LOOH 
formation during oxidation of LDL by Cue +, and also inhibited formation of LOOH and spared 
a- tocopherol during oxidation of LDL mediated by peroxyl radicals (Lass et al., 1996). 
Studies using oxLDL are complicated by the considerable variation in the products formed 
between different preparations. The products formed, and the extent of the changes in the 
LDL, are dependent on several factors including; the cell type used to initiate oxidation, the 
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metal ion concentration in the medium as well as the composition of the medium, the 
incubation conditions (e.g. length of time of exposure to pro- oxidant conditions) and the 
inherent susceptibility of the native LDL to be oxidised in the peroxidation conditions used for 
different studies (Esterbauer and Jürgens, 1993; Kuzuya et al., 1991; Witzum and Steinberg, 
1991) as well as isolation procedures (Parthasarathy et al., 1999). In addition, marked 
variations in the degree to which LDL preparations can be modified have been observed with 
LDL from various donor individuals (van Hinsberg et al., 1986) possibly due to differences in 
levels of PUFA, ubiquinol, and free cholesterol (Kontush et al., 1996). 
Therefore, there is no unique LDL particle corresponding to `oxidised LDL', but rather there is 
a broad spectrum of 'oxidised LDLs'. Thus, the toxic composition of any one batch of oxLDL 
made using LDL isolated from different sources, even when using constant conditions is 
known to vary, which can make interpretation of results difficult. 
t -BuOOH is a widely -used model toxicant (Elliot et al., 1995; Hara et al., 2001; Nardini et al., 
1998; Schuppe et al., 1992; Thomas et al., 1993), which is a redox -cycling agent ( Comporti, 
1989). The compound causes cytotoxicity, following reduction itself by intracellular 
reductases, via oxygen reduction (predominantly one -electron reduction) and consequent 
formation of ROS ( Comporti, 1989). t -BuOOH has the advantage of not being subject to the 
inherent problem of between -batch variation which exists when oxLDL is used as an 
oxidative stress -inducing agent. However, it could be argued that t -BuOOH is not an agent 
that occurs naturally, unlike oxLDL. In addition, t -BuOOH is a substrate for cyGPX and 
PHGPX, but cyGPX is at least 10 -fold more active than PHGPX on t -BuOOH (Geiger et al., 
1993), and thus may bias the mode of detoxification towards the GPX enzymes. This study 
encompassed experiments using both oxLDL and t- BuOOH. Cytoprotection studies using 
sodium selenite were performed using both oxLDL and t- BuOOH, whilst investigation of the 
individual selenoproteins responsible for the protection utilised t -BuOOH for all studies 
except one due to an unlimited supply of t- BuOOH. 
Conceptualized forms of oxLDL 
LDL at varying stages of oxidation is used in studies of cytotoxicity and protection, and LDL 
receptor studies. Although various groups have designated the LDL used as either 
'minimally modified LDL' (mmLDL) or 'oxidised LDL' ( oxLDL), there are a variety of oxidation 
processes used. An extensive variety of normal and pathological conditions may occur to 
oxidise intrinsic LDL de novo. When such oxidation is conducted to a minimal degree, the 
resultant particle may characterise mmLDL. This LDL form may be undistinguishable 
(physically) from the native LDL, apart from the loss of antioxidants and PUFA. The apoB- 
100 is intact, and minor protein damage or modification has occurred. In contrast, the lipids 
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are affected to a large degree. mmLDL has low levels of TBARS and is taken up by specific 
LDL receptors. 
When LDL is oxidised, by copper for example, it undergoes oxidation after an initiation, 
propagation and termination sequence (Esterbauer et al., 1992). At the point when oxidation 
reaches a plateau, all the oxidisable fatty acids are consumed, and the particle is abundant 
in oxidised fatty acids. A fully oxidised LDL particle will have extensive proteolysis, oxidation 
of amino acids, cross -linking, and modification of the amino acid groups of the apoB. Such a 
particle is unlikely to occur in vivo, and would probably be cleared from plasma by the liver 
(Parthasarathy et al., 1999). 
The most common method for the initiation of oxidation of LDL in vitro is incubation in the 
presence of Cu (II) ions. Lipid peroxidation in LDL can be initiated by adding Cu (II) ions, 
which are suggested to participate in redox cycling reactions with endogenous or 
contaminating lipid hydroperoxides (Burkitt, 2001). 
3.1.5 Homocysteine and endothelial cells 
Hyperhomocysteinemia has been described as an independent risk factor for endothelial 
dysfunction and the subsequent development of atherosclerosis (Outinen and Austin, 2000; 
Outinen et al., 1999; Outinen et al., 1998; Upchurch et al., 1997). Hyperhomocysteinemia is 
believed to injure EC in vivo through a number of mechanisms, including generation of H2O2 
and O2'- via auto -oxidation of homocysteine (Hcy) (Weiss et al., 2001). The increased H2O2 
accumulation may result from the ability of Hcy to down -regulate the expression of cyGPX 
(Upchurch et al., 1997). Hcy also decreases the expression of SOD as well as cyGPX in 
HUVEC (Outinen et al., 1999). Homocysteinemia may also affect endothelial dysfunction by 
decreasing the production and /or bioavailability of NO' (Upchurch et al., 1997; Weiss et al., 
2001). The 02- formed via autooxidation of Hcy may react with NO' to produce ON00 ", 
leading to oxidative inactivation of NO' with the resultant endothelial dysfunction. Over - 
expression of cyGPX in mice protects against Hcy- induced endothelial dysfunction (Weiss et 
al., 2001). Other studies have linked decreased GPX levels with an increased incidence of 
coronary artery disease. For example, platelet GPX activity is impaired in patients with 
coronary artery disease (Guidi et al., 1986). However, a study in 10 patients with inherited 
defects of Hcy metabolism showed that those individuals with elevated plasma Hcy (> 20 
pM) had increased SOD and cyGPX activities (Moat et al., 2000). 
3.1.6 Endothelial cell models 
The use of cell culture has allowed the study of homogenous cell populations uncomplicated 
by the confounding factors of other tissues. Large vessel endothelial cell culture is a well- 
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established model for the study of the endothelium. The human umbilical vein is often the 
chosen vessel for the study of human endothelial function as it has several advantages as a 
source of EC. It is a non -branching vessel with a large intimai surface area making technical 
isolation of cells easy. However, many variables can affect the viability of isolated cells, 
including foetal stress, maternal anaesthesia, smoking and other toxins (Gimbrone et al., 
1974; Tu et al., 1994). The use of HUVEC is also complicated by the genetic variability 
between preparations, limited population doublings, difficulty in culture and the requirement 
for specialised growth factors. In addition, a varied susceptibility to toxic agents between 
different isolates of HUVEC, and different passage number within the same isolate, has been 
reported (Harlan et al., 1984). 
Human coronary arterial EC (HCAEC) may be a good model for human EC as the coronary 
artery is one of the principal vascular sites affected by the formation of atheroma. In 
addition, HCAEC have a similar selenoenzyme profile of expression to HUVEC. However, 
HCAEC are not as easy to culture as HUVEC, are technically more difficult to isolate due to 
their anatomical source, and obtaining donor material for preparations is problematic. 
An alternative to the use of HUVEC or HCAEC is to use human transformed cell lines such 
as EAhy926. EAhy926 is an endothelial cell line established by hybridising primary HUVEC 
with A549 human lung tumour cells (Edgell et al., 1983). Cells in primary culture have a 
limited replication potential and show a tendency to senesce in culture (Schwartz, 1978), 
whilst EAhy926 cells retain many of the differentiated functions common to primary EC 
beyond 100 passages. These functions include the expression of von Willebrand Factor 
(Edgell et al., 1983), prostacyclin formation (Suggs et al., 1986) and expression of 
endothelin- 1(Saijonmaa et al., 1991). The selenoprotein profile of EAhy926 cells has not 
been previously determined, which is essential in order to establish whether this more 
convenient cell line would provide a suitable model for future studies of selenoprotein 
expression in EC. 
Endothelial cells isolated from a number of different species have been used as model 
systems to investigate human pathologies. For example bovine aortic EC (BAEC) were 
used in the earliest studies due to their ease of isolation and subcultivation. When initially 
isolated and characterised, porcine aortic EC (PAEC) (Slater and Sloan, 1975) were thought 
to provide a suitable alternative to HUVEC based on similarities of the porcine 
cardiovascular system with that in man. In addition porcine aorta is subject to atheroma 
formation and should provide a useful model for the study of atherosclerosis (Rosenthal and 
Gotleib, 1990). However, the source of EC used for culture is extremely important because 
responses and properties of cells of different species vary considerably. For example PAEC, 
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unlike HUVEC and BAEC, do not have Factor VIII -related antigen immunoreactivity 
(Rosenthal and Gotleib, 1990). 
As well as species differences in the properties of EC it has also been shown that EC 
isolated from different sites in the vasculature exhibit different properties. For example, EC 
derived from human dermal microvasculature (HMVEC) form capillary-like tubes at a faster 
rate than HUVEC, and fibroblast growth factor stimulates increased production of tissue 
plasminogen activator (t -PA) in aortic EC but inhibits t -PA production in HUVEC (Halliday et 
al., 1998). HMVEC do not show an age- dependent decrease in sensitivity to killing by 
activated neutrophils that is a characteristic function of HUVEC (Varani and Dame, 1995; 
Varani et al., 1992). Arterial and venous EC show differences in the production of 
angiotensin- converting enzyme (Johnson, 1980) and their response to cytokine stimulation 
(Hauser et al., 1993). These observations have led to the suggestion that HUVEC, despite 
being used by a number of researchers in the field of vascular disease (Jornot and Junod, 
1997; Kvietys and Granger, 1997; Milner et al., 1990; Zhao et al., 1997), may not be the 
most suitable model in the study of human cardiovascular disease. Indeed a more suitable 
model to study vascular disease may be EC isolated from arterial vascular beds as opposed 
to venous; thus HCAEC may provide a good model as the coronary artery in particular is one 
of the main vascular beds affected by the formation of atherosclerotic lesions. 
If the efficacious effect of Se on EC function is to be studied, it is essential that a model 
system be chosen which reflects the selenoprotein expression and function of EC which line 
vessels prone to developing vascular disease. In addition, although previous work on Se and 
BAEC is of importance, it would be valuable to determine if Se can exert a similar protective 
response in human EC. 
Unstimulated EC in culture can generate superoxide (Rosen and Freeman, 1984) and H2O2 
(Sundqvist, 1991). This suggests that cultured EC may be under oxidative stress. This may 
be an important point to consider for cytoprotection studies since conventional culture media 
have been reported to be deficient in antioxidants (Baker et al., 1998; Brigelius -Flohé et al., 
1995; Leist et al., 1996) (see section below on culture media). EC in vivo are exposed to a 
maximum PO2 of 80 -90 mm Hg (10.65 - 11.98 KPascal) (arterial), and a minimum PO2 of 40 
mm Hg (5.33 KPascal) (venous). In comparison, EC in culture are typically maintained at an 
ambient PO2 of 140 mm Hg (18.64 KPascal) (Kvietys and Granger, 1997). The magnitude of 
this oxidative stress may alter with varying culture conditions. For example, the EC content 
of antioxidant enzymes (catalase, SOD, and GPX) varies as a function of passage number 
(Bishop et al., 1985; Hart et al., 1985; Varani et al., 1992). The cyGPX activity and catalase 
activity significantly decrease after the first subculture of bovine pulmonary artery EC (Hart et 
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al., 1985). Glutathione levels decrease in HUVEC with passage number (Tu et al., 1994). 
This variation in antioxidant status with EC age in culture is, however, unpredictable, i.e. 
some enzymes increase with age while other enzymes decrease. As the age of HUVEC in 
culture increases, the intracellular iron, which facilitates production of ROS, decreases 
(Varani et al., 1992), thereby rendering the cells more resistant to oxidative damage. Thus, 
in any EC model system in which oxidative stress is being studied, it is important to consider 
the antioxidant status of the cells (in their 'natural' state). 
3.1.7 Culture media and selenium 
To study the ability of Se to protect EC against oxidative damage from t- BuOOH, EAhy926 
cells were cultured and maintained as described in section 2.3.2. Prior to each experiment, 
the cells were sub -cultured and seeded into 24 -well culture plates in high glucose (4.5 g /L) 
Dulbecco's Modified Eagles medium (DMEM) containing 10 % FBS, 5 mM hypoxanthine, 
0.02 mM aminopterin, and 0.8 mM thymidine, in a humidified atmosphere of 5 % CO2, 95 
air at 37 °C. The Se content of the DMEM basal medium and the FBS used for 
supplementation was determined by acid digestion followed by fluorimetric analysis (section 
2.3.16). DMEM basal medium had a Se concentration of 0.351 nM, and was therefore 
classified as Se- deficient medium. FBS (undiluted) had a Se concentration of 13.78 nM, 
although this form of Se is unlikely to be bioavailable to the cells (see below). The Se 
content of basal culture media varies between types of media; for example, basal DME 
medium for mouse hybridomas contains 1 nM (0.001 pM) Se, but RPMI 1640 medium for 
human hepatoma cells contains 0.03 pM Se (Freshney, 1992). The Se content of FBS can 
also vary greatly, with values ranging from zero to 0.2 pM (Leist et al., 1996), 0.48 pM 
(Fujiwara et al., 1999), and between 0.16 and 0.18 pM (Geiger et al., 1993). Skin cells in 
culture with media of differing basal Se levels supplemented with sodium selenite or 
selenomethionine are afforded similar levels of protection against UVB- mediated oxidative 
stress with the same selenite and selenomethionine concentrations despite the differing Se 
content of the basal media (Rafferty, 2000); this may indicate that the Se in the basal 
medium is not bioavailable for use by the cells. Se contained in conventional culture media 
is predominantly incorporated into the proteins of serum supplements, and as such is not 
easily utilised by cells in culture (Brigelius -Flohé et al., 1995; Marcocci et al., 1997). 
Conventional culture media require Se supplementation in order to guarantee selenoprotein 
synthesis in cultured cell lines (Baker et al., 1998; Brigelius -Flohé et al., 1995). 
HAEC in culture under standard conditions are deficient in vitamin C, and as a result may be 
under increased oxidative stress (Smith et al., 2002). Deficiency of vitamin C in HAEC lead 
to a compromised intracellular thiol redox status (GSH /GSSG ratio), and a higher rate of 
production of ROS, both of which were attenuated by repletion with vitamin C. Standard 
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culture media for HAEC do not routinely contain vitamin C since it is unstable in aqueous 
solution. 
The studies reported in this chapter aimed to: 
determine the suitability of the cell line EAhy926 as an appropriate model in which to 
investigate the role of Se and selenoproteins in human endothelial cells 
examine the ability of sodium selenite supplementation to protect EAhy926 cells from 
cytotoxicity resulting from exposure to oxidised lipids, and associate any observed 
protection with changes in the expression and activity of TR and the activity of cyGPX 
and PHGPX 
investigate the importance of TR, cyGPX and PHGPX in the protection of EAhy926 cells 
from toxicity of oxidised lipids by use of gold thioglucose- mediated inhibition of 
selenoenzyme activity 
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3.2 MATERIALS AND METHODS 
3.2.1 General methods for cytotoxicity and selenoenzyme expression 
studies 
In all cytotoxicity studies using endothelial cells, the cells were passaged into 24 -well culture 
plates using Se- deficient medium, with all test conditions in triplicate wells of confluent cells, 
unless otherwise stated. After an incubation in the presence of t -BuOOH or oxLDL, both the 
medium and cells were harvested and analysed for LDH activity as described in section 
2.3.13. Details on the Se content of cell culture media are described in section 3.1.7. 
For all studies of selenoprotein expression, endothelial cells were passaged into 75 cm2 
flasks, with all test conditions in triplicate flasks, except control cells which were grown in 
quadruplicate. Following the incubation, the medium was sampled for LDH assay to check 
for cytotoxicity, and the cells were washed twice with 10 ml EBSS, and harvested via 
scraping into 20 ml EBSS. Efficiency of harvesting was determined by light microscopy. 
The cells were then pelleted by centrifugation at 500 x g for 10 min. The EBSS was 
aspirated, and the pellets frozen at - 80 °C until enzyme assays were carried out. Prior to 
enzyme activity determinations, the cell pellets were thawed and lysed by sonication (three 
pulses of 10 sec using a Soniprep 150 Sonicator) on ice in 0.125M potassium phosphate 
buffer (pH 7.4) containing 1 mM EDTA and 0.1 % Triton X -100 (peroxide- and carbonyl- free). 
The levels of the selenoenzymes were then determined as detailed in sections 2.3.5.1, 2.3.6, 
2.3.7 and 2.3.8. 
3.2.2 Intracellular f75Se]- selenoprotein expression profile in EAhy926 
cells and HUVEC 
The intracellular selenoprotein profile of the human endothelial cell line EAhy926 was 
compared to that of HUVEC. 75 cm2 flasks of both HUVEC and EAhy926 cells were seeded 
and maintained in EGM -2 and DMEM containing 10 % FBS and 1 % HAT respectively as 
described in sections 2.3.2 and 2.3.3. At confluence the cells were labelled with [75Se]- 
selenite (0.02 MBq /ml). After 48 hr incubation, the cells were harvested into 20 ml EBSS by 
scraping, and centrifuged at 2000 x g for 10 min at 4 °C. The resulting cell pellet was re- 
suspended in 200 pl 60 mM Tris buffer, pH 7.4 (4 °C), containing 1 mM EDTA and 1 mM 
dithiothreitol (Tris buffer). The cells were lysed by sonication on ice for 30 sec (three ten 
second pulses) using a Soniprep 150 Sonicator. 
Protein concentrations were measured using the Bradford assay (section 2.3.9) and the 
samples were diluted to a common protein concentration with Tris buffer. The cell lysates 
were prepared for separation by SDS -PAGE (section 2.3.10). The [755e]- labelled proteins 
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present in 25 pg of protein from each of the cell types were separated on a single SDS - 
PAGE gel (section 2.3.10) to allow a direct comparison between the two cell types. The 
resulting gel was dried and the [75Se]- labelled selenoproteins visualised by autoradiography 
(section 2.3.11). 
The SDS -gels were scanned using an EpsonGT -9500 to create a digitalized image. The 
radioactivity in each band was quantified using the Phoretix software. SDS -PAGE for this 
experiment was carried out by Mrs S Miller of the Department of Clinical Biochemistry, The 
University of Edinburgh. 
3.2.3 Intracellular selenoprotein expression and activity of different 
vascular endothelial cells 
HUVEC, EAhy926 cells, HCAEC and BAEC were isolated and /or maintained as previously 
described (see sections 2.3.2 and 2.3.3). 
For measurement of TR concentration and activity, the cyGPX activity and the PHGPX 
activity (sections 2.3.6, 2.3.5.1, 2.3.7 and 2.3.8), triplicate 75 cm2 flasks of each cell type was 
grown and maintained as previously described (2.3.2 and 2.3.3). At confluence the cells 
were harvested and lysed as detailed in section 3.2.1. The cell lysates were subsequently 
frozen at - 80 °C until assay. All the samples for each measurement were analysed in the 
same assay to avoid any between -assay variation. 
3.2.4 The effect of sodium selenite supplementation on intracellular 
selenoprotein expression and activity in HUVEC, HCAEC, BAEC and 
EAhy926 cells 
EAhy926 cells were passaged into 75 cm2 flasks and grown to 70 % confluence. The cells 
then received medium containing 0, 1, 10, 40, 50, 100, 200 or 1000 nM sodium selenite for 
an incubation of 48 hr. Harvesting was carried out as described in section 3.2.1. TR activity, 
cyGPX and PHGPX activity were determined as described in sections 2.3.5.1, 2.3.7 and 
2.3.8, respectively. 
For measurement of TR concentration and activity, cyGPX and PHGPX activity, HUVEC, 
HCAEC and BAEC were passaged and seeded at a density of approximately 3000 cells/cm2 
into 75 cm2 flasks for selenoprotein measurement. The cells were cultured and maintained 
in Se- deficient medium to which selenite had been added at concentrations ranging from 1 to 
1000 nM for HUVEC, and from 1 to 160 nM for HCAEC and BAEC. The culture medium was 
removed and replaced with fresh medium containing sodium selenite on every other day. 
Upon reaching full confluence (approximately 9 to 12 days) the cells were harvested as 
described in section 3.2.1. TR concentration and activity, cyGPX and PHGPX activity were 
determined as described in sections 2.3.6, 2.3.5.1, 2.3.7 and 2.3.8, respectively. It was not 
3 -13 
The role of TR in the prevention of oxidative damage in EC Chapter three 
possible to determine TR expression in BAEC due to the lack of cross -reactivity of the 
antibody to human TR with the bovine protein. The cyGPX and PHGPX activity were not 
measured in all experiments due to a shortage of cells. 
3.2.5 The cellular localisation of TR in EAhy926 cells and HUVEC 
EAhy926 cells and HUVEC were grown to approximately 70 % confluence on 22 x 22 cm 
sterile glass coverslips in six well culture plates. Each respective culture medium was 'Se- 
deficient' unless stated otherwise. The medium was aspirated from the cells, and each well 
washed twice with 4 ml PBS. The glass coverslips were then removed from the culture 
plates and fixed in acetone. After fixing, the glass coverslips were rinsed with fresh PBS, 
and placed back into the wells of the original culture plates which had been filled with 
absolute ethanol. The cells remained preserved in this state at 4 °C until 
immunohistochemistry took place, as described in section 2.3.19. 
3.2.6 t -BuOOH cytotoxicity in EAhy926 cells cultured in selenium - 
deficient medium assessed by % LDH activity retention 
The effect of a range of concentrations of t -BuOOH (0 - 325 NM) on % LDH activity retention 
by EAhy926 cells was determined. After a 20 hr incubation in the presence of t- BuOOH, 
both the medium and cells were harvested and analysed for % LDH activity retention 
(section 2.3.13). 
3.2.7 The effect of cellular confluence level on susceptibility of 
EAhy926 cells to oxidative damage by t -BuOOH 
Preliminary experiments to investigate the effect of different concentrations of t -BuOOH on 
LDH activity in EAhy926 cells cultured in Se- deficient medium showed great variability in the 
t -BuOOH concentrations seen to produce cell damage. One of the factors proposed to 
account for this observed variability was the degree of confluence of the cell monolayer. To 
investigate this, EAhy926 cells were passaged into 24 well plates and left to grow in Se- 
deficient medium until the required level of confluence was reached. The dose -response 
curve of t -BuOOH (0 - 125 pM and 0 - 400 pM respectively for the two experiments) on 
EAhy926 cells at differing confluence levels was determined. After a 20 hr incubation in the 
presence of t- BuOOH, both the medium and cells were harvested and analysed for % LDH 
retention (section 2.3.13). All plates of cells at differing confluence level received the same t- 
BuOOH solutions which had been prepared and stored at 4 °C until further use. 
To investigate the effect of the length of time between passage and treatment with t -BuOOH 
on the susceptibility of cells to cytotoxic damage, EAhy926 cells were passaged into 24 -well 
plates, with one plate at double the seeding density of the other, such that both plates would 
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be of a similar confluence level when exposed to t -BuOOH (-100 % confluence). The cells 
were left to grow for either 2 days or 4 days after passage before exposure to t -BuOOH at a 
range of concentrations (0, 25, 50, 75, 100, 150, 200, 250 NM). Identical t -BuOOH solutions 
were used for both lots of cells, prepared on the day of first use, and stored at 4 °C until 
required again. After a 20 hr incubation in the presence of t- BuOOH, both the medium and 
cells were harvested and analysed for LDH activity (section 2.3.13). 
3.2.8 The ability of sodium selenite to protect against oxidative 
damage resulting from t -BuOOH exposure in EAhy926 cells 
To investigate the possible protective effect of sodium selenite against oxidative damage 
mediated by t- BuOOH, EAhy926 cells were sub -cultured into 24 well plates using Se- 
deficient medium. The cells were then grown for 48 hr. Se- deficient medium to which a 
range of sodium selenite concentrations (0, 1, 10, 40, 50, 100, 200, 1000 nM) had been 
added was then placed on the cells. After an incubation period of 48hr, the cells were 
washed twice with 1 ml EBSS. Concentrations of 0 pM or 300 pM t -BuOOH were then 
added, prepared in Se- deficient medium, and left to incubate with the cells for 20 hr. After 
20 hr both the medium and cells were harvested and analysed for % LDH retention as 
described in section 2.3.13. 
3.2.9 Assessment of the direct effect of sodium selenite in the 
protection of EAhy926 cells against oxidative damage resulting from t- 
BuOOH exposure 
To determine whether sodium selenite can exert a direct antioxidant effect against t- BuOOH- 
mediated cytotoxicity in EAhy926 cells, rather than through modification of selenoprotein 
expression, the following approach was utilised. EAhy926 cells were sub -cultured into 24 
well plates using Se- deficient medium. After 48 hr, some cells received Se- deficient medium 
supplemented with 40 nM sodium selenite, whilst other cells continued to be maintained in 
Se- deficient medium. After an incubation period of 48 hr, all cells were washed twice with 1 
ml EBSS. The cells then received Se- deficient medium supplemented with 40 nM sodium 
selenite simultaneously with the addition of a range of t -BuOOH concentrations (0 - 250 
pM), or the same range of concentrations of t -BuOOH made up in Se- deficient, 
unsupplemented medium. 
Control cells received no t -BuOOH or sodium selenite supplementation. After 20 hr both the 
medium and cells were harvested from all the culture plates and analysed for LDH activity as 
described in section 2.3.13. 
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3.2.10 Assessment of the effect of gold thioglucose on cyGPX activity, 
PHGPX activity and TR activity of EAhy926 cells 
An experiment to investigate the timecourse of inhibition of TR activity by 10 pM gold 
thioglucose (GTG) was constructed to assess the optimal time for pre- incubation with GTG. 
EAhy926 cells were passaged into 75 cm2 flasks and grown to 70 % confluence. The cells 
then received medium containing 10 pM GTG for an incubation of 24, 48 or 72 hr (triplicate 
flasks for each time point). Control cells received medium unsupplemented by GTG. The 
cells that received an incubation of 72 hr received fresh medium supplemented with 10 pM 
GTG after 48 hr. Following the incubation, the cells were washed twice with 10 ml EBSS, 
and harvested as detailed in section 3.2.1. 
Once the time for pre- incubation had been optimised, the aim of these studies was to 
determine a concentration of GTG that would selectively inhibit only TR activity, without 
inhibiting the GPXs. Briefly, EAhy926 cells were passaged into 75 cm2 flasks and grown to 
70 % confluence. The cells then received medium containing 0, 1, 10, or 100 pM GTG for 
an incubation of 48 hr. Following the incubation, the cells were washed twice with 10 ml 
EBSS, and harvested as detailed in section 3.2.1. This experiment was performed twice. A 
further experiment using 0, 1.75, 2.5 pM GTG was performed in order to assess whether any 
of these concentrations of GTG was more selective in its inhibition of TR over that of cyGPX 
and PHGPX. 
3.2.11 Assessment of the effect of gold thioglucose on the 
susceptibility of EAhy926 cells to oxidative damage resulting from t- 
BuOOH exposure 
EAhy926 cells were passaged into 24 well plates using Se- deficient medium, and left to grow 
for 48 hr. After this time, the cells received normal unsupplemented medium, or the same 
medium containing 10 pM GTG for 48 hr. When the incubation was finished, the cells were 
washed twice with 1 ml EBSS, and fresh medium containing t -BuOOH (0, 75, 100 pM) was 
added for a 20 hr incubation. Both the medium and cells were harvested and analysed for 
LDH retention as described in section 2.3.13. This experiment was then repeated using 1 
pM or 10 pM GTG pre- incubations prior to t -BuOOH exposure (0 to 250 pM). 
In addition, further experiments was performed in order to investigate the effect of 0, 1.75, 
and 2.5 pM GTG, or 0, 1, 2.5, 5, 7.5 or 10 pM GTG on the susceptibility of EAhy926 cells to 
t- BuOOH- mediated cytotoxicity. Associated experiments on the effect of all concentrations 
of GTG (used for t -BuOOH cytotoxicity studies) on selenoenzyme activities have been 
performed (section 3.2.11). 
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3.2.12 Assessment of the effect of consecutive sodium selenite and 
gold thioglucose pre- treatment on susceptibility of EAhy926 cells to 
oxidative damage resulting from t -BuOOH exposure 
To investigate whether the protection of EAhy926 cells from t- BuOOH- mediated cytotoxicity 
by Se could overcome /compensate for the deleterious effect of GTG pre- incubation, the 
following approach was employed. 
EAhy926 cells were passaged into either Se- deficient medium or medium supplemented with 
40 nM sodium selenite, and incubated for 48 hr. After this time, the cells were washed twice 
with 1 ml EBSS, and received normal unsupplemented medium, or the same medium 
containing 10 ,uM GTG for 48 hr. When the incubation was finished, the cells were again 
washed, and fresh medium containing various concentrations of t -BuOOH (0 - 100 NM) 
added for a 20 hr incubation. Both the medium and cells were harvested and analysed for 
LDH activity as described in section 2.3.13. 
The same experiment was repeated, with the concentration range of t -BuOOH extended to 
250 pM to confirm the effects seen in the first experiment over a more appropriate portion of 
the toxicity curve. 
In the final two experiments, EAhy926 cells received either no pre- incubation (control cells), 
40 nM sodium selenite alone, 1 pM GTG alone, 10 pM GTG alone, or 40 nM selenite 
followed by 1 pM GTG as a pre- incubation before t -BuOOH exposure, as follows. EAhy926 
cells were passaged into either Se- deficient medium or medium supplemented with 40 nM 
selenite, and incubated for 48 hr. After this time, the cells were washed twice with 1 ml 
EBSS, and received normal unsupplemented medium, or the same medium containing either 
1 pM GTG or 10 pM GTG for 48 hr. When the incubation was finished, the cells were again 
washed, and fresh medium containing various concentrations of t -BuOOH (0 - 250 pM and 0 
- 300 pM respectively for the two experiments) added for a 20 hr incubation. Both the 
medium and cells were harvested and analysed for % LDH retention as described in section 
2.3.13. 
3.2.13 The ability of sodium selenite to protect against oxidative 
damage resulting from oxLDL exposure in EAhy926 cells 
EAhy926 cells were passaged into 24 well plates and left to grow in Se- deficient medium for 
48 hr. The medium was then replaced with fresh unsupplemented medium, or medium 
supplemented with 40 nM sodium selenite, and the cells left to incubate 48 hr. At this stage 
the cells were at confluence. After this pre- incubation, all cells were washed twice with 1 ml 
EBSS, and medium containing either native or oxidised LDL (prepared from the same blood 
donation, and diluted to a common protein value in medium) was added. This was left to 
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incubate with the cells for 24 hr. LDH activity was then measured in the medium and cell 
lysates as described in section 2.3.11, and % LDH retention calculated. Three different LDL 
preparations were used, the third batch having two paired fractions of both native and 
oxidised LDL (two isolated fractions native LDL were made from one large pool plasma, 
which were then oxidised). Total protein was measured in the LDL using the Bradford assay 
(section 2.3.9) prior to dilution and addition to the cells. 
One experiment was performed with oxLDL alone (no native LDL), using sodium selenite (40 
nM) and /or GTG (1 pM) pre- incubations (each for 48 hr) to investigate whether GTG would 
increase the susceptibility of the cells to oxLDL- mediated cytotoxicity, and whether sodium 
selenite would be able to overcome this deleterious effect. 
The endogenous LDL concentration was measured in the FBS used to supplement the 
culture medium using a method routinely used in clinical biochemistry to measure HDL 
cholesterol in human serum (see section 2.3.17). The concentration of LDL was measured 
at 0.404 mmol /L using the equation: LDL cholesterol = Total cholesterol - (HDL cholesterol + 
0.16 X Triglycerides). However, this equation is accurate only at levels of >0.5 mmol /L HDL 
for the assay conditions used, which did not hold true for this measurement. Thus, this 
offers only a rough approximation. In addition, this assay is set up to measure human 
lipoproteins, but the measurement here was of bovine, thus introducing further inaccuracy. 
The amount of LDL in FBS has previously been measured to be 0.76 ± 0.04 mM /L by Saint - 
Marie et al. (1989) (Saint -Marie et al., 1989). Such low values fall in line with what is 
generally known that serum cholesterol is much lower in animals than in man; not all of this 
will be LDL as the relative amount of HDL : LDL tends to be higher in animals than in man 
(personal communication, Prof. R. Riemersma, Dept. Cardiovascular Biology, University of 
Edinburgh). 
3.2.14 The effect of sub -lethal oxLDL concentrations on the expression 
of TR in EAhy926 cells 
Five different batches of LDL were used to investigate the effect of sub -lethal oxLDL on TR 
expression in EAhy926 cells. Only one was of the same batch as in protection experiment 
(figures 3.37 c and 3.39 a (c)). LDL was prepared from native LDL isolated from fresh serum 
by ultracentrifugation, and oxLDL was prepared by oxidation of native LDL by 20 pM CuCl2 
(section 2.3.12). 
EAhy926 cells were pre- incubated and exposed to LDL as detailed in section 3.2.13. The % 
LDH activity retention was then measured in the medium (section 2.3.13), to monitor 
cytotoxicity. The cell lysates for which LDL concentrations had been shown to be non -toxic 
were frozen at - 80° until RIA for TR (section 2.3.6) was performed. Total protein in the 
samples was measured by the Bradford assay system (section 2.3.9). 
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3.2.15 The effect of homocysteine on the expression of selenoproteins 
in EAhy926 cells 
EAhy926 cells were passaged into 75 cm2 flasks and grown to confluence. The cells then 
received medium containing 1 mM homocysteine, except 4 flasks which were harvested as 
controls to serve as the zero time point. Triplicate flasks were incubated with the 
homocysteine for 4, 10, 24 and 48 hr respectively. At the end of each respective incubation 
period, the medium was sampled and analysed for LDH activity, as described in section 
2.3.13, to check for any cytotoxicity. The cells were then washed twice with 10 ml EBSS, 
and harvested as detailed in section 3.2.1. 
3.2.16 The potential of EAhy926 cells and HUVEC to oxidise native LDL, 
and the effect of Se supplementation on the oxidation process 
EAhy926 cells and HUVEC were passaged into 24 -well plates at a seeding density of 5 x 105 
cells /cm2 and 3000 cells /cm2 respectively, in DMEM or EGM -2 growth medium, respectively. 
The HUVEC culture medium was changed for medium M199 (supplemented with EGM -2 
bulletkit) the following day. The cells were then left to grow in this medium for 48 hr. After 
the cells had been growing for 48 hr, half of each plate was given medium (M199 in the case 
of HUVEC, and DMEM for EAhy926 cells) containing 40 nM selenite, while the other wells 
received their normal, unsupplemented medium. The cells were left to incubate for 48 hr. 
Following this incubation, the cells were washed twice with 1 ml PBS, and the cells received 
native LDL (200 /ug /ml). Prior to addition to the cells, the total protein content of the LDL was 
measured using the Bradford protein assay (section 2.3.9), and the LDL was diluted to 200 
pg /ml in either serum -free DMEM or serum -free Ham's F -12 for EAhy926 cells, or in serum - 
free M199 (supplemented with the EGM -2 medium bulletkit, except for the FCS) for the 
HUVEC. The diluted native LDL was divided into portions, which were either left 
unsupplemented, or was supplemented with 2.5 pM CuSO4 or 5.0 pM CuSO4 (final 
concentration). Addition of PBS was used as a control for CuSO4. The incubation with the 
native LDL was for 24 hr. Native LDL in the wells (± CuSO4) without cells was included for 
the incubation period as the LDL control. All experimental conditions were arranged in 
duplicate wells. Normal serum was included in each lipoprotein gel run to serve as a 
standard. 
Following the incubation, the media was removed from the wells, and butylated 
hydroxytoluene (BHT) and EDTA were added to the sampled media to arrest any further 
oxidation. BHT and EDTA were added at final concentrations of 25 pM and 100 pM 
respectively. The samples were then centrifuged at 2000 rpm for 10 min, and put on ice until 
they were loaded onto a lipoprotein gel (section 2.3.18). 
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3.2.17 Statistical analysis 
One -way analysis of variance (ANOVA) was used to test for significant differences in % LDH 
activity retained in response to different concentrations of t -BuOOH or oxLDL. In the event 
that the variation was significant (p > 0.05), a Tukey- Kramer multiple comparisons post -test 
was used to test for the level of significance of differences in % LDH retained in response to 
t -BuOOH or oxLDL. One -way ANOVA and a Tukey- Kramer multiple comparisons post -test 
were also used to investigate significant differences between levels of selenoprotein 
expression and activity in cells cultured in different concentrations of sodium selenite. In the 
event of large SDs in a particular data set (> 3 SDs from the mean), the data was log 
transformed prior to ANOVA evaluation. 
The different groups of cells (e.g. Se- deficient cells versus Se- supplemented cells) were 
compared at individual t -BuOOH or oxLDL concentrations using the Student's t -test for 
unpaired data. The Student's t -test for unpaired data was also used to compare 
selenoprotein expression between different endothelial cell types, and for the activities of 
selenoenzymes of cells at different confluence levels. 
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3.3 RESULTS 
All graphs presented are the data from a single experiment, using culture flasks /wells in 
triplicate, unless stated otherwise. 
3.3.1 Intracellular selenoprotein expression in EAhy926 cells and 
HUVEC 
Figure 3.01 demonstrates that the overall pattern of [75Se]- selenoprotein expression in 
EAhy926 cells resembles that observed in HUVEC with some significant differences in the 
levels of expression of a few selenoproteins. TR is dominantly expressed to a similar extent 
in both HUVEC and EAhy926 cells. Figure 3.02 ('a' and 'b') compares the TR activity and 
concentration of both cell types and confirms that there is no significant difference in the TR 
expression in these two cell types. 
A lower expression of both cyGPX and PHGPX in EAhy926 cells compared to HUVEC is 
illustrated in figure 3.01. Figure 3.02 confirms this observation, showing that cyGPX activity 
is 73 % lower in EAhy926 cells (23 + 0.5 U/g protein, mean + SD, n =3) compared to HUVEC 
(86 + 0.7 U/g protein, mean + SD, n =3) (p < 0.0001). Although the PHGPX activity in the 
EAhy926 cells illustrated a tendency towards being lower than that observed in HUVEC, this 
difference was not statistically significant (figure 3.02 c). 
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Figure 3.01 Autoradiograph of an SDS -PAGE gel of the intracellular selenoproteins of 
human umbilical vein endothelial cells (HUVEC) and EAhy926 cells labelled with 
[75Se]- selenite (0.02 MBq/ ml) for 48 hr. Lane 1, HUVEC; lane 2, EAhy926 cells. Both 
lanes were loaded with 25 pg protein. TR, thioredoxin reductase; cyGPX, cytoplasmic 
glutathione peroxidase; PHGPX, phospholipid hydroperoxide glutathione peroxidase. 
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3.3.2 Intracellular selenoprotein expression of different vascular 
endothelial cells 
TR activity measured in BAEC was 76 % lower than that measured in HUVEC (figure 3.02a) 
(p < 0.05). TR concentration was not measured in BAEC as the antisera to human TR did 
not cross react with bovine TR. PHGPX activity in BAEC was 27 % lower than that 
measured in HUVEC (not significant), but cyGPX activity was 25 % higher in BAEC than in 
HUVEC (figure 3.02 c and d) (p < 0.05). 
TR concentration was measured to be 42 % higher, and TR activity 27 % higher in HCAEC 
compared to HUVEC, but the differences were not statistically significant. There were no 
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3.3.3 The effect of sodium selenite supplementation on selenoprotein 
expression in EAhy926 cells, HUVEC, HCAEC, and BAEC 
a) Selenoprotein expression in EAhy926 cells 
TR activity, cyGPX and PHGPX activity were determined in two different batches of 
EAhy926 cells. In the first batch of cells, incubation of EAhy926 cells with 1 nM sodium 
selenite resulted in a small induction of TR (Figure 3.03a) and cyGPX (Figure 3.03c). Figure 
3.03 a shows that TR activity was significantly increased in EAhy926 cells grown in 
increasing concentrations of sodium selenite (p < 0.05). Significant induction of TR activity 
(p < 0.01) was first achieved with a concentration of 10 nM selenite. The maximal increase 
in TR activity was a 3.9 -fold (n =3) increase measured in EAhy926 cells cultured in 10 nM 
sodium selenite compared to that measured in Se- deficient cells. Increasing the selenite 
concentration above 10 nM had no further significant effect on induction of TR above that 
seen with 10 nM selenite. Figure 3.03 c shows that cyGPX activity was significantly 
increased in EAhy926 cells grown in increasing concentrations of sodium selenite (p < 0.05). 
Significant induction of cyGPX (p < 0.05) was first achieved with a concentration of 10 nM 
selenite. The maximal increase in cyGPX activity was a 4.2 -fold (n =3) increase measured in 
EAhy926 cells cultured in 10 nM sodium selenite compared to that measured in Se- deficient 
cells. Increasing the selenite concentration above 10 nM had no further significant effect on 
induction of cyGPX above that seen with 10 nM selenite. PHGPX activity in EAhy926 cells 
supplemented with sodium selenite increased with increasing concentrations of selenite, but 
only reached statistical significance at 1000 nM selenite (p < 0.05), with a 2.2 -fold increase 
over the activity of the basal level in control cells (figure 3.03b). 
In the second batch of cells (fig 3.04) incubation of EAhy926 cells with 1 nM sodium selenite 
resulted in a small but significant induction of TR (p < 0.05) (Figure 3.04 a), and cyGPX (p < 
0.05) (Figure 3.04 c). Maximal induction of both cyGPX (p < 0.001) and TR (p < 0.01) was 
with 40 nM selenite. Increasing the selenite concentration above 40 nM had no further 
significant effect on induction of cyGPX or TR above that seen with the 40 nM selenite 
concentration. Figure 3.04 b shows that PHGPX activity was increased in a dose dependent 
manner to sodium selenite supplementation, with significant increases at 200 nM and 1000 
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b) Selenoprotein expression in HUVEC 
TR activity and concentration and cyGPX and PHGPX activity was determined in HUVEC 
cultured in different concentrations of sodium selenite (0, 10, 40, 160 nM). Figure 3.05 a and 
b show that both TR activity and concentration were significantly increased in HUVEC 
cultured in 40 nM sodium selenite by 2.47 -fold and 1.54 -fold, respectively, compared to 
HUVEC in Se- deficient medium (p < 0.001 and p < 0.01, respectively). Expression of TR 
was maximal in HUVEC cultured in 40 nM sodium selenite, although all concentrations of 
selenite tested increased TR activity and concentration to higher than basal levels. PHGPX 
activity and cyGPX activity in HUVEC cultured in all concentrations of selenite tested was 
higher than the levels in Se- deficient cells. Activity was maximal at 10 nM sodium selenite 
for PHGPX (p < 0.05), and at 40 nM for cyGPX (p < 0.05), with fold increases of 3.65 and 
5.31 over basal levels, respectively. 
Both the TR activity and concentration increased in response to sodium selenite in a dose - 
dependent manner in the second experiment. As observed previously, the increase was 
maximal in HUVEC grown with 40 nM sodium selenite, which expressed a 3.96 -fold and 
2.03 -fold increase in TR activity and TR concentration respectively over cells which were 
cultured in Se- deficient medium (figure 3.06). 
Both the TR activity and concentration increased in response to sodium selenite in a dose - 
dependent manner in the third HUVEC preparation. The increase in TR activity was 
maximal in HUVEC supplemented with 160 nM sodium selenite, which expressed a 6.39 -fold 
increase in activity over Se- deficient control cells. TR concentration was maximal in HUVEC 
cultured in 40 nM sodium selenite, a 3.70 -fold increase (figure 3.07). 
In a fourth preparation of HUVEC, both TR concentration and activity were significantly 
increased in cells cultured in 40 nM sodium selenite (by 2.2 -fold and 3.0 -fold, respectively) 
compared to HUVEC in Se- deficient medium (p < 0.05) (figure 3.08 a and b). The TR 
activity was maximal in HUVEC cultured in 40 nM sodium selenite, although all 
concentrations of selenite tested increased the TR activity to higher than that seen in the 
basal state. At 1000 nM sodium selenite, TR expression was maximally increased by 2.9- 
fold over basal. Figure 3.08 d shows that cyGPX activity was significantly increased in 
HUVEC grown in increasing sodium selenite concentrations (p < 0.01). The maximal 
increase in cyGPX activity was a 5.4 -fold increase in HUVEC cultured in 1000 nM sodium 
selenite compared to Se- deficient controls. PHGPX activity was increased in a dose 
dependent manner to sodium selenite, with significant increases at 200 nM (p < 0.05) 
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d) TR activity in BAEC 
TR activity was measured in response to increasing concentrations of sodium selenite in two 
different passages of BAEC. Figure 3.11 shows the changes in TR activity in BAEC in 
response to increasing sodium selenite concentrations. In BAEC, of the same passage 
number, cultured in 40 nM and 160 nM sodium selenite the activity of TR significantly 
increased (p < 0.05) from being undetectable in Se- deficient medium to 0.59 ± 0.12 U/g 
protein (p < 0.01) and 0.48 ± 0.17 U/g protein (p < 0.05) respectively (figure 3.11 a) at 40 nM 
and 160 nM selenite. In the subsequent experiment using BAEC of a later passage number, 
TR activity was significantly augmented in the BAEC cultured in sodium selenite 
concentrations of 5 nM and above (p < 0.001) (figure 3.11 b). 
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Figure 3.11 Thioredoxin reductase (TR) activity in bovine aortic endothelial cells 
(BAEC). BAEC of the same preparation were of consecutive passage number for 
experiments (a) and (b). Results shown are those of the mean of triplicate flasks + SD. p < 
0.05 *, p < 0.01 * *, p < 0.001 * ** cf. basal level of activity in Se- deficient control cells. 
3 -37 
The role of TR in the prevention of oxidative damage in EC Chapter three 
3.3.4 The cellular localisation of TR in EAhy926 cells and HUVEC 
HUVEC and EAhy926 cells appear to have cytoplasmic staining for TR1 (figures 3.12a and 
3.13a). No other cellular locations displayed staining. 
The EAhy926 cells displayed a considerable amount of intense, non -specific staining with 
non -immune serum (figures 3.12b and 3.13c), suggesting interference with some cellular 
factors in the culture system. 
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Figure 3.12a Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of human umbilical vein endothelial cells (HUVEC). x 100 
magnification. Both the primary and secondary antibodies were present. 
Figure 3.12b Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of human umbilical vein endothelial cells (HUVEC). x 100 
magnification. Non -reactive serum was applied as a control. 
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¢. 
Figure 3.13a Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of EAhy926 cells. x 100 magnification. Both the primary and 
secondary antibodies were present. 
Figure 3.13b Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of EAhy926 cells. x 100 magnification. For the 
immunohistochemistry here the secondary antibody was present, but without the primary 
antibody. 
3 -40 




Figure 3.13c Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of EAhy926 cells. x 100 magnification. Non -reactive serum was 
applied as a control. 
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3.3.5 The effect of different doses of t -BuOOH on LDH activity in 
EAhy926 cells cultured in selenium -deficient medium 
Cell damage of EAhy926 cells was increased in a dose -dependent manner in response to 
treatment with t -BuOOH (figure 3.14). The cytotoxic effect was initially observed at 175 pM 
(44.5 ± 3.70 % LDH retention; mean ± SD, n =3). A concentration of 200 pM t -BuOOH 
further decreased LDH retention to 16.4 ± 0.1 %. Concentrations exceeding 250 pM t- 
BuOOH gave >95% cell damage such that no LDH retention could be measured in the cells. 
The inter -experiment reproducibility of cell damage varied greatly during the initial series of 
experiments; a concentration of 100 pM t -BuOOH yielded LDH retentions of 91.6 ± 1.2 %, 
3.5 ± 3.6 %, 83.0 ± 2.7 %, and 97.4 ± 0.5 % respectively in separate experiments (data not 
shown). This led to an investigation of the effect of cellular confluence level on the 
susceptibility of EAhy926 cells to oxidative damage by t -BuOOH (section 3.3.6). A cell 
density plating protocol was employed following these investigations to decrease the 
variation in the response of cells due to confluence. The EAhy926 cells were passaged at a 
cell density of 5 x 105 cells /cm2, which took 4 days to reach confluence. 
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Figure 3.14 The effect of increasing concentrations of tert-butyl hydroperoxide (t- 
BuOOH) on % LDH retained in EAhy926 cells after 20 hr exposure. Cells were cultured 
in Se- deficient medium, and incubated with a range of concentrations of t -BuOOH (0 to 325 
pM, in 25 pM increments) when confluent. Results shown are mean + SD of triplicate wells. 
p < 0.01 `* ; p < 0.001 * ** cf. control cells. 
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3.3.6 The effect of cellular confluence level on susceptibility of 
EAhy926 cells and HUVEC to oxidative damage by t -BuOOH 
EAhy926 cells at 100 % confluence or 2 days post -confluence showed no loss of viability 
when exposed to 50 pM t- BuOOH, but only 30.6 ± 8.1 % LDH was retained by cells that 
were 50 % confluent (p < 0.0001 cf. control cells) (figure 3.15 a). (p < 0.05 cf. 100 % 
confluent cells at the same t -BuOOH concentration). The EAhy926 cells at 2 days post 
confluence did not sustain any cytotoxicity at any of the t -BuOOH concentrations tested, the 
range of which extended to 125 pM. The cells at 100 % confluence sustained slight but 
significant cytotoxicity at 100 pM t -BuOOH (p < 0.05 cf. control cells), and a higher level of 
cytotoxicity at 125 pM t -BuOOH (p < 0.001), retaining 84.4 ± 2.9 % LDH. In comparison, at 
125 pM t- BuOOH, 50 % confluent cells retained 9.3 ± 2.3 % LDH (p < 0.001 cf. control cells; 
p < 0.001 cf 100 % confluent cells). 
In a second experiment, cells exposed to either 50 pM or 100 pM t -BuOOH at 50 % 
confluence were significantly more susceptible to cytotoxicity than either 100 % confluent 
cells (p < 0.01) or 2 day post -confluent cells (p < 0.01) (figure 3.15 b). At a concentration of 
150 pM t- BuOOH, 50 % confluent cells were more susceptible to cytotoxicity than were 100 
% confluent cells or 2 day post -confluent cells (p < 0.0001). At a concentration of 200 pM t- 
BuOOH, the cytotoxicity to 50 % and 100 % confluent cells was not significantly different, but 
2 day post -confluent cells were significantly less susceptible to damage than were 50 % or 
100 % confluent cells (p < 0.05). This trend of the 2 day post -confluent cells showing less 
susceptibility to damage was repeated for all the remaining concentrations of t -BuOOH 
tested (p < 0.05). 
The time between passage and cytotoxic insult was also found to affect the level of 
cytotoxicity sustained by EAhy926 cells from t- BUOOH. The cells were seeded at differing 
densities upon sub -culturing such that both groups of cells achieved full confluence upon 
cytotoxic insult. The cells left to grow for 2 days between passage and t -BuOOH exposure 
were significantly more susceptible to cytotoxic damage by t -BuOOH than were the cells left 
for 4 days between passage and t -BuOOH exposure (p < 0.001) (figure 3.16). EAhy926 
cells left to grow for 4 days between sub -culture and t -BuOOH exposure did not experience 
any significant decrease in viability at any of the t -BuOOH concentrations tested; the cells 
left to grow for 2 days between sub -culture and t -BuOOH exposure sustained significant 
damage at t -BuOOH concentrations of 150pM and above (p < 0.001). 
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HUVEC exposed to t -BuOOH at different confluence levels also showed differences in 
susceptibility to cytotoxic damage (figure 3.17). 1 day pre -confluent HUVEC and 100 
confluent HUVEC first sustained cytotoxicity from 55 pM t -BuOOH (p < 0.001), but at this t- 
BuOOH concentration 2 day post -confluent HUVEC showed no susceptibility to cytotoxicity 
(p < 0.05 cf. 100 % confluent cells). 2 day post -confluent HUVEC first showed susceptibility 
to cytotoxicity at 70 pM t -BuOOH (p < 0.01), retaining 65.5 ± 13.6 % LDH, whilst pre - 
confluent cells and 100 % confluent cells retained 24.6 ± 5.8 % and 23.4 ± 8.3 % of their 
LDH respectively (p < 0.001) (p < 0.05, 2 day post -confluent cells versus 100 % confluent 
cells). 
The level of FCS in the culture medium also influenced the cytotoxicity of t -BuOOH to 
EAhy926 cells. Cells cultured in medium containing 5 % FCS were significantly more 
susceptible to t- BuOOH- induced cytotoxicity (p < 0.05) than corresponding cultures in 
medium containing 10 % FCS (data not shown). The toxicity of t -BuOOH was found to be 
inversely proportional to the concentration of FCS in the medium in which the t -BuOOH is 
dissolved prior to addition to the cells. The % FCS was kept constant at 10 % for EAhy926 
cells in culture for all experiments described. 
3 -45 

















0 25 50 75 100 125 
[t -BuOOH (11M)] 
50% confluent 
100% confluent 
2 day post - 
conf luent 
0 50 100 150 200 250 300 400 
[t -BuOOH OA] 
50% confluent 
100% confluent 
2 day post - 
conf luent 
Figure 3.15 The effect of tert-butyl hydroperoxide (t- BuOOH) on % LDH retained in 
EAhy926 cells grown to differing confluence levels. Cells were cultured in Se- deficient 
medium, and incubated with a range of concentrations of t -BuOOH at 50 % confluence, 100 
confluence, or at 2 days post -confluence. Results shown are those of the mean of 
triplicate wells + SD. p < 0.05 *, p < 0.001 * ' cf. control cells receiving 0 pM t- BuOOH. (a) 
and (b) are two different experiments. p < 0.05t, p < 0.01$, p < 0.001$$ cf. 100 % confluent 
cells receiving the same t -BuOOH concentration. 
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Figure 3.16 The effect of tert -butyl hydroperoxide (t- BuOOH) on % LDH retained in 
EAhy926 cells left to grow for differing times between passage and cytotoxic insult. 
Cells were cultured in Se- deficient medium, and incubated with a range of concentrations of 
t -BuOOH (0, 25, 50, 75, 100, 150, 200, 250 pM) at 2 days or 4 days post -passage (similar 
confluence level upon exposure to t- BuOOH). Results shown are mean + SD of triplicate 
wells. p < 0.001' cf. control cells receiving 0 pM t- BuOOH. p < 0.001t cf. cells at 4 days 
post -passage receiving the same concentration of t- BuOOH. 
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Figure 3.17 The effect of tert-butyl hydroperoxide (t- BuOOH) on % LDH retained in 
HUVEC grown to differing confluence levels. Cells were cultured in Se- deficient medium, 
and incubated with a range of concentrations of t -BuOOH (0, 10, 25, 40, 55, 70, 85, 100 pM) 
at 1 day pre -confluence, 100 % confluence, or at 2 days post -confluence. Results shown 
are mean + SD of triplicate wells. p < 0.01**; p < 0.001 * ** cf. control cells. p < 0.05t, p < 
0.01$ cf. cells at 100 % confluence receiving the same t -BuOOH concentration. 
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3.3.7 The ability of sodium selenite to protect against oxidative 
damage resulting from t -BuOOH exposure in EAhy926 cells 
Figure 3.18 shows that EAhy926 cells pre- incubated for 48 hr in the presence of sodium 
selenite concentrations (1 nM to 1000 nM) were significantly less sensitive to the cytotoxic 
effects of 300 pM t -BuOOH compared to EAhy926 cells cultured in Se- deficient medium (p < 
0.05). The optimal protective effect of sodium selenite was observed at 40 nM sodium 
selenite (p < 0.001) in the first experiment, and at 10 nM sodium selenite in the other two 
experiments (p < 0.001). Selenite when added at a concentration of 1000 nM was 
significantly toxic to EAhy926 cells in the absence of t -BuOOH (p < 0.05) only in one 
experiment (figure 3.18 b). 
TR activity and concentration, cyGPX activity and PHGPX activity were determined in 
EAhy926 cells cultured in the same concentrations of sodium selenite as described above 
for the protection experiments. Figures 3.03 a and c show that both TR activity and cyGPX 
activity were significantly increased in EAhy926 cells cultured in the presence of 10 nM 
sodium selenite compared to EAhy926 cells cultured in Se- deficient medium (p < 0.01; p < 
0.05). The TR and cyGPX activities were maximal in EAhy926 cells cultured in 10nM 
sodium selenite (first experiment) and 40 nM sodium selenite (second experiment), although 
all the concentrations of sodium selenite tested increased TR activity above that seen in the 
basal state. 
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Figure 3.18 The effect of sodium selenite pre- incubation on the susceptibility of 
EAhy926 cells to tert -butylhydroperoxide (t- BuOOH)- induced cell damage. EAhy926 
cells were incubated in Se- deficient medium supplemented with different concentrations of 
sodium selenite (0, 1, 10, 40, 50, 100, 200, 1000 nM) for 48 hr. Following the pre -incubation 
the EAhy926 cells were exposed to t -BuOOH (0 or 300 pM). After 20 hr cell viability was 
assessed by determining the % LDH activity retained. Results shown are the mean of 
triplicate wells + SD. p < 0.05`, p < 0.01 "', p < 0.001*** cf. Se- deficient control cells. Graphs 
(a) - (c) are each a separate experiment. 
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3.3.8 Assessment of the direct effect of sodium selenite in the 
protection of EAhy926 cells against oxidative damage resulting from t- 
BuOOH exposure 
Figure 3.19a shows the importance of a pre- incubation period with sodium selenite in order 
for Se to exert a protective effect against cytotoxicity induced by t- BuOOH. In EAhy926 cells 
which had been pre -cultured in 40 nM sodium selenite, and which also received selenite (40 
nM) simultaneously with the t- BuOOH, total protection from toxicity from concentrations of t- 
BuO0H up to 150 pM was observed, giving 98.0 ± 0.2 % LDH retention. Slight but 
significant cytotoxicity was sustained at 200 pM and 250 pM t- BuOOH, with 95.8 ± 0.6 % 
and 94.5 ± 0.6 % LDH retention respectively (p < 0.001). In contrast, in EAhy926 cells 
which received no pre -incubation with selenite but the sodium selenite (40 nM) was added at 
the same time as t -BuOOH treatment no protection was afforded, and the cells were more 
prone to damage by t -BuOOH at 150 pM (p < 0.05) and 250 pM (p < 0.01). 
In a second experiment, Figure 3.19b, the above results were confirmed. In EAhy926 cells 
which had been pre -cultured in 40 nM sodium selenite, and which also received selenite (40 
nM) simultaneously with the t- BuOOH, total protection from toxicity from all concentrations of 
t -BuOOH tested (25 to 250 pM) was observed (p < 0.05), apart from 100 pM. In EAhy926 
cells to which sodium selenite (40 nM) was added at the same time as t -BuOOH treatment, 
but not as a pre- incubation, no protection was afforded, and the cells were seen to be more 
sensitive to damage by 75 pM t -BuOOH than were the control cells that received no selenite 
supplementation at any time, although the increase in damage was not significant. 
A third experiment showed EAhy926 cells pre -cultured in 40nM sodium selenite, and which 
also received selenite (40 nM) simultaneously with the t -BuOOH to be protected from t- 
BuOOH toxicity produced by concentrations of 25 pM to 100 pM (figure 3.19c). There was a 
small but significant protective effect at 150 pM t- BuOOH, but all protection was lost by 200 
pM t- BuOOH. In EAhy926 cells to which sodium selenite (40 nM) was added at the same 
time as t -BuOOH treatment, again no protection was afforded, and the cells were seen to 
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Figure 3.19 The effects of sodium selenite on the sensitivity of EAhy926 cells to tert- 
butyihydroperoxide (t- BuOOH) cytotoxicity added either prior to t -BuOOH treatment or 
at the same time as t -BuOOH treatment. EAhy926 cells were pre- incubated with either 
Se- deficient medium supplemented with sodium selenite (40 nM) or Se- deficient medium 
with no addition. After 48 hr incubation the medium was removed and replaced with medium 
containing 40 nM sodium selenite and t -BuOOH (0 to 250 pM) or t -BuOOH unsupplemented 
with selenite for 20 hr. Control cells received no t -BuOOH or Se supplementation. Results 
shown are the mean of triplicate wells + SD. p < 0.01**, p < 0.001*** cf. control cells for 
each respective treatment group. p < 0.05t, p < 0.01$ cf cells which did not receive selenite 
pre- incubation or in conjunction with t- BuOOH, receiving the same t -BuOOH concentration. 
Graphs (a) - (c) are separate experiments. 
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3.3.9 Assessment of the timecourse of inhibition of TR activity by 10pM 
gold thioglucose in EAhy926 cells 
The TR activity retained by EAhy926 cells incubated with 10 pM GTG for 24 hr was 
measured at 63.2 ± 13.6 % (mean ± SD, n = 3) retention (p < 0.01) (figure 3.20). The level 
of retention of TR activity was seen to significantly decrease to 36.6 ± 4.0 % when incubation 
with GTG was for 48 hr (p < 0.001 cf. control cells; p < 0.05 cf. 24 hr incubation). An 
incubation period of 72 hr with 10 pM GTG in EAhy926 cells produced 29.1 ± 1.9 % retention 
of TR activity (p < 0.001), which was not significantly different to the retention of activity 
measured for 48 hr incubation. 
3.3.10 Assessment of the effect of gold thioglucose on cyGPX activity, 
PHGPX activity and TR activity of EAhy926 cells 
Figure 3.21 illustrates the differing sensitivities of the three selenoenzymes to inhibition by 
gold thioglucose (GTG). At a concentration of 1 pM GTG, 74.8 ± 11.1 % (mean ± SD, n = 6) 
of TR activity (p < 0.01 cf. control cells) was retained (figure 3.21 a), whereas no significant 
loss of cyGPX (figure 3.21 c) or PHGPX activity (figure 3.21 b) was observed. Using 10 pM 
GTG, 14.02 ± 20.9 % of TR activity (p < 0.001), 40.2 ± 5.6 % of cyGPX activity (p < 0.001), 
and 77.5 ± 17.7 % of PHGPX activity (p < 0.01) were retained compared to control cells. 
When GTG was added at a concentration of 100 pM, marked inhibition of all selenoenzymes 
was observed such that 0.56 ± 1.4 %, 15.1 ± 2.7 %, and 54.4 ± 11.3 % of enzyme activities 
were retained for TR, cyGPX and PHGPX respectively (p < 0.001, < 0.001, and < 0.001 cf. 
control cells). 
TR was also more sensitive to inhibition by 1.75 pM and 2.5 pM GTG than cyGPX and 
PHGPX (figure 3.22). When the pre- incubation was with a GTG concentration of 1.75 pM, 
75.1 ± 23.0 % of TR activity was retained, whereas no significant loss of cyGPX or PHGPX 
activity was observed. Using 2.5 pM GTG, 71.7 ± 3.2 % of TR activity, 82.2 ± 3.9 % of 
PHGPX activity, and 66.0 ± 10.6 % of cyGPX activity (p < 0.05) was retained compared to 
control cells. 
Supplementation of cells with GTG at concentrations of 1 pM or 10 pM did not alter the TR 
concentration of the cells compared to control cells as assessed by TR RIA (data not 
shown). There are no methods currently available to us to assess cyGPX concentration. 
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Figure 3.20 Timecourse of inhibition of thioredoxin reductase (TR) activity by gold 
thioglucose (GTG) in EAhy926 cells. Cells were incubated with Se- deficient medium 
supplemented with GTG (10 AM) for 24, 48, and 72 hr respectively. Results shown are 
those of the mean of 3 flasks + SD. The basal level of activity in control cells untreated with 
GTG is indicated by the dashed line. p < 0.01 * *; p < 0.001 "* cf. control cells. p < 0.05t, p 
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3.3.11 Assessment of the effect of gold thioglucose on the 
susceptibility of EAhy926 cells to oxidative damage resulting from t- 
BuOOH exposure 
Figure 3.23 shows the effect of pre- incubation with 10 pM GTG for 48 hr on the susceptibility 
of EAhy926 cells to the damage caused by a range of t -BuOOH concentrations (0, 75, 100 
pM). At a concentration of 75 pM t- BuOOH, cells which had received a 10 pM GTG pre - 
incubation were significantly more susceptible (p < 0.05) to cytotoxic damage (4.4 ± 1.6 
LDH retained) than cells which had received no pre- incubation (23.3 ± 3.7 % LDH retained). 
At t -BuOOH concentrations of 100 pM and above, >95 % cell damage occurred in the control 
cells; thus the GTG pre- incubation was unable to show an increased susceptibility at these 
doses. 
Pre -incubation of EAhy926 cells with 10 pM GTG for 48 hr resulted in 14.02 ± 20.9 % of TR 
activity (p < 0.001), 40.2 ± 5.6 % of cyGPX activity (p < 0.001), and 77.5 ± 17.7 % of PHGPX 
activity (p < 0.01) retention compared to control cells (section 3.3.10 above). 
Figure 3.24 shows the effect of either a 1 pM GTG or 10 pM GTG pre- incubation on the 
susceptibility of EAhy926 cells to damage caused by a range of t -BuOOH concentrations (0 
to 250 pM). At a concentration of 50 pM t- BuOOH, cells which had received a pre - 
incubation of 10 pM GTG were significantly more susceptible to damage (68.3 ± 5.5 % LDH 
retained) than were control cells, (95.2 ± 0.8 % LDH retained) or cells which received 1 pM 
GTG pre- incubation (91.1 ± 0.8 % LDH retained) (p < 0.05). This trend of increased 
susceptibility of cells which had been pre- treated with 10 pM GTG over control cells, and 
cells which had received 1 pM GTG pre- treatment, was apparent until 200 pM t- BuOOH, 
when the distinction between the treatment groups was lost. Cells which had received 1 pM 
GTG pre- treatment were more susceptible to cytotoxic damage by t -BuOOH at 
concentrations of 100 pM and greater than were control cells. LC50 values for control cells, 
cells pre- treated with 1 pM GTG, and cells pre- treated with 10 pM GTG were calculated as 
112 ± 7 /uM; 93 ± 13 pM; 62 ± 12 pM (p < 0.05 cf. control cells) respectively. 
At a concentration of 1 pM GTG, 74.8 ± 11.1% (mean ± SD, n = 6) of TR activity (p < 0.01 cf. 
control cells) is retained in EAhy926 cells, whereas no significant loss of cyGPX or PHGPX 
activity is observed. Using 10 NM GTG, 14.02 ± 20.9 % of TR activity (p < 0.001), 40.2 ± 5.6 
% of cyGPX activity (p < 0.001), and 77.5 ± 17.7 % of PHGPX activity (p < 0.01) was 
retained compared to control cells (sections 3.3.9 and 3.3.10 detail the experiments 
performed to assess selenoprotein activity inhibition by GTG). 
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Concentrations of 1.75 pM and 2.5 pM GTG were investigated to determine whether they 
would offer further selectivity of inhibition of TR activity without affecting the activity of cyGPX 
and PHGPX. Figure 3.25 shows the effect of either a 1.75 pM or 2.5 pM GTG pre- incubation 
on the susceptibility of EAhy926 cells to the damage caused by a range of t -BuOOH 
concentrations (0 to 300 pM). Cells pre- incubated with either 1.75 pM or 2.5 pM GTG 
showed similar susceptibility to cytotoxic damage from all the concentrations of t -BuOOH 
tested. Significant cytotoxicity was first sustained at a concentration of 75 pM t -BuOOH (p < 
0.001) when cells received a pre- incubation of 1.75 pM or 2.5 pM GTG, whereas control 
cells first showed cytotoxicity at 150 pM t- BuOOH. There were no significant differences in 
the susceptibilities of the cells that received either 1.75 pM or 2.5 pM GTG to cytotoxicity at 
any concentration of t- BuOOH. 
Using these GTG concentrations, 1.75 pM GTG resulted in 75.1 ± 23.0 % of TR activity 
retention, whereas no significant loss of cyGPX or PHGPX activity was observed. Using 2.5 
pM GTG, 71.7 ± 3.2 % of TR activity, 82.2 ± 3.9 % of PHGPX activity, and 66.0 ± 10.6 % of 
cyGPX activity (p < 0.05) was retained compared to control cells (figure 3.22). 
Using a range of GTG concentrations for pre- incubation of the EAhy926 cells (1, 2.5, 5, 7.5, 
and 10 pM GTG) demonstrated a trend for increasing damage mediated by t -BuOOH with 
increasing GTG concentration (figure 3.26). At a t -BuOOH concentration of 150 pM, it was 
demonstrated that the higher the GTG concentration used for the pre- incubation of the 
EAhy926 cells, the more damage was sustained from the t- BuOOH. However, the 
differences between the cells receiving the differing GTG concentrations were not significant 
due to large variations between the amount of LDH released from individual wells. The trend 
for increasing susceptibility was partially demonstrated at a concentration of 200 pM t- 
BuOOH, although the differential susceptibility between the higher GTG concentrations had 
been lost at this concentration. Again, the large variations in the data meant that differences 
between the treatment groups were not significant. A GTG concentration of 1 pM used for 
pre- treatment did not significantly increase the susceptibility of the cells to damage by t- 
BuOOH at any of the concentrations tested, although it had been demonstrated to do so in a 
previous experiment (figure 3.24). 
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Figure 3.23 The effect of gold thioglucose pre -incubation on the % LDH retained by 
EAhy926 cells exposed to t- BuOOH. EAhy926 cells were pre- treated with 10 pM gold 
thioglucose (GTG) for 48 hr prior to exposure to t -BuOOH (0, 75, 100 pM) for 20 hr. Cell 
viability was then assessed by % LDH retention. Control cells did not receive a pre -incubation. 
Results shown are those of the mean of triplicate wells + SD. p < 0.001*** cf. control cells 
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3.3.12 Assessment of the effect of consecutive sodium selenite and 
gold thioglucose treatment on susceptibility of EAhy926 cells to 
oxidative damage resulting from t -BuOOH exposure 
Following exposure to t -BuOOH after pre- incubation with 10 pM GTG for 48 hr, EAhy926 
cells were significantly more susceptible (p < 0.05) to damage by t -BuOOH (40 ,uM to 100 
pM) than control cells (figure 3.27 a). A pre- incubation of 40 nM sodium selenite for 48 hr 
significantly protected against the cytotoxicity (p < 0.05) sustained by Se- deficient control 
cells. When EAhy926 cells were pre- incubated with 40 nM sodium selenite for 48 hr 
followed by GTG (10 pM) for 48 hr, the protective effects of the selenite were seen to 
override the deleterious effects of the GTG pre- incubation. Thus, the cells which received 
pre- incubation with 40 nM sodium selenite followed by GTG retained a significantly higher 
LDH than cells which received the corresponding GTG concentration alone as a pre- 
treatment (p < 0.01). 
The ability of sodium selenite- mediated protection to override the deleterious effect of the 
GTG treatment was a reproducible response in three further experiments (figures 3.27 b, 
3.28 a and 3.28 b). In the last two experiments, the sodium selenite was used to overcome 
the effects of 1 pM GTG pre- treatment, but in figures 3.27 a and 3.27 b the GTG treatment 
was with 10 pM GTG. 
The GPX and TR activity of cells receiving pre- incubations as detailed above were not 
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Figure 3.27 The effect of consecutive sodium selenite and gold thioglucose pre - 
incubations on the % LDH retained by EAhy926 cells exposed to t- BuOOH. EAhy926 
cells were pre- treated with sodium selenite (40 nM) followed by gold thioglucose (GTG) (10 
pM), or either one of these pre- incubations, each for 48 hr. Cells were washed between and 
following pre- incubations. Exposure to t -BuOOH (0 - 100 pM, or 0 - 250 pM) was for 20 hr. 
Cell viability was then assessed by % LDH retention. Control cells did not receive a selenite 
or GTG pre- incubation. Results shown are those of the mean of triplicate wells + SD. p< 
0.01' *, p < 0.001*** cf. respective control cells receiving 0 pM t- BuOOH. p < 0.05t, p < 
0.01$, p < 0.001$$ cf. control cells receiving the same t -BuOOH concentration. Graphs (a) 















0 25 50 75 100 150 






0 40nM Sodium Selenite 
Selenite, 1 uM GTG 
1 u M GTG 
10uM GTG 
Control 
O 40nM Sodium Selenite 
Selenite, 1 uM GTG 
1uMGTG 
10uMGTG 
0 50 75 100 150 200 250 300 
[t -BuOOH (MM)] 
Figure 3.28 The effect of consecutive sodium selenite and gold thioglucose pre - 
incubations on the % LDH retained by EAhy926 cells exposed to t- BuOOH. EAhy926 
cells were pre- treated with sodium selenite (40 nM) followed by gold thioglucose (GTG) (1 
pM), or either one of these pre- incubations, or 10 pM GTG, each for 48 hr. Cells were 
washed between and following pre- incubations. Exposure to t -BuOOH (0 - 250 pM or 300 
pM) was for 20 hr. Cell viability was then assessed by % LDH retention. Control cells did 
not receive a selenite or GTG pre- incubation. Results shown are those of the mean of 
triplicate wells + SD. p < 0.05 «, p < 0.01**, p < 0.001 ' cf. respective control cells receiving 
0 pM t- BuOOH. p < 0.05 t, p < 0.01 t, p < 0.001$$ cf. control cells receiving the same t- 
BuOOH concentration. Graphs (a) and (b) are each a separate experiment. 
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3.3.13 The ability of sodium selenite to protect against oxidative 
damage resulting from oxLDL exposure in EAhy926 cells 
Using the first batch of LDL, there was a concentration -dependent cytotoxicity of oxLDL to 
EAhy926 cells (figure 3.29 a). OxLDL first showed toxicity at a concentration of 400 mg /L (p 
< 0.001). Native LDL was not cytotoxic to EAhy926 cells at any of the concentrations tested. 
In the presence of 400 mg /L oxLDL, only 31.1 ± 3.7 % of LDH was retained in the absence 
of selenite. In contrast, 92.27 ± 2.06 % LDH retention was demonstrated for cells pre - 
incubated with 40 nM selenite for 48 hr when exposed to oxLDL (400 mg /L) (p < 0.0001). A 
concentration of 800 mg /L oxLDL caused <1 % LDH retention in the absence of a selenite 
pre- incubation. When pre- incubated with 40 nM selenite and exposed to 800 mg /L oxLDL, 
38.4 ± 8.3 % of LDH was retained (p < 0.001). A concentration of 1600 mg /L oxLDL 
produced <1 % LDH retention in the absence of selenite pre- incubation, but 18.8 ± 9.1 % of 
LDH was retained when cells were pre- incubated with 40 nM selenite before exposure to 
1600 mg /L oxLDL. 
Using the second batch of LDL, there was a concentration -dependent cytotoxicity of oxLDL 
to EAhy926 cells (figure 3.29 b). Native LDL did not demonstrate cytotoxicity to EAhy926 
cells at any of the concentrations tested. In the presence of 480 mg /L oxLDL, only 57.7 ± 
10.3 % of LDH was retained in the absence of selenite, compared with 97.47 ± 0.14 % LDH 
retention when pre- incubated with 40 nM selenite for 48 hr (p < 0.05). A concentration of 
960 mg /L oxLDL produced almost 100 % cell damage (0.1 ± 0.2 % LDH retained), whereas 
6.9 ± 5.6 % LDH retention was demonstrated following the same concentration of oxLDL 
exposure after first receiving a 40 nM selenite pre- incubation. This small protective effect did 
not achieve statistical significance. 
The two paired fractions of the third batch of LDL also exhibited a concentration -dependent 
cytotoxicity of the oxLDL to EAhy926 cells. Native LDL was not cytotoxic to EAhy926 cells at 
any of the concentrations tested. In the presence of 560 mg /L oxLDL, (fraction A) only 19.8 
± 1.8 % of LDH was retained in the absence of selenite (figure 3.30 a), compared with 92.7 ± 
0.4 % LDH retention by cells pre- incubated with 40 nM selenite for 48 hr and exposed to 
oxLDL (560 mg /L) (p < 0.001). A concentration of 1120 mg /L oxLDL produced more 
cytotoxicity than 560 mg /L, demonstrating only 2.5 ± 0.4 % LDH retention in the absence of a 
selenite pre- incubation. When pre- incubated with 40 nM selenite and exposed to 1120 mg /L 
oxLDL, 2.5 ± 0.8 % of LDH was retained, indicating that the level of cell damage produced 
by a concentration of 1120 mg /L oxLDL was too extensive to protect against. 
In the presence of 560 mg /L oxLDL, (fraction B) only 17.5 ± 2.2 % of LDH was retained in 
the absence of selenite (figure 3.30 b). Cells pre- incubated with 40 nM selenite for 48 hr 
retained 93.1 ± 1.4 % LDH in comparison when exposed to oxLDL (560 mg /L) (p < 0.001). A 
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concentration of 1120 mg /L oxLDL produced further cytotoxicity than 560 mg /L, resulting in 
7.2 ± 0.3 % LDH retention in the absence of a selenite pre- incubation. When pre- incubated 
with 40 nM selenite and exposed to 1120 mg /L oxLDL, 7.3 ± 0.9 % of LDH was retained, 
indicating that the level of cell damage produced by 1120 mg /L oxLDL was too extensive to 
protect against. 
13.14 The effect of sodium selenite and /or gold thioglucose pre - 
incubation on the susceptibility of EAhy926 cells to oxidative damage 
resulting from oxLDL exposure 
OxLDL demonstrated a concentration dependent cytotoxicity to EAhy926 cells, producing 
significant cytotoxicity at 220, 440, and 880 mg /L (p < 0.001) (figure 3.31 a). In the presence 
of 220 mg /L oxLDL, Se- deficient control cells retained 70.4 ± 2.5 % of their LDH activity, 
compared to 59.8 ± 5.1 % LDH activity retention by cells pre- incubated with 1 pM GTG for 48 
hr (p < 0.05). At the same dose of oxLDL, cells pre- incubated with 40 nM sodium selenite for 
48 hr retained 99.1 ± 1.6 % of their LDH, which was highly significant protection compared to 
Se- deficient cells (p < 0.0001). Cells which were pre- treated with 40 nM sodium selenite for 
48 hr followed by 1 pM GTG for 48 hr prior to exposure to 220 mg /L oxLDL demonstrated 
98.5 ± 0.9 % LDH retention, which was not significantly different to the % LDH retention by 
cells which received sodium selenite pre- incubation alone. This protection was highly 
significant 0.0001). 
At a concentration of 440 mg /L oxLDL, EAhy926 cells pre- incubated with 1 pM GTG showed 
increased susceptibility to damage, retaining 6.2 ± 0.5 % LDH in comparison to controls 
which retained 10.0 ± 0.2 % LDH (p < 0.0001). Cells which received a pre- incubation with 
40 nM sodium selenite retained 22.8 ± 4.8 % LDH, which was significant protection in 
comparison to Se- deficient control cells (p < 0.05). The % LDH retention by cells pre - 
incubated with 40 nM sodium selenite alone was not significantly different to the level 
retained by cells which received 40 nM sodium selenite for 48 hr followed by 1 pM GTG for 
48 hr as pre- incubations. Thus, the sodium selenite pre- incubation was able to overcome 
the deleterious effect of the GTG pre- incubation. 
Cytotoxicity of oxLDL to the EAhy926 cells was first evident at a concentration of 220 mg /L, 
producing 70.4 ± 2.5 % LDH retention in control cells. At this oxLDL concentration, total 
glutathione was depleted in the cells so as to be beyond the lower detection limit of our 
assay (figure 3.31 b). Depletion of total glutathione was not evident at any of the 
concentrations of oxLDL studied below 220 mg /L. There were no significant differences in 
the total glutathione level of cells in any of the treatment groups between different oxLDL 
concentrations. 
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Figure 3.29 The effects of sodium selenite on the sensitivity of EAhy926 cells to 
oxidised and native low- density lipoprotein (LDL) cytotoxicity. EAhy926 cells were pre - 
incubated with either Se- deficient medium supplemented with sodium selenite (40 nM) or 
Se- deficient medium with no addition. After 48 hr incubation the medium was removed, the 
cells washed, and the cells received medium containing native LDL or oxidised LDL (oxLDL) 
(0, 200, 400, 800, 1600 pM) (experiment 'a') or (0, 240, 480, 960 pM) (experiment 'b') for 24 
hr. Control cells received no Se supplementation. Results shown are the mean of triplicate 
wells + SD. p < 0.01-, p < 0.001- cf. respective control cells receiving 0 mg /L LDL. p < 
0.05t, p < 0.0001$ cf. Se- deficient cells treated with the same concentration of oxLDL. 
Graphs (a) and (b) are each a separate experiment using a different preparation of LDL. 
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Figure 3.30 The effects of sodium selenite on the sensitivity of EAhy926 cells to 
oxidised and native low- density lipoprotein (LDL) cytotoxicity. EAhy926 cells were pre - 
incubated with either Se- deficient medium supplemented with sodium selenite (40 nM) or 
Se- deficient medium with no addition. After 48 hr incubation the medium was removed, the 
cells washed, and the cells received medium containing native LDL or oxidised LDL (oxLDL) 
(0, 280, 560, 1120 pM) for 24 hr. Control cells received no Se supplementation. Results 
shown are the mean of triplicate wells + SD. p < 0.001' *' cf. respective control cells 
receiving 0 mg /L LDL. p < 0.001 t, p < 0.0001$ cf. Se- deficient cells treated with the same 
concentration of oxLDL. Graphs (a) and (b) are each a different experiment with a paired 





















0 110 220 440 880 
[oxLDL (mg /L)] 
oxLDL control 
1uMGTG 
40nM Selenite, GTG 
40nM Selenite 
111111111 




40nM Selenite, GTG 
40nM Selenite 
Figure 3.31 The effects of gold thioglucose and/or sodium selenite on the sensitivity 
of EAhy926 cells to oxidised low- density lipoprotein (oxLDL) cytotoxicity, and on total 
glutathione status. EAhy926 cells were pre- incubated for 48 hr with Se- deficient medium 
supplemented with sodium selenite (40 nM) or 1pM gold thioglucose (GTG), or selenite 
followed by GTG. After pre- incubation the medium was removed, the cells washed, and the 
cells received medium containing oxidised LDL (oxLDL) (0, 13.8, 27.5, 55, 110, 220, 440, 
880 pM) for 24 hr. Control cells received no Se or gold thioglucose supplementation. 
Cytotoxicity was assessed by % LDH activity retained. For glutathione assay, cells were 
harvested into 3.3 % sulphosalicylic acid, and lysed by 2 freeze -thaw cycles at -80 °C. 
Results shown are the mean of triplicate wells + SD. p < 0.001*** cf. control cells receiving 
the respective pre- incubation, but no oxLDL. p < 0.05t, p < 0.0001$ cf. control cells 
receiving the same oxLDL concentration. Graphs (a) and (b) are data from one experiment, 
graph (a) detailing cytotoxicity, and graph (b) detailing total glutathione status. 
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3.3.15 The effect of sub -toxic oxLDL concentrations on the expression 
of TR in EAhy926 cells 
Using five different preparations of LDL, the expression of TR in EAhy926 cells was 
investigated (data not shown). None of the oxLDL or native LDL of any of the preparations 
was seen to significantly alter the expression of TR in EAhy926 cells. There were no 
differences in TR concentration with increasing oxLDL concentration or native LDL 
concentration. There were slight but significant differences in the TR concentration of the 
cells which received oxLDL as compared with native LDL in some of the batches of LDL. 
Two of the five batches saw significantly increased TR concentration at 50 mg /L oxLDL and 
at 24 mg /L oxLDL respectively (p < 0.05) when compared with the corresponding cells which 
received the same concentration of native LDL. One batch of LDL demonstrated that cells 
treated with a concentration of 200 mg /L oxLDL had a significantly lower (p < 0.05) TR 
concentration than the corresponding cells which received the same concentration of native 
LDL. 
3.3.16 The effect of homocysteine on the expression of selenoproteins 
in EAhy926 cells 
EAhy926 cells in their normal Se- deficient medium demonstrated no significant changes in 
either TR concentration or cyGPX activity when treated with 1 mM homocysteine for a range 
of time points (4 to 48 hr) (data not shown). At 4 hr both the TR concentration and cyGPX 
activity fell to below the control levels, but the differences were not significant. At 10, 24 and 
48 hr the cyGPX activity was elevated above the control levels, but the differences were not 
significant due to very large variations in the data. 
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3.3.17 The potential of endothelial cells to oxidise native LDL, and the 
effect of Se supplementation on the oxidation process 
a) EAhy926 cells 
Figure 3.32 shows the effect of sodium selenite supplementation (of EAhy926 cells) and /or 
CuSO4 supplementation (of LDL) on the relative electrophoretic mobility (REM) of LDL. 
Figure 3.32a demonstrates that the EAhy926 cells did not alter the REM of the LDL 
compared to the LDL without cells present (lanes 7 and 3). When the EAhy926 cells were in 
differing culture media, oxidation of the LDL differed. The REM of the LDL when incubated 
with EAhy926 cells in Ham's F -12 medium (lane 5) was higher than that when the cells were 
cultured in DMEM (lane 3). The Se status of the cells did not attenuate the slight alteration 
in REM seen in cells cultured in Ham's F -12 medium (lanes 5 and 6). A slight increase in 
REM of LDL in the absence of cells was demonstrated when the LDL was treated with 2.5 
pM Cu, also in the absence of cells (lanes 7 and 8). 
Figure 3.32b again demonstrates the increased REM of LDL treated with Cu in the absence 
of cells; 5 pM Cu increased the REM of the LDL (lane 5) to a greater extent than 2.5 ,uM Cu 
(lane LDL treated with Cu (lane 3). The LDL in the absence of 
cells had a very slight increase in REM when diluted in Ham's F -12 medium (lane 6) in 
comparison with dilution in DMEM (lane 3). When cells were present, the REM of the LDL 
diluted in Ham's F -12 was slightly increased (lane 7) over that seen when cells were absent 
(lane 6). 
Four gels were run in total for EAhy926 cells, but only two are shown here as representative 
results. 
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Figure 3.32 Lipoprotein gel of native low density lipoprotein (LDL) incubated with 
EAhy926 cells for 24 hr. Cells received Se- deficient medium containing either 40nM 
sodium selenite, or unsupplemented DMEM medium for a 48 hr pre- incubation. The cells 
were then washed, and received native LDL, supplemented with 2.5 pM or 5 pM CuSO4, or 
unsupplemented, diluted in serum -free DMEM medium or Ham's F -12 medium (200 pg /ml 
final concentration). Incubation with LDL was for 24 hr. Upon completion of the incubation, 
the LDL was removed from the wells and BHT (25 pM) and EDTA (100 pM) added to arrest 
further oxidation. Normal serum was included to serve as a standard. 
(a) Lane 1, normal serum with no additions; lane 2, normal serum with no additions; lane 3, 
Se- deficient cells with LDL in DMEM; lane 4, Se- supplemented cells with LDL in DMEM; lane 
5, Se- deficient cells with LDL in Ham's F -12; lane 6, Se- supplemented cells with LDL in 
Ham's F -12; lane 7, LDL in DMEM without cells; lane 8, LDL supplemented with 2.5 pM Cu 
in DMEM without cells. 
(b) Lane 1, normal serum with no additions; lane 2, Se- deficient cells with LDL in DMEM; 
lane 3, LDL in DMEM without cells; lane 4, LDL supplemented with 2.5 pM Cu in DMEM 
without cells; lane 5, LDL supplemented with 5 pM Cu in DMEM without cells; lane 6, LDL in 
Ham's F -12 without cells; lane 7, Se- deficient cells with LDL in Ham's F -12; lane 8, normal 
serum with no additions. 
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b) HUVEC 
Figure 3.33a illustrates the difference in the two batches of LDL (lanes 2 and 4) in that batch 
'B' appeared to be oxidised to a slightly larger degree by the HUVEC than batch 'A'. This is 
impossible to confirm without showing batch 'B' LDL alone in the absence of cells to act as a 
control. This was confirmed on subsequent gels (data not shown). The small increase in 
REM mediated by HUVEC was not attenuated by supplementing the HUVEC with Se (lanes 
2 and 3). 
Figure 3.33b demonstrates that in the presence of HUVEC, native LDL that is supplemented 
with Cu at a concentration of 2.5 pM or 5 pM (lanes 2 and 3) has an increased REM 
compared to that of LDL that is not treated with Cu (lane 1). This was also demonstrated 
with the second batch of LDL (batch 'B') (lanes 4, 5 and 6). The Se status of the cells did not 
attenuate the rise in REM mediated by 5 pM Cu with the second LDL batch (lanes 6 and 7). 
Figure 3.33c illustrates oxidation of LDL mediated by Cu in the absence of HUVEC. 
Treatment of the LDL with 2.5 pM Cu increased its REM compared to LDL untreated with Cu 
(lanes 2 and 3). Although 5 pM Cu appeared to oxidise the LDL, the sample did not run 
straight on the gel, so the band is difficult to interpret (lane 4). This was confirmed on other 
gels subsequently (data not shown). 
Five gels were run in total for HUVEC, but only three are shown here as representative 
results. 
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Figure 3.33 Lipoprotein gel of native low density lipoprotein (LDL) incubated with 
HUVEC for 24 hr. Cells received Se-deficient medium containing either 40n[N sodium 
se|onite, or unsupplemented M199 medium for a 48 hr pre-incubation. The cells were then 
washed, and received native LOL, supplemented with 2.5 p[W or 5 pM CuSO4, or 
unnupp|emenbsd, diluted in serum-free M199 (200 pg/mI final concentration). Incubation with 
LDL was for 24 hr. Two different LDL preparations were used ('A' and in parallel. Upon 
completion of the incubation, the LDL was removed from the wells and BHT (25 pM) and 
EDTA (100 pM) added to arrest further oxidation. Normal serum was used as a standard. 
(a) Lane 1, normal serum with no additions; lane 2, Se-deficient HUVEC with native LDL 
batch 'A'; lane 3, Se-supplemented HUVEC with native LDL batch lane 4, Se-deficient 
HUVEC with native LDL batch 'B'; lane 5, Se-supplemented HUVEC with native LDL batch 
'B' 
(b) Lane i , Se-deficient HUVEC with native LDL batch 'A'; lane 2, Se-deficient HUVEC with 
LDL batch 'A' supplemented with 2.5 pM Cu; lane 3, Se-deficient HUVEC with LDL batch 'A' 
supplemented with 5 pM Cu¡ lane 4, Se-deficient HUVEC with native LDL batch 'B'; lane 5, 
Se-deficient HUVEC with LDL batch 'B' supplemented with 2.5 pM Cu¡ lane 6, Se- 
supplemented HUVEC with LDL batch 'B' supplemented with 5 pM Cu¡ lane 7, Se- 
supplemented HUVEC with LDL batch 'B' supplemented with 5 pM Cu¡ lane 8, normal serum 
with no additions. 
(c) Lane 1, normal serum with no additions; lane 2, native LDL batch 'A' without cells; lane 3, 
LDL (batch 'A') supplemented with 2.5 pM Cu. without cells; lane 4, LDL (batch 'A') 
supplemented with 5 pM Cu, without cells. 
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3.4 DISCUSSION 
Model systems of human endothelial cells 
BAEC differed considerably from HUVEC and EAhy926 cells in their selenoprotein 
expression, particularly in their TR activity which was 76 % lower (p < 0.05) than the activity 
found in HUVEC. These data imply that BAEC may not be a suitable model in which to 
study selenoproteins in relation to atherosclerotic mechanisms in human disease. A 
difference in the ability of sodium selenite to protect EC has been demonstrated between 
BAEC and HUVEC, and this may be related to the significantly lower TR activity found in 
BAEC. 
There were no differences in the expression of TR, cyGPX or PHGPX between HUVEC and 
HCAEC. The similar selenoprotein expression in these two cell types was also reflected in 
the similar ability of sodium selenite to protect against oxidative damage by t- BuOOH. 
The endothelial cell line EAhy926 has been used for a number of studies of endothelial 
function. The cyGPX activity in EAhy926 cells was only 27 % of that found in HUVEC (p < 
0.0001), but PHGPX activity in the EAhy926 cells was no different to that found in HUVEC. 
The basal medium for EAhy926 cells is different from that used to culture HUVEC, and 
HCAEC, and contains a different Se concentration. For a true comparison to be made, all 
the cell types would need to be cultured in the same medium, but this was not possible. 
Although the basal cyGPX activity was different in EAhy926 cells and HUVEC, the 
selenoenzyme was induced to a similar amount in both cell types upon supplementation with 
similar selenite concentrations. TR was the dominantly expressed selenoprotein in both 
HUVEC and EAhy926 cells (figure 3.01), and the TR activity and concentration were not 
significantly different between cell types (figure 3.02). Furthermore, the sensitivity of 
EAhy926 cells to t -BuOOH and the concentrations of selenite that confer optimal protection 
from t -BuOOH toxicity are also similar to previous results using HUVEC and HCAEC. These 
data taken together indicate that the EAhy926 cell line may be a suitable and convenient 
model to study the role of Se in preventing oxidative damage to human EC. 
The influence of variations in confluence and FCS on cytotoxicity 
The susceptibility of EAhy926 cells to damage by t -BuOOH was variable in early 
experiments. This variability was related to the degree of confluence and FCS 
concentration, with the most susceptible cells being those with a low degree of confluence or 
low FCS concentration. 
Alterations in signalling pathways accompany cellular confluency (Rizzino et al., 1988), and 
rapidly dividing cells may produce more ROS, thereby changing cellular signalling and redox 
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state. Growth arrest induced by contact inhibition is partly due to a decrease in steady state 
levels of ROS with consequent impairment of redox signalling (Pani et al., 2000). These 
alterations in signal transduction pathways may affect the antioxidant status of the cell, 
rendering it less susceptible to cytotoxic insult. Certain cell lines which exhibit density 
limitation of growth demonstrate induction of Mn -SOD upon cessation of proliferation of cells 
in culture (Oberley et al., 1995). SOD activities also vary with the phases of the cell cycle 
(Oberley et al., 1995). The toxicity of oxLDL to fibroblasts (Kosugi et al., 1987) and UVB to 
keratinocytes (Norio and Okamoto, 1987) varies with the stage of cell cycle. 
Cellular energy consumption may be dominated by cell replication at low cell densities, 
whereas cellular energy could be redirected to differentiated functions at higher cell densities 
(Krekels et al., 1991). Cytotoxicity of LDL to EC is greater in subconfluent cells than 
confluent cells (Hessler et al., 1979; Hodis et al., 1994; Kosugi et al., 1987). 
Antioxidant enzymes may vary between different stages of confluency in some cell types 
(Bishop et al., 1985), but our experiments did not show any significantly reproducible 
changes in TR, cyGPX, or PHGPX activity in EAhy926 cells with differing confluence levels 
(data not shown). This does not, of course, rule out differences in antioxidant enzymes other 
than the selenoenzymes studied here. 
The cytotoxicity of t -BuOOH to EAhy926 cells was inversely proportional to the concentration 
of FCS in the medium, either in which the cells were growing or in which the t -BuOOH was 
dissolved prior to addition to the cells. FCS attenuates in vitro cytotoxicity of silver nitrate to 
human dermal fibroblasts (Hidalgo and Domínguez, 1998), 13-carotene cytotoxicity to human 
colonic tumour cells (Peram et al., 1996), and organochlorine cytotoxicity to human placental 
choriocarcinoma cell lines (Letcher et al., 1999). The serum content of culture medium can 
directly decrease ROS generation (Bishop et al., 1985). Hydrophobic compounds can be 
sequestered by serum proteins, such as albumin, thus decreasing the effective free 
concentration of toxicant accessible to the cell (Fisher et al., 1993). In addition, FCS 
contains various growth factors, attachment factors, protease inhibitors and binding proteins 
which may affect the response of the cell to cytotoxic insult. 
For all further experiments, the concentration of FCS and confluence level were kept 
constant, at 10 % FCS and full confluency for treatment of the EAhy926 cells. 
3 -77 
The role of TR in the prevention of oxidative damage in EC Chapter three 
Protection against t- BuOOH- and oxLDL- mediated cytotoxicity in 
EAhy926 cells by selenium 
As in HUVEC and HCAEC, oxidative damage to EAhy926 cells by t -BuOOH could be 
prevented by pre- incubation with low nanomolar concentrations of selenite. Such protection 
was also afforded to EAhy926 cells against cytotoxicity mediated by oxLDL. Protection was 
accompanied by significantly increased TR, cyGPX and PHGPX expression, optimal TR and 
cyGPX expression being achieved at concentrations ranging from 10 nM to 40 nM sodium 
selenite. PHGPX activity also responded to sodium selenite supplementation in a dose - 
dependent manner, but in both experiments high doses of selenite were required to achieve 
significant induction (200 nM and 1000 nM). It is likely however that the lack of effect of Se 
at low concentrations was due in part to the poor precision of the PHGPX assay at the low 
activities being measured in the cells. 
Plasma Se levels have been measured for 15 to 18 year old males and females in the UK, 
giving values of 0.89 +/- 0.14 pmol /L (n = 159) for males, and 0.91 +/- 0.14 pmol /L (n = 163) 
for females (Bates et al., 2002a). The Se level in plasma of UK residents over the age of 65 
years is similar to those measured for 15 to 18 year olds, at 0.9 pmol /L (n = 1134) (Bates et 
al., 2002b). Selenium deficiency is defined as a plasma concentration at or below 85 pg /L, a 
concentration not attained in many northern European countries (Rayman, 2000). Such in 
vivo Se concentrations (pM) are dramatically higher than the concentrations required to 
protect endothelial cells and skin cells in vitro from oxidative stress, and to maximally 
upregulate TR, cyGPX and PHGPX (nM). This apparent discrepancy may arise due to 
albumin, selenium- binding proteins, and SeIP taking up Se in the plasma, meaning that a 
higher concentration is required to have the effects seen with lower concentrations in vitro. 
In addition, thiols in the plasma may react with sodium selenite, lowering the amount of Se 
that is bioavailable for selenoprotein synthesis. Using cells in vitro, the whole amount of 
supplemental Se is available to the cells in its entirety at the same time. This is obviously 
not an accurate reflection of the in vivo situation. 
Pre -incubation of EAhy926 cells with selenite, thereby inducing TR, cyGPX and PHGPX, 
was necessary to provide protection against t -BuOOH cytotoxicity. At sodium selenite 
concentrations which provided protection against t -BuOOH and oxLDL cytotoxicity in 
EAhy926 cells, the activity of TR, cyGPX and PHGPX were all maximally induced. To 
determine the relative importance of each of these selenoenzymes in the protection of 
EAhy926 cells against oxidative stress, a selective gold thioglucose (GTG) concentration 
was established to selectively inhibit TR. 
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A 48 hr pre- incubation with GTG (1 pM) resulted in 74.8 % of TR activity retention compared 
to control EAhy926 cells (p < 0.01), whilst cyGPX and PHGPX activities were not 
significantly changed (figure 3.21). EAhy926 cells treated in this way were significantly more 
susceptible to cytotoxicity from t -BuOOH (p < 0.05) (figures 3.24, 3.26, 3.28) and oxLDL (p < 
0.05) (figure 3.31 a). These data suggest that factors other than GPX, perhaps TR, may 
play an important role in preventing damage to human endothelial cells from oxidised lipids. 
The fact that such a small inhibition of TR activity by 1 pM GTG produced a significant 
increase in susceptibility of the cells to damage by t -BuOOH or oxLDL suggests that 
although TR is present in high concentrations in EC, such high concentrations are required 
for optimal protection from oxidative stress. Alternatively, it could be that this concentration 
of GTG has inhibited an as yet unidentified protein /enzyme that is important in cytoprotection 
(see below). 
Cells treated with GTG at a concentration that inhibited both TR and the GPXs (10 NM) (14.0 
% TR activity retention; p < 0.001, 40.2 % cyGPX activity retention; p < 0.001, 77.5 % 
PHGPX activity retention; p < 0.01) were more susceptible to t -BuOOH toxicity than cells in 
which only TR was inhibited (1 pM GTG). This may suggest that under normal 
circumstances both TR and the GPXs may be involved in prevention of oxidative damage to 
human endothelial cells. However, it could also be that the increased susceptibility of the 
cells to damage when treated with 10 pM is due, alone or partly, to a greater level of 
inhibition of TR activity alone. Selective inhibition of the GPXs in future studies, with specific 
inhibitory antibodies for example, would help to further elucidate the role of the GPXs in an 
antioxidant role in endothelial cells. 
The protective effects of Se supplementation were able to override the deleterious effects of 
GTG treatment prior to t -BuOOH or oxLDL exposure. These studies further suggest that 
both TR and the GPX selenoenzymes are important in protection from the oxidative damage 
produced by oxidised lipids. This reinforces the importance of an adequate Se status in cells 
which may have impaired antioxidant status due to oxidative stress as a result of disease 
states or pharmacological interventions. 
The differing sensitivities of the selenoenzymes TR and GPX to inhibition by gold 
compounds have been shown both in -vitro (Gromer et al., 1998) and in -vivo (Smith et al., 
1999). The GPXs are relatively resistant to inhibition whilst TR is very sensitive, having an 
IC50 - 1000 -fold lower than that of the GPXs (Gromer et al., 1998). The differences in the 
susceptibility of the selenoenzymes to inhibition by GTG was also shown in human placental 
cytosol, where GTG concentrations of 150 pM and 96 nM GTG were required to inhibit 50 
% of cyGPX activity and TR activity respectively. This -1500 -fold difference is comparable 
to data reported by Gromer et al. In endothelial cells, a concentration of 1 pM GTG 
3 -79 
The role of TR in the prevention of oxidative damage in EC Chapter three 
produced 74.8 % retention of TR activity (p < 0.01), but the same concentration produced < 
1 % retention of TR activity in human placental cytosol. This may imply that the cells contain 
other molecules in their cytosol which react with the GTG, thus requiring a higher 
concentration to inhibit selenoenzymes. Alternatively, the cells may actively take up the 
GTG and concentrate the compound. 
These data cannot exclude the possibility that GTG has inhibited another, as yet, 
unidentified selenoenzyme with an antioxidant role. Gold compounds may have other 
effects in the cells which could affect their response to oxidative insult, including induction of 
anti -oxidative genes including haem oxygenase -1 and y- glutamylcysteine synthetase 
(Kataoka et al., 2001), down -regulation of the expression of genes involved in the 
inflammatory response (collagenases, cytokines (interleukins, and TNF -a) and producers of 
chemical mediators (cyclooxygenase -2 and iNOS)) (Yoshida et al., 1999) (Yamashita et al., 
1999) (Bondesona and Sundlera, 1995) , and inhibition of the DNA -binding activity of NFKB 
and AP -1, that regulate a range of genes (Handel et al., 1995). Gold compounds also inhibit 
proliferation of HUVEC, suggesting an antiangiogenic effect (Matsubara and Ziff, 1987), and 
may inhibit PKC in vitro (Mahoney et al., 1989), altering cellular signalling pathways and 
concomitant cellular functions. 
The cytotoxicity of oxLDL to EAhy926 cells and HUVEC, and activities of SOD, catalase and 
cyGPX have previously been compared (Claise et al., 1997). EAhy926 cells had significantly 
lower SOD, catalase and cyGPX activities compared with HUVEC, and were susceptible to 
damage by 150 pg /ml oxLDL. No cytotoxicity was observed in HUVEC using oxLDL 
concentrations of up to 200 pg /ml (Claise et al., 1997). SOD and CAT were ineffective in 
protecting cells from oxLDL cytotoxicity in both cell types (Claise et al., 1997), whilst pre - 
incubation of EAhy926 cells with cyGPX protected against oxLDL cytotoxicity. The higher 
susceptibility of EAhy926 cells to oxLDL cytotoxicity was attributed to the lower antioxidant 
defences of these cells compared to HUVEC, particularly with respect to the cyGPX activity 
which was 8 % of that of HUVEC. Our studies found the cyGPX activity in EAhy926 cells 
was 26 % of that found in HUVEC. The TR activity and mass and PHGPX activity were 
shown not to be significantly different. Claise's group did not measure the activities of either 
TR or PHGPX. 
At the concentration of oxLDL at which cytotoxicity was first evident to the EAhy926 cells, 
total glutathione was depleted to below the lower detection limit of our assay. Whilst 
glutathione is important in preventing oxLDL- induced damage (Moellering et al., 2002) (Cho 
et al., 1999), the doses of Se and GTG used in our experiments produced no significant 
modification to intracellular glutathione concentrations. It is likely that the fall in GSH levels 
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was due to leakage from cell membranes damaged by oxLDL toxicity. In EAhy926 cells 
oxidised lipids from cholesteryl esters induce GSH depletion without inducing cytotoxicity, 
whilst fractions containing oxysterols were more cytotoxic than GSH -depleting, suggesting 
that their cytotoxicity is mediated by a GSH- independent mechanism (Thérond et al., 2000). 
TR may be a candidate for such GSH- independent effects, whilst GSH- dependent effects 
could be due to GPX, glutathione- S- transferase, or direct interaction. 
Cell injury induced by oxLDL may be due to lipid peroxidation involving lipid hydroperoxide- 
induced, iron -mediated formation of alkoxyl, lipid and peroxyl radicals (Coffey et al., 1995). 
The Se mimic Ebselen has cytoprotective effects against oxLDL toxicity (Coffey et al., 1995). 
Detoxification of LOOH is through a GPX- mediated reduction. However, the TR /Trx system 
has a high capacity to detoxify LOOH and may provide an important alternative to the GPXs 
for detoxification (Björnstedt et al., 1995), as suggested by our data. 
Studies on oxLDL are complicated by the varying chemical composition of oxLDL from 
different pools (Esterbauer and Jürgens, 1993). There are distinct variations in the degree to 
which LDL preparations from different donor individuals can be modified (van Hinsberg et al., 
1986). Foetal calf serum (FCS) was not excluded from the culture media for our oxLDL 
toxicity studies, but some studies report excluding it or replacing it for the duration of the 
incubation with oxLDL. FCS may have a buffering effect which may provide some 
cytoprotection. We have observed differing susceptibilities in EC to t- BuOOH- mediated 
cytotoxicity depending on the level of FCS in the medium (see above sections). The FCS 
may contain trace amounts of ceruloplasmin which may contribute to further lipid 
peroxidation, depending on the culture medium used (Burkitt, 2001). 
The data of Avogaro et al. (Avogaro et al., 1991) quotes normal LDL levels in middle -aged 
men of 3.7 (2.3 - 5.2) mMol /L (mean (5 and 95% Cl)). Since LDL contains 25 % protein and 
75 % lipid, it is possible to make an estimate of an in vivo oxLDL concentration of 31.5 mg /L. 
Although similar oxLDL concentrations to this were used in the cytotoxicity experiments in 
this thesis, such concentrations were not cytotoxic. The higher concentrations (maximum 
1600 mg /L) of oxLDL were cytotoxic to EAhy926 cells, but are obviously much higher than 
physiological levels of oxLDL seen in vivo. 
Modulation of oxidation of native LDL by selenium supplementation of 
endothelial cells 
In vitro studies suggest the formation of oxLDL is mediated in part by the enhanced 
production of ROS by the cell types which constitute the arterial wall. The data presented 
provides no evidence to agree with previous studies that have shown HUVEC to oxidise LDL 
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to a degree easily detected by lipoprotein electrophoresis (Fernando et al., 1998). Differing 
media were used to culture the HUVEC in our studies (Medium M199) compared to those of 
Fernando et al. (RPMI medium), which differ in their components, including amino acids and 
vitamins. This may explain some of the disparity in results. Chelating agents which interfere 
with the Cue+ binding to the LDL particle, including EDTA, free histidine and other 
components of cell culture media, can protect the particle from oxidation (Burkitt, 2001). 
Other substances in culture media which vary between media and may affect the oxidation 
of LDL by EC include phenol red and ascorbic acid (Steinbrecher, 1988). Amino acids and 
vitamins in buffer ameliorate ROS- mediated chlorobenzene hepatotoxicity in vitro (Fisher et 
al., 1993). 
When native LDL was added to EAhy926 cells or HUVEC for an incubation of 24 hr, 
oxidation of the LDL by the cells was dependent upon transition metal ions in the culture 
medium, confirming previous observations (Burkitt, 2001) (Steinbrecher et al., 1984) 
(Steinbrecher, 1988). Oxidation of LDL took place to a similar degree when copper was 
present in the absence of cells. Oxidation of LDL by Cu in the absence of cells is a well - 
reported phenomenon (Burkitt, 2001; Heinecke, 1998; Lamb and Leake, 1992; Steinbrecher 
et al., 1984). It is unsurprising that Se supplementation of EAhy926 cells and HUVEC did 
not alter their oxidation of native LDL since the cells did not oxidise LDL in the absence of Se 
supplementation. 
Conclusions 
Whilst Se has been shown to protect against t- BuOOH- mediated cytotoxicity in HCAEC and 
HUVEC, there is insufficient existing evidence regarding the relative importance of TR and 
the GPXs in the role of the protection. The data presented here suggest that Se can protect 
human EC against t -BuOOH -and oxLDL- mediated cytotoxicity in vitro. Furthermore, the use 
of GTG in our study has allowed us to begin to associate some of the effects of Se with 
specific selenoproteins, and in particular suggest that both TR and the GPXs are involved in 
antioxidant protection of the endothelium. These multiple enzyme systems may act in 
different cellular compartments. 
Our observations support the view that a low Se status would promote endothelial injury and 
atherosclerosis initiated by oxLDL in humans. The results presented suggest that Se 
supplementation at doses which optimise the expression of the TR and the GPXs may have 
significant beneficial effects when applied to populations that have a Se intake below that 
currently recommended. 
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CHAPTER FOUR 
THE ROLE OF THIOREDOXIN REDUCTASE IN THE 
PREVENTION OF OXIDATIVE DAMAGE TO THE SKIN 
BY SELENIUM 
4.1 INTRODUCTION 
4.1.1 UVB and the skin 
The UK population is increasingly being exposed to ultraviolet (UV) irradiation. Such 
exposure produces photo- oxidative damage induced by ROS, leading to phototoxicity, 
photoaging and skin cancer. UVB radiation can damage cells by numerous means and is far 
more effective at causing cell death than UVA. Exposure to UVB can induce DNA damage, 
protein cross -linking and the production of free radicals and ROS, which can damage DNA 
and induce lipid peroxidation in cell membrane lipids (Danno et al., 1984; Norio and 
Okamoto, 1987; Miyachi et al., 1983). Further effects of UVB radiation are discussed in 
detail in chapter 1. In vitro, cultured cells exposed to high doses of UVB radiation exhibit 
necrotic cell death. However at lower doses of UVB radiation cultured cells are reported to 
undergo apoptosis (Mammone et al., 2000). Damaged keratinocytes known as sunburn 
cells are characteristic of UVB- and UVC- induced epidermal damage (Soter and Baden, 
1991), and are thought to be undergoing apoptotic cell death (Bayer) et al., 1995). 
Melanocytes, keratinocytes and fibroblasts have all demonstrated susceptibility to cell death 
mediated by UVB radiation (Dissanayake et al., 1993). 
4.1.2 Skin cells and oxidative stress 
Defence strategies of the skin against endogenous and exogenous ROS include small 
radical trapping molecules, such as vitamins A, C and E, thiols, such as reduced glutathione, 
and enzymes such as SODs, catalase, GPX, TR /Trx and the thioredoxin peroxidases. There 
are also intrinsic free radical traps in melanin. UV exposure of human and animal skin 
produces a range of ROS which may derive from melanin, from reactions with 
photosensitizers (e.g. phenothiazines, cosmetics, food additives), or may be part of the 
inflammatory response of erythema (Fuchs, 1998; Maccarrone et al., 1997; Schallreuter and 
Wood, 1989). Cellular sources of ROS, and ROS generation in the skin are described in 
detail in section 1.8. 
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4.1.3 Selenium and the skin 
The upregulation of selenoprotein expression in cultured cells through Se- supplementation 
has been extensively reported (Buckman et al., 1993; Dreher et al., 1998; Ricetti et al., 1994; 
Takahashi et al., 1986; Thomas et al., 1993; Yarimizu et al., 2000), including skin cells 
(Marcocci et al., 1997; Stewart et al., 1999). The function and regulation of the GPX and TR 
selenoenzymes have been discussed in detail in Chapter 1. In conditions of Se deficiency, 
decreased expression of GPX and TR could increase the susceptibility of cells to ROS- 
induced damage. TR has been reported to be located on the surface of keratinocytes, an 
ideal location to detoxify ROS (Schallreuter and Wood, 1989). Immunohistochemical 
staining for TR and Trx in skin of adult rats has shown localisation in the stratum 
germinativum, hair follicles, nail beds and sweat glands (Rozell et al., 1985). Keratinizing 
cells stained positive for Trx only, whilst melanocytes showed staining for TR and Trx. A 
study by Lee et al. has confirmed the expression of TR and Trx to be mainly in the hair 
follicle in rat skin, with only weak staining of both proteins in the basal cell layer of the 
epidermis (Lee et al., 2000). 
There is abundant evidence to suggest that Se has an important role in protecting skin from 
the deleterious effects of UVB exposure. Low plasma Se levels have been inversely linked 
to skin cancer (Clark et al., 1984; Reinhold et al., 1989), and plasma Se status is reported to 
be predictive of future skin cancer risk (Combs et al., 1993). 
Supplementation of human skin fibroblasts with sodium selenite (1.2 NM) decreased cell 
death from 50 % to 25 %, following exposure to 120 J /m2 UVB (Richard et al., 1990). Similar 
results using UVA radiation and sodium selenite (1.3 NM) reported that cell death in human 
skin fibroblasts was decreased from 50 % to 10 % (Leccia et al., 1993). However, these 
studies used Se concentrations that are not achievable in vivo. In a subsequent study using 
more physiological Se concentrations, supplementation with 320 nM sodium selenite 
decreased cell death of human skin fibroblasts from 67 % to 30 % following exposure to UVA 
(Moysan et al., 1995b). Pre -treatment of primary keratinocytes, melanocytes, or HaCaT 
cells with sodium selenite or selenomethionine protects each of these cell types from UVB - 
induced cell death (Rafferty et al., 1998). Sodium selenite provided optimum protection at 10 
nM in all cell types tested, whereas with selenomethionine concentrations of 50 nM, 100 nM 
and 100 nM were required for optimal protection of keratinocytes, HaCaT cells and 
melanocytes respectively (Rafferty et al., 1998). Se protects DNA from oxidative damage, 
but not from direct damage by UVB irradiation (Rafferty, 2000). 
In 1965 Shamberger and Rudolph demonstrated a significant reduction of skin cancer 
incidence in carcinogen- treated mice given a topical application of sodium selenite 
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(Shamberger and Rudolf, 1965). In later studies, Se supplementation decreased the 
incidence of skin tumours in mice (Overvad et al., 1985; Pence et al., 1994), and 
inflammation and sunburn in hairless mice following exposure to UVB (Thorling et al., 1983). 
Se, given both orally and topically, increases the minimal erythemal dose (MED) in humans 
(Burke et al., 1992a; Burke et al., 1992b), and decreases the number of sunburn cells in 
human skin following UVB exposure (la Ruche and Césarini, 1991). It should be noted that 
in two of the murine studies which showed protection with Se (Overvad et al., 1985; Thorling 
et al., 1983) the doses of Se were so high (reaching 8 mg /L) (Overvad et al., 1985) as to be 
unacceptable for human use. 
Polyunsaturated fatty acids (PUFA) in the phospholipids of plasma membranes are one of 
the cellular targets of ROS. Malondialdehyde (MDA) is one of the main aldehyde by- 
products of lipid peroxidation. The thiobarbituric acid (TBA) assay is the most commonly 
used method to assess lipid peroxidation, and is based upon the reaction of TBA with MDA 
to form an adduct. The term ` thiobarbituric acid reactive substances' (TBARS) is often used 
to describe the results more accurately since other substances can also react with TBA such 
as other lipid peroxides, amino acids and sugars. 
MDA is formed, in a dose -dependant manner, following exposure of cells to UVB (Stewart et 
al., 1996). Exposure to UVA also causes MDA formation in a dose -dependent manner 
(Moysan et al., 1995b). Se also decreases the formation of TBARS in humans in vivo. 
When given prior to exposure of patients to a solar simulator, Se (200 /vg /day) decreased 
TBARS formation by 13 % (Pietschmann et al., 1992). Furthermore, cultured fibroblasts 
supplemented with sodium selenite (320 nM) for 3 days prior to exposure to UVA exhibited a 
50 % decrease in the formation of TBARS (Leccia et al., 1993; Moysan et al., 1995b). 
4.1.4 Antioxidant supplementation and the skin 
Other antioxidants apart from selenoenzymes, such as vitamin C (ascorbate), a- tocopherol 
and glutathione, can protect human skin cells in vitro from UVB- induced cell death, apoptosis 
and MDA formation (Fuchs, 1998; Kondo et al., 1990; Savini et al., 1999; Straface et al., 
1995). These results are strongly indicative that UVB exposure produces ROS in the skin. 
Antioxidants such as selenoproteins can prevent ROS- induced damage to skin cells by 
detoxifying these molecules. 
4.1.5 Methods to assess cytotoxicity 
Interpretation of the significance of assay results is dependent upon distinguishing between 
assays which measure cytotoxicity and those measuring cell survival. When the oxidative 
stressor exhibits toxicity which is not specifically related to proliferative potential, and results 
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in loss of essential cell functions rather than loss of reproductive capacity, a cytotoxicity test 
is appropriate. Cytotoxicity assays measure oxidative stress -induced alterations in metabolic 
pathways or structural integrity which may or may not be related directly to cell death, 
whereas survival assays measure the end result of such metabolic perturbations which may 
be either cell recovery or cell death. 
Two different assays have been utilised in this chapter to assess cytotoxicity. The trypan 
blue assay was employed to measure cell viability following UVB irradiation, whilst lactate 
dehydrogenase (LDH) activity retention was used to measure viability following menadione 
treatment in HaCaT cells. LDH can still leak from viable cells, so LDH retention is actually 
an assessment of membrane integrity rather than true viability. The trypan blue dye 
exclusion method relies on the fact that live cells exclude dye, whilst dead cells take up the 
dye, thereby also relying on membrane integrity. Membrane leakiness can also be caused 
by recent trypsinisation and freezing /thawing in the presence of DMSO, so care has to be 
taken with cell cultures to avoid artifactual membrane damage. A decrease in cell number 
has been reported during trypsinisation of cells which have been UVA- damaged, due to the 
cells disintegrating (Moysan et al., 1995a), further reinforcing the importance of avoiding 
damage to already- injured cells. 
4.1.6 Skin cells used in UV studies 
Keratinocytes are the most numerous cell type in the epidermis, receive the greatest 
exposure to UVB, and are the cell type that forms basal and squamous cell carcinomas. 
Basal and squamous cell carcinomas are likely to be induced by exposure to UVB radiation 
(Black et al., 1997; Stenbäck, 1975; Urbach, 1997). The majority of experiments in this 
chapter were performed using the human keratinocyte cell line HaCaT, while a limited 
number of studies have been performed on primary keratinocytes due to lack of available 
material for cell preparations. Established epidermal and dermal cell lines are frequently 
used in studies of UV- induced cellular damage in vitro. The keratinocyte cell line HaCaT is a 
spontaneously transformed human epithelial cell line from adult skin that maintains full 
epidermal differentiation capacity (Boukamp et al., 1988). This cell line has been used in 
numerous studies (Aragane et al., 1998; Didier et al., 1999; Göhring et al., 2000; Haycock et 
al., 2000; Kroll et al., 1999; Leccia et al., 1998; Lehmann et al., 1998; Licht et al., 1992; 
Mammone et al., 2000; Marcocci et al., 1997; Petersen et a/., 2000; Podhaisky et al., 2000; 
Saliou et al., 1999; Savini et al., 1999; Savini et al., 2000; Schürer et al., 1993). However, 
due to mutations on both p53 alleles (p53 -/ -) (Magal et al., 1998), the HaCaT cell line may 
not behave exactly like native keratinocytes (Göhring et al., 2000; Merryman, 1999). 
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A study by Leccia et al. has demonstrated that HaCaT cells are more resistant to UVA 
irradiation than normal human primary keratinocytes (Leccia et al., 1998), and found that the 
cell line contains lower GPX and SOD activities, but higher total GSH than primary 
keratinocytes. The sensitivity of primary and cell lines cannot easily be explained by 
variations in antioxidant profiles alone, and may involve media composition, number of 
subcultures, or confluency (Leccia et al., 1998). The sensitivity of keratinocytes to UV 
irradiation is also related to the cell cycle (Horio and Okamoto, 1987). 
4.1.7 Model agents as oxidative stressors 
Menadione, a synthetic vitamin K, is used frequently as a model toxicant (Buckman et al., 
1993; Cho et al., 1997; Comporti, 1989; Malorni et al., 1993; Rosen and Freeman, 1984; 
Santini et al., 1996). Menadione (2- methyl -1,4- naphthoquinone) is a strong oxidising, redox- 
cycling agent that can generate a great quantity of ROS when it enters cells (Thor et al., 
1982). These ROS are produced by one -electron reduction of quinones to semiquinone 
radicals, which can rapidly reduce dioxygen to form O2'-, and subsequently H2O2, OH', and 
singlet oxygen by dismutation of 02.- (Comporti, 1989). When the rate of redox cycling of 
menadione exceeds the capacity of antioxidant enzymes, cytotoxicity occurs. 
4.1.8 Inhibitors of TR 
Several in vitro inhibitors of TR have been reported (Becker et al., 2001; Lin et al., 1999; Lin 
et al., 2001; Schallreuter and Wood, 1987). The clinically used inhibitors of TR (nitrosoureas 
of the carmustine type) only inhibit the reduced form of the enzyme (Arscott et al., 1997; 
Williams et al., 2000); the oxidized form of TR is not inactivated. Using a bioassay for TR 
based on reduction of a spin -labelled nitroxide, Schallreuter et al. have investigated the 
inhibition of TR by various compounds. The reduction of their spin label on skin, 
keratinocytes, melanocytes and purified E. coli TR was inhibited by thioprotein inhibitors, 
NADP +, anthralin, azelaic acid and other saturated dicarboxylic acids, and Trx (a competitive 
substrate) (Schallreuter et al., 1986; Schallreuter and Wood, 1987). 
4.1.9 Different chemical forms of selenium 
Selenomethionine is a less- available metabolic source of Se than selenite or selenate, since 
these need only be reduced to selenide to provide selenophosphate, the precursor of 
selenocysteine, the active form of Se in selenoproteins. Studies comparing the efficacy of 
sodium selenite and selenomethionine in the prevention of UVB- induced oxidative damage 
to skin cells have been performed previously (Rafferty et al., 1998). However, comparative 
studies of the two forms of Se on induction of selenoenzymes in human skin cells have not 
been carried out. Previous studies have ruled out that the protective effects of Se were 
mediated by alterations of growth patterns or direct antioxidant effects alone (Rafferty, 2000). 
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It has been suggested that the effects of Se may be acting through incorporation into 
selenoproteins, so studies were needed to directly confirm this assumption. 
The studies reported in this chapter aimed to: 
determine the suitability of the HaCaT cell line as a suitable model in which to investigate 
the role of Se and selenoproteins in human keratinocytes 
examine the ability of sodium selenite supplementation to protect HaCaT cells from 
cytotoxicity resulting from exposure to menadione or UVB irradiation, and associate any 
observed protection with changes in the expression and activity of TR and the activity of 
cyGPX and PHGPX 
investigate whether TR, cyGPX or PHGPX were contributing to the protection of HaCaT 
cells from cytotoxicity of menadione or UVB irradiation by use of gold thioglucose- 
mediated inhibition of selenoenzyme activity 
the DTNB and insulin assay systems for TR activity 
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4.2 MATERIALS AND METHODS 
4.2.1 General methods for cytotoxicity and selenoenzyme expression 
studies 
In all cytotoxicity studies using skin cells, the cells were passaged into 24 -well culture plates 
using Se- deficient medium (basal medium Se content of 3.4 ng /ml), with all test conditions in 
triplicate wells of confluent cells, unless otherwise stated. Following incubation in the 
presence of menadione, both the medium and cells were harvested and analysed for LDH 
activity as described in section 2.3.13. Following irradiation, the cells were harvested for 
trypan blue assay as detailed in section 2.3.14. Details on the Se content of cell culture 
media are described in section 3.1.7. 
For studies of selenoprotein expression, HaCaT cells were passaged into 225 cm2 flasks, 
with all test conditions in triplicate flasks (except control cells, which were grown in 
quadruplicate) unless otherwise stated. Following the incubation, the cells were washed 
twice with 30 ml EBSS, and harvested via scraping into 50 ml EBSS. Efficiency of 
harvesting was determined by light microscopy. The cells were then pelleted by 
centrifugation at 500 x g for 10 min. The EBSS was aspirated, and the pellets frozen at - 
80°C until enzyme assays were carried out. Prior to enzyme activity determinations, the cell 
pellets were thawed and lysed by sonication (three pulses of 10 sec using a Soniprep 150 
Sonicator) on ice in 0.125 M potassium phosphate buffer (pH 7.4) containing 1 mM EDTA 
and 0.1 % Triton X -100 (peroxide- and carbonyl- free). The levels of the selenoenzymes 
were then determined as detailed in sections 2.3.5.1, 2.3.6, 2.3.7 and 2.3.8. 
4.2.2 The effect of sodium selenite or selenomethionine 
supplementation on intracellular selenoprotein expression and activity 
in HaCaT cells 
HaCaT cells were passaged into 75 cm2 or 225 cm2 tissue culture flasks and grown to 70 
confluence in DMEM containing 5 % FCS. The cells then received medium containing 0, 1, 
10, 40, 50, 100, 200 or 1000 nM sodium selenite for an incubation of 48 hr. Following the 
incubation, cell detachment was checked by light microscopy, the medium was sampled for 
LDH assay to assess any cytotoxicity (section 2.3.13), and the cells were washed twice with 
10 ml EBSS, and harvested as detailed in section 4.2.1. 
For incubation with selenomethionine, the culture conditions were as described above, in 
225 cm2 tissue culture flasks, using concentrations of selenomethionine ranging from 0 to 
100,000 nM (triplicate flasks for each selenomethionine concentration, and quadruplicate 
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flasks for the control). Harvesting of the cells and treatment of the cell pellets was as 
detailed above. 
4.Z3 The cellular localisation of TR in HaCaT cells and primary 
keratinocytes 
Adult human primary keratinocytes and HaCaT were grown to approximately 70 
confluence on 22 x 22 cm sterile glass coverslips in six well culture plates. Each respective 
culture medium was 'Se- deficient 'unless stated. The medium was aspirated from the cells, 
and each well washed twice with 4 ml PBS. The glass coverslips were then removed from 
the culture plates and fixed in acetone for 3 min. After fixing, the glass coverslips were 
rinsed with fresh PBS, and placed back into the wells of the original culture plates which had 
been filled with absolute ethanol. The cells remained preserved in this state at 4 °C until 
immunohistochemistry took place, as described in section 2.3.19. 
4.2.4 Comparison of TR and cyGPX concentration in human primary 
keratinocytes and HaCaT cells 
Human primary keratinocytes and HaCaT cells were grown in Se- deficient medium to 
confluence in 6 well plates. The cells were then harvested by scraping into 4 ml PBS, and 
immediately assayed for TR concentration (section 2.3.6) and total protein (section 2.3.9). 
T75 flasks of primary keratinocytes and HaCaT cells were grown in Se- deficient medium to 
confluence, and assayed for cyGPX activity as detailed in section 2.3.7. 
4.2.5 The effect of menadione on LDH retention in HaCaT cells cultured 
in selenium- deficient medium 
HaCaT cells were passaged into 24 well plates with Se- deficient medium. The effect of 
menadione (0 - 300 pM, and 0 - 240 pM, respectively, for two separate experiments) on 
HaCaT cell viability was determined using confluent cells. After an 18 hr incubation in the 
presence of menadione, both the medium and cells were harvested and the % LDH retention 
was determined (section 2.3.11). Exposure of cells to menadione for 18 hr has previously 
been reported (Bai et al., 1999; Chen and Cederbaum, 1997). 
4.2.6 The effect of cellular confluence level on the susceptibility of 
HaCaT cells to menadione -induced oxidative damage 
Preliminary experiments to investigate the effect of different concentrations of menadione on 
LDH activity in HaCaT cells cultured in Se- deficient medium showed great variability in the 
menadione concentrations required to produce cell damage. One of the factors proposed to 
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account for this observed variability was the level of confluence of the cell monolayer, as 
found in EAhy926 cells. HaCaT cells were passaged into 24 well plates and left to grow in 
Se- deficient medium until the required level of confluence was reached. The effect of a 
range of concentrations of menadione (0 - 150 pM, 0 - 140 pM, and 0 - 120 pM, 
respectively, for three separate experiments) on the viability of HaCaT cells at differing 
confluence levels was determined. After an 18 hr incubation in the presence of menadione, 
both the medium and cells were harvested and analysed for LDH retention (section 2.3.13). 
All plates of cells at differing confluence level received the same menadione solutions which 
had been prepared and stored at 4 °C until use. 
4.2.7 The effect of cellular confluence level on TR expression and 
activity, and cyGPX and PHGPX activity in HaCaT cells 
HaCaT cells were passaged into 75 cm2 flasks and grown to 75 %, 100 % confluence and 
supraconfluence (2 days post -confluence) in unsupplemented, Se- deficient medium. The 
time period taken to reach 75 %, 100 %, and 2 -days post confluence were 3, 5, and 7 days 
respectively from passage. Fresh medium was put on the cells every second day as 
required by the respective flasks. Upon reaching the required level of confluence (assessed 
by eye under the light microscope), the cells were washed and harvested as described in 
section 4.2.1. The levels of the selenoenzymes were then determined as detailed in 
sections 2.3.5.1, 2.3.6, 2.3.7 and 2.3.8. Triplicate flasks were grown for each different 
confluence level. 
4.2.8 The ability of sodium selenite supplementation to protect HaCaT 
cells against oxidative damage resulting from menadione exposure 
To investigate the possible protective effect of sodium selenite against oxidative damage 
mediated by menadione, HaCaT cells were passaged into 24 well plates using Se- deficient 
medium. The cells were then left to grow for 48 hr. Se- deficient medium to which a range of 
sodium selenite concentrations (0, 1, 10, 40, 50, 100, 200, 1000 nM) had been added was 
then placed on the cells. After an incubation period of 48 hr, the cells were washed twice 
with 1 ml EBSS. Menadione was then added (80 pM) prepared in Se- deficient medium, and 
left to incubate with the cells for 18 hr. The control was Se- deficient medium to which no 
menadione had been added. After 18 hr both the medium and cells were harvested and 
analysed for LDH retention as described in section 2.3.13. 
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4.2.9 Assessment of the direct effect of sodium selenite in the 
protection of HaCaT cells against oxidative damage resulting from 
exposure to menadione 
To investigate whether sodium selenite can exert a direct antioxidant effect against 
menadione- mediated cytotoxicity in HaCaT cells, rather than through modification of 
selenoprotein expression, the following approach was used. HaCaT cells were passaged 
into 24 well plates using Se- deficient medium. After 48 hr, some cells received Se- deficient 
medium supplemented with 40 nM sodium selenite, whilst other cells continued to be 
maintained in Se- deficient medium. After an incubation period of 48 hr, all cells were 
washed twice with 1 ml EBSS. The cells then received Se- deficient medium supplemented 
with 40 nM sodium selenite simultaneously with the addition of a range of menadione 
concentrations (0 - 140 pM), or the same range of concentrations of menadione made up in 
Se- deficient, unsupplemented medium. 
Control cells received no menadione or sodium selenite supplementation. After 18 hr both 
the medium and cells were harvested from all the culture plates and analysed for LDH 
activity as described in section 2.3.13. 
4.2.10 The effect of gold thioglucose on the activities of cyGPX, PHGPX, 
and TR of HaCaT cells 
An experiment was performed to study the timecourse of inhibition of TR activity in HaCaT 
by 10 pM GTG. HaCaT cells were passaged into 75 cm2 flasks and grown to 70 
confluence (to parallel the growth of cells in the corresponding toxicity experiments). The 
cells then received medium containing 10 pM GTG for an incubation of either 24, 48 or 72 hr 
(triplicate flasks for each time point). Control cells received medium unsupplemented by 
GTG. The cells that received an incubation of 72 hr received fresh medium supplemented 
with 10 pM GTG after the cells had been growing for 48 hr. Following the incubation, by 
which time the cells had reached confluence, the cells were washed and harvested as 
described in section 4.2.1. The levels of TR activity were then determined as detailed in 
section 2.3.5.1. 
Preliminary studies were carried out prior to the menadione toxicity studies described below 
to optimise the GTG concentration required for selective inhibition of TR activity in HaCaT 
cells. The HaCaT cells were passaged into 75 cm2 flasks and grown to 70 % confluence. 
The cells then received medium containing 0, 1, 10, or 100 pM GTG for an incubation of 48 
hr. Following the incubation, the cells were washed and harvested as detailed in section 
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4.2.1. The levels of the selenoenzyme activities were then determined as detailed in 
sections 2.3.5.1, 2.3.7, and 2.3.8. 
A further experiment using identical incubation conditions was carried out, except that the 
cells were cultured in 225 cm2 flasks. The cells were treated and harvested as described 
above. 
4.2.11 The effect of gold thioglucose on the susceptibility of HaCaT 
cells to oxidative damage resulting from menadione exposure 
To assess the effect of pre- treatment with various GTG concentrations on the susceptibility 
of HaCaT cells to menadione cytotoxicity, HaCaT cells were passaged into 24 well plates 
using Se- deficient medium, and left to grow for 48 hr. The cells then received normal 
unsupplemented medium, or the same medium containing 1 pM and /or 10,uM GTG for 48 hr 
(these concentrations of GTG have been used in an associated experiment to investigate the 
effect of these GTG concentrations on the selenoenzyme activities (section 4.2.10)). After 
incubation, cells were washed twice with 1 ml EBSS, and fresh medium containing various 
concentrations of menadione (0 - 150 pM; 0 - 100 pM; 0 - 140 pM) added for an 18 hr 
incubation. Both the medium and cells were harvested and analysed for LDH retention as 
described in section 2.3.13. An experiment to investigate a wider range of concentrations of 
GTG was also performed. The pre- incubations were with 0, 1, 2.5, 5, 7.5 or 10 pM GTG for 
48 hr. 
4.2.12 The effect of consecutive sodium selenite and gold thioglucose 
treatment on susceptibility of HaCaT cells to oxidative damage 
resulting from menadione exposure 
To investigate whether the protection of HaCaT by Se supplementation from menadione- 
mediated cytotoxicity could overcome /compensate for the deleterious effect of GTG pre - 
incubation, the following approach was employed. HaCaT cells were passaged into either 
Se- deficient medium or medium supplemented with 40 nM selenite, and incubated for 48 hr. 
After this time, the cells were washed twice with 1 ml EBSS, and received normal 
unsupplemented medium, or the same medium containing 10 pM GTG for 48 hr. When the 
incubation was finished, the cells were again washed, and fresh medium containing various 
concentrations of menadione (0 - 140 pM) added for an 18 hr incubation. Both the medium 
and cells were harvested and analysed for LDH activity as described in section 2.3.13. 
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4.2.13 The effect of consecutive sodium selenite and gold thioglucose 
treatment on selenoenzyme activities in HaCaT cells 
To determine the effects of the pre- incubation conditions described in section 4.2.12 above 
(i.e. 48 hr 40 nM sodium selenite alone, 48 hr 10 pM GTG alone, or 48hr 40 nM sodium 
selenite followed by 48 hr 10 pM GTG), HaCaT cells were passaged into 225 cm2 flasks. 
Treatment of the cells (conditions and time periods, without menadione addition) was as 
described in section 4.2.11. When the incubations were over, the cells were washed and 
harvested as described in section 4.2.1. The activities of TR and cyGPX were determined 
as detailed in sections 2.3.5.1 and 2.3.7. There was insufficient cellular material to assay for 
PHGPX activity. 
4.2.14 Comparison of LDH retention and trypan blue exclusion as 
measures of damage to HaCaT cells by menadione 
HaCaT were passaged into a 24 well plate and grown to confluence. The cells were then 
exposed to menadione (0 - 160 pM) for 18 hr. The medium was removed from the cells and 
spun to remove any cells or cell debris. The cell -free medium was then assayed for LDH 
activity (LDH release in U /L) as detailed in section 2.3.13. The cells remaining in the wells 
were trypsinized and added to cells removed from the medium, and assessed for cell viability 
by Trypan Blue assay (detailed in section 2.3.14). 
4.2.15 Assessment of LDH retention as a measure of damage to HaCaT 
cells by UVB irradiation 
HaCaT cells were passaged into 24 well plates and grown to 70 % confluence. The cells 
were then prepared and irradiated as detailed in section 2.3.20. Cells received an irradiation 
dose of 0, 480, 720, 960, or 1200 J /m2, with each plate receiving a single dose of UVB. The 
medium and cell lysates were harvested for LDH analysis (as detailed in section 2.3.11) at 
time points of 0, 6, 12, and 24 hr respectively. This timecourse of LDH release following 
irradiation was repeated to extend the time period to 48 hr, and to 120 hr. In the case of 
UVB as the stressor agent, 48 hr is the optimal time required for the cells to die. Leaving the 
cells for 120 hr would obviously be an unsuitable time to leave between oxidative insult and 
cytotoxicity assay, and was performed in this case to illustrate the inactivation of LDH alone. 
4.2.16 The ability of sodium selenite supplementation to protect HaCaT 
cells from cytotoxicity resulting from UVB exposure 
To investigate the possible protective effect of sodium selenite against UVB- mediated 
damage, HaCaT cells were passaged into 24 well plates using Se- deficient medium. The 
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cells were then left to grow for 48 hr. Selenium- deficient medium to which a range of sodium 
selenite concentrations (0, 1, 10, 40, 50, 100, 200, 1000 nM) had been added was then 
placed on the cells. After an incubation period of 48 hr, the cells were washed twice with 1 
ml PBS and irradiated, with a dose of 960 J /m2 UVB, as described in section 2.3.20. After 
48 hr the cells were harvested for trypan blue assay as described in section 2.3.14. 
4.2.17 The ability of gold thioglucose supplementation to modify the 
susceptibility of HaCaT cells to cytotoxicity resulting from UVB 
exposure 
HaCaT cells were passaged into 24 well plates using Se- deficient medium. The cells were 
then left to grow for 48 hr. Se- deficient medium to which GTG concentrations (1, 10, or 100 
pM) had been added was then placed on the cells. After an incubation period of 48 hr, the 
cells were washed twice with 1 ml PBS and irradiated, with a dose of 720 J /m2 UVB, as 
described in section 2.3.20. After 48 hr the cells were harvested for trypan blue assay as 
described in section 2.3.14. 
4.2.18 Investigation of potential TR inhibitors using the DTNB assay 
system 
Stock solutions of azelaic acid and N- ethylmalemide (NEM) were prepared in ethanol, and 
those of anthralin and 13 -cis retinoic acid (13 -cis RA) were prepared in acetone. The final 
concentrations of inhibitors in human placental cytosol were: azelaic acid 0.01, 0.02, 0.06, 
0.11, 0.22, 0.56, 1.11 mM; anthralin 0.01, 0.03, 0.06, 0.11, 0.28 mM; NEM 0.01, 0.02, 0.03, 
0.04, 0.06, 0.11 mM; 13 -cis RA 0.01, 0.03, 0.06, 0.11, 0.28, 0.56 mM. After an overnight 
incubation at 4 °C, TR activity was measured using the DTNB assay as detailed in section 
2.3.5.1. Blanks for ethanol and acetone were run, along with blanks for the appropriate 
inhibitor compounds. 
4.2.19 Comparison of potential TR inhibitors in the DTNB assay system 
and the insulin assay system for TR 
Fresh stock solutions of inhibitor compounds were prepared as described in section 4.2.18 
above, and added to human placental cytosol to give the same final concentrations as 
detailed in section 4.2.18. In addition, p- chloromercuri- benzoic acid (PCMB) was added at 
concentrations of 0.01, 0.03, 0.06, 0.11, 0.28 mM to human placental cytosol. After an 
overnight incubation at 4 °C, TR activity was measured in the cytosols using both the DTNB 
assay system (section 2.3.5.1) and the insulin reduction assay system (section 2.3.5.2). 
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4.2.20 Statistical analysis 
One -way analysis of variance (ANOVA) was used to test for significant differences in LDH 
retention in response to different concentrations of menadione, and in % trypan blue stained 
cells in response to UVB irradiation. In the event that the variation was significant (p < 0.05), 
a Tukey- Kramer multiple comparisons post -test was used to test for the level of significance 
of differences in % LDH retained. The different groups of cells (e.g. Se- deficient cells versus 
Se- supplemented cells) were compared at individual menadione concentrations using the 
Student's t -test for unpaired data. One -way ANOVA and a Tukey- Kramer multiple 
comparisons post -test were also used to investigate significant differences between levels of 
selenoprotein expression and activity in cells cultured in different concentrations of sodium 
selenite or selenomethionine. In the event of large SDs in a particular data set (> 3 SDs 
from the mean), the data was log transformed prior to ANOVA evaluation. The expression of 
selenoenzymes in cells at different confluence levels was compared using the Student's t- 
test for unpaired data. 
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4.3 RESULTS 
All graphs presented are the data from a single experiment, using culture flasks /wells in 
triplicate, unless stated otherwise. 
4.3.1 The effect of sodium selenite or selenomethionine 
supplementation on intracellular selenoprotein expression and activity 
in Ha Ca T cells 
a) Sodium selenite supplementation 
In the first experiment, incubation with 10 nM sodium selenite resulted in a significant 
induction of TR (Figure 4.01 a and b), and cyGPX (Figure 4.01 d) (p < 0.05). Although 
PHGPX activity appeared to be induced by concentrations of 50 nM and 1000 nM sodium 
selenite, (Figure 4.01 c) the differences did not achieve statistical significance due to large 
standard deviations on the data. The maximal increase in TR activity was a 4.0 -fold (n =3) 
increase measured in HaCaT cells supplemented with 10 nM sodium selenite compared to 
that measured in Se- deficient cells. Increasing the selenite concentration above 10 nM had 
no further significant effect on induction of TR activity above that seen with 10 nM selenite. 
Figure 4.01 d shows that significant induction of cyGPX activity was first achieved by 
supplementation of HaCaT cells with 10 nM sodium selenite (p < 0.05), which increased the 
activity by 2.3 -fold over that seen in Se- deficient control cells. CyGPX activity was maximally 
induced by 100 nM sodium selenite, resulting in 4.8 -fold (p < 0.001) the activity of that seen 
in control cells. A sodium selenite concentration of 200 nM to 1000 nM had no further effect 
on cyGPX activity. LDH release did not indicate cytotoxicity at any of the selenite 
concentrations used. 
In the second experiment, TR activity was again optimally induced by 10 nM sodium selenite 
(p < 0.001) (figure 4.02 b). PHGPX activity increased to 1.6 -fold that of Se- deficient control 
cells when HaCaT cells were supplemented with 10 nM sodium selenite, but again this failed 
to reach statistical significance due to wide variation in the response in individual flasks. 
Similarly, the cyGPX activity differences from control activity were not statistically significant 
at any sodium selenite concentration tested due to high standard deviation found in this 
experiment. However, the trend towards decreasing cyGPX activity at concentrations higher 
than 100 nM sodium selenite was again observed. The cyGPX activity of cells 
supplemented with 1000 nM sodium selenite was not statistically significantly different to that 
of the Se- deficient control cells. 
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b) Selenomethionine supplementation 
Concentrations of 10, 100, 200 and 1000 nM selenomethionine increased TR, PHGPX and 
cyGPX activities in a concentration -dependent manner (figure 4.03). The increase in activity 
in TR and PHGPX activities above basal levels was statistically significant only at 1000 nM 
selenomethionine (p < 0.05). CyGPX activity was significantly increased over basal levels 
by 200 nM and 1000 nM selenomethionine (p < 0.01). None of the selenoenzyme activities 
appeared to have reached a plateau by 1000 nM selenomethionine. 
HaCaT cells supplemented with selenomethionine concentrations extending to 100,000 nM 
showed a different pattern of selenoprotein expression (figure 4.04). TR activity was 
increased over that seen in control cells by all concentrations of selenomethionine tested, 
and showed maximal expression at 10,000 nM selenomethionine (p < 0.05). PHGPX activity 
showed maximal expression at 1000 nM selenomethionine, although this failed to reach 
statistical significance. At selenomethionine concentrations of 10,000 and 100,000 nM, the 
PHGPX activity fell to below the level of activity seen at 1000 nM selenomethionine, and was 
not significantly different to control levels with 100,000 nM. CyGPX activity increased in a 
concentration -dependent manner, reaching maximal expression at 1000 nM 
selenomethionine (p < 0.001). However, the level of activity decreased slightly with 10,000 
nM selenomethionine. Using 100,000 nM selenomethionine, there was no significant 
difference compared to the basal level in control cells. LDH release did not indicate any 
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4.3.2 Comparison of TR concentration and cyGPX activity in primary 
keratinocytes and HaCaT cells 
As illustrated in figure 4.05 a, the concentration of TR in primary keratinocytes (81.5 ± 14.4 
pg /g protein; n = 6) was not significantly different from the concentration measured in HaCaT 
cells (75.8 ± 12.1 pg /g protein; n = 6). The cyGPX activity in primary keratinocytes was 2- 
fold higher (32.1 ± 15.9 U/g protein; n = 3) than the value measured in HaCaT cells (16.6 ± 
6.8 U/g protein; n = 3) (figure 4.05 b). However, the difference was not statistically 
significant. 
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HaCaT (n = 6) PK (n = 6) 
HaCaT (n = 3) PK (n = 3) 
Figure 4.05 Thioredoxin reductase (TR) concentration (a) and cytoplasmic glutathione 
peroxidase (cyGPX) activity (b) in HaCaT cells and primary keratinocytes. TR 
concentration was measured by radioimmunoassay in cells grown in Se- deficient medium in 
6 well plates for the radioimmunoassay, and in 75cm2 flasks for the cyGPX activity 
measurements. 
A nn 
The role of TR in the prevention of oxidative damage in skin cells Chapter four 
4.3.3 The cellular localisation of TR in HaCaT cells and primary 
keratinocytes 
As shown by figures 4.06 a and 4.07 a, primary keratinocytes and HaCaT cells appear to 
have nuclear /peri- nuclear staining, and some cytoplasmic staining. 
Dividing HaCaT appear to have more intense staining than non -dividing cells (figure 4.07 a). 
The HaCaT cells displayed very little specific staining overall (figure 4.07 a), with high 
background staining using the non -immune serum (figure 4.07 b). 
The staining for TR was more intense in primary keratinocytes which had been 
supplemented with 50 nM sodium selenite for 24 hr (figure 4.06 c) than in unsupplemented 
control cells (figure 4.06 a). 
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Figure 4.06a Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of human primary keratinocytes. x 100 magnification. Both the 
primary and secondary antibodies were present. 
.__ 
Figure 4.06b Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of human primary keratinocytes. x 100 magnification. For the 
immunohistochemistry here the secondary antibody was present, but without the primary 
antibody. 
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Figure 4.06 c Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of human primary keratinocytes. x 100 magnification. The primary 
keratinocytes were supplemented with 50 nM Se for 24 hr prior to immunohistochemistry. 
Figure 4.07a Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of HaCaT cells. x 100 magnification. Both the primary and 
secondary antibodies were present. 
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I 
Figure 4.07b Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of HaCaT cells. x 100 magnification. Non -reactive serum was 
applied as a control. 
1 
Figure 4.07c Immunohistochemical staining of thioredoxin reductase in a non - 
confluent monolayer of HaCaT cells. x 100 magnification. For the immunohistochemistry 
here the secondary antibody was present, but without the primary antibody. 
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4.3.4 The effect of different concentrations of menadione on LDH 
retention in HaCaT cells cultured in selenium -deficient medium 
The viability of HaCaT cells was decreased in a dose -dependent manner in response to 
treatment with menadione (figure 4.08 a and b). In the first experiment (figure 4.08 a), the 
cytotoxic effect of menadione was first evident at a concentration of 100 pM, resulting in 
66.83 ± 5.84 % LDH retention (mean ± SD, n =3) (p < 0.01 cf. control cells). A further 
decrease in cell viability was measured when cells were exposed to 150 pM menadione, 
resulting in 9.50 ± 8.02 % LDH retention (p < 0.001 cf. control cells). Concentrations 
exceeding 150 pM menadione (200, 250, 300 pM) gave 100 % cell damage such that no 
LDH retention could be measured in the cells. A second cytotoxicity dose -response curve 
was then performed to expand the concentration range. 
In the second dose -response experiment (figure 4.08 b), cytotoxicity was initially observed at 
80,uM menadione (83.79 ± 3.92 % LDH retention; mean ± SD, n =3) (p < 0.01 cf. control 
cells). A concentration of 100 pM menadione further decreased cell viability to 40.23 ± 5.62 
% LDH retention (p < 0.001 cf. control cells). Cell viability was measured to be 11.47 ± 2.61 
LDH retention with a concentration of 140 pM menadione (p < 0.001), which decreased to 
6.22 ± 1.77 % LDH retention when the cells were exposed to 160 pM menadione (p < 
0.001). Concentrations of menadione higher than 160 pM menadione produced no further 
cytotoxicity than that seen with 160 pM menadione. 
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Figure 4.08 The effect of menadione on % LDH retained in HaCaT cells after 18 hr 
exposure. Cells were cultured in Se- deficient medium, and incubated with a range of 
concentrations of menadione (a) (0, 100, 150, 200, 250, 300 pM) (b) (0 to 240 pM, in 20 pM 
increments) when confluent. Results shown are those of the mean of triplicate wells + SD. 
p < 0.01'* ; p < 0.001 * "* cf. control cells receiving 0,uM menadione. 
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4.3.5 The effect of cellular confluence level on the susceptibility of 
HaCaT cells to menadione- induced oxidative damage 
The inter -experiment reproducibility of cell damage showed high variation during the initial 
series of experiments; this led to an investigation of the effect of cellular confluence level on 
the susceptibility of HaCaT cells to menadione- induced oxidative damage. 
HaCaT cells at 2 days post -confluence were significantly less susceptible than 100 % 
confluent cells to menadione- mediated toxicity at 40 pM menadione (p < 0.05) or 60 pM 
menadione (p < 0.01) (figure 4.09). At menadione concentrations of 80 pM and 100 pM 
menadione, HaCaT cells grown to 2 days post confluence retained 68.37 ± 2.12 % and 
36.64 ± 6.98 % LDH respectively, whilst the confluent HaCaT cells showed 100 % cell 
damage at these doses of menadione such that no LDH retention could be measured in the 
cells. 
In a second experiment (figure 4.10), 100 % confluent HaCaT cells were significantly more 
susceptible to cytotoxicity from all concentrations of menadione than cells at 1 day post - 
confluence (p < 0.05). Cells at confluence were also significantly more susceptible to 
menadione toxicity than cells at 2, 3, 4 and 5 days post -confluence (p < 0.05). HaCaT cells 
at 3 days post- confluence were the most resistant to the cytotoxic effects of menadione, after 
which time the cells became significantly more susceptible to menadione cytotoxicity (p < 
0.05). 
As figure 4.11 illustrates, HaCaT cells grown to 50 % confluence were significantly more 
susceptible to damage by menadione at all concentrations tested than cells at 100 % 
confluence, 1, 2, or 4 days post -confluence (p < 0.01). Cells at 100 % confluence suffered 
significant cytotoxicity at a concentration of 40 pM menadione (p < 0.001), but cells at 1, 2, 
or 4 days post -confluence did not suffer any significant damage. HaCaT cells at 2 days 
post -confluence tended to be the most resistant to the cytotoxic effects of menadione. 
A cell density plating protocol was employed following these investigations to decrease the 
variation in the response of cells due to confluence differences. The HaCaT cells were 
passaged at a cell density of 2 x 105 cells /cm2, which took 4 days to reach confluence. 
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Figure 4.09 The effect of menadione on % LDH retained in HaCaT cells grown to 
differing confluence levels. Cells were cultured in Se- deficient medium, and incubated 
with a range of concentrations of menadione (0, 20, 40, 60, 80, 100, 150 pM) at 100% 
confluence or at 2 days post -confluence. Results shown are those of the mean of triplicate 
wells + SD. p < 0.05 *, p < 0.01*" ; p < 0.001-" cf. respective control cells receiving 0 pM 
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4.3.6 The effect of cellular confluence level on TR expression and 
activity, and cyGPX and PHGPX activity of HaCaT cells 
TR concentration and activity did not significantly differ between 75 % confluent, 100 % and 
2 day post -confluent HaCaT cells (figure 4.12 a and b). There were no significant 
differences in cyGPX activity between 75 % confluent, 100 % confluent and 2 day post - 
confluent cells, although there were very large standard deviations in this data group (figure 
4.12 d). PHGPX activity in HaCaT cells was 75.9 % lower in 2 day -post confluent cells 
compared with 100 % confluent cells (p < 0.05) (figure 4.12 c). There were no significant 
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4.3.7 The ability of sodium selenite supplementation to protect HaCaT 
cells against oxidative damage resulting from menadione exposure 
Figure 4.13 a shows that HaCaT cells pre- incubated for 48 hr in the presence of sodium 
selenite at concentrations of 10 nM and above (ranging from 0 to 1000 nM) were significantly 
less sensitive to the cytotoxic effects of menadione (80 pM) compared to HaCaT cells 
cultured in Se- deficient medium (p < 0.01). A protective effect was observed at 1 nM sodium 
selenite, which was significant in one experiment (a), but did not achieve statistical 
significance in the other two experiments. The maximal protective effect of sodium selenite 
against cytotoxicity induced by 80 pM menadione was observed at 10 nM (p < 0.01), 1000 
nM (p < 0.001), and 40 nM (p < 0.01) sodium selenite respectively for the three different 
experiments (figure 4.13 a, b, and c). The protective effect was not lost at high 
concentrations (200 nM and 1000 nM) of sodium selenite. 
TR activity and mass, cyGPX activity and PHGPX activity were determined in HaCaT cells 
incubated with the same concentrations of sodium selenite as described above for the 
protection experiments. Figure 4.01 a and d shows that both TR and cyGPX activity were 
significantly increased in HaCaT cells cultured in the presence of 10 nM sodium selenite (by 
4 -fold and 2.3 -fold, respectively) compared to HaCaT cells cultured in Se- deficient medium 
(p < 0.05). 
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Figure 4.13 The effect of sodium selenite pre -incubation on the susceptibility of HaCaT 
cells to menadione- induced cell damage. HaCaT cells were incubated with Se- deficient 
medium supplemented with different concentrations of sodium selenite (0, 1, 10, 40, 50, 100, 
200, 1000 nM) for 48 hr. Following the pre -incubation the HaCaT cells were exposed to 
concentrations of menadione (0 or 80 pM). After 18 hr cell viability was assessed by 
determining the % LDH retained. Results shown are the mean of triplicate wells + SD. p < 
0.05 *, p < 0.01**, p < 0.001-* cf. Se- deficient control cells receiving 0 pM menadione. Graphs 
(a) - (c) are each a separate experiment. 
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4.3.8 The requirement for pre- incubation in the protection of HaCaT 
cells against oxidative damage resulting from exposure to menadione 
by sodium selenite 
Figure 4.14 a shows the effects of sodium selenite pre- incubation or incubation on the 
viability of HaCaT cells exposed to menadione. The selenite was added either prior to (i.e. 
as a pre- incubation) or at the same time as menadione (0 to 140 pM) treatment, or a 
combination of both conditions. Control cells received no pre- incubation of selenite and 
received menadione alone in the absence of selenite. In HaCaT cells which had been pre - 
cultured in 40 nM sodium selenite, and which also received selenite (40 nM) simultaneously 
with the menadione, significant protection was offered when the cells were exposed to 40 
pM, 80 pM, or 120 pM menadione (p < 0.05) in comparison with Se- deficient control cells. 
At 60, 80, 100, 140 pM menadione, cells which received selenite at the same time as 
menadione but not as a pre- incubation suffered significantly more cytotoxicity than Se- 
deficient control cells (p < 0.05). 
The results were confirmed in a second experiment (figure 4.14 b). In HaCaT cells which 
had been pre -cultured in 40 nM sodium selenite, and which also received selenite (40 nM) 
simultaneously with the menadione, significant protection was afforded when the cells were 
exposed to 60 pM or 80 pM menadione (p < 0.05) in comparison with Se- deficient control 
cells. 
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Figure 4.14 The effect of sodium selenite on the sensitivity of HaCaT cells to 
menadione cytotoxicity added either prior to menadione treatment or at the same time 
as menadione treatment. HaCaT cells were pre- incubated with either Se- deficient medium 
supplemented with sodium selenite (40 nM) or Se- deficient medium with no addition. After 
48 hr incubation the medium was removed and replaced with medium containing 40 nM 
sodium selenite and menadione (0, 20, 40, 60, 80, 100, 120, 140 pM) or menadione 
unsupplemented with selenite for 20 hr. Control cells received no menadione or Se 
supplementation. Results shown are the mean of triplicate wells + SD. p < 0.001*** cf. 
control cells receiving 0 pM menadione. p < 0.05t; p < 0.001$ cf. control (Se- deficient) cells 
at the same menadione concentration. Graphs (a) and (b) are each a separate experiment. 
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4.3.9 Assessment of the timecourse of inhibition of TR activity by 
10 pM gold thioglucose in HaCaT cells 
Figure 4.15 illustrates that the maximal inhibition of TR activity was seen by 24 hr. The TR 
activity of HaCaT cells incubated with 10 pM GTG for 24 hr was measured at 37.73 ± 15.42 
(mean ± SD, n = 3) of the basal level of activity seen in control cells (p < 0.05). Increasing 
the time of incubation to 48 hr or 72 hr did not significantly increase the inhibition of TR 
above that seen at 24 hr. 
4.3.10 The effect of gold thioglucose on the activities of cyGPX, PHGPX, 
and TR of HaCaT cells 
Figure 4.16 shows the differing sensitivities of the three selenoenzymes to inhibition by gold 
thioglucose (GTG). At a concentration of 1 pM GTG, 85.1 ± 14.2 % (mean ± SD, n = 6) of 
TR activity (p < 0.01 cf. control cells) was retained, whereas no significant loss of cyGPX or 
PHGPX activity was observed. Using 10 pM GTG, 18.1 ± 5.7 % of TR activity (p < 0.001), 
93.0 ± 27.0 % of cyGPX activity, and 71.1 ± 23.0 % of PHGPX activity were retained 
compared to control cells. When GTG was added at a concentration of 100 pM, marked 
inhibition of TR activity was observed such that 3.18 ± 4.1 % of activity was retained 
compared to control cells. At the same GTG concentration, 33.3 ± 6.1 % and 63.0 ± 53.0 
of cyGPX activity and PHGPX activity was retained respectively. 
Supplementation of cells with GTG at concentrations of 1 pM or 10 pM did not alter the TR 
concentration of the cells compared to control cells as assessed by TR RIA (data not 
shown). There are no methods currently available to us to assess cyGPX concentration. 
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Figure 4.15 Timecourse of inhibition of thioredoxin reductase (TR) activity by gold 
thioglucose (GTG) in HaCaT cells. Cells were incubated with Se- deficient medium 
supplemented with GTG (10 µM) for 24, 48, and 72 hr respectively. Results shown are 
those of the mean of 3 flasks + SD. The basal level of activity in control cells is indicated by 
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4.3.11 The effect of gold thioglucose on the susceptibility of HaCaT 
cells to oxidative damage resulting from menadione exposure 
A concentration of 100 pM menadione was chosen since it had previously been shown to 
result in 50 - 60 % LDH retention (figure 4.08), providing an opportunity to see altered 
viability with GTG. Figure 4.17 shows the effect of pre- incubation with 10 pM GTG for 48 hr 
on the susceptibility of HaCaT cells to menadione- mediated damage. At 100 pM 
menadione, cells which had received a 10 pM GTG pre- incubation were significantly more 
susceptible (p < 0.05) to cytotoxic damage (3.74 ± 3.36 % LDH retained) than control cells 
which had received no GTG pre- incubation (19.83 ± 6.27 % LDH retained) but were exposed 
to the same menadione concentration. 
Incubation of HaCaT cells with 10 pM GTG for 48 hr was found to result in 18.1 ± 5.7% 
retention of TR activity (p < 0.001), 93.0 ± 27.0 % of cyGPX activity, and 71.1 ± 23.0 % of 
PHGPX activity retention compared to control cells (section 4.3.10, above; figure 4.16). 
In a second experiment, when exposed to 40 pM menadione, control HaCaT cells retained 
66.91 ± 3.53 % LDH activity; in comparison, cells pre- incubated with 10 pM GTG prior to 
menadione exposure retained 24.05 ± 2.84 % LDH activity (p < 0.0001) (figure 4.18 a). Cells 
exposed to 60 pM menadione retained 48.76 ± 7.20 % LDH activity in control cells, or 4.91 ± 
3.49 % LDH activity in GTG pre- treated cells in comparison (p < 0.0001). Control cells 
retained 9.37 ± 7.82 % LDH activity upon exposure to 80 pM menadione, but cells pre - 
incubated with GTG showed 100 % cell damage. 
Two further experiments confirmed the increased susceptibility of HaCaT cells pretreated 
with 10 pM compared with control cells at menadione concentrations of 60 pM (p < 0.01) and 
80 pM to 140 pM (p < 0.05) (figure 4.18 b), and at 40 pM, 60 pM, and 120 pM menadione (p 
< 0.05) (figure 4.18 c). 
When HaCaT cells were pre- incubated with GTG concentrations of 1, 2.5, 5, 7.5, and 10 pM 
prior to menadione exposure, there was a tendency towards greater cell damage with 
increasing GTG concentration (figure 4.19). HaCaT cells exposed to 100 pM menadione 
were significantly more susceptible to damage when pre- treated with 2.5 pM GTG (p < 0.05), 
5 pM GTG (p < 0.001), 7.5 pM GTG (p < 0.05), or 10 pM GTG (p < 0.01) compared to 
control cells exposed to 100 pM menadione but which did not receive GTG pre- treatment. 
The cells pre- incubated with 2.5 pM GTG suffered significantly more damage (p < 0.05) than 
those treated with 1 pM GTG, and those cells pre- incubated with 5 pM GTG suffered 
significantly more damage (p < 0.01) than those treated with 2.5 pM GTG. 
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Figure 4.17 The effect of gold thioglucose pre -incubation on the % LDH retained by 
HaCaT cells exposed to menadione. HaCaT cells were pre- treated with 10 pM gold 
thioglucose (GTG) for 48 hr prior to exposure to menadione (0, 100, 150 pM) for 18 hr. Cell 
viability was then assessed by % LDH retention. Control cells did not receive a GTG pre - 
incubation. Results shown are those of the mean of triplicate wells + SD. p < 0.001 * ** cf. 
control cells receiving 0 pM menadione. p < 0.05t cf. control cells receiving 100 pM 
menadione. 
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Figure 4.18 The effect of gold thioglucose pre- incubation on the % LDH retained by 
HaCaT cells exposed to menadione. HaCaT cells were pre- treated with 10pM gold 
thioglucose (GTG) for 48 hr prior to exposure to menadione (0 to 100 pM; or 0 to 140 pM) for 18 
hr. Cell viability was then assessed by % LDH retention. Control cells did not receive a GTG 
pre- incubation. Results shown are those of the mean of triplicate wells + SD. p < 0.001*** cf. 
control cells receiving 0 pM menadione. p < 0.05t, p < 0.001$, p < 0.0001$$ cf. control cells 
receiving the same menadione concentration. Graphs (a) - (c) are each a separate experiment. 
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Figure 4.19 The effect of gold thioglucose pre -incubation on the % LDH retained by 
HaCaT cells exposed to menadione. HaCaT cells were pre- treated with gold thioglucose 
(GTG) (1, 2.5, 5, 7.5, 10 pM) for 48 hr prior to exposure to menadione (0 or 100 pM) for 18 hr. 
Cell viability was then assessed by % LDH retention. Control cells did not receive a GTG pre - 
incubation. Results shown are those of the mean of triplicate wells + SD. p < 0.01 tt, p < 
0.001$ cf. control cells receiving 0 pM menadione. p < 0.05*, p < 0.01**, p < 0.001*** cf. control 
cells receiving the same menadione concentration. 
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4.3.12 The effect of consecutive sodium selenite and gold thioglucose 
treatment on susceptibility of HaCaT cells to oxidative damage 
resulting from menadione exposure 
Following exposure to menadione after pre- incubation with 10 pM GTG, cells were 
significantly more susceptible (p < 0.05) to damage induced by menadione than control cells. 
Sodium selenite (40 nM) pre- incubation alone significantly protected against menadione- 
induced cytotoxicity at concentrations of 60 pM and 80 pM menadione compared to Se- 
deficient cells (p < 0.05). When HaCaT cells were pre- incubated with 40 nM sodium selenite 
for 48 hr followed by GTG (10 pM) for 48 hr, the protective effects of the sodium selenite 
were seen to override the deleterious effects of the GTG pre- incubation (figure 4.20). The 
HaCaT cells which had received pre- incubation with 40 nM sodium selenite for 48 hr 
followed by GTG (10 pM) for 48 hr retained approximately the same % LDH as the cells 
which had received a sodium selenite pre- incubation (48 hr) alone. Thus, cells which had 
received pre- incubation with 40 nM sodium selenite for 48 hr followed by GTG (10 pM) for 48 
hr were significantly protected from the cytotoxic effects of menadione (p < 0.05) in 
comparison with control cells which did not receive any pre- treatment. 
The TR and cyGPX activities were measured for HaCaT cells which had received 
incubations identical to those for the menadione exposure (figure 4.21). The cells which 
received a GTG (10 pM) pre- incubation alone had significantly lower TR activity (figure 4.21 
a) (p < 0.0001) and cyGPX activity (figure 4.21 b) (p < 0.05) than control cells. Both TR 
activity (p < 0.001) and cyGPX activity (p < 0.01) were significantly increased by a pre - 
incubation with 40 nM sodium selenite compared to control cells. A pre- incubation with 40 
nM sodium selenite followed by a pre- incubation with 10 pM GTG resulted in a TR activity 
and cyGPX activity which were significantly higher (p < 0.05, and p < 0.01 respectively) than 
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Figure 4.21 Thioredoxin reductase (TR) activity (a), and cytoplasmic glutathione 
peroxidase (cyGPX) activity (b) in HaCaT cells treated with gold thioglucose (GTG), or 
sodium selenite, or sodium selenite followed by gold thioglucose. HaCaT cells were 
incubated with sodium selenite (40 nM) followed by gold thioglucose (GTG) (10 pM), or 
either one of these pre- incubations, each for 48 hr. Cells were washed between and 
following pre- incubations. Control cells did not receive a selenite or GTG pre- incubation. 
Results shown are those of the mean of triplicate flasks + SD. The basal level of activity of 
each respective selenoenzyme in control cells is indicated by the dashed line. p < 0.05 *, p 
< 0.01"*, p < 0.001-, p < 0.0001 * * ** cf. control cells; p < 0.05t , p < 0.01 tt cf. cells 
receiving 10 pM GTG; p < 0.01$ cf. cells receiving 40 nM Se followed by 10 pM GTG. 
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4.3.13 Comparison of LDH retention and trypan blue exclusion as 
measures of damage to HaCaT cells by menadione 
HaCaT cells exposed to menadione (0 - 160 pM) suffered similar cytotoxicity whether 
assessed by LDH release or by trypan blue exclusion (figures 4.22 a and 4.22 b). In the first 
experiment, cytotoxicity measured by LDH release first confirmed significant cytotoxicity at 
40 pM menadione (p < 0.001), but assessment by trypan blue did not reveal any significant 
cytotoxicity at this menadione concentration (figure 4.22 a). At 60 pM menadione, slight but 
significant cytotoxicity (p < 0.05) was measured by trypan blue; LDH release measured a 
more significant cytotoxicity (p < 0.001) at the same menadione concentration. At 
menadione concentrations of 80 ,uM and higher, significant cytotoxicity (p < 0.001) was 
measured by both cytotoxicity assays. 
In the second experiment, menadione concentrations of 40 - 80 pM did not produce any 
significant cell damage using either method of assessment of cytotoxicity (figure 4.22 b). 
Significant cytotoxicity occurred first when the HaCaT cells were exposed to 100 pM 
menadione using both cytotoxicity measurement methods (p < 0.001). 
LDH release (U /L) has been shown to be almost identical to the corresponding % LDH 
released (the % released of the total LDH in the cell) (data not shown). 
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Figure 4.22 Cell viability of HaCaT cells exposed to menadione assessed by LDH 
release and trypan blue exclusion. Cells were cultured in Se- deficient medium, and 
incubated with a range of concentrations of menadione (0 - 160 pM) for 18 hr. Cell medium 
was assayed for LDH activity, and the cells were counted for trypan blue staining. Results 
shown are those of the mean of triplicate wells ± SD. Where the SD are not visible, they lie 
within the data point. p < 0.05 *, p < 0.001*** cf. control cells exposed to 0 pM menadione. 
Graphs (a) and (b) are each a separate experiment. 
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4.3.14 Assessment of LDH retention as a measure of damage to HaCaT 
cells by UVB irradiation 
When cell damage mediated by the varying UVB doses was plotted as % LDH retained 
(figure 4.23), it was apparent that the apparent cell damage even with the highest UVB dose 
did not agree with experiments assessed by trypan blue in the literature. LDH retention by 
HaCaT cells measured 48 hr after exposure to 1200 J /m2 UVB was measured at 62.9 ± 6.1% 
(i.e. 37.1 % 'cell damage'). Cell damage measured by trypan blue assay at a dose of 960 
J /m2 UVB has previously been measured at 69 % (Rafferty, 2000) and 80 % (Rafferty et al., 
1998) in HaCaT. This discrepancy between different cytotoxicity assays suggested that the 
LDH may have been denatured /inactivated by the UVB; therefore the data from three further 
experiments was plotted as total LDH activity (LDH released plus LDH retained in U /L) 
(figure 4.24 a - c). 
Total LDH was decreased in a dose -dependent manner by UVB when measured 24 hr after 
irradiation (figure 4.24 a). No inactivation of LDH was apparent at 6 or 12 hr post- irradiation. 
In another experiment extending to 48 hr (figure 4.24 b), the total LDH was significantly 
decreased by a UVB dose of 1200 J /m2 when the LDH measurement was taken at 12 hr (p < 
0.05) or 24 hr (p < 0.001) post- irradiation when compared with cells at time zero. In the third 
experiment (figure 4.24 c), the LDH decreased in a dose -dependent manner with UVB 
irradiation when measured 48 hr post- irradiation. Whilst this trend was also apparent for all 
other time points used, there was an increase in total LDH at a UVB dose of 480 J /m2 when 
the LDH measurement was 72, 96 or 120 hr post- irradiation. This may be due to a resistant 
population of cells or uninjured cells having multiplied over such a time period. 
There was high variability in the total LDH between the three experiments. The cells used to 
produce the data illustrated in graph 4.24 c may have been pre -confluent, since the total 
LDH had increased by 24 hr; this was not apparent in the other two graphs. The cells may 
have responded differently to the cytotoxic insult due to differences in their stage of growth. 
The data in graph 4.24 c is also different to that of graphs 4.24 a and 4.24 b since the LDH 
values of the control are 500 U /L, compared to 300 U/L total LDH in graphs a and b. There 
is no clear explanation for this discrepancy, but it further illustrates potential problems in 
using LDH as a measure of cytotoxicity resulting from in vitro exposure of cells to UVB. It is 
also unclear why the amount of total LDH increased with increasing UVB dose in the cells 
receiving 0 J /m2 UVB in graph 4.24 b. This may be due to methodological errors. 
The inactivation of LDH did not appear to be immediate since the levels of LDH in sham - 
irradiated control cells and cells which were irradiated and assayed for LDH immediately had 
similar levels of LDH. 
4 -51 

















Figure 4.23 The effect of UVB irradiation on the % LDH retained by HaCaT cells after 
0, 6, 12, 24 or 48 hr. HaCaT cells were irradiated with UVB (480 - 1200 J /m2) through PBS, 
and the original medium replaced on the cells for 0, 6, 12, 24, or 48 hr before LDH assay 
took place. Results shown are those of the mean of triplicate wells + SD. p < 0.05 *, p < 
0.01**, p < 0.001*** cf. control cells, at the respective time point, which did not undergo 
irradiation with UVB (represented by 0 J /m2 UVB). 
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Figure 4.24 The effect of UVB irradiation on the total LDH of HaCaT cells. HaCaT cells 
were irradiated with UVB (480 - 1200 J /m2) through PBS, and the original medium replaced 
on the cells for 0, 6, 12, 24, 48, 72, 96 or 120 hr before LDH assay took place. Results 
shown are those of the mean of triplicate wells + SD. Total LDH was calculated by addition 
of LDH released and retained (U /L). p < 0.05 *, p < 0.01**, p < 0.001# cf. cells which were 
irradiated and had their LDH assessed immediately (time zero). Control cells were sham 
irradiated. Graphs (a) - (c) are each a separate experiment. 
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4.3.15 The ability of sodium selenite supplementation to protect HaCaT 
cells from cytotoxicity resulting from UVB exposure 
HaCaT cells suffered 79.1 ± 4.2 % cell damage, assessed by trypan blue assay, when 
irradiated with 960 J /m2 UVB (figure 4.25). Sodium selenite pre- incubation for 48 hr prior to 
UVB exposure with concentrations of 1 to 1000 nM significantly reduced the level of cell 
damage (p < 0.001). Sodium selenite concentrations of 1 to 100 nM reduced the cell 
damage to below 30 % compared to the 79.1 % cell damage in control cells (p < 0.001). The 
optimal level of protection was offered by pre- incubation with 1 nM sodium selenite for 48 hr. 
Cell damage from UVB when a pre- incubation of 200 nM sodium selenite took place was 
significantly higher, at 36.0 ± 2.1 %, than was seen with the lower concentrations of selenite 
(p < 0.01), but the protection was significant (p < 0.001). A concentration of 1000 nM sodium 
selenite used for pre- incubation produced 62.0 ± 2.1 % cell damage upon UVB exposure; 
although this was still significantly protective in comparison to Se- deficient control cells (p < 
0.001), the level of cell damage was significantly more than that found at all other selenite 
concentrations tested (p < 0.001). 
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Figure 4.25 The effect of sodium selenite pre -incubation on the susceptibility of 
HaCaT cells to UVB- induced cell damage. HaCaT cells were incubated with Se- deficient 
medium supplemented with different concentrations of sodium selenite (1, 10, 40, 50, 100, 
200, 1000 nM) for 48 hr. Control cells received no Se supplementation, and were sham - 
irradiated. Following the pre- incubation the HaCaT cells were exposed to UVB (960 J /m2). 
After 48 hr cell viability was assessed by determining the % of cells staining positive for 
trypan blue. Results shown are the mean of triplicate wells + SD. p < 0.001 * ** cf. Se- 
deficient control cells exposed to UVB. 
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4.3.16 The ability of gold thioglucose supplementation to modify the 
susceptibility of HaCaT cells to cytotoxicity resulting from UVB 
exposure 
Pre -incubation of HaCaT cells with either 1 pM or 10 pM GTG prior to an irradiation with 720 
J /m2 UVB did not affect the % cell damage in any of three separate experiments (figure 
4.26). In the third experiment (figure 4.26 c), a pre- incubation of HaCaT cells with 100 pM 
GTG for 48 hr prior to irradiation significantly increased the % cell damage, as measured by 
trypan blue assay, from 9.8 ± 3.3 % in cells untreated with GTG to 28.2 ± 4.4 % in cells pre- 
treated with 100 pM GTG (p < 0.01). 
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Figure 4.26 The effect of gold thioglucose pre -incubation on UVB- mediated cell 
damage of HaCaT cells. HaCaT cells were pre- treated with 1, 10, or 100 pM gold 
thioglucose (GTG) for 48 hr prior to exposure to UVB- irradiation (720 J /m2). Cell viability 
was assessed 48 hr later by trypan blue assay. Control cells did not receive UVB- irradiation. 
Results shown are those of the mean of triplicate wells + SD. p < 0.01** cf. UVB- irradiated 
control cells receiving 0 pM GTG pre- incubation. Graphs (a) - (c) each represent a separate 
experiment. 
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4.3.17 Investigation of potential TR inhibitors using the DTNB assay 
system 
The compounds azelaic acid (0.01 to 1.11 mM), anthralin (0.01 to 0.28 mM), and 13 -cis 
retinoic acid (0.01 to 0.56 mM) did not produce any inhibition of TR activity in human 
placental cytosol any of the concentrations tested (figure 4.27 a, b, and d). N- ethylmalemide 
(NEM), which was used at concentrations of 0.01 to 0.11 mM, produced inhibition of TR 
activity at all concentrations tested such that < 10 % of control TR activity was retained (p < 
0.001) (figure 4.27 c). 
4 -58 














o ° 20 
ó 
0 
d) s 250 
as 200 
F 0 150- 







0.01 0.02 0.06 0.11 0.22 0.56 1.11 
[Azelaic acid (mM)] 
0.01 0.03 0.06 0.11 0.28 
[Anthralin (mM)] 
0.01 0.02 0.03 0.04 0.06 0.11 
[NEM (mM)] 
i tti 
0.01 0.03 0.06 0.11 0.28 0.56 
[13 -cis retinoic acid (mM)] 
Figure 4.27 The effect of various TR inhibitors on TR activity in human placental 
cytosol assessed by DTNB assay. The results shown are the meaned data from two 
experiments. The inhibitors assessed were (a) azelaic acid; (b) anthralin; (c) N- 
ethylmaleimide (NEM); and (d) 13 -cis retinoic acid. The inhibitor concentrations quoted are 
final concentrations in the assay. Incubation of placental cytosol with the inhibitors took 
place overnight at 4 °C. p < 0.001*** cf. control TR activity. 
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4.3.18 Comparison of potential TR inhibitors in the DTNB assay system 
and the insulin assay system for TR 
Azelaic acid at concentrations of 0.01 to 0.56 mM did not produce any significant TR 
inhibition as measured by the DTNB and insulin assays (figure 4.28 a i). A concentration of 
1.11 mM azelaic acid caused TR inhibition such that 79.9 ± 2.41 % of control activity was 
retained as measured by the DTNB assay, but no significant inhibition was measured using 
the insulin assay. 
Anthralin at concentrations of 0.01 to 0.11 mM did not produce any significant TR inhibition 
as measured by the DTNB and insulin assays (figure 4.28 a ii). A concentration of 0.28 mM 
anthralin produced TR inhibition resulting in 87.4 ± 3.2 % retention of control activity in the 
DTNB assay (p < 0.05), and 11.5 ± 7.8 % retention of control activity in the insulin assay (p < 
0.001). The difference in retention of control activity between the two assay systems was 
significant (p < 0.001). 
N- ethylmalemide (NEM) caused significant TR inhibition measured by both assay systems 
such that retention of control activity was < 25 % for all concentrations measured by insulin 
assay (p < 0.001), and < 1 % for all concentrations assessed by DTNB assay (figure 4.28 a 
iii). 
13 -cis retinoic acid (0.01 to 0.56 mM) did not produce any inhibition of TR activity in human 
placental cytosol at any of the concentrations tested when assessed by DTNB assay (figure 
4.28 b i). When measured by insulin assay, concentrations of 13 -cis retinoic acid produced 
a dose -dependent decrease in activity. The highest concentration of 13 -cis retinoic acid, 
0.56 mM, caused 5.2 ± 0.2 % retention of control activity (p < 0.001). 
p- chloromercuri- benzoic acid (PCMB) caused TR inhibition measured by both assays such 
that retention of control activity was < 15 % for all concentrations measured by insulin assay 
(p < 0.001), and < 10 % for all concentrations assessed by DTNB assay (figure 4.28 b ii). 
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Figure 4.28 a The effect of various TR inhibitors on TR activity in human placental 
cytosol assessed by DTNB assay and insulin assay. The results shown are the meaned 
data from two experiments. The inhibitor concentrations quoted are final concentrations in 
the assay. Incubation of placental cytosol with the inhibitors took place overnight at 4 °C. p < 
0.05 *; p < 0.001*** cf. control activity. The TR activity of the control is indicated by the 
dashed line. 
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Figure 4.28 b The effect of various TR inhibitors on TR activity in human placental 
cytosol assessed by DTNB assay and insulin assay. The results shown are the meaned 
data from two experiments. The inhibitor concentrations quoted are final concentrations in 
the assay. Incubation of placental cytosol with the inhibitors took place overnight at 4 °C. p < 
0.001 * ** cf. control activity. The TR activity of the control is indicated by the dashed line. 
4 -62 
The role of TR in the prevention of oxidative damage in skin cells Chapter four 
4.3 DISCUSSION 
The HaCaT cell line as a model of human keratinocytes in which to 
study oxidative damage and selenoproteins 
Keratinocytes are the most numerous cell type in the epidermis, they receive the highest 
exposure to UVB and are the cell type that forms basal and squamous cell carcinomas, 
which are induced by exposure to UVB radiation. HaCaT cells and human primary 
keratinocytes were seen to have a similar TR concentration, but HaCaT had cyGPX activity 
of an order 2 -fold lower than that of primary keratinocytes (figure 4.05). HaCaT cells have 
previously been shown to have lower cyGPX and SOD activity, but higher GSH levels, than 
primary keratinocytes (Leccia et al., 1998). The Se content of basal culture media for PK 
and HaCaT was 8.9 nM and 0.351 nM, respectively. FBS used to supplement the HaCaT 
medium had a Se concentration of 13.78 nM. Thus, the Se content of the media was similar, 
suggesting that the basal selenoprotein expression was not due to exposure to differing Se 
concentrations in the media. HaCaT are more resistant to UVA- induced damage than 
primary keratinocytes (Leccia et al., 1998), but more susceptible to UVB- induced damage 
(Rafferty, 2000). Despite this, the concentrations of Se which afford protection against UVB - 
mediated damage are similar in both cell types, as are the UVB doses required to kill 70 % of 
cells at 48 hr (Rafferty, 2000). The HaCaT cell line is thus a suitable model in which to study 
the role of selenoproteins in protection against oxidative stress. It is of importance to note, 
however, that HaCaT cells are p53- deficient (Magal et al., 1998; Merryman, 1999) and this 
limits their use in cell survival studies. 
The doses of UVB irradiation used in the cytotoxicity experiments (720 J /m2 and 960 J /m2) in 
this thesis were similar to physiological doses of UVB. The physiological dose of UVB 
required to cause mild reddening of the skin, i.e. the standard erythemal dose (SED), is 150 
J /m2 for human skin type I (very pale, always burns) and 600 J /m2 for type IV skin (olive or 
mediterranean complexion) (Honigsmann, 2002). 
The Trypan blue and LDH assay systems for assessing cytotoxicity 
Cell damage was assessed in all the menadione cytotoxicity experiments using LDH 
retention, and in the UV experiments using trypan blue exclusion since LDH was unsuitable 
as a measure when UVB was the stressor. Exposure to UVB inactivated LDH in a dose - 
dependent manner in HaCaT cells (figure 4.24). Previous studies have demonstrated that 
UV can inactivate LDH both in vitro (Artiukhova et al., 1997; Chen et al., 1989) and in vivo 
(Löfgren and Söderberg, 2001), in a dose -dependent manner (Chen et al., 1989) consistent 
with the results presented here. The damage to LDH by UV appears to be ROS- mediated 
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since irradiation in the presence of ROS scavengers /quenchers results in restoration of 
catalytic activity (Artiukhova et al., 1997). The absorption spectrum of LDH changes during 
UVB exposure, suggesting an alteration of tryptophan residues in the LDH molecule (Chen 
et al., 1989). Photo -oxidation of tryptophan also causes oxidation of tyrosine, which may 
alter the structural conformation of the enzyme, and possibly its activity. The loss of LDH 
activity is due to decreased activity of the LDH molecules rather than an altered affinity 
between the enzyme and substrate (Chen et al., 1989). 
Previous studies have shown the LDH assay and trypan blue assay correlate well in their 
assessment of cytotoxicity in rat hepatocytes (R = 0.92) (Jauregui et al., 1981). Our studies 
suggest that the two methods correlate well in the assessment of menadione cytotoxicity in 
HaCaT cells. 
Cellular confluence as a source of variation in cytotoxicity 
The damage suffered by HaCaT cells upon exposure to menadione was influenced by 
cellular confluence level (figures 4.09, 4.10, 4.11). Pre -confluent cells were more 
susceptible to damage (p < 0.01) by menadione than were 100 % confluent cells, with post - 
confluent cells the most resistant to damage. These results are similar to those obtained 
with EAhy926 cells (section 3.4). In HaCaT cells the expression of keratinocyte growth 
factor receptors is induced by confluence and high cell density (Capone et al., 2000). Such 
expression of growth factor receptors may have concomitant effects on the ability of cells to 
resist oxidative stress. The levels of cyGPX, PHGPX, and TR activity and concentrations did 
not increase with increasing confluency in HaCaT cells (figure 4.12). Thus, it does not 
appear that the increased resistance to damage with confluency level was due to increases 
in selenoenzyme expression. However, this was a single experiment only, so the results 
need to be confirmed in further studies. The increased resistance may be due to other 
antioxidant enzymes that we did not measure. Other possible explanations for the 
differences in susceptibility with confluency level are discussed in section 3.4. For all further 
experiments, HaCaT cells were treated with menadione or UVB when at 100 % confluence 
to reduce the variation between experiments. 
Protection against menadione- and UVB- mediated damage by Se, and 
Se supplementation of skin cells 
Se- deficient HaCaT cells pre- incubated with sodium selenite (1 to 1000 nM) for 48 hr were 
significantly less sensitive to damage by menadione (p < 0.01) (Figure 4.13). Optimal 
protection against menadione- induced cytotoxicity (p < 0.01) was offered by 10 nM sodium 
selenite in two out of three experiments (figure 4.13 a, b). Protection was not lost at higher 
selenite concentrations. Some of the variation observed between the individual experiments 
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was likely to be due to confluence differences since some experiments were performed 
using non -confluent cells. 
Pre -incubation with sodium selenite, inducing selenoprotein expression, was necessary for 
protection against menadione cytotoxicity (figure 4.14). Sodium selenite added to the cells 
at the same time as menadione was possibly acting as a pro- oxidant, overwhelming the 
antioxidant capacity of the cells with oxidative stress resulting from insults from both 
menadione and sodium selenite simultaneously. One of these compounds may be reduced 
or possibly redox -cycled by the other, causing formation of further ROS. 
Pre -incubation of HaCaT cells for 48 hr with sodium selenite (1 to 1000 nM) provided 
significant protection (p < 0.001) from cytotoxic insult by UVB irradiation as assessed by 
trypan blue assay (figure 4.25). Optimal protection was offered by 1 nM sodium selenite (p < 
0.001). Loss of protection was seen with increasing concentrations of sodium selenite 
greater than 100 nM such that at 1000 nM no protective effect of selenite was observed. 
Such loss of protection was shown previously in primary human keratinocytes and HaCaT 
(Rafferty et al., 1998a). Loss of protection was associated with a loss of cyGPX activity (p < 
0.05), but not of TR or PHGPX expression (see below). When menadione was used as the 
oxidative stressor, no loss of protection was demonstrated at the higher selenite 
concentrations. 
Se- deficient HaCaT cells supplemented with sodium selenite demonstrated dose -dependent 
increases in TR activity. TR activity was optimal at 10 nM sodium selenite (p < 0.05, p < 
0.001). Increasing the selenite concentration above 10 nM did not further increase the TR 
activity. This was not the case with cyGPX activity. The cyGPX activity of HaCaT cells 
decreased with increasing selenite concentration. At 1000 nM selenite, the cyGPX activity 
was not significantly different to Se- deficient controls. One explanation for this decrease in 
cyGPX activity could be that ROS are being produced by sodium selenite in the cell, and 
although the level of ROS is not enough to cause membrane damage and LDH release, the 
ROS are at a level substantial enough to inactivate or destroy cyGPX. The activity of cyGPX 
can be induced or inactivated by oxidative stress, which may be dependent upon the level of 
the stress. Enzymatic inactivation of cyGPX by ROS has been demonstrated in cultured 
keratinocytes (Vessey and Lee, 1993). Some enzymes may be more susceptible to 
oxidative inactivation because the active site is more accessible to ROS, or because they 
contain functional groups consisting of amino acids which are more easily damaged. ROS 
react with several amino acid residues in vitro, generating modified and less active enzymes, 
cross -linked, denatured, or inactive proteins. Among the most susceptible amino acids are 
sulphur- (or selenium)- containing residues, methionine and cysteine residues (Halliwell and 
Gutteridge, 1999). Such loss of cyGPX activity was not seen in EAhy926 cells with these 
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selenite concentrations, and this mechanism of ROS- induced inactivation would likely be 
common to cell types. EAhy926 cells have a higher amount of TR than skin cells however, 
so potential ROS could be reduced before they had an opportunity to inactivate cyGPX in 
endothelial cells. 
An alternative explanation for the down -regulation of cyGPX may be end product inhibition 
involving negative feedback of selenide, which down -regulates selenoenzyme expression at 
high sodium selenite concentrations. Sustained exposure (weeks) of cells to high levels of 
Se, generating reactive Se intermediates may cause diselenide formation, leading to 
inhibition of TR activity over time (Ganther, 1999). It would seem a reasonable assumption 
that the same may be true for inhibition of GPX activity by diselenide formation with the 
SeCys of its active site. However, incubation with selenite was only for 48 hr in our 
experiments, which may be insufficient time for such inhibition to occur. TR and cyGPX can 
be regulated independently, for example, p53 expression results in elevated cyGPX 
expression, but down -regulation of TR expression (Gladyshev et al., 1998). The inhibition of 
GPX activity in skin cells, but lack of inhibition of TR activity observed in the studies 
presented here may represent selenide formation which differs in its threshold for effects on 
TR and GPX. However, recent studies have revealed that methylseleninate, a metabolite of 
Se, does not inhibit TR activity, but is a substrate for the enzyme (Gromer and Gross, 2002). 
Thus, the mechanism is far from clear. 
The loss of protection appears not be to due to cytotoxicity of sodium selenite, since 
concentrations up to 1000 nM were not cytotoxic to HaCaT cells, as assessed by LDH 
release and gross morphological examination by light microscope. However, the pro- oxidant 
status of sodium selenite at ,uM concentrations is well documented in both in vivo and in vitro 
studies (Dougherty and Hoekstra, 1982; Rafferty et al., 1998a; Stewart et al., 1999; Yan and 
Spallholz, 1993), and 1000 nM selenite has previously been shown to be toxic to HaCaT 
cells as assessed by trypan blue assay (Rafferty, 2000). The LDH and trypan blue assay 
systems, which correlate well in their assessment of cytotoxicity, are discussed in earlier 
sections. The reason for the apparent discrepancies in cytotoxic measurements between 
studies are unclear. One possible explanation is differing sensitivity between the two assay 
systems. 
Sodium selenite can oxidize glutathione to form selenodiglutathione (GSSeSG), which is 
cytotoxic to cultured tumour cell lines, and other thiols to form selenotrisulphides which react 
to produce OZ- and H2O2 (Spallholz, 1994). At higher selenite concentrations, GSSeSG may 
be formed, causing GSH depletion which could also account for loss of cyGPX activity. 
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Supplementation of Se- deficient HaCaT cells with selenomethionine gave optimal TR and 
PHGPX activities at 1000 nM selenomethionine (p < 0.05), and cyGPX at 200 nM 
selenomethionine (p < 0.01) (figure 4.03). In the second experiment, much higher 
concentrations were needed to induce all three selenoenzymes (figure 4.04). At a 
concentration of 100,000 nM selenomethionine there was no significant difference in the 
cyGPX activity compared to the basal level in control cells. LDH release, and gross 
morphological examination by light microscope, did not indicate any cytotoxicity to HaCaT 
cells at any selenomethionine concentration tested. 
Using selenomethionine concentrations from 10 nM to 1000 nM, TR, PHGPX and cyGPX 
activities of HaCaT cells were optimal at 1000 nM. At this selenomethionine concentration, 
Rafferty et al. saw a decrease in the protection of HaCaT cells from UVB, but the reason for 
this decrease in unclear. Selenomethionine did not show any signs of cytotoxicity to HaCaT 
cells up to a concentration of 100 pM in the studies presented here, as assessed by LDH 
release. Concentrations of up to 10 pM selenomethionine show no cytotoxicity to primary 
human keratinocytes as assessed by trypan blue exclusion (Rafferty et al., 1998a). It would 
appear that the loss of protection was not due to cytotoxicity of the selenomethionine or to a 
decrease in selenoenzyme expression. The loss of protection demonstrated with 
selenomethionine may be due to a mechanism distinct from that operating with sodium 
selenite. 
Supplementation of HaCaT cells with Se in the form of selenomethionine produced 
increases of a lesser magnitude in TR and GPX activity than those produced by sodium 
selenite. A concentration of 100 nM sodium selenite increased TR activity by 3.7 -fold and 
1.8 -fold respectively in two separate experiments (figures 4.01 and 4.02), whereas 100 nM 
selenomethionine increased TR activity in HaCaT by 1.3 -fold in two experiments (figures 
4.03 and 4.04). Although these data cannot be directly compared as assays were performed 
on different batches of cells at different times, it suggests that the organic form of Se, 
selenomethionine, induces TR expression to a lesser extent than sodium selenite, a non - 
organic form. Berggren et al. have also shown that L- selenomethionine produces a smaller 
change in TR activity than sodium selenite (Berggren et al., 1997). The chemical form of Se 
added to cells is an important factor in determining the ability of Se to afford protection from 
UVB irradiation in skin cells (Rafferty et al., 1998a; Rafferty et al., 1998b). Optimal 
protection of human primary keratinocytes was afforded by 10 nM sodium selenite, and by 
50 nM selenomethionine, demonstrating the lesser potency of selenomethionine. Studies 
using endothelial cells have also shown that sodium selenite is more potent than 
selenomethionine in conferring protection against t- BuOOH- mediated cytotoxicity in cultured 
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HUVEC. This difference may reflect the differing abilities of each compound to modify 
selenoprotein status. 
L- methionine is present in different culture media (DMEM medium for HaCaT cells: 30 mg /L), 
and may compete with the selenomethionine for its Se. This may explain the lower efficacy 
of selenomethionine in the protection of HUVEC against toxicity from t- BuOOH, and the 
protection of keratinocytes against UVB- irradiation. It is feasible that there is less 
selenomethionine uptake by the cell when methionine is competing, resulting in less 
bioactivity and efficacy. The degree of selenomethionine incorporation into proteins depends 
upon the dosage and methionine status, and diminishes at high methionine intakes 
(Schrauzer, 2001). Methionine -free culture media could be used to investigate this. 
However, preliminary experiments with methionine -free medium have demonstrated that 
cells in culture do not grow well in such medium (personal communication, Dr Forbes 
Howie). 
Studies in skin cells using GTG to examine the role of individual 
selenoproteins in protection 
Se was demonstrated to protect against cytotoxicity in HaCaT cells mediated by UVB and 
menadione, but it was essential to determine which selenoenzymes were responsible for the 
protection. To investigate this, the differing sensitivities of the three selenoenzymes to 
inhibition by gold thioglucose (GTG) were exploited. 
After pre- incubation with 10 pM GTG (18.1 % of TR activity (p < 0.001), 93.0 % of cyGPX 
activity, and 71.1 % of PHGPX activity retained), HaCaT cells were significantly more 
susceptible (p < 0.05) to damage by menadione (figures 4.17, 4.18, 4.19, 4.20). This would 
suggest that TR is important in the protection of HaCaT cells from oxidative stress mediated 
by menadione. 
Pre -incubation of HaCaT cells with 10 pM GTG prior to an irradiation with 720 J /m2 UVB did 
not affect the extent of cell damage (figure 4.27). Pre -incubation of HaCaT cells with 100 pM 
GTG (3.18 % TR activity (p < 0.001) 33.3 % cyGPX activity (p < 0.001) 63.0 % of PHGPX 
activity retained respectively) for 48 hr prior to irradiation significantly increased the cell 
damage (p < 0.01), as measured by trypan blue assay (figure 4.26 c). These data suggest 
that TR alone may not be as crucial for protection of HaCaT against UVB- mediated damage 
as it is in protection against menadione- mediated cytotoxicity. The GPX's appear important 
for protection against UVB- mediated damage since inhibition of their activity by 100 pM GTG 
significantly increased the damage to HaCaT cells by UVB exposure. The decrease of 
cyGPX activity at higher concentrations of sodium selenite coinciding with loss of protection 
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against UVB- mediated damage further supports an important role for cyGPX in such 
protection. Only one experiment was performed to demonstrate increased susceptibility of 
HaCaT cells to UVB irradiation when pre- treated with 100 pM GTG. Ideally, further 
experiments should be carried out to confirm this in HaCaT cells, and also in primary 
keratinocytes. 
Although Se has been demonstrated to modulate the cyGPX activity of HaCaT cells, no data 
is available on the cyGPX protein concentration. Investigation of whether the modulation of 
cyGPX concentration follows the pattern of the activity is needed to further elucidate the 
underlying mechanisms. Selective inhibition of the GPXs by means other than GTG (for 
example, antisense technology, or specific antibodies) in skin cells exposed to UVB would 
provide further information on the importance of these selenoenzymes in protection against 
damage mediated by UV- irradiation. 
Menadione model versus UVB model 
Menadione is a redox -cycling compound used widely as a model oxidative stress agent, 
which generates ROS in cells. In comparison, UVB is a more physiological oxidative 
stressor, which can injure cells by means of ROS- mediated cascades as well as by direct 
effect of the energy of UV irradiation. UV irradiation is well known to cause lipid peroxidation 
(Black et al., 1997; Fuchs, 1998; Girotti, 2001; Yuen and Halliday, 1997), and some studies 
report menadione to cause lipid peroxidation also (Sorg et al., 2002; Tzeng et al., 1995). 
However, other reports suggest a cytotoxic mechanism of menadione that is independent of 
lipid peroxidation (Comporti, 1989; Thor et al., 1982), since menadione is an inhibitor of the 
propagation reactions of lipid peroxidation (Wills, 1972). Cytotoxicity by menadione also 
involves rapid GSH depletion, ROS generation, protein thiol oxidation, and perturbations in 
Cat+ homeostasis (Chen and Cederbaum, 1997; Cho et al., 1997; Santini et al., 1996; Thor 
et al., 1982), and DNA damage (Halliwell and Gutteridge, 1999; Woods et al., 1997). In 
addition, menadione is a substrate for TR1 (Arnér et al., 1999; Gromer et al., 1998; Luthman 
and Holmgren, 1982) which introduces bias towards TR as the protective enzyme in cells 
exposed to menadione. TR may reduce menadione before it can produce a large quantity of 
ROS, but the same would not be true for physiological stressors such as UVB, whose ROS 
have to be detoxified after production. 
It is unclear how the differently mediated types of stress relate to the intensity of the other. 
Because of the discrete nature of UV light absorption by chromophores, the location of the 
primary photochemical target plays a considerable role in the development of the oxidative 
stress, as well as free iron. Thus, data obtained with `dark' oxidative stresses, such as 
menadione, cannot easily be extrapolated to those produced by UV light. Different 
4 -69 
The role of TR in the prevention of oxidative damage in skin cells Chapter four 
antioxidant protection systems may be important against differing types of oxidative stress. 
In human keratinocytes ferritin is more important in protection against t- BuOOH- mediated 
oxidative stress than against photochemically -induced oxidative stress (Giordani et al., 
2000). This may imply that the induction of oxidative stress by the different toxic agents 
differs in its mechanism. 
Menadione is not a substrate for mitochondrial TR, unlike cytosolic TR (TRI) (Rigobello et 
al., 1998). By using menadione our studies may have 'weighted' the protection in favour of 
the cytosolic form of TR. The relative importance of the different TR isoforms in protection 
against oxidative stress is unknown at present. In vivo, a large proportion of ROS generation 
is from mitochondria, so mitochondrial TR is likely to be important in antioxidant defence. 
ROS are produced in the cytosol of cells exposed to UV, demonstrating a requirement for 
antioxidant protection in this location. The cytoplasmic and mitochondrial compartments of 
the cell are known targets of menadione (Santini et al., 1996). Both the cytosolic and 
mitochondria) forms of TR are likely to be vital for protection of the cell from oxidative stress, 
but may vary according to the type of stressor. 
The ability of Se to override the effects of GTG 
Se- deficient HaCaT cells pre- incubated with 40 nM selenite for 48 hr were afforded 
significant protection (p < 0.05) from menadione- mediated cytotoxicity (figure 4.20), but cells 
pre- incubated with 10 pM GTG were significantly more susceptible (p < 0.05) to such 
damage. When HaCaT cells were treated with 40 nM selenite in addition to 10 pM GTG, the 
up- regulation of selenoenzyme expression by Se supplementation was sufficient to override 
the effects of the GTG in the cells, offering significant protection (p < 0.05) despite the loss of 
a percentage of the TR activity (> 80 %) and /or GPX activity. The level of protection 
provided to cells which had received selenite treatment alone or selenite in addition to GTG 
was almost identical. The corresponding selenoprotein activities for such pre- incubations 
were measured. 
HaCaT cells pre- incubated with GTG (10 pM) alone had significantly lower TR (p < 0.0001) 
and cyGPX (p < 0.05) activities than controls (figure 4.21). Both TR activity and cyGPX 
activity were significantly increased (p < 0.001, and p < 0.01, respectively) by pre- incubation 
with selenite alone compared to controls. Pre -incubation with sodium selenite followed by 
GTG resulted in significantly augmented TR and cyGPX activities (p < 0.05, and p < 0.01 
respectively) compared to those with GTG alone. However, the TR activity of HaCaT cells 
incubated with selenite followed by GTG was significantly lower (p < 0.01) than cells 
incubated with sodium selenite alone, whilst the cyGPX activity of these two treatment 
groups was not significantly different. The cyGPX activity was induced by selenite to a 
4 -70 
The role of TR in the prevention of oxidative damage in skin cells Chapter four 
greater extent, despite the GTG- mediated inhibition, than the TR activity. This may imply 
that Se upregulates the expression of more selenoprotein, which overcomes the protein 
already inhibited by GTG. The upregulation of cyGPX may compensate for the loss of TR 
activity, i.e. the protection observed in cells treated with selenite and GTG in conjunction 
may be largely due to cyGPX. 
Inhibition of TR activity may lead to a number of potentially pro- oxidant effects in the cell, 
including either decreased TR activity, reduced Trx activity, decreased GSH concentration 
(and thus increased GSSG), increased Trx expression, increased expression of NFxB- 
dependent proteins, or increased expression of TR ( Nordberg and Amer, 2001). This further 
emphasises the inter -dependence of antioxidant systems of the cell. 
Sub -cellular localisation of TR in skin cells 
Immunohistochemical staining for Trx in human skin fibroblasts has revealed Trx to be 
located mainly in the cytoplasm and also around the nuclear membrane (Didier et al., 2001). 
It would seem a reasonable assumption that TR must be localised to the same areas to keep 
Trx in its functional reduced state. TR can be detected in nuclei, mitochondria, lysosomes, 
microsomes, and cytosol (Chen et al., 2002), and in the perimembraneous area of the 
plasma membrane (Hansson et al., 1986; Rozell et al., 1985) as well as the granular 
endoplasmic reticulum and cisternae of the Golgi body (Rozell et al., 1988). The principal 
site of TR activity is the cytosol, where all TR isoforms are synthesized. Our 
immunocytochemical analysis of TR in skin cells showed TR to be localised largely in the 
cytosol and around the nuclear membrane for human primary keratinocytes and HaCaT 
cells. Dividing HaCaT cells appeared to have more intense staining for TR than did non - 
dividing cells. One function of Trx is as a growth factor, which is required to be in a reduced 
state to carry out this function. Rozell et al. suggested variations in immunoreactivity of TR 
in non -proliferating and differentiated cells to be related to their metabolic activity (Rozell et 
al., 1985). 
Schallreuter et al. have suggested that TR is located on the plasma membrane of 
keratinocytes. The immunohistochemistry presented here suggests that TR is largely 
cytoplasmic rather than membrane -associated. Although the studies of Rozell et al. showed 
TR to be localised to the perimembraneous area of the plasma membrane of salivary gland 
cells, secretory gland cells of the pancreas, and hepatocytes (Hansson et al., 1986; Rozell 
et al., 1985), this was not true for skin cells. Preliminary studies attempting to separate the 
subcellular fractions of [75Sej- labelled skin cells during the studies presented here were 
unsuccessful. Such studies need to be repeated to provide further clarification of the specific 
localisation of TR in skin cells. Unsaturated membrane lipids are a crucial target for singlet 
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oxygen and ROS- mediated attack in photodynamic reactions, and modifications of such 
lipids may play a crucial role in UV- induced skin cancer, drug- sensitized phototoxicities, and 
anti -tumour PDT treatments (Girotti, 2001). 
Comparison of inhibitors in the DTNB and insulin assay systems for TR 
The DTNB and insulin assays for measurement of TR activity correlate well in their 
measurements of TR activity in calf liver and HeLa cells respectively (Zhong et al., 1998) 
(Gorlatov and Stadtman, 1998). In these assay systems, the substrate is either DTNB, or, in 
the alternative assay, Trx (oxidised) and insulin (Gorlatov and Stadtman, 1998; Zhong et al., 
1998). 
Various compounds were tested in the DTNB and insulin assay systems for TR activity in 
human placental cytosol. Comparing the two assay systems directly, a concentration of 1.11 
mM azelaic acid, 0.28 mM anthralin, and 0.56 mM13 -cis retinoic acid caused significantly 
different levels of inhibition between the two assay systems (p < 0.001; p < 0.0001; p < 
0.0001 respectively). Significant inhibition was evident in the insulin assay, but not in the 
DTNB assay. Using azelaic acid, Becker et al. (2000) found no inhibition of human TR 
activity (Becker et al., 2000). Kroll et al. (1999) found azelaic acid to have no inhibitory effect 
on spin label reduction by TR (Kroll et al., 1999). Rigobello et al. (1998) found inhibition of 
mitochondria! TR activity by 100 pM and 500 pM 13 -cis retinoic acid using the DTNB assay 
(Rigobello et al., 1998). We only assessed the effects of inhibitors on the cytosolic form of 
TR however. 
Schallreuter and Wood used their bioassay for TR, based on the decrease in electron spin 
resonance spectroscopy (ESR) amplitude of a cationic nitroxide spin label, a reduction 
proposed to be specific for TR in epidermis, to investigate TR inhibitors. Reduction of spin 
label on skin, on keratinocytes, melanocytes and purified E. coli TR was inhibited by 
thioprotein inhibitors, anthralin, azelaic acid and 13 -cis retinoic acid. However these studies 
have been criticised because of the non -specific nature of the assay employed for measuring 
TR (Fuchs, 1988) (Fuchs et al., 1990). Fuchs suggested that such inhibitors are not specific 
for TR. For example, azelaic acid inhibits tyrosinase and several oxidoreductases in vitro 
(Nazzaro -Porro, 1987); p- chloromercuribenzoate can inhibit many thiol mediated enzymatic 
and non -enzymatic reactions; anthralin is a strong reducing agent that may unspecifically 
modulate various enzymes including oxidoreductases (Fuchs et al., 1990). In addition, 
nitroxides are reduced to ESR silent products by a variety of different NADH- or NADPH- 
dependent oxidoreductases in microsomes, mitochondria and plasma membranes (Fuchs, 
1988). 
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Fuchs et al. also criticized the bioassay for TR regarding the fact that the nitroxide spin label 
did in fact penetrate the lipid bilayer of cell membranes, and propose the possibility that for 
different cell types, sites of intracellular reduction must be evaluated carefully. Schallreuter 
et al. had suggested that their radical substrate was selectively reduced by TR at the outer 
surface of the cell (Schallreuter and Wood, 1986). The studies presented in this thesis 
favour the opinion of Fuchs et al. in that the compounds suggested to be inhibitors of TR did 
not inhibit TR activity overall, as measured by the DTNB and insulin assay systems, and 
immunohistochemistry in skin cells did not reveal TR to be localised to membranes, but 
largely to the cytosol. 
A further complication is that Schallreuter and Wood assessed the effect of inhibitor 
compounds on E.Coli TR using the DTNB assay with Trx addition for the majority of their 
studies. E.Coli TR requires Trx to reduce DTNB, but the mammalian enzyme does not. It is 
possible that these inhibitors were inhibiting Trx in the Schallreuter and Wood assay 
systems. Anthralin and 13 -cis retinoic acid inhibited TR activity in human placental cytosol to 
a greater degree when measured by insulin assay than DTNB assay in the studies 
presented here. This further suggests the possibility of Trx inhibition since the insulin assay 
employs Trx in its linked assay system, whereas the DTNB assay system does not. Further 
studies should be carried out to either validate or invalidate these compounds as useful tools 
with which to study TR or Trx. 
Conclusions 
The HaCaT cell line is a suitable model for human keratinocytes in which to study 
selenoproteins and protection against oxidative stress. At sodium selenite concentrations 
required for optimal expression of TR, cyGPX and PHGPX, protection was afforded against 
damage mediated by menadione or UVB irradiation in HaCaT cells. This protection would 
appear to be due to the selenoprotein induction rather than a direct effect of sodium selenite 
since menadione was not directly detoxified by sodium selenite, and the cytotoxic damage 
mediated by menadione was exacerbated by the presence of selenite. Further evidence of 
the importance of the selenoproteins in protection against oxidative stress was provided by 
the observation that inhibition of TR activity alone in HaCaT cells increased their 
susceptibility to damage by menadione. This was not the case for damage by UVB, possibly 
indicating a differing role for TR against different types of oxidative stress, and that 
menadione and UVB differ in their cytotoxic mechanism. 
At concentrations of sodium selenite higher than 100 nM, protection against UVB- mediated 
injury was lost in HaCaT cells. This was not the case with menadione cytotoxic insult, again 
highlighting the possibility of a differing cytotoxic mechanism, and protection mechanism. At 
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the sodium selenite concentrations at which protection was lost, cyGPX activity was seen to 
decrease. Such a decrease in activity was not seen with TR. This implies that the loss of 
protection may be due to the loss of cyGPX activity, and underlines the importance of cyGPX 
in Se- mediated protection against UVB damage. The underlying mechanism of the loss of 
cyGPX activity and loss of protection against UVB did not appear to be due to cytotoxicity of 
the sodium selenite. Negative feedback of the Se metabolite selenide or loss of GSH 
through GSSG formation may account for the loss of activity. 
The dose of Se used for protection against damage by UVB is crucial. This has clinical 
implications for Se supplementation in community, i.e. supplementation with Se decreases 
risk for some cancers but may be ineffective against skin cancer, or even increase the risk. 
From the work presented here, it is not certain that Se supplementation would decrease the 
incidence of skin cancer formation. However, Se supplementation in vitro does protect skin 
cells from damage induced by UVB irradiation. Sodium selenite induces selenoprotein 
expression at lower concentrations than selenomethionine. Selenite also provides protection 
from UVB- mediated damage at lower concentrations than selenomethionine (Rafferty, 2000). 
However, selenite is more toxic than selenomethionine, and doubts have been raised over 
whether it is the most suitable form for dietary Se supplementation (Schrauzer, 2001; 
Whanger, 2002). Se supplementation with selenomethionine may be preferable. 
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CHAPTER FIVE 
THIOREDOXIN REDUCTASE AND CYTOPLASMIC 
GLUTATHIONE PEROXIDASE ACTIVITY IN HUMAN 
FOETAL AND NEONATAL LIVER 
5.1 INTRODUCTION 
The TR /Trx system has been implicated in a number of cellular processes including 
regulation of cell growth, apoptosis and the modification of the activity of transcription factors 
and receptors (Holmgren, 1989; Holmgren and Björnstedt, 1995). Mutant redox- inactive 
forms of Trx are incapable of stimulating cell growth or inhibiting apoptosis suggesting that 
Trx must be reduced to exert its effects on cell growth (Gallegos et al., 1996). TR catalyses 
the NADPH -linked reduction of Trx and treatment of cells with the TR inhibitors doxorubicin 
or diaziquinone leads to an inhibition of ribonucleotide reductase activity, and inhibition of 
cell growth (Mau and Powis, 1992). 
In addition to its growth promoting properties, TR also acts as an antioxidant either directly or 
through the action of Trx. TR can reduce and detoxify lipid hydroperoxides, hydrogen 
peroxide, and organic hydroperoxides directly using NADPH as a cofactor (Björnstedt et al., 
1995). In addition, TR is able to regenerate bioactivity in proteins inactivated by oxidative 
stress (Ejima et al., 1999b; Spector et al., 1988) and can also regenerate ascorbic acid from 
dehyroascorbate (May et al., 1997). 
Regulation of TR expression is through a number of factors including Se supply (Gallegos et 
al., 1997), redox state of the cell (Sun et al., 1999), oxidative stress (Ejima et al., 1999a) and 
also through activation of protein kinase C (PKC) (Anema et al., 1999). Increases in Se 
supply and oxidative stress lead to increased expression of TR (Ejima et al., 1999a; 
Gallegos et al., 1997), whilst activation of PKC may decrease (Anema et al., 1999) or 
increase (Kumar and Holmgren, 1999) the expression of the enzyme. In the newborn 
primate lung oxygen appears to be an important factor in promoting an increased expression 
of the TR/Trx system (Das et al., 1999). The process of childbirth is associated with an 
increase in oxidative stress in the lungs. With the first few postnatal breaths taken, the lung 
undergoes hyperoxia due to an abrupt change from the in utero PO2 of 20 - 25 mm Hg (2.66 
- 3.33 KPascal) to 100 mm Hg (13.3 KPascal) in air breathing (Kim et al., 2001; Robles et 
al., 2001). During hyperoxia there is increased generation of ROS including H202, which can 
react with Fe (II) to form the highly -toxic OH'. 
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The selenoenzyme cytoplasmic glutathione peroxidase (cyGPX) is also considered to exert 
powerful antioxidant function in the cell cytoplasm (Brigelius -Flohé, 1999), and the 
expression of cyGPX can be increased in situations of oxidative stress (Mitchell et al., 1996) 
and when Se supply is increased (Brown et al., 2000). The essential role of Se for 
mammalian development is illustrated by the finding that disruption of the mouse tRNAseC 
gene results in early embryonic lethality (Bösl et al., 1997). 
The association between TR expression, cell growth and oxidative stress has lead us to 
speculate that changes in TR expression may be important in human foetal development. 
The aims of the study in this chapter were:- 
to examine TR concentration and TR activity, and cyGPX activity, in human liver cytosol 
obtained from 7 foetuses (gestational age 16 to 20 weeks) and 5 neonates (aged 1 day 
to 15 weeks) 
to assess any correlations between TR and cyGPX in the hepatic cytosols 
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5.2 MATERIALS AND METHODS 
5.2.1 Liver samples 
Human liver tissue was obtained at autopsy from 7 foetuses (16 -20 weeks gestation), and 6 
term neonates who survived up to between 1 day and 15 weeks postnatally. Post -mortem 
time varied between 1 and 48 h after death. The study was approved by the Paediatric - 
Reproductive Medicine Ethics of Medical Research Sub -Committee of Lothian Health Board 
and the Ethics Committee of Tayside Health Board. Informed written consent was obtained 
from relatives prior to removing tissue. 
5.2.2 Preparation of hepatic cytosols 
Tissue was homogenised on ice, in 3 volumes of HEPES buffer (10 mM; pH 7.4) containing 
2- mercaptoethanol (3 mM) and sucrose (0.25 M), using a glass Potter -Elvehjem 
homogeniser with a motor -driven Teflon pestle. The homogenate was centrifuged at 10,000 
x g for 15 min, and the supernatant centrifuged at 100,000 x g for 1 hr. Aliquots of cytosol 
were snap- frozen on dry ice and stored at - 80 °C. 
Prior to assay for TR activity, cytosols were treated using Centricon -10 concentrator tubes 
(Amicon, MA, USA) to remove mercaptoethanol (which interferes with the TR activity assay). 
Cytosol (200 pl) was dispensed into the concentrator tube, together with 180 pl of assay 
buffer (100 mM potassium phosphate, 50 mM potassium chloride, 10 mM EDTA, 0.2 mg /ml 
BSA; pH 7.0). The concentrator tube was then centrifuged at 5,000 x g for 1 hr. After 
centrifugation, the filtrate was removed and a further 180 pl of buffer was added to the 
sample, and the centrifugation step repeated. At the end of the procedure, all samples were 
made up to a volume of 200 pl using assay buffer. 
523 Measurement of cyGPX activity, TR activity and TR concentration 
cyGPX and TR activity were measured as described in sections 2.3.7 and 2.3.5.1 
respectively. All samples were measured in duplicate. Results were corrected for cytosol 
protein content, measured by the Bradford method (section 2.3.9). The TR concentration 
was measured in hepatic cytosols using the RIA detailed in section 2.3.6. 
5.2.4 Statistical Analysis 
The significance of the differences in TR concentration, TR activity and cyGPX activity 
between foetal and neonatal cytosols was assessed using the students 't' test with Welch 
correction for unpaired data. 
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5.3 RESULTS 
5.3.1 Cytoplasmic glutathione peroxidase (cyGPX) activity , thioredoxin 
reductase (TR) activity and concentration in hepatic cytosols 
The results are shown in Figures 5.01 and 5.02. The activity of TR was significantly greater 
(p < 0.0005) in foetal liver (median 2.05 U/g protein, inter -quartile range 1St to 3`d 1.76 - 2.47 
U/g protein) than in the neonatal liver (0.65, 0.44 - 0.74 U/g protein). Similarly the 
concentration of TR in foetal liver (43.56, 37.92 - 50.80 pg /g protein) was significantly higher 
(p < 0.05) than the concentration found in neonatal liver (11.59, 8.70 - 14.99 pg /g protein). 
The activity of cyGPX activity in the foetal cytosols (199.8 U/g protein ;143.9 - 227.9 U/g 
protein), was significantly greater (p < 0.005) than that found in the neonatal cytosols (77.0 
U/g protein; 58.4 - 110.3). There were strong correlations between cyGPX activity and TR 
concentration (r2 = 0.58 ; p < 0.002) and cyGPX activity and TR activity (r2 = 0.4 ; p < 0.02) 
(Figure 5.03). 
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Figure 5.01 Thioredoxin reductase (TR) concentration (a) and TR activities (b), and 
cytoplasmic glutathione peroxidase (cyGPX) activities (c) of foetal (hatched bars) and 
neonatal (solid bars) hepatic cytosols. TR concentration was measured by 
radioimmunoassay; TR activity was measured by DTNB assay once the samples had been 
treated with Centricon- concentrator tubes to remove mercaptoethanol. Results shown are 
those of duplicate measurements of individual samples. ND = not determined. 
5 -5 




















Figure reductase (TR) concentration and TR activities, and 
cytoplasmic glutathione peroxidase (cyGPX) activities of Foetal (F) and Neonatal (N) 
hepatic cytosols. TR concentration () was measured by radioimmunoassay; TR activity 
() was measured by DTNB assay once the samples had been treated with Centricon- 
concentrator tubes to remove mercaptoethanol; cyGPX activity () was measured using a 
method adapted for use on the Cobas Fara centrifugal analyser. Results shown are those of 
duplicate readings of individual samples. 
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Figure 5.03 Correlation between thioredoxin reductase (TR) activity and cytoplasmic 
glutathione peroxidase (cyGPX) activity, and TR concentration and cyGPX activity in 
foetal and neonatal hepatic cytosols. The correlation of TR activity with cyGPX activity (a) 
gave an R2 value of 0.44 (p < 0.02), and the correlation of TR concentration with cyGPX 
activity (b) an R2 value of 0.58 (p < 0.002). 
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5.4 DISCUSSION 
TR activity and concentration in human foetal liver were found to be approximately 3 -fold 
greater than in neonatal liver, with similar differences observed for hepatic cyGPX activity. 
These findings in the human contrast markedly with results reported in the rat where TR 
activity was found to increase progressively throughout the foetal, newborn and adult stages 
(Demarquoy et al., 1991). However, using immunohistochemistry one study in the rat 
reported that TR and Trx concentrations were higher in foetal and developing cells than adult 
tissue (Hansson et al., 1986). The major enzymes of the glutathione redox cycle tend to 
increase in the liver of rats as the animals develop through the foetal, neonatal and adult 
stages (Asayama et al., 1996; Pallardo et al., 1991). For example, cyGPX activities in 
neonatal and adult rat liver are 2.4 -fold and 13 -fold greater respectively than in the foetus 
(Pallardo et al., 1991). 
In mice the expression of Trx and Grx in the embryo appears to coincide with the stage at 
which the rodent embryos acquire the capacity of aerobic metabolism, suggesting a role in 
antioxidant protection of the embryo (Kobayashi et al., 2000). In the mouse foetus, Trx 
expression in hepatocytes showed positive immunoreactivity for Trx at foetal days 11.5, 13.5 
and 16.5, which decreased in adult mice. In the human foetus, Trx is also expressed more 
intensely than in the adult liver (Fujii et al., 1991). The localisation of Trx in the cell may 
reflect the functional state of the cell, or its phase in the cell cycle. In addition to a protective 
role against ROS, Trx and Grx may be involved in cell proliferation and differentiation in 
various tissues. Their roles may differ in varying tissues. 
We can find no previous reports of TR ontogeny in humans but our results suggest that the 
rat model does not reflect the pattern observed in the human. Similar discrepancies have 
been found between rat and human for the ontogeny of other selenoenzymes in the liver, 
including type I and type III iodothyronine deiodinases (Richard et al., 1998). Furthermore, 
our observations suggest that the changes in selenoenzyme expression seen around birth in 
the rat may not be due to maturation of selenoenzyme expression but rather a physiological 
regulation process that is not yet fully understood. 
We found that cyGPX activity was approximately 3 -fold higher in foetal than neonatal liver. 
Asikaninen et al (Asikainen et al., 1998) have reported that cyGPX expression does not 
change significantly between the foetal and neonatal period in humans. The reasons for the 
discrepancy between our results and those of Asikaninen et al. are unclear, although their 
data for cyGPX activities showed a markedly skewed distribution. 
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Developmental changes in cyGPX expression have been observed in rat lungs where it 
increased after birth, especially when exposed to high oxygen tensions (Clerch and 
Massaro, 1993). Developmental changes in cyGPX have also been demonstrated in rat 
intestine (Tauchi et al., 1991). Two weeks after birth, cyGPX protein became undetectable 
in duodenum and disappeared after weaning in ileum. 
TR has many functions acting alone or in concert with thioredoxin. The TR/Trx system may 
modify cell growth (Gallegos et al., 1996), exhibit oncoprotein -like properties (Koishi et al., 
1997) and promote cell proliferation by increasing cellular resistance to apoptosis (Gallegos 
et al., 1996) (Baker et al., 1997). The association between TR expression and cell growth 
might thus suggest that changes in TR expression may provide a mechanism by which foetal 
and neonatal development is controlled. 
Alternatively, changes in TR expression in the foetus and neonate may be linked to oxidative 
stress, modified redox state of the cell or changes in calcium signalling or Se supply (Das et 
al., 1999; Howie et al., 1998). In baboon lung, TR is expressed constitutively at low levels in 
the foetus, and increases rapidly with the onset of 02 or air breathing at birth (Das et al., 
1999). Similarly the induction of GPX expression is frequently observed in situations where 
there is an increased oxidant stress; for example, thyroidal cyGPX increases in iodine 
deficiency (Brown et al., 2000). Oxygen also induces Mn -SOD, but not Cu /Zn -SOD, in 
neonatal rat lung (Stevens and Autor, 1977), and induces Prx I but not Prx Il (Kim et al., 
2001). Prx I expression is also upregulated by oxygen in the newborn primate lung (Das et 
al., 2001). The situation in the lung may be different to the other organs of the neonate in its 
antioxidant regulation since it is directly exposed to hyperoxic stress. 
It has been suggested that changes in TR activity may be linked to the redox state of the 
cell, with a consequent effect on redox -regulated cell signalling (Sun et al., 1999). These 
workers proposed that intracellular generation of ROS oxidises the selenol group of TR, with 
a consequent decrease in enzymic activity. The resulting oxidation of Trx would then 
modulate Trx- dependent cellular constituents, including transcription factors (e.g. NFKB) and 
antioxidant enzymes (e.g. thioredoxin peroxidase /peroxiredoxin). We have observed that TR 
activity and concentration change in parallel between foetal and neonatal liver suggesting 
that this mechanism does not explain the differences in TR activity between the foetus and 
neonate. 
Whilst TR may act as a growth factor, our observations that activities of both TR and cyGPX 
are higher in the foetus than the neonate could be explained by induction of these 
antioxidant enzymes by oxidative stress in foetal liver. Indeed we found very strong 
correlations between cyGPX activity and TR activity and expression. Although it is possible 
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that the parallel changes in TR and cyGPX may have resulted from changes in Se supply 
after birth this is highly unlikely. One liver was obtained from a 1- day -old neonate and in this 
tissue, TR expression was lower than that found in any of the foetal livers studied. 
Moreover, changes of selenoprotein expression in response to Se supply take weeks rather 
than days to occur. 
In conclusion, we have found that the activities of the antioxidant selenoenzymes TR and 
cyGPX are higher in the foetal than the neonatal liver. We speculate that these differences 
may reflect altered states of oxidative stress during development. 
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CHAPTER SIX CONCLUDING REMARKS 
Atherosclerosis is the leading cause of mortality in the Western world and damage to the 
endothelium by reactive oxygen species (ROS) leads to endothelial dysfunction, favouring 
atherogenesis. Skin damage caused by ultraviolet (UV) irradiation involves ROS and such 
damage is thought to be involved in the pathogenesis of skin cancer. 
The trace element selenium (Se) exerts many of its effects through modifying the expression 
of specific selenoproteins. The glutathione peroxidases (GPX) and thioredoxin reductases 
(TR) are families of selenoproteins that may have antioxidant functions and are found in 
most tissues including the endothelium and the skin. Se supplementation can protect 
against UVB- induced damage in skin cells (Leccia et al., 1993; Moysan et al., 1995; Rafferty 
et al., 1998a; Rafferty et al., 1998b; Richard et al., 1990), and oxidative damage to 
endothelial cells (Miller et al., 2001; Ochi et al., 1992; Thomas et al., 1993). Although the 
underlying mechanisms of protection have not been fully elucidated, it has been proposed 
that the GPXs and possibly TR are important mediators of such protection. The relative 
importance of the individual selenoproteins in a protective role has not been assessed so far 
in the literature to date. 
In this thesis the role of TR and the GPXs in protection of endothelial cells and skin cells 
from oxidative damage was studied. The EAhy926 cell line and HaCaT cell line were used 
as models of human endothelial cells and keratinocytes, respectively, and their suitability as 
such models was assessed. The modification of the expression of TR and the GPXs 
through Se supply and treatment with gold thioglucose formed the main studies to assess 
selenoprotein- mediated protection. Both physiological (oxLDL and UVB) and non - 
physiological (t -BuOOH and menadione) oxidative stress agents were used to investigate 
protection in in vitro endothelial cells and skin cells respectively. 
The work in this thesis has provided evidence to demonstrate the following:- 
1. The [75Se]- selenoprotein profile of EAhy926 cells and HUVEC was similar. The basal 
levels and the induction of the selenoproteins by Se supplementation was similar in 
EAhy926 to HUVEC, suggesting that the EAhy926 cell line is a good model in which to 
study expression and function of these selenoproteins. BAEC differed considerably from 
HUVEC and EAhy926 cells in their selenoprotein expression, suggesting that BAEC are 
an unsuitable model for human EC. 
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2. The ability of sodium selenite to protect against oxidative damage from t -BuOOH or 
oxidised LDL was demonstrated in EAhy926 cells, and is likely to be through the 
modification of selenoprotein expression rather than a direct antioxidant effect. The 
concentrations of sodium selenite which provided protection against cytotoxicity from t- 
BuOOH or oxLDL maximally induced TR and cyGPX in EAhy926 cells. 
3. The gold compound gold thioglucose (GTG) was shown to modify selenoprotein activity, 
with TR being more sensitive to inhibition of activity than either cyGPX or PHGPX in 
cultured cells. The relative importance of TR, cyGPX and PHGPX in the protection of 
cells against oxidative stress was thus investigated. 
4. In EAhy926 cells, significant inhibition of TR activity alone, but not the GPXs, (1 pM GTG) 
rendered the cells more susceptible to oxidative damage from t -BuOOH or oxidised LDL. 
These results suggest that TR is important in protection of endothelial cells from oxidative 
damage resulting from oxidised lipids. Cells treated with GTG at a concentration that 
inhibited the activity of both TR and the GPXs were more susceptible to t -BuOOH toxicity 
(p < 0.05) than cells treated with 1 pM GTG. These data suggest that under normal 
circumstances both TR and the GPXs are involved in the prevention of oxidative damage 
to human EC. 
5. The HaCaT cell line had similar levels of TR activity to primary keratinocytes. HaCaT 
cells are afforded protection against oxidative stress by similar concentrations of Se to 
those in primary keratinocytes. These data suggest that the HaCaT cell line is a suitable 
model in which to study selenoprotein function of keratinocytes. 
6. The ability of sodium selenite to protect against oxidative damage from menadione or 
UVB irradiation was demonstrated in HaCaT cells. This is also likely to be through 
modification of selenoprotein expression. The sodium selenite concentrations that 
maximally induced TR and cyGPX were those which provided protection against damage 
from menadione or UVB. 
7. In HaCaT cells, inhibition of TR activity alone, using 10 pM GTG, rendered the cells more 
susceptible to oxidative damage from menadione, but not to damage from UVB 
irradiation. The results here suggest that TR is more important in protecting 
keratinocytes from menadione- mediated oxidative stress than UVB- mediated stress. 
These results also suggest that the mechanism of cytotoxicity due to menadione 
exposure is different to that caused by UVB irradiation; this may be due to the fact that 
menadione is a substrate for TR1. Menadione may not be a suitable model agent to use 
to represent damage caused by irradiation with UVB. 
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8. Using UVB as the toxic agent, loss of protection was seen with increasing concentrations 
of sodium selenite greater than 100 nM. Loss of protection was associated with a loss of 
cyGPX activity (p < 0.05), but not of TR or PHGPX expression. When menadione was 
used as the oxidative stressor, no loss of protection was demonstrated at the higher 
selenite concentrations. This further highlights a potentially different cytotoxic 
mechanism, and protection mechanism. The loss of cyGPX activity may be due to 
negative feedback of the Se metabolite selenide, or loss of GSH through GSSG 
formation. 
9. Both TR and cyGPX may also have an antioxidant role in the developing foetus. TR 
activity and concentration, and cyGPX activity in human foetal liver were approximately 3- 
fold greater than in neonatal liver. These findings in the human contrast markedly with 
results reported in the rat where TR and cyGPX activities increase through the foetal, to 
the newborn and adult stages. These results show that the rat is not a representative 
model for studying the role of cyGPX and TR in human development. These differences 
in antioxidant enzymes may reflect altered states of oxidative stress during development. 
In conclusion, the activity of the selenoproteins TR, cyGPX and PHGPX, which are present 
in endothelial cells and skin cells, can be modified by Se supplementation and GTG 
treatment. The GPXs and TR are important contributors to the antioxidant defence 
mechanisms of endothelial cells and skin cells, and may have a role in protecting against 
atherogenesis and skin carcinogenesis. The GPXs and TR may be differentially regulated in 
cells, as well as being of differing importance in different cell types, and in protection against 
different types of oxidative stress. These antioxidant enzymes may operate in different 
cellular compartments. 
Further work leading on from the studies presented here could be to investigate which 
components of oxLDL are detoxified by a selenoenzyme- dependent mechanism. 
Impaired endothelium- dependent vasodilation and increased oxidative stress is seen in GPX 
(-I-) knockout mice (Forgione et al., 2002). Development of TR knockout mice would be 
useful to complement data already obtained from cyGPX knockout mice on the role of these 
selenoproteins in protection against endothelial dysfunction. 
Further studies of interest in skin cells would be to establish the mechanism of loss of 
cyGPX at higher sodium selenite concentrations. Investigations of cyGPX protein may be 
useful in ascertaining the mechanism. Studies in mice would be valuable to determine 
whether the loss of cyGPX activity is a mechanism that also occurs in vivo. Although there 
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may be justification for intervention to increase the daily intake of Se in the UK, there should 
be caution since the dosage is crucial for the above reason. 
If an improvement can be made on the sensitivity of the PHGPX assay, the role of this 
selenoenzyme in protection against oxidative stress in skin cells and endothelial cells could 
be studied. Antisense probes, specific antibodies, or specific inhibitors of selenoproteins 
could be used to further investigate the role of individual selenoproteins in protection against 
oxidative stress. In addition, cell lines could be established to over -express TR. 
Work to investigate the subcellular localisation of TR is required to definitively confirm the 
location of TR in skin cells. Subcellular fractionation of [75Se]- labelled primary keratinocytes 
and HaCaT cells would provide data to confirm this. 
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Abstract 
The human endothelial cell line EAhy926 was used to determine the importance of selenium in preventing oxidative damage induced by 
tert -butyl hydroperoxide (tert- BuOOH) or oxidised low density lipoprotein ( LDLox). In cells grown in a low selenium medium, tert -BuOOH 
and LDLox killed cells in a dose -dependent manner. At 555 mg /I LDLox or 300 µM tert- BuOOH, >80% of cells were killed after 20 h. No 
significant cell kill was achieved by these agents if cells were pre- incubated for 48 h with 40 nM sodium selenite, a concentration that 
maximally induced the activities of cytoplasmic glutathione peroxidase (cyGPX; 5.1- fold), phospholipid hydroperoxide glutathione 
peroxidase (PHGPX;1.9 -fold) and thioredoxin reductase (TR; 3.1- fold). Selenium -deficient cells pre -treated with 1 gM gold thioglucose 
(GTG) (a concentration that inhibited 25% of TR activity but had no inhibitory effect on cyGPX or PHGPX activity) were significantly 
(P<0.05) more susceptible to tert -BuOOH toxicity (LC50 110 µM) than selenium -deficient cells (LC50 175 µM). This was also the case for 
LDLox. In contrast, cells pre- treated with 40 nM selenite prior to exposure to GTG were significantly more resistant to damage from tert- 
BuOOH and LDLox than Se- deficient cells. Treatment with GTG or selenite had no significant effect on intracellular total glutathione 
concentrations. These results suggest that selenium supplementation, acting through induction of TR and GPX, has the potential to protect the 
human endothelium from oxidative damage. 
© 2002 Elsevier Science B.V. All rights reserved. 
Keywords: Selenium; Endothelial cell; Thioredoxin reductase; Glutathione peroxidase; Low density lipoprotein; Human; EAhy926 
1. Introduction 
Endothelial cells are continually exposed to a pro- oxidant 
environment in the vasculature, and to the possibility of 
Abbreviations: BAEC, bovine aortic endothelial cells; DMEM, 
Dulbecco's modified Eagle's medium; EBSS, Earle's balanced salt solution; 
EC, endothelial cells; FBS, foetal bovine serum; GSH, glutathione; GTG, 
gold thioglucose; cyGPX, cytoplasmic glutathione peroxidase; HCAEC, 
human coronary artery endothelial cells; HUVEC, human umbilical vein 
endothelial cells; LDH, lactate dehydrogenase; LDLox, oxidised low 
density lipoprotein; PHGPX, phospholipid hydroperoxide glutathione 
peroxidase; Se, selenium; tert- BuOOH, tertiary-butyl hydroperoxide; TR, 
thioredoxin reductase 
* Corresponding author. Tel.: +44- 131 -536 -2702; fax: +44- 131 -536- 
2759. 
E -mail address: G.J.Beckett@ed.ac.uk (G.J. Beckett). 
damage by reactive oxygen species, hydrogen peroxide and 
lipid peroxides, etc. [ 1 -3]. Oxidised low density lipoprotein 
(LDLox) is an important mediator of oxidative damage to the 
endothelium [4 -6], and is directly cytotoxic to human 
endothelial and smooth muscle cells [7 -11 ]. Lipid perox- 
idation of LDL by metal ions or by cells in vitro gives rise to a 
large variety of primary and secondary products from the 
lipid constituents. Some of these products react with the 
lysine groups of apoprotein B, resulting in recognition by 
the scavenger receptor [7]. Other products are cytotoxic [ 11 ]. 
Oxidative damage to the endothelium by LDLox may be 
one of the principal mechanisms in the pathogenesis of 
atherosclerosis [1 -3]. Protection against oxidative damage 
is achieved through numerous enzymatic and non -enzy- 
matic systems [12,13]. It has been suggested that the 
development and progression of atherosclerosis may be 
0167 -4889/02/$ - see front matter © 2002 Elsevier Science B.V. All rights reserved. 
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inhibited by selenium (Se). This essential trace metal exerts 
antioxidant actions through increased expression of sele- 
noenzymes, such as the family of glutathione peroxidases 
(GPX) [14 -17]. More recent evidence has suggested that 
the selenoenzyme thioredoxin reductase (TR; EC 1.6.4.5) 
may be particularly important in providing an antioxidant 
role in the human endothelium [17,18]. 
Studies using cultured animal endothelial cells have 
provided convincing evidence that Se is essential to provide 
maximum protection from oxidative damage. For example, 
bovine aortic endothelial cells (BAEC) in culture are more 
resistant to cytotoxic damage by photo -generated LDLox or 
tert -butyl hydroperoxide (tert- BuOOH), when pre -treated 
with sodium selenite compared with unsupplemented con- 
trols [ 16]. This resistance was ascribed to increased expres- 
sion of cytoplasmic GPX (cyGPX; EC 1.11.1.9) and phos- 
pholipid hydroperoxide GPX (PHGPX; EC 1.11.1.12). The 
involvement of other selenoenzymes, such as TR, in such a 
protective role was not considered. 
TR is a homodimeric selenoenzyme belonging to the 
flavoprotein family of pyridine nucleotide -disulfide oxidor- 
eductases, which include lipoamide dehydrogenase and 
glutathione reductase [19]. Each subunit of TR has a 
selenocysteine residue as the penultimate amino acid residue 
at the carboxyl terminal that is essential for catalytic activity 
of the enzyme [ 19]. Three isoforms of TR have been 
identified in humans, one mitochondrial and two cytoplas- 
mic. They share considerable homology (reviewed in Ref. 
[20]). The predominant isoform of TR is the ubiquitous 
cytoplasmic form, TR1 [20]. TR is a multifunctional sele- 
noprotein that, in conjunction with thioredoxin (Trx) and 
NADPH, forms a powerful dithiol -disulfide oxidoreductase 
system. TRI can reduce and detoxify lipid hydroperoxides, 
hydrogen peroxide, and organic hydroperoxides directly 
using NADPH as a cofactor [19 -21]. In addition, TRl 
restores bioactivity in some enzymes inactivated by oxida- 
tive stress [22]. It can regenerate ascorbic acid from dehyr- 
oascorbate [23]. The TRs may also exert antioxidant action 
through their ability to reduce thioredoxin [19,20]. 
The GPXs have antioxidant function in the cell [24], with 
cyGPX catalysing the reduction of hydrogen peroxide and a 
variety of hydroperoxides [25]. PHGPX is capable of 
catalysing the reduction of phospholipid hydroperoxides 
and cholesterol hydroperoxides, many of which are not 
substrates for cyGPX [26]. TR can detoxify hydrogen 
peroxide and lipid peroxides more efficiently than the GPXs 
under certain conditions [21]. This, together with the high 
expression of TR in human EC [ 17,18], suggests that the 
selenoenzyme may be more efficient than the GPXs in 
defence against oxidative damage. Thus, it is possible that 
decreased expression and activity of these selenoproteins as 
a result of Se deficiency in man, increases the susceptibility 
of the endothelium to oxidative damage by LDLox or other 
lipid hydroperoxides. 
Gold thioglucose (GTG) interacts with Se residues in 
selenoenzymes [27], and thus inhibits their activity. Sele- 
noenzymes show marked variation in their sensitivity to 
inhibition by GTG. The GPXs are relatively resistant to 
inhibition by gold compounds. TR is very sensitive, having 
an IC50 - 1000 -fold lower than that of the GPXs [28]. Gold 
compounds can be administered to animals in specific doses 
that can inhibit TR activity without modifying the activity of 
the GPX [29]. Thus, the use of different concentrations of 
GTG may offer a convenient tool to elucidate the relative 
importance of selenoenzymes in antioxidant defence of 
endothelial cells. 
Sodium selenite pre -treatment affords protection against 
the harmful effects of tert -BuOOH in human endothelial 
cells from different sources [17]. However, no studies in 
human endothelial cells have investigated the possibility 
that Se can protect such cells from the harmful effects of 
LDLox. The human endothelial cell line EAhy926, estab- 
lished by hybridising primary human umbilical vein endo- 
thelial cells (HUVEC) with A549 human lung tumour cells 
[30], has been used in a number of functional studies. 
EAhy926 retain many of the differentiated functions com- 
mon to primary endothelial cells beyond 100 passages. 
These functions include the expression of von Willebrand 
Factor [30], prostacyclin formation [31], and expression of 
endothelin -1 [32]. This cell line is susceptible to damage 
from LDLox [ 10]. We have used this as a model system to 
determine if human endothelial cells can be protected from 
the harmful effects of LDLox by selenite. In addition, we 
have used GTG at selective concentrations that predomi- 
nantly inhibit TR, to examine whether the enzyme plays a 
significant antioxidant role in human endothelial cells. 
2. Materials and methods 
2.1. Chemicals and cell culture reagents 
GTG, sodium selenite, 5,5'- dithiobis(2- nitrobenzoate) 
(DTNB), hydrogen peroxide, hypoxanthine, glutathione, 
aminopterin, thymidine media supplement (HAT), lactate 
dehydrogenase (LDH) assay kit, NADPH, and tert -BuOOH 
were supplied by Sigma Aldrich, Poole, Dorset, UK. 
Dulbecco's modified Eagle's medium (DMEM) with (25 
mM HEPES) and 4500 mg/l glucose, phosphate -buffered 
saline (PBS), Earle's balanced salt solution (EBSS), foetal 
bovine serum (FBS) were supplied by Gibco, Life Tech- 
nologies, Paisley, UK. 
Cell culture plastics were supplied by Iwaki, Japan. 
2.2. Cell culture 
The human endothelial cell line EAhy926, derived from 
umbilical vein endothelial cells, was a kind donation from 
Professor C. -J.S. Edgell, University of North Carolina, 
Chapel Hill, NC, USA. The cell line was maintained in 
high glucose (4.5 g/1) DMEM containing 10% FBS, 5 mM 
hypoxanthine, 0.02 mM aminopterin, and 0.8 mM thymi- 
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dine, in a humidified atmosphere of 5% CO2, 95% air at 37 
°C. The cells were passaged weekly using 0.25% trypsin- 
0.02% EDTA solution. EAhy926 cells displayed the char- 
acteristic morphology of endothelial cells in culture and 
stained positively for von Willebrand Factor. 
The selenium content of the basal medium (without 
FBS), determined by acid digestion followed by fluorimetric 
analysis [33,34], was 0.35 nM and was classified as 'sele- 
nium- deficient medium'. 
2.3. Determination of cellular integrity by measurement of 
LDH retention 
Cell viability was assessed, in 24 -well plates, as the 
percentage retention of LDH by the cell layer after 20 h 
exposure to tert -BuOOH or LDLox. Intracellular LDH activ- 
ity in cells and in the culture medium was determined using a 
kit method (Sigma Diagnostics), modified for use on the 
Cobas Fara centrifugal analyser (Roche Diagnostics, Welwyn 
Garden City, UK). The culture medium (1 ml) was removed 
for analysis, and the cells washed twice with 1 ml EBSS. The 
cells were then lysed in 0.5 ml of 0.5% Triton X -100 (in PBS, 
pH 7.4). After 15 min, the cell lysates were collected and the 
wells were washed with a further 0.5 ml EBSS and the 
washings combined with the respective lysates. Cell debris 
in the culture medium and cell lysates was removed by 
centrifugation at 11,500 x g for 10 min prior to assay. 
The LDH activity was also measured in culture media 
that had not been in contact with cells as a measure of 
endogenous LDH in the culture medium (blank). All results 
were blank- corrected. Results were expressed as percent 
LDH activity retained. 
2.4. Total protein measurement 
The Bradford assay [35] was used to measure total 
protein in the native LDL, oxLDL and cells using BSA as 
the standard. All enzyme activity results were corrected for 
total protein measured using this method. 
2.5. Measurement of TR activity 
TR activity was measured by an optimised method based 
on the method of Hill et al. [36] using DTNB (5 mM) as 
substrate in the presence and absence of 720 nM GTG (final 
concentration). This method was adapted for use on the 
Cobas FARA centrifugal analyser (Roche Diagnostics). All 
samples were measured in duplicate. Results were corrected 
for total protein content and one unit of TR activity was 
defined as 1 µmot of DTNB reduced per minute. 
2.6. Measurement of cytoplasmic GPX, phospholipid GPX 
and total glutathione 
cyGPX activity was measured by monitoring the rate of 
oxidation of NADPH at 340 nm in the presence of H2O2 
87 
(2.2 mM), using a Unicam UVNis spectrometer (UV4) 
linked to a computer installed with `Vision' software [37]. 
All samples were measured in triplicate and results were 
corrected for total protein concentration. PHGPX activity 
was determined using the same assay system as for 
cyGPX, but with phosphatidyl choline hydroperoxide as 
the substrate. Total glutathione was measured according to 
Tietz [38], and adapted for use on a Cobas FARA cen- 
trifugal analyser. All samples were measured in triplicate 
and results corrected for total protein [35]. One unit of 
GPX activity was defined as 1 µcool of NADPH oxidised 
per minute. 
2.7. Preparation of LDLox 
LDL was isolated from 300 to 450 ml of human citrate 
plasma (Blood Transfusion Service, Edinburgh) by ultra - 
centrifugation using a Ti 45 rotor in a Beckman L8.55 
ultracentrifuge (Beckman, Glenrothes, UK). Plasma (45 ml) 
was overlayered with 15 ml of a buffered saline solution (p 
1.019 g/m1) containing EDTA (10 mg/1) and centrifuged for 
18 h at 186,000 x g max at 4 °C. The very low density 
lipoproteins were discarded. The density of the infranatant 
(40 ml) was adjusted to 1.063 g /ml by addition of 14.7 ml of 
buffered saline (p 1.182 g/ml), overlayered with 5.3 ml of 
saline solution (p 1.063 g/ml) and recentrifuged for 18 h at 
186,000 x g. The LDL fraction was removed and trans- 
ferred into 30 cm dialysis tubing (7.5 mm diameter, Spectra/ 
Por, MW cut -off 300,000; Medicel, London) and dialysed 
overnight against 5 1 of PBS @H 7.4, 0.2 g/1 chelex resin). 
The combined dialysates of known protein concentration 
were divided, one part was kept as native LDL (control for 
experiments) and the other was used to prepare LDLox as 
follows. Approximately 25 ml native LDL was oxidised at 
37 °C using CuC12 (Cu- protein ratio 0.16 p.mol/mg pro- 
tein), and the formation of conjugated dienes monitored at 
234 nm. At peak absorbance (usually 60 -90 min after 
initiation), 10% excess EDTA was added to stop lipid 
peroxidation and the volume of the lipoprotein fraction 
was reduced to - 5 -10 ml using a 30,000 MW cut -off 
polyethersulfone filter and an Amicon 52 filtration unit 
(Amicon Millipore, Bedford, MA, USA). Traces of Cue+ 
were then removed by chromatography over a Sephadex 
G25 column (PD -10; Amersham Pharmacia Bio- Technics, 
Uppsala, Sweden) using PBS as the eluant. The tube 
containing LDLox was flushed with a 0.22 lam filtered 
stream of argon, and the LDL stored at 4 °C until required 
(within 2 -3 weeks). Native LDL was treated in an identical 
manner (filtration, chromatography, storage under argon) 
except the fraction was not exposed to Cue +. 
2.8. Statistical analysis 
Comparison of all data was performed using ANOVA 
and the Student's t -test (with Welch correction as appropri- 
ate) for unpaired data. Enzyme activities in Table I were 
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Table 1 
The effect of sodium selenite supplementation on the activity of TR, 




(U /g protein) 
cyGPX activity 
(U /g protein) 
PHGPX activity 
(U /g protein) 
0 2.0 ± 0.5 27.3 ± 1.6 5.7 ± 1.2 
1 3.2 ± 0.14 40.8 ± 3.94 5.4 ± 0.8 
10 5.3 ± 2.6* 115.4 ± 10.24 8.8 ± 2.04 
50 6.1 ± 0.4t 138.5 ± 5.94 11.1 ± 1.14 
100 5.1 ± 0.3* 182.5 ± 26.94 10.5 ± 2.54 
200 4.7 ± 0.3* 166.2 ± 29.44 10.5 ± 1.14 
1000 7.4± 1.11 153.7 ± 13.64 12.6 ± 0.74 
Cells were cultured in 75 -cm2 flasks with selenite for 48 h. All 
measurements are for triplicate flasks, except the controls for which n =4. 
One unit of GPX activity was defined as 1 µmol of NADPH oxidised per 
minute. 
One unit of TR activity was defined as 1 µmol of DTNB reduced per 
minute. 
*P <0.01 cf. control cells (ANOVA with Fisher's test for least sig- 
nificant difference). 
tP <0.05 cf. control cells (ANOVA with Fisher's test for least sig- 
nificant difference). 
tP <0.001 cf. control cells (ANOVA with Fisher's test for least sig- 
nificant difference). 
compared using ANOVA with Fisher's test for least signifi- 
cant difference. 
3. Protocols 
3.1. The ability of selenite to prevent tent -BUOOH and 
LDLox toxicity 
EAhy926 cells were passaged into 24 -well plates at a 
density of 5 x105 cells/cm2 and left to grow in high glucose 
(4.5 g/1) DMEM containing 10% FBS, 5 mM hypoxan- 
thine, 0.02 mM aminopterin, and 0.8 mM thymidine for 
48 h. 
To assess the optimal concentration of sodium selenite 
for protection of EAhy926 cells from tert- BuOOH- mediated 
cytotoxicity, cells were pre- incubated with a range of 
selenite concentrations (0 -1000 nM) for 48 h before being 
washed twice with 1 ml of EBSS. For each experiment, a 
concentration of tert -BuOOH was found that would kill 
approximately 90% of Se- deficient cells and this was 
determined from a pilot experiment that was performed 
while the cells to be used for the main experiment were 
being preincubated with selenite. This concentration varied 
slightly between experiments ranging from approximately 
200 to 300 1.1M tert- BuOOH. Cell damage was produced by 
incubating cells with tert -BuOOH for 20 h. LDH retention 
was measured as described above, all determinations being 
carried out in triplicate wells. 
The ability of EAhy926 cells to resist LDLox toxicity 
in the presence or absence of 40 nM selenite was 
determined as for tert -BUOOH above. Medium containing 
either native or oxidised LDL (prepared from the same 
blood donation, and diluted to a common protein value in 
medium) was added to the cells at the specified concen- 
trations and cells left to incubate for 20 h. LDH activity 
was then measured in the medium and cell lysates as 
described above, and percentage LDH retention calcu- 
lated. All determinations were carried out in triplicate 
wells. 
3.2. Induction of TR, cyGPX, and PHGPX activities in 
EAhy926 cells by selenite 
EAhy926 cells were passaged into 75 -cm2 flasks and 
grown to 70% confluence. The cells then received medium 
containing 0, 1, 10, 40, 50, 100, 200 or 1000 nM sodium 
selenite (triplicate flasks for each selenite concentration, 
and quadruplicate flasks for the control) for 48 h. Follow- 
ing this incubation, the cells were washed twice with 10 
ml EBSS, and harvested by scraping into 20 ml EBSS. 
Efficiency of harvesting was determined by light micro- 
scopy. The cells were then pelleted by centrifugation at 
500 x g for 10 min. The EBSS was aspirated, and the 
pellets frozen at - 70 °C until enzyme assays were carried 
out. Prior to enzyme activity determinations, the cell 
pellets were thawed and lysed by sonication (three pulses 
of 10 s using a Soniprep 150) on ice in 0.125 M potassium 
phosphate buffer (pH 7.4) containing 1 mM EDTA and 
0.1% Triton X -100 (peroxide- and carbonyl -free). The 
activities of the selenoenzymes were then determined as 
detailed above. 
3.3. Optimisation of the GTG concentration 
EAhy926 cells were passaged into 75 -cm2 flasks and 
grown to 70% confluence. The cells then received medium 
containing 0, 1, 10, or 100 µM GTG (triplicate flasks for 
each GTG concentration, and quadruplicate flasks for the 
control) for 48 h. Following the incubation, the cells were 
washed twice with 10 ml EBSS, and harvested via scrap- 
ing into 20 ml EBSS. Efficiency of harvesting was 
checked by light microscopy. The cells were then pelleted 
by centrifugation at 500 x g for 10 min. The EBSS was 
aspirated, and the pellets frozen at - 70 °C until enzyme 
assays were carried out. Prior to enzyme activity determi- 
nations, the cell pellets were thawed, lysed and the 
activities of the selenoenzymes were then determined as 
described above. 
3.4. tert - BuOOH and LDLox toxicity in the presence of 
GTG 
EAhy926 cells were passaged into 24 -well plates in 
either normal medium or medium containing 40 nM selen- 
ite, and incubated for 48 h. After this time, the cells were 
washed twice with 1 ml EBSS. Cells then received normal 
unsupplemented medium, or the same medium containing 
either 1 or 10 µM GTG for 48 h. When the incubation was 
M.H. Lewin et al. / Biochimica et Biophysica Acta 1593 (2002) 85 -92 
finished, the cells were again washed, and fresh medium 
containing tert -BuOOH (0 -250 µM) added for a 20h 
incubation. LDH retention was then measured as described 
above. All determinations were carried out in triplicate 
wells. 
The effect of 1µM GTG on modifying the susceptibility 
of EAhy926 cells to LDLox was carried out in an identical 
manner to that described above using an LDLox protein 
concentration of 220 mg/l. 
4. Results 
4.1. Effect of selenite on tert -BuOOH and LDLox- induced 
cell damage 
Pre -incubation of EAhy926 cells with sodium selenite for 
48 h showed that selenite provided optimal protection from 
the cytotoxic effects of 300 µM tert -BuOOH at concen- 
trations ranging from 10 to 50 nM (P <0.0005, Fig. 1). 
Selenite when added at a concentration of 1000 nM was 
significantly toxic to EAhy926 cells in the absence of tert- 
BuOOH (P <0.05). 
There was a concentration- dependent cytotoxicity of 
LDLox (Fig. 2). Native LDL was not cytotoxic to EAhy926 
cells at any of the concentrations tested. In the presence of 
555 mg/1 LDLox, only 19.8 ± 1.8% of cells survived in the 
absence of selenite. In contrast, 92.7 ± 0.4% of cells pre - 








exposed to (555 mg/1) LDLox (P<0.0005). This concen- 
tration of 40 nM selenite was chosen as this was the lowest 
concentration of selenite that gave optimal protection from 
tert -BuOOH (Fig. 1). 
4.2. Effect of selenite on GPX and TR activity 
Incubation of EAhy926 cells with 50 nM sodium selenite 
resulted in maximal expression of TR and PHGPX while 
maximal expression of cyGPX was achieved at a selenite 
concentration of 100 nM. Significant induction of cyGPX 
(P< 0.05), and TR (P< 0.01) was first achieved with a 
concentration of 1 nM selenite, and for PHGPX (P< 0.05) 
with 10 nM selenite (Table 1). 
4.3. Effect of GTG on GPX and TR activity 
At a concentration of 1 µM GTG, 75 ± 7.0% of TR 
activity was retained (P< 0.05 cf. control cells). There was 
no significant loss of cyGPX or PHGPX activity (Table 2). 
Using 10 .tM GTG, 15 ± 10% of TR activity, 40 ± 4% of 
cyGPX, and 65 ± 3% of PHGPX activity were retained 
compared to control cells (P< 0.01, P< 0.05, and P <0.005, 
respectively). When GTG was added at a concentration of 
100 µM, marked inhibition of all selenoenzymes was 
observed such that 0.5 ± 0.5 %, 15.0 ± 1.6 %, and 54 ± 7% 
of enzyme activities were retained for TR, cyGPX and 
PHGPX, respectively (P< 0.0005, <0.0005, and <0.01 cf. 
control cells). 
F , 
0 1 10 50 200 1000 
Selenite (nM) 
Fig. 1. Cytoprotection of EAhy926 cells from tert -BuOOH by sodium selenite pre- incubation. Pre -incubations with sodium selenite were for 48 h, prior to 
exposure to 0 µM tert -BuOOH (0) or 300 µM tert -BuOOH (0) for 20 h. Cytotoxicity was determined by LDL retention ( %). All determinations are 
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Fig. 2. Cytoprotection of EAhy926 cells from LDLox by preincubation with (40 nM) selenite. Cells were pre- incubated with sodium selenite (40 nM) for 48 h. 
Exposure of selenium -supplemented cells (closed symbols) or selenium -deficient cells (open symbols) to native LDL (squares) or LDLox (circles) was for 24 h. 
Cytotoxicity was determined by LDH retention. Results shown are means of triplicate wells ± S.E. *P< 0.0005 cf. LDLox, cells plus Se (t -test for unpaired data). 
4.4. Effect of GTG and /or selenite on oxidative cell damage 
The LC50 for tert -BuOOH for Se- deficient cells was 175 
M. The same cells treated with either 1 or 10 ttM GTG 
showed an increase in susceptibility to tert -BuOOH toxicity 
(LC50 =110 and 75 .tM, respectively). Cells pre -treated with 
40 nM selenite were more resistant to cytotoxic damage by 
Table 2 
The effect of gold thioglucose on the activity of TR, cyGPX, and PHGPX 





(U /g protein) 
cyGPX activity 
(U /g protein) 
PHGPX activity 
(U /g protein) 
0 1.6 ±0.1 (n =7) 39.2 ±3.0 (n =4) 5.5 ±0.4 (n =4) 
1 1.2 ±0.1 (n =6)* 39.6 ±2.0 (n =3) 5.4 ±0.3 (n =3) 
10 0.2 ±0.1 (n =6)t 15.6± 1.5 (n =3) ** 3.6 ±0.2 (n =3)* 
100 0.01 ±0.01 (n =6)t 5.9 ±0.6 (n =3)t 3.0 ±0.4 (n =3)t 
Results are activity determinations in duplicate from a minimum of trip- 
licate 75 -cm2 flasks incubated for 48 h. 
One unit of GPX activity was defined as 1 µmol of NADPH oxidised per 
minute. 
One unit of TR activity was defined as 1 µmol of DTNB reduced per 
minute. 
*P< 0.05 cf. control cells (t -test for unpaired data, with Welch 
correction). 
* *P <0.005 cf. control cells (t -test for unpaired data, with Welch 
correction). 
P< 0.01 cf. control cells (t -test for unpaired data, with Welch 
correction). 
1P< 0.0005 cf. control cells (t -test for unpaired data, with Welch 
correction). 
tert -BuOOH in the presence of 1 p.M GTG than the 
corresponding cells pre- treated with 1 p.M GTG alone 
(LC50 195 cf. 110 ltM P <0.05), or Se- deficient cells 
(Fig.3). 
A similar pattern of results was found using LDLox as 
the cytotoxic agent (Table 3). Cells treated with 1 GTG 
were more susceptible to LDLox toxicity than Se- deficient 
cells, while preincubation with 40 nM selenite prevented 
LDL toxicity in cells treated with GTG. 
Pretreatment with selenite (40 nM) or GTG (1 µM) had 
no significant effect on total glutathione concentrations in 
the cells (data not shown). 
Table 3 
Cytotoxicity (% LDL retention) of LDLox on EAhy926 cells pre- incubated 
with GTG and selenite 
Control LDLox (220 mg/l) 
LDH retention ( %) LDH retention ( %) 
No pretreatment 100 ± 0.1 70 ± 2.5* 
GTG (1 1 M) 99 ± 0.8 60 ± 5.1* 
GTG (1 µM), 
selenite (40 nM) 
99 ± 0.4 99 ± 1.0 
Selenite (40 nM) 98 ± 1.7 99 ± 1.6 
The sodium selenite pre- incubation was for 48 h at a concentration of 40 
nM. GTG pre- incubation was with I µM for 48 h. The cytoxicity of LDLox 
was tested at 220 mg protein per liter. 
Results are mean ± S.E. determinations from triplicate wells. 
Cells treated with GTG alone had significantly (P< 0.05) more cell death 
than cells not treated with GTG or selenite. 
* Significant (P <0.05) differences from control cells. 
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5. Discussion 
The endothelial cell line EAhy926 [30], has been used 
for a number of studies of endothelial function [8 -10]. The 
activities of TR and the GPXs that we have found in these 
EAhy926 cells (Table 1) are similar to values we have 
reported in primary cultures of human endothelial cells [ 17]. 
Furthermore, the sensitivity of EAhy926 cells to tert- 
BuOOH (Fig. 1) and the concentrations of selenite that 
confer optimal protection from tert -BuOOH toxicity (Fig. 1) 
are also similar to previous results using HUVEC and 
human coronary artery endothelial cells (HCAEC) [17]. 
These data taken together indicate that the EAhy926 cell 
line provides an ideal and convenient model to study the 
role of Se in preventing oxidative damage to human 
endothelial cells. 
As in HUVEC and HCAEC, oxidative damage to 
EAhy926 cells by tert -BuOOH can be prevented by pre - 
incubation with low nanomolar concentrations of selenite 
(Fig. 1) [ 17]. Protection was accompanied by significantly 
increased TR, cyGPX and PHGPX expression, which was 
optimal with a selenite concentration of approximately 50 
nM (Table I). While tert -BuOOH is widely used as a model 
agent to induce oxidative stress, in vitro, LDLox is consid- 
ered to be the principal agent that damages the endothelium 
and promotes atherogenesis. LDLox has also been shown to 
damage EAhy926 cells in culture [8]. Supplementation of 
cells with 40 nM selenite provides protection from oxidative 







with (1 µM) GTG (a concentration that inhibited TR, but not 
the GPXs), were more susceptible to toxicity from both tert- 
BuOOH and LDLox than cells not exposed to this com- 
pound (Fig. 3, Table 3). These data suggest that TR plays an 
important role in preventing damage to human endothelial 
cells from oxidised lipids. Although unlikely, these data 
cannot exclude the possibility that GTG has inhibited 
another, as yet, unidentified selenoenzyme with an antiox- 
idant role. Cells treated with GTG at a concentration that 
inhibited both TR and the GPXs (10 .tM) were more 
susceptible to tert -BuOOH toxicity than cells in which only 
TR was inhibited. This suggests that under normal circum- 
stances, both TR and the GPXs are involved in the pre- 
vention of oxidative damage to human endothelial cells. 
These multiple enzyme systems could act in different 
cellular compartments. While glutathione is important in 
preventing LDLox- induced damage [ 13], the doses of Se 
and GTG used in our experiments produced no significant 
modification to intracellular glutathione concentrations. 
Gold compounds are also administered to humans for the 
treatment of rheumatoid arthritis, although the mechanism 
by which these compounds produce a therapeutic effect is 
unknown. Reglinski et al. [39] have shown that such treat- 
ment increases `oxidative stress'. Our data shows that GTG 
increases the susceptibility of Se- deficient endothelial cells 
to oxidative damage and that this damage may be prevented 
by pre -treatment with selenite at doses that maximally 
induce the expression of the GPXs and TR (Fig. 3, Table 
3). Countries, such as the United Kingdom, have a Se intake 
50 100 150 
tert-BuOOH (NM) 
_ o ,-ço. 
200 250 
Fig. 3. Cytotoxicity profile of tert -BuOOH to EAhy926 cells pre- incubated with various combinations of GTG and selenite. (D) Selenite (40 nM) GTG 
(1 µM), (Q) No additions, (0) GTG (1 µM), (U) GTG (10 µM). Sodium selenite pre- incubation was for 48 h at a concentration of 40 nM. GTG pre - 
incubations were for 48 h. Results are mean ± S.E. determinations from triplicate wells. Significant (P<0.05) differences from control cells are shown by ( *). 
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that is insufficient to maximally induce selenoenzyme 
expression [40]. It could thus be argued that in such 
populations, GTG treatment may lead to damage to the 
endothelium. If this were the case, such patients may benefit 
from selenium supplementation prior to treatment with 
GTG. However, if the efficacious effects of GTG on 
rheumatoid arthritis required the production of oxidative 
stress, it is possible that Se supplementation may prevent the 
therapeutic action of GTG. Clinical trials would be required 
to determine the potential benefits of Se supplementation 
prior to GTG treatment. 
Finally, our observations support the view that a low Se 
status would promote endothelial injury and atherosclerosis 
initiated by LDLox in humans [41 -43]. There are no reports 
to our knowledge that show in vivo how the Se content of 
the endothelium responds to Se supplementation. However, 
our results suggest that selenium supplementation at doses 
which optimise the expression of the TR and the GPXs may 
have significant beneficial effects when applied to popula- 
tions that have an Se intake below that currently recom- 
mended. Properly conducted controlled trials of selenium 
supplementation are urgently required. 
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Abstract 
Cytosolic thioredoxin reductase (TR) is an FAD -containing homodimeric selenoenzyme which, together with thioredoxin (Trx) and 
NADPH, forms a powerful oxidoreductase system. Cytoplasmic glutathione peroxidase (GPX -1) is a selenoprotein with antioxidant 
activity. The TR/Trx system has been associated with cellular processes including regulation of cell growth, and modification of activity of 
transcription factors. TR may also act as an antioxidant. We have measured TR activity, TR concentration, and GPX -1 activity in human 
hepatic cytosols from foetuses and neonates. The concentration of TR was significantly greater (P < 0.05) in foetal (43.6, 37.9 -50.8 µg/g 
protein, median, interquartile range) than in neonatal liver (11.6, 8.70 -15.0 µg/g). This was also true of TR activity which was 2.1, 1.8- 
2.5 U/g protein in foetal, and 0.65, 0.44-0.74 U/g protein in neonatal liver (P < 0.0005). Similarly, GPX -1 activity was significantly higher 
(P < 0.005) in the foetal (199.7, 144.0 -227.9 U/g protein) than in neonatal (77.0, 58.4 -110.3 U/g protein) hepatic cytosol. Overall, foetal liver 
expressed approx. 3 -fold higher activities of TR and GPX -1 than neonatal liver. © 2001 Elsevier Science B.V. All rights reserved. 
Keywords: Hepatic; Thioredoxin reductase; Antioxidant; Fetal; Neonatal; Measurement 
1. Introduction 
Thioredoxin reductase (TR) is a homodimeric selenoen- 
zyme belonging to the flavoprotein family of pyridine nu- 
cleotide- disulphide oxidoreductases that include lipoamide 
dehydrogenase and glutathione reductase. Each subunit of 
TR has a selenocysteine residue as the penultimate amino 
acid residue at the carboxyl terminus that is essential for 
catalytic activity of the enzyme [1]. Three isoforms of TR 
have been identified in humans, one mitochondrial [2] and 
two cytoplasmic [3], and they share considerable homol- 
ogy. The predominant isoform of TR quantitatively is the 
ubiquitous cytoplasmic form, TR 1 [3]. 
TR is a multifunctional selenoprotein that, with thiore- 
doxin (Trx) as a substrate and NADPH as a cofactor, 
forms a powerful dithiol- disulphide oxidoreductase sys- 
tem. The TR/Trx system has been implicated with a num- 
ber of cellular processes including regulation of cell 
* Corresponding author. Fax: +44- 131 -536 -2759; 
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growth, apoptosis and the modification of the activity of 
transcription factors and receptors [4]. Mutant redox -in- 
active forms of Trx are incapable of stimulating cell 
growth or inhibiting apoptosis suggesting that Trx must 
be reduced to exert its effects on cell growth [5]. TR cat- 
alyses the NADPH -linked reduction of Trx and treatment 
of cells with the TR inhibitors doxorubicin or diaziqui- 
none leads to an inhibition of ribonucleotide reductase 
activity, and inhibition of cell growth [6]. 
In addition to its growth promoting properties, TR also 
acts as an antioxidant either directly or through the action 
of thioredoxin. TR can reduce and detoxify lipid hydro - 
peroxides, hydrogen peroxide, and organic hydroperoxides 
directly using NADPH as a cofactor [7]. In addition, TR is 
able to regenerate bioactivity in proteins inactivated by 
oxidative stress [8,9] and can also regenerate ascorbic 
acid from dehydroascorbate [10]. 
The expression of TR appears to be regulated through a 
number of factors including Se supply [11], redox state of 
the cell [3], oxidative stress [12] and also through activa- 
tion of protein kinase C (PKC) [13]. Increases in Se supply 
and oxidative stress lead to increased expression of TR 
0304-4165/01/$ - see front matter © 2001 Elsevier Science B.V. All rights reserved. 
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[10,12], whilst activation of PKC decreases the expression 
of the enzyme [13]. In the newborn primate lung oxygen 
appears to be an important factor in promoting an in- 
creased expression of the TR/Trx system [14]. 
The selenoenzyme glutathione peroxidase (GPX) is also 
considered to exert powerful antioxidant function in the 
cell cytoplasm [15], and the expression of GPX can be 
increased in situations of oxidative stress [16] and when 
selenium supply is increased [17]. 
The association between TR expression, cell growth and 
oxidative stress has led us to speculate that changes in TR 
expression may be important in human foetal develop- 
ment. If this were the case, it is also of relevance that in 
the UK and other countries the intake of selenium may be 
insufficient to sustain optimal expression of TR and other 
selenoenzymes [18]. 
In the present study we have examined TR concentra- 
tion and TR activity, and GPX -1 activity, in human liver 
cytosol obtained from seven foetuses (gestational age 16- 
20 weeks) and five neonates (aged 1 day -15 weeks). 
2. Materials and methods 
2.1. Chemicals 
All reagents were from Sigma (Dorset, UK). 
2.2. Liver samples 
Human liver tissue was obtained at autopsy from seven 
foetuses (16-20 week gestation), and six term neonates 
who survived up to between 1 day and 15 weeks postna- 
tally. Postmortem time varied between 1 and 48 h after 
death. The study was approved by the Paediatric- Repro- 
ductive Medicine Ethics of Medical Research Sub -Com- 
mittee of Lothian Health Board and the Ethics Committee 
of Tayside Health Board. Informed written consent was 
obtained from relatives prior to removing tissue. 
2.3. Preparation of hepatic cytosols 
Homogenisation of the tissue took place on ice, in 3 vols. 
of HEPES buffer (10 mM) (pH 7.4) containing 2- mercap- 
toethanol (3 mM) and sucrose (0.25 M), using a glass 
Potter -Elvehjem homogeniser with a motor -driven Teflon 
pestle. The homogenate was centrifuged at 10 000 x g for 
15 min, and the supernatant centrifuged at 100 000 X g for 
1 h. Aliquots of cytosol were snap- frozen on dry ice and 
stored at -80 °C. 
Prior to assay for TR activity, cytosols were treated 
using Centricon -10 concentrator tubes (Amicon, MA, 
USA) to remove mercaptoethanol (which interferes with 
the TR activity assay). Cytosol (200 µl) was dispensed into 
the concentrator tube, together with 180 pl of assay buffer 
(100 mM potassium phosphate, 50 mM potassium chlo- 
ride, 10 mM EDTA, 0.2 mg/ml BSA; pH 7.0). The con- 
centrator tube was then centrifuged at 5000 X g for 1 h. 
After centrifugation, the filtrate was removed and a fur- 
ther 180 pl of buffer was added to the sample, and the 
centrifugation step repeated. At the end of the procedure, 
all samples were made up to a volume of 200 pl using 
assay buffer. 
2.4. Measurement of TR activity 
TR activity was measured by the method of Hill et al. 
using DTNB (5,5'- dithiobis(2- nitrobenzoate)) as substrate 
in the presence and absence of 20 I.LM gold thioglucose 
[19], adapted for use on the Cobas FARA centrifugal an- 
alyser (Roche Diagnostics, Welwyn Garden City, UK). All 
samples were measured in duplicate. Results were cor- 
rected for cytosol protein content, measured by the Brad- 
ford assay method [20] with BSA as standard. 
2.5. Measurement of cytoplasmic GPX activity 
GPX -1 activity was measured by the method of Paglia 
and Valentine [21], adapted for use on a Cobas FARA 
centrifugal analyser. All samples were measured in dupli- 
cate. Results were corrected for protein measured by the 
Bradford assay system. 
2.6. Radioimmunoassay (RIA) of TR1 
An in -house double- antibody RIA was used to measure 
TR1 concentration in hepatic cytosols. Human TR1 was 
purified from human placental cytosol as described by 
Holmgren and Björnstedt [22] and this was used to pre- 
pare standards, tracer and act as an immunogen to raise 
antiserum in rabbits. The tracer was 125I- labelled human 
placental TR1 prepared using Bolton- Hunter reagent ac- 
cording to the manufacturer's instructions (Amersham, 
Bucks, UK). 
For the assay 100 pl of tracer (approx. 15 000 cpm) was 
pipetted with 100 µl standard or sample. Anti -TR1 anti- 
body (100 µ1; initial dilution 1/30 000) was then added to 
all tubes which were incubated at 4 °C overnight. The fol- 
lowing day, pre -precipitated second antibody (donkey 
anti -rabbit serum) prepared as described previously [23] 
was added to each tube and incubated at room temper- 
ature with shaking for 1 h. After this second incubation 
step, 1.5 ml wash solution (0.05% v/v Brij 35 and 0.001% 
w/v microcrystalline cellulose) was added and the tubes 
centrifuged at 3000 X g for 30 min. The supernatants 
were then removed by decanting and the radioactivity in 
the pellet counted on a 1261 Multigamma Gamma Coun- 
ter (Wallac, Gaithersburg, MD, USA). The standard curve 
was plotted and results interpolated using a multicalc data 
processing package (Wallac). 
Results were corrected for protein measured by the 
Bradford method [20]. All samples and standards were 
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assayed in duplicate. The intra -assay precision of the TR 
radioimmunoassay was < 10% coefficient variation over 
the range of concentrations measured. 
2.7. Statistical analysis 
The significance of the differences in TR concentration, 
TR activity and GPX -1 activity between foetal and neo- 
natal cytosols was tested using the t -test with Welch cor- 
rection for unpaired data. 
3. Results 
3.1. Thioredoxin reductase activity and concentration in 
hepatic cytosols 
The results are shown in Fig. 1 and Table 1. The median 
and interquartile (1st to 3rd) range of activity of TR was 
significantly greater (P < 0.0005) in foetal liver (2.05, 1.76- 
2.47 U/g protein) than in the neonatal liver (0.65, 0.44- 
0.74 U/g protein). Similarly the concentration of TR in 
foetal liver (43.56, 37.92 -50.80 .tg/g protein) was signifi- 
cantly higher (P < 0.05) than the concentration found in 
neonatal liver (11.59, 8.70 -14.99 tg/g protein). 
3.2. Cytoplasmic glutathione peroxidase activity in hepatic 
cytosols 
The median and interquartile (1st to 3rd) range of GPX - 
1 activity in the foetal cytosols was 199.8 U/g protein 
(143.9- 227.9), which was significantly greater (P < 0.005) 
than that found in the neonatal cytosols, 77.0 U/g protein 
(58.4 -110.3) (Table 1). 
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Fig. 1. Thioredoxin reductase concentration and activities, and cytoplas- 
mic glutathione peroxidase activities of foetal and neonatal hepatic cyto- 
sols. TR concentration (), TR activity (), and GPX -1 activity () of 
foetal (F) and neonatal (N) cytosols are expressed as median values. 
and TR concentration (r2 = 0.58; P < 0.002) and GPX -1 
activity and TR activity 02=0.4; P < 0.02). 
4. Discussion 
We found that TR activity and concentration in human 
foetal liver are approx. 3 -fold greater than in neonatal 
liver, with similar differences observed for hepatic cyto- 
plasmic GPX activity. 
These findings in the human contrast markedly with 
results reported in the rat where TR activity was found 
to increase progressively throughout the foetal, newborn 
and adult stages [24]. However, using immunohistochem - 
istry one study in the rat reported that TR and Trx con- 
centrations were higher in foetal and developing cells than 
in adult tissue [25]. The major enzymes of the glutathione 
redox cycle tend to increase in the liver of rats as the 
Table 1 
TR concentration and TR activities, and cytoplasmic GPX activities of foetal and neonatal hepatic cytosols 
Gestational/postnatal age (weeks) TR concentration (Itg/g protein) TR activity (U /g protein) GPX -I activity (U /g protein) 
Foetal 
17/52 43.6 3.2 168.1 
20/52 52.5 1.7 199.8 
16/52 49.1 1.7 109.0 
20/52 30.4 2.1 119.8 
Unknown 38.1 2.1 247.7 
16/52 105.3 1.8 250.0 
16/52 37.8 2.8 208.1 
Median (interquartile range) 43.6 (37.9 -50.8) 2.1 (1.8 -2.5) 199.7 (144.0- 227.9) 
Neonatal 
40/52 +9 8.7 0.57 49.0 
28/52 +1 day 14.5 0.39 92.5 
40/52 +13 19.5 0.74 116.2 
40/52 +13 15.2 ND 61.5 
40/52 +15 8.7 1.13 121.9 
40/52 +5 8.5 0.73 57.3 
Median (interquartile range) 11.6/ (8.7 -15.0) 0.65/ (0.44-0.74) 77.0/ (58.4-110.3) 
ND, not detectable. 
/P > 0.05 significant difference from foetal values (unpaired t -test with Welch correction). 
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animals develop through the foetal, neonatal and adult 
stages [26,27]. For example, GPX -1 activities in neonatal 
and adult rat liver are 2.4 -fold and 13 -fold greater respec- 
tively than in the foetus [26]. 
We can find no previous reports of TR ontogeny in 
humans but our results suggest that the rat model does 
not reflect the pattern observed in the human. Similar 
discrepancies have been found between rat and human 
for the ontogeny of other selenoenzymes in the liver, in- 
cluding type I and type III iodothyronine deiodinases [28]. 
Furthermore our observations suggest that the changes in 
selenoenzyme expression seen around birth in the rat may 
not be due to maturation of selenoenzyme expression but 
rather a physiological regulation process that is not yet 
fully understood. 
We found that GPX -1 activity was approx. 3 -fold high- 
er in foetal than in neonatal liver. Asikaninen et al. [29] 
have reported that GPX -1 expression does not change 
significantly between the foetal and neonatal period in 
humans. The reasons for the discrepancy between our re- 
sults and those of Asikaninen et al. are unclear, although 
their data for GPX -1 activities showed a markedly skewed 
distribution. 
TR has many functions acting alone or in concert with 
thioredoxin. The TR/Trx system may modify cell growth 
[5], exhibit oncoprotein -like properties [30] and promote 
cell proliferation by increasing cellular resistance to apo- 
ptosis [5,31]. The association between TR expression and 
cell growth might thus suggest that changes in TR expres- 
sion may provide a mechanism by which foetal and neo- 
natal development is controlled. 
Alternatively, changes in TR expression in the foetus 
and neonate may be linked to oxidative stress, modified 
redox state of the cell or changes in calcium signalling or 
selenium supply [14,32]. In baboon lung, TR is expressed 
constitutively at low levels in the foetus, and increases 
rapidly with the onset of 02 or air breathing at birth 
[15]. Similarly the induction of GPX expression is fre- 
quently observed in situations where there is an increased 
oxidant stress; for example, thyroidal GPX -1 increases in 
iodine deficiency [17]. It has been suggested that changes 
in TR activity may be linked to the redox state of the cell, 
with a consequent effect on redox -regulated cell signalling 
[3]. These workers proposed that intracellular generation 
of reactive oxygen species oxidises the selenol group of 
TR, with a consequent decrease in enzymic activity. The 
resulting oxidation of Trx would then modulate Trx -de- 
pendent cellular constituents, including transcription fac- 
tors (e.g. nuclear factor xB) and antioxidant enzymes (e.g. 
thioredoxin peroxidase). We have observed that TR activ- 
ity and concentration change in parallel between foetal 
and neonatal liver, suggesting that this mechanism does 
not explain the differences in TR activity between the foe- 
tus and neonate. 
Whilst TR may act as a growth factor, our observations 
that activities of both TR and GPX -1 are higher in the 
foetus than in the neonate could be explained by induction 
of these antioxidant enzymes by oxidative stress in foetal 
liver. Indeed we found very strong correlations between 
GPX -1 activity and TR activity and expression. Although 
it is possible that the parallel changes in TR and GPX -1 
may have resulted from changes in selenium supply after 
birth this is highly unlikely. One liver was obtained from a 
1- day -old neonate and in this tissue, TR expression was 
lower than that found in any of the foetal livers studied. 
Moreover, changes of selenoprotein expression in response 
to Se supply take weeks rather than days to occur. 
In conclusion, we have found that the activities of the 
antioxidant selenoenzymes TR and GPX -1 are higher in 
the foetal than in the neonatal liver. We speculate that 
these differences may reflect altered states of oxidative 
stress during development. 
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Abstract 
Selenium (Se) can protect endothelial cells (EC) from oxidative damage by altering the expression of selenoproteins with antioxidant 
function such as cytoplasmic glutathione peroxidase (cyGPX), phospholipid hydroperoxide glutathione peroxidase (PHGPX) and thioredoxin 
reductase (TR). If the role of Se on EC function is to be studied, it is essential that a model system be chosen which reflects selenoprotein 
expression in human EC derived from vessels prone to developing atheroma. We have used [75Se]- selenite labelling and selenoenzyme 
measurements to compare the selenoproteins expressed by cultures of EC isolated from different human vasculature with EC isolated from 
bovine and porcine aorta. Only small differences were observed in selenoprotein expression and activity in EC originating from human 
coronary artery, human umbilical vein (HUVEC), human umbilical artery and the human EC line EAhy926. The selenoprotein profile in 
HUVEC was consistent over eight passages and HUVEC isolated from four cords also showed little variability. In contrast, EC isolated from 
pig and bovine aorta showed marked differences in selenoprotein expression when compared to human cells. This study firmly establishes the 
suitability and consistency of using HUVEC (and possibly the human cell line EAhy926) as a model to study the effects of Se on EC function 
in relation to atheroma development in the coronary artery. Bovine or porcine EC appear to be an inappropriate model. 
© 2002 Elsevier Science B.V. All rights reserved. 
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1. Introduction 
The intake of selenium (Se) can to be inversely correlated 
with the incidence of atherosclerosis and coronary heart 
disease [1,2]. Oxidative damage to the endothelium is 
thought to be a primary event in the pathogenesis of 
atherosclerosis and Se, added as selenite, can protect the 
EC from such damage by altering the expression of specific 
selenoproteins [3,4]. The intracellular selenoproteins iden- 
tified to date as having a potential antioxidant function 
include cytoplasmic glutathione peroxidase (cyGPX), phos- 
pholipid hydroperoxide glutathione peroxidase (PHGPX) 
and isoenzymes of thioredoxin reductase (TR). 
Labelling cells with [75Se]- selenite provides a sensitive 
method for assessing the expression of selenoproteins. Since 
Corresponding author. Tel.: +44- 131 -536 -2702; fax: +44- 131 -536- 
2758. 
E -mail address: G.J.Beckett@ed.ac.uk (G.J. Beckett). 
equilibration of exogenous [755e]- selenite with the endoge- 
nous pool of Se and selenoproteins can take in excess of 24 
h [5,6], such labelling experiments require incubation with 
[75Se]- selenite for 36 -48 h. Using these techniques to detect 
selenoproteins in human umbilical vein endothelial cells 
(HUVEC), TR has been identified as the predominant 
selenoprotein comprising 43% of the total selenoproteins 
[6]. Both cyGPX and PHGPX are also expressed by 
cultured EC obtained from a number of species including 
humans [4,7,8] but the relative activities of TR in EC 
isolated from different species have not been defined. 
The culture of EC derived from the large vasculature is a 
well -established model for the study of the endothelium. 
Ideally, EC isolated from human coronary arteries would be 
preferred for studies relating to cardiovascular disease in man 
since atheroma is common in these vessels and is a major 
cause of morbidity and mortality. In practice, the human 
umbilical vein is often the chosen source of EC for the study 
of human endothelial function because of its accessibility. 
0925- 4439/02/$ - see front matter m 2002 Elsevier Science B.V. All rights reserved. 
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Moreover, it is a non -branching vessel with a large intimai 
surface area, making it technically easy to isolate cells. 
Unfortunately, the viability of isolated EC can be modified 
by several factors including foetal stress, maternal anaesthe- 
sia, smoking and other toxins [9,10]. The use of HUVEC and 
other primary cultures of EC is also complicated by genetic 
variability between preparations, limited population dou- 
blings and the requirement for specialised growth factors. 
Arterial and venous EC show differences in the production of 
angiotensin- converting enzyme [ 1 l ] and their response to 
cytokine stimulation [12]. These observations have led to the 
suggestion that HUVEC, despite being widely used by 
researchers in the field of vascular disease, may not be the 
most suitable model for studying human cardiovascular 
disease [13 -15]. 
Bovine aortic endothelial cells (BAEC) and porcine aortic 
endothelial cells (PAEC) are also often used as models to 
study EC function. PAEC may be a suitable alternative to 
HUVEC since there are similarities between the porcine and 
human cardiovascular system [16]. In addition, porcine aorta 
is subject to atheroma formation and has been used as a model 
for the study of this process [ 17]. However, variation between 
EC isolated from different species has been acknowledged to 
occur; for example, PAEC, unlike HUVEC and BAEC, do 
not express Factor VIII- related antigen [17]. 
The EC line EAhy926, established by hybridising pri- 
mary HUVEC with A549 human lung tumour cells [ 18], has 
been used in a number of studies of EC function. EAhy926 
retain many of the differentiated functions common to 
primary EC beyond 100 passages. These functions include: 
the expression of von Willebrand Factor [ 18]; prostacyclin 
formation [19]; expression of endothelin -1 [20]. The sele- 
noprotein profile of EAhy926 cells has not been previously 
determined, but such work is essential in order to establish 
whether this convenient cell line would provide a suitable 
model for future studies of selenoprotein expression in EC. 
If the role of Se on EC function is to be studied, it is 
essential that a model system be chosen which reflects the 
selenoprotein expression and function of human EC derived 
from vessels prone to developing atheroma. The experi- 
ments reported here use [75Se]- selenite labelling and 
enzyme measurements to compare the selenoproteins 
expressed by cultures of EC isolated from different human 
vasculature with EC isolated form bovine and porcine aorta. 
The selenoprotein profile of the human EC cell line 
EAhy926 has also been studied. 
2. Methods 
2.1. Isolation and culture of EC 
2.1.1. HUVEC and human umbilical artery endothelial cells 
(HUAEC) 
Human umbilical cords (> 100 mm in length) were 
obtained at normal deliveries or Caesarean section from 
nonsmoking women. Immediately after delivery, the cords 
were placed into sterile Earle's balanced salt solution 
(EBSS) containing penicillin (100 units /ml), streptomycin 
(100 µg/ml) and amphotericin B (2.5 tg/ml) and kept at 4 
°C. EC were isolated within 20 h of delivery using a method 
adapted from that described previously by Anema et al. [6] 
and Jaffe et al. [21]. Cells were cultured in Endothelial 
Growth Medium -2 (EGM -2: Biowhittaker, Berkshire, UK) 
containing penicillin (100 units /ml), streptomycin (100 µg/ 
ml) and amphotericin B (2.5 µg /ml) at 37 °C in an 
atmosphere of 5% CO2, 95% air. 
The cells showed the morphology characteristic of EC in 
culture previously described by Jaffe et al. [21]. Cells also 
synthesised von Willebrand Factor as determined by an 
indirect immuno- fluorescent detection system. 
2.1.2. Human coronary arterial endothelial cells (HCAEC) 
These were purchased from Biowhittaker, and tested 
positive for the presence of von Willebrand Factor and 
acetylated LDL (an alternative method for the specific 
characterisation of EC in culture) [22]. The HCAEC also 
displayed the characteristic morphology of EC. HCAEC were 
maintained in EGM -2 containing penicillin (100 units /ml), 
streptomycin (100 gg/ml) and amphotericin B (2.5 gg/ml), 
and cultured at 37 °C in an atmosphere of 5% CO2, 95% air. 
2.1.3. EAhy926 EC line 
EAhy926 cells were kindly donated by Professor Cora - 
Jean Edgell of the University of North Carolina, North 
Carolina, USA. The cells were maintained in high glucose 
(4.5 g /1) Dulbeco's Modified Eagle's medium (DMEM) 
containing 10% foetal bovine serum (FBS), 5 mM hypoxan- 
thine , 0.02 mM aminopterin, 0.8 mM thymidine, penicillin 
(100 units /ml), streptomycin (100 tig/ml) and amphotericin B 
(2.5 .ig /ml). The cells were incubated at 37 °C in an 
atmosphere of 5% CO2, 95% air and were passaged weekly 
using 0.25% trypsin -0.02% EDTA solution. EAhy926 cells 
displayed the characteristic morphology of EC in culture and 
stained positive for vWF. 
2.1.4. BAEC 
These were purchased from Biowhittaker. The certificate 
of analysis supplied with this product stated that the BAEC 
tested positive for acetylated LDL. The cells were maintained 
in EGM (Biowhittaker) containing penicillin (100 units /ml), 
streptomycin (100 µg /ml) and amphotericin B (2.5 µg/ml) 
and incubated at 37 °C in an atmosphere of 5% CO2, 95% air. 
2.1.5. PAEC 
Porcine aorta was obtained within 5 -10 min of slaughter 
from pigs aged under 2 years and was immediately placed 
into sterile EBSS at 4 °C containing penicillin (100 units /ml), 
streptomycin (100 µg/ml) and amphotericin B (2.5 µg/m1). 
EC were isolated within 2 -3 h of dissection using a method 
adapted from that previously described by Slater and Sloan 
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minor vessels were ligated. The segments were washed with 
approximately 25 ml of EBSS (prewarmed to 37 °C). One 
end of the aorta was then clamped shut and the opposite end 
infused with 0.1% collagenase in EBSS (approximately 10 
ml). This end was then closed and the cord incubated at 37 
°C in an atmosphere of 5% CO2, 95% air. After 15 min the 
segment was gently massaged and the contents collected 
into a sterile universal container. The vessel was then cut 
along its longitudinal axis and the luminal surface gently 
scraped gently with a sterile stainless steel scalpel blade 
angled at approximately 60° to the intimal surface. The 
blade was washed with EBSS and the washings added to the 
cell suspension previously collected. The sample was then 
centrifuged at 450 x g for 10 min and the resulting cell 
pellet was washed with the culture medium [M199 
containing 20% FBS, penicillin (100 units /ml), streptomy- 
cin (100 µg/ml) and amphotericin B (2.5 µg /ml)]. The cells 
were resuspended into a 25 -cm2 flask and incubated at 37 
°C in an atmosphere of 5% CO2, 95% air. The growth 
medium was changed and replaced after 24 h and then on 
alternate days. Cells displayed the characteristic morphol- 
ogy of EC. 
2.2. Time -course of [75Se]- labelling in HUVEC 
HUVEC were isolated and maintained as described 
previously. For labelling with 75Se -selenite, cells were 
grown to confluence and the culture medium was changed 
and replaced with fresh medium containing [75Se] -selenite 
(0.02 MBq /ml). At time 0, 12, 24, 48, 72 and 96 h, the 
medium was removed from all the flasks and the cells were 
washed three times with EBSS (4 °C). The cells were 
harvested into 20 ml of EBSS by scraping and centrifuged 
at 2000 x g for 10 min at 4 °C. The supernatant was 
aspirated and the cell pellet resuspended in 200 µl of 60 
mM Tris buffer, pH 7.8, containing 1 mM EDTA and 1 mM 
dithiothreitol (Tris buffer). The cells were then lysed by 
sonication whilst kept at 4 °C on ice. 
Protein concentrations were measured using the Bradford 
assay [23] and the samples were diluted to a common protein 
concentration with Tris buffer. The cell lysates were subjected 
to SDS -polyacrylamide gel electrophoresis to separate the 
[75Se]- labelled proteins present in 25 µg of protein. The 
resulting gel was dried and the [75Se]- labelled selenoproteins 
were visualised by autoradiography using Kodak X -OMAT 
XAR -5 film. 
2.3. The effect of passage number on [75Se]- labelling in 
HUVEC 
The intracellular [75Se]- selenoprotein profiles of eight 
passages of a preparation of HUVEC isolated from a single 
umbilical vein were compared. HUVEC were isolated and 
maintained as described above. The HUVEC from the 
primary isolate (passage zero) were grown to confluence 
and passaged into at least three T75 flasks (passage one). At 
confluence, HUVEC in two of the T75 flasks were labelled 
with [75Se] -selenite (0.02 MBq /ml) for 48 h, whilst the third 
was subcultured further to provide passage two. This proce- 
dure was continued until cells had reached passage eight, at 
which point distinct morphological changes were observed, 
such as significant cell enlargement and a partial loss of the 
characteristic cobblestone appearance. 
After a 48 -h labelling period, cells from each passage were 
harvested and stored at - 20 °C. Samples were thawed, lysed 
and prepared for separation using SDS -PAGE as described 
above. 
2.4. The [75Se]- labelling of vascular EC isolated from 
different vasculature 
The intracellular selenoprotein profile of HUVEC, 
HCAEC, HUAEC, EAhy926, BAEC and PAEC were 
compared. Each cell type was isolated and maintained 
as previously described above and labelled for 48 h with 
[75Se] -selenite (0.02 MBq /m1) prior to SDS -PAGE elec- 












Fig. 2. Autoradiograph of an SDS -PAGE gel of the intracellular 
selenoproteins of HUVEC and HCAEC labelled with [75Se] -selenite 
(0.02 MBq /ml) for 48 h. Lane I, HUVEC; lane 2, HCAEC. Each lane 
was loaded with 25 -µg protein. The selenoprotein bands representing 
cyGPX, PHGPX and TR are indicated. 
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four different preparations of cells isolated from four 
different cords were also compared. 
2.5. Glutathione peroxidase and TR in EC 
For each cell type the activities of TR, cGPX and 
PHGPX were measured in parallel subcultures of EC grown 
in triplicate 75 -cm2 flasks using the same culture medium as 
was used for the 75Se labelling experiments. The activity of 
the selenoenzymes in EAhy926 cells was measured in cells 
grown in the DMEM culture medium specified above in the 
presence or absence of 40 nM selenite. After culture, cells 
were harvested by scrapping and lysed in 0.125 M potas- 
sium phosphate buffer (pH 7.4) by sonication on ice. TR 
concentration was measured by an in -house radioimmuno- 
assay using antiserum raised against human placental TR. 
The activity of TR was determined using 5,5' -dithiobis 2- 
nitrobenzoic acid (DTNB) as substrate in the presence and 
absence of 720 nM gold thioglucose [24]. The activities of 
cyGPX and PHGPX activity were determined as described 
previously [25]. 
2.6. Se content of culture medium 
The Se content of the culture medium used for each cell 
type was determined using a fluorometric assay as described 
by Olsen et al. [26]. 
2.7. Statistical analysis 
An unpaired Student's t test (with Welch correction when 
appropriate) was used to test for significant differences 
between the levels of TR, cyGPX and PHGPX. 
3. Results 
3.1. [75Se)- labelling in HUVEC 
Fig. 1 (left panel) shows the autoradiograph of a SDS - 
PAGE gel demonstrating the changes in [75Se]- labelling 
Table 1 
Selenoproteins expressed by EC and the EC line EAhy926 
over time. Selenoproteins were only faintly labelled after a 
12 -h exposure to [75Se] -selenite. The intensity of labelling 
of all selenoproteins increased up until 48 h, at which time a 
steady state of labelling was achieved. Three major [75Se] - 
labelled selenoproteins were observed with mean molecular 
masses of 58.1, 21.7 and 24.4 kDa. A selenoprotein of 
approximately 15 kDa was also moderately expressed. A 
number of minor labelled selenoproteins were observed. 
No distinct variations in the pattern of intracellular 
[75Se]- labelled selenoproteins between four different prep- 
arations of HUVEC were observed (Fig. 1, centre panel) 
and similarly the selenoprotein profile did not change 
over eight passages in HUVEC obtained form a single 
cord (Fig. 1, right panel). 
Using antiserum to rat TR and human TR, we have 
previously identified by Western blotting the 58.1 -kDa 
[75Se]- labelled band in HUVEC as TR. Western blotting with 
antiserum to rat testis PHGPX demonstrated an immunor- 
eactive band that co- migrated with the 21.7 -kDa [755e]- 
labelled band. The same approach using antiserum to human 
cyGPX failed to visualise an immunoreactive band in 
HUVEC. However, purified human cyGPX (Sigma Chem- 
ical Co., Poole, UK) co- migrated with an identical Rf to the 
24.4 -kDa protein [755e]- labelled band on the SDS -PAGE gel. 
The 58 -, 21.7- and 24.4 -kDa 75Se- selenoproteins observed on 
the autoradiograph of the SDS -PAGE gels were thus consid- 
ered to represent TR, PHGPX and cyGPX, respectively. 
3.2. Selenoproteins expressed by human EC and the cell line 
EAhy926 
The pattern of [75Se]- labelled selenoproteins found in 
HCAEC and HUVEC were almost identical (Fig. 2). TR 
appeared to be expressed to a higher degree in HCAEC than 
in HUVEC and mass measurements (Table 1) confirmed this. 
No significant difference was observed in the activities of 
cyGPX or PHGPX between HCAEC and HUVEC (Table 1). 
The [75Se]- selenoprotein expression in venous EC and 
arterial EC isolated from the same umbilical cord differed 
only slightly. In HUVEC an additional selenoprotein with a 
molecular mass of approximately 27 kDa was labelled, 
HUVEC HCAEC EAhy926 BAEC 
CyGPX activity (mU /mg protein) 86 ± 0.7 88 ± 0.03 23 ± 0.5 ** 115 ± 7.0 
158 ± 24.5* 
PHGPX activity (mU /mg protein) 7.15 ± 2.09 8.36 ± 0.01 4.41 ± 1.86 4.54 ± 0.76 
12.5± 3.0 
TR concentration (ng/mg protein) 721 ± 63 1245 ± 335* 871 ± 149 ND 
1002 ± 267 
TR activity (mU /mg protein) 8.9 ± 0.60 24.4 ± 0.34 ** 11.7 ± 1.37 1.06 ± 0.16** 
Results for EAhy926 are given for cells grown in basal culture medium and results in italics are from cells 
sodium selenite. 
TR was not detectable (ND) in BAEC because of the lack of cross -reactivity of the antisera with bovine 
* Results significantly different from HUVEC, P< 0.05. 
** Results significantly different from HUVEC, P< 0.001. 
grown in basal medium supplemented with 40 nM 
TR. 
90 S. Miller et al. / Biochimica et Biophysica Acta 1588 (2002) 85 -93 
which was not observed in HUAEC. TR expression in 
HUAEC also appeared to be slightly greater than in 
HUVEC (Fig. 3). 
The pattern of selenoprotein expression in EAhy926 cells 
closely resembled that observed in HUVEC (Fig. 4). The 
levels of TR and PHGPX in HUVEC were not significantly 
different to the levels found in EAhy926 cells grown in the 
basal medium or when supplemented with 40 nM selenite 
(Table 1). The activity of cyGPX in EAhy926 grown in 
basal medium was significantly lower than that found in 
HUVEC, however, EAhy926 cells supplemented with 40 
nM selenite had significantly higher activities of cyGPX 
than HUVEC (Table 1). Supplementation with 40 nM 
selenite significantly (P< 0.05) increased the expression 
of TR, cyGPX and PHGPX in EAhy926 cells. 
3.3. Selenoprotein expression in BAEC and PAEC 
Compared to HUVEC, PAEC showed quite distinct 
differences in the pattern of [75Se]- labelled selenoproteins 
(Fig. 5, left panel). TR was not the most prominently 
labelled selenoprotein in PAEC but rather a selenoprotein 
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Fig. 3. Autoradiograph of an SDS -PAGE gel of the intracellular 
selenoproteins of HUVEC and HUAEC labelled with [75Se]- selenite 
(0.02 MBq /ml) for 48 h. Both HUVEC and HUAEC were isolated from a 
single umbilical cord and samples were taken from duplicate flasks. Lanes I 
and 2, HUVEC; lanes 3 and 4, HUAEC. Each lane was loaded with 25 -µg 
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Fig. 4. Autoradiograph of an SDS -PAGE gel of the intracellular 
selenoproteins of HUVEC and EAhy926 cells labelled with [75Se]- selenite 
(0.02 MBq /ml) for 48 h. Lane 1, HUVEC; lane 2, EAhy926 cells. Both 
lanes were loaded with 25 -µg protein. The selenoprotein bands representing 
cyGPX, PHGPX and TR are indicated. 
The [75Se]- labelling of many selenoproteins in BAEC 
was significantly less than in HUVEC (Fig. 5, right panel). 
In particular, the expression of the TR band was much less 
in BAEC than HUVEC, an observation that was confirmed 
by activity measurements of TR (Table 1). 
3.4. Se content of culture medium 
The EGM2 used for the culture of HUVEC, HCAEC and 
HUAEC had a Se content of 30 ± 2 nM, which was not 
significantly different to the Se content of EGM used for the 
















Fig. 5. Left. Autoradiograph of an SDS -PAGE gel of PAEC labelled with [75Se] -selenite (0.02 MBq /ml) for 48 h. The lane was loaded with 25 µg of protein. 
Right. Autoradiograph of an SDS -PAGE gel of the intracellular selenoproteins of HUVEC and BAEC labelled with [75Se] -selenite (0.02 MBq /ml) for 48 h. 
Lane 1, HUVEC; lane 2, BAEC. Both lanes were loaded with 25 -µg protein. The selenoprotein bands representing cyGPX, PHGPX and TR are indicated. 
culture of BAEC (43 ± 10 nM). In both of these culture 
media, Se is present as selenious acid. The Se content of the 
DMEM /10% FCS/HAT culture medium used for the culture 
of EAhy926 cells was 18 ± 2 nM, with the Se provided by 
the FBS in the form of selenoprotein. The basal M199 
medium used to culture PAEC had no detectable Se content, 
however, since these cells are grown in the presence of 20% 
FBS, the final concentration of Se in this culture medium 
was 36 ± 2 nM present as selenoprotein. 
4. Discussion 
These studies indicate that for HUVEC, an incubation 
period of at least 48 h must be employed to achieve 
maximal 75Se labelling of selenoproteins (Fig. 1, left panel). 
This contrasts with human thyrocytes where [75Se]- labelling 
reaches a steady state by 27 h [5]. This difference may be 
due to the variability in selenoprotein turnover between 
tissues and possibly different rates of [75Se] -selenite uptake 
between cell types. 
In primary culture, HUVEC have a limited replication 
potential, tending to senesce [27] and, in addition, the 
activities of some enzymes have been reported to vary with 
successive passages [28]. We observed no differences in the 
[75Se] -selenoprotein labelling of HUVEC throughout eight 
passages of the same preparation under identical growth 
conditions (Fig. 1, right panel), arguing that the expression 
of selenoproteins in HUVEC remains constant over at least 
eight passages. In addition, we found that the selenoprotein 
profile in four individual preparations of HUVEC showed 
no marked variability between preparations (Fig. I, centre). 
We have also confirmed our previous observation that 
HUVEC show dominant expression of the 58.1 -kDa sele- 
noprotein, TR [6]. Two other major [75Se]- selenoproteins 
expressed by HUVEC, which were labelled to a much lesser 
extent than TR, had molecular masses of 21.7 and 24.4 kDa 
and were provisionally identified as cyGPX and PHGPX, 
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respectively. Since identification was based on co- migration 
with purified material and by Western blotting, we cannot 
exclude the possibility that selenoproteins with identical 
molecular mass co- migrate with these peroxidases on the 
SDS -PAGE system. 
EC show functional differences according to the vascular 
bed from which they are derived. Arterial EC differ from 
venous EC in a number of aspects, such as the production of 
angiotensin- converting enzyme, ability to form prostacyclin 
[ 11 ] and their cell adhesion molecule response to cytokine 
stimulation [12]. We compared selenoprotein expression in 
a range of primary human EC cells using similar culture 
conditions that included keeping the concentration and 
chemical form of Se in the culture medium constant. The 
[75Se]- selenoprotein profiles of HUVEC and HCAEC were 
remarkably similar, with the only observable difference 
being a slight increased expression of TR in HCAEC that 
was confirmed by assay of TR concentration. The [75Se]- 
labelled selenoprotein profiles of EC isolated from the 
human umbilical vein (which is arterial -like in the umbilical 
cord) and human umbilical artery of the same umbilical cord 
were also very similar. The most obvious difference was that 
HUVEC expressed an additional selenoprotein (27 kDa) 
when compared to HUAEC (Fig. 2). We did not characterise 
this selenoprotein but it has a molecular mass similar to type 
I iodothyronine deiodinase [29]. 
Distinct differences in the pattern of selenoprotein 
expression between human EC and EC isolated from bovine 
and porcine vascular beds were observed. In HUVEC and 
other human EC studied, TR was the dominantly [75Se]- 
labelled selenoprotein. In PAEC the expression of TR was 
relatively weak, the predominant selenoprotein having an 
approximate molecular mass of 15 kDa (Fig. 5 left panel). 
This 15 -kDa [75Se]- selenoprotein was also found in 
HUVEC but labelled to a lesser extent. The identity of the 
15 -kDa selenoprotein was not established, although its 
electrophoretic mobility is consistent with it being either 
the uncharacterised 15 -kDa selenoprotein described by 
Gladyshev et al. [30] or the Se- containing protein, epider- 
mal fatty acid -binding protein (E -FABP) [30]. Masouyé et 
al. [31 ] have demonstrated the presence of E -FABP in 
HUVEC but they were unable to detect the protein in the 
endothelium of the umbilical vein from which the EC were 
isolated, suggesting that the expression of E -FABP may be 
induced by cell culture. 
The pattern of [75Se]- selenoprotein expression in BAEC 
also differed considerably from that observed in HUVEC 
(Fig. 5, right panel). The [75Se]- labelling of the majority of 
selenoproteins was significantly lower in BAEC compared 
to HUVEC and TR expression and activity was consider- 
ably lower in BAEC than in HUVEC (Table 1). The 
expression of selenoproteins is modified by the Se status 
of the cell. However, the Se content and the chemical form 
of Se (ie selenious acid) present in the culture medium for 
HUVEC (EGM2) and BAEC (EGM) were identical. This 
suggests that differing selenoprotein profiles seen in 
HUVEC and BAEC is not a consequence of altered Se 
status. 
The selenoprotein profile found for EAhy926 cells was 
very similar to HUVEV and HCAEC, however, the activity 
of cyGPX in EAhy926 grown in basal medium was sig- 
nificantly lower than in HUVEV or HCAEC (Table 1). 
Inclusion of 40 nM selenite into the basal culture medium 
resulted in significant increases in the expression of each of 
the selenoenzymes, such that cyGPX activity increased to 
levels that were significantly higher than that found in 
HUVEC (Table 1). These data suggest that the small differ- 
ences in selenoenzyme activity observed between HUVEC 
and EAhy926 grown in basal medium are due to the limiting 
supply of Se in the basal medium used to culture EAhy926. 
This basal medium has Se included as selenoprotein incor- 
porated into the FBS. The Se in extracellular selenoproteins 
is not readily available to the cell whilst selenite is rapidly 
taken up by the cell and utilised for selenoprotein synthesis. 
This study has firmly established the suitability and 
consistency of using EC from the human umbilical vein 
as a model to study the effects of Se on EC function in 
relation to atheroma development in the coronary artery. EC 
isolated from pig and bovine aorta showed marked differ- 
ences in selenoprotein profile when compared to human 
cells, particularly as regards the expression of the antiox- 
idant enzyme TR. Only small differences were observed in 
selenoprotein expression and activity in EC originating from 
the coronary artery and other various human vasculature and 
the human cell line EAhy926. 
We conclude that whilst the most appropriate cell culture 
model for the study of selenoprotein expression in athero- 
sclerotic disease in man might be HCAEC, the supply of 
such cells is limited and even then the cells are often 
isolated from diseased vessels. Our studies suggest that 
HUVEC and possibly EAhy926 cells are suitable alternative 
model systems to HCAEC in which the role of selenopro- 
teins in protecting against atheroma formation can be 
studied. 
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A B S T R A C T 
The ability of selenium to protect cultured human coronary artery endothelial cells (HCAEC), 
human umbilical vein endothelial cells (HUVEC) and bovine aortic endothelial cells (BAEC) from 
oxidative damage induced by 100µM t -butyl hydroperoxide (t- BuOOH) was compared. 
Preincubation of human endothelial cells for 24 h with sodium selenite at concentrations as low 
as 5 nM provided significant protection against the harmful effects of 100µM t- BuOOH, with 
complete protection being achieved with 40 nM selenite. The preincubation period was required 
for selenite to exert this protective effect on endothelial cells. When compared with selenium - 
deficient cells, the activities of cytoplasmic glutathione peroxidase (GPX -I), phospholipid 
hydroperoxide glutathione peroxidase (GPX -4) and thioredoxin reductase (TR) were each 
induced approx. 3-4-fold by40 nM selenite. HCAEC and HUVEC showed great similarity in their 
relative abilities to resist oxidative damage in the presence and absence of selenite, and the 
activities of TR and the GPXs were also similar in these cell types. BAEC were more susceptible 
to damage by 100µM t -BuOOH than were human endothelial cells, and could not be protected 
completely by incubation with selenite at concentrations up to 160 nM. The activity of TR in 
human endothelial cells was approx. 25 -fold greater than that in BAEC of a similar selenium 
status, but GPX -I and GPX -4 activities were not significantly different between the human and 
bovine cells. These studies, although performed with a small number of cultures, show for the 
first time that selenium at low doses can provide significant protection of the human coronary 
artery endothelium against damage by oxidative stress. TR may be an important antioxidant 
selenoprotein in this regard, in addition to the GPXs. The data also suggest that HUVEC, but not 
BAEC, represent a suitable model system in which to study the effects of selenium on the 
endothelium of human coronary arteries. 
INTRODUCTION 
Endothelial cells (EC) are constantly exposed to the 
possibility of oxidative damage from reactive oxygen 
species, such as superoxide, hydroxyl radicals, hydrogen 
peroxide, lipid peroxides and singlet oxygen. Oxidative 
damage to the endothelium is considered to be one of the 
principle mechanisms in the pathogenesis of athero- 
Key words: endothelium, glutathione peroxidase, oxidative damage, selenium, thioredoxin reductase. 
Abbreviations: BAEC, bovine aortic endothelial cells; DTNB, 5,5'- dithiobis -(2- nitrobenzoic acid); EBSS, Earl's balanced salt 
solution; EC, endothelial cells; EGM, endothelial growth medium; GPX, glutathione peroxidase; HCAEC, human coronary artery 
endothelial cells; HUVEC, human umbilical vein endothelial cells; LDH, lactate dehydrogenase; t- BuOOH, t -butyl hydroperoxide; 
TR, thioredoxin reductase. 
Correspondence: Dr G. J. Beckett (e -mail G. J.Beckett @ed.ac.uk). 
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sclerosis [1 -3]. Cytoprotection against oxidative damage 
is generally the function of vitamins and enzymes with 
antioxidant actions. These antioxidant enzymes include 
superoxide dismutases, catalase and a range of seleno- 
enzymes, such as the glutathione peroxidases (GPXs) [4]. 
There is some evidence to suggest that selenium (Se) 
may prevent oxidative damage to EC, and thus protect 
against the development of atherosclerosis. For example, 
in humans low plasma Se levels have been associated with 
an increased risk of cardiovascular disease, including 
coronary atherosclerosis [4-6]. In addition, cultures of 
bovine aortic EC (BAEC) pretreated with sodium 
selenite are more resistant to oxidative damage induced 
by t -butyl hydroperoxide (t- BuOOH) or photo - 
generated oxidized low- density lipoprotein than are cells 
grown in Se- deficient medium [7]. This acquired re- 
sistance to oxidative damage in BAEC treated with 
selenite was attributed to increased activities of the 
selenoenzymes cytoplasmic GPX (GPX -1) and phospho- 
lipid hydroperoxide GPX (GPX -4) [7]. However, the 
involvement of other selenoenzymes with antioxidant 
actions, such as thioredoxin reductase (TR), was not 
investigated, since, at the time of the study, TR was 
not known to be a selenoenzyme [8]. 
Ideally, EC isolated from human coronary arteries 
(HCAEC) would be the preferred model for studies 
relating to coronary atheromatous disease in humans. In 
practice, aortic EC isolated from animals are widely used 
in model systems; alternatively, EC isolated from the 
human umbilical vein (HUVEC) are studied because of 
the accessibility of such tissues. However, HCAEC and 
HUVEC show differences in their production of 
angiotensin- converting enzyme [9] and their response to 
cytokine stimulation [10]. These observations have led 
to the suggestion that HUVEC may not be the most 
suitable model for studying human cardiovascular 
disease [11 -13]. Similarly, we have found that the pattern 
of selenoprotein expression in 75Se- labelled BAEC is 
clearly different from the pattern expressed in HUVEC 
(S. Miller, S. W. Walker and G. J. Beckett, unpublished 
work), an observation which suggests that the published 
data regarding the ability of Se to confer resistance to 
oxidative stress in BAEC may not be applicable to the 
human situation. 
EC isolated from different vascular beds and from 
different species may thus show clear differences in their 
ability to resist oxidative stress in response to Se 
supplementation. Although previous work using BAEC 
[7] may be of relevance to humans, it is essential to 
determine if Se can exert a similar antioxidant response in 
HCAEC. Since it is now known that TR is a seleno- 
enzyme with an antioxidant action [8], it is also important 
to establish if TR can be induced in HCAEC by 
concentrations of Se that are able to confer significant 
antioxidant effects. 
In the present study we have thus used HCAEC, 
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HUVEC and BAEC to determine if these cell types show 
differences in their ability to resist oxidative stress in the 
presence and absence of Se supplementation. We have 
also monitored the changes that occur in the activities of 
the three main antioxidant selenoenzymes, GPX -1, 
GPX -4 and TR, in response to small changes in Se 
supply. These studies were performed to investigate 
whether or not Se exerts important antioxidant actions 
on human EC, as is the case with BAEC. In addition, it 
was hoped to obtain evidence that TR is a potential 
mediator of the antioxidant actions of Se in human EC. 
METHODS 
Isolation and culture of HUVEC 
Human umbilical cords (> 100 mm in length) were 
obtained at normal delivery or Caesarean section from 
non -smoking women. Immediately after delivery, the 
cords were placed into sterile Earl's balanced salt solution 
(EBSS) containing penicillin (100 units /ml), strepto- 
mycin (100 pg /ml) and amphotericin B (2.5 pg /ml), and 
kept at 4 °C. EC were isolated within 20 h of delivery 
using a method adapted from that described previously 
[14,15]. Briefly, the umbilical vein was cannulated with a 
Venflon cannula (gauge 17/45 mm), which was then 
clamped into place. The vein was washed with 100 ml of 
EBSS (prewarmed to 37 °C) to remove any blood clots, 
and the outside was wiped using sterile gauze. One end of 
the cord was clamped shut and the opposite end was 
infused with 0.07 % (w /v) collagenase in EBSS (5 -15 ml). 
The cord was then incubated at 37 °C in an atmosphere of 
5 % CO2/95 % air. 
After 10 min the cord was removed and massaged 
gently. The contents of the cord were flushed out with 
30 ml of Cat + - and Mgt+ -free Hanks balanced salt 
solution. The resulting cell suspension was collected and 
centrifuged at 450 g for 10 min, and the cell pellet 
was washed once with endothelial growth medium -2 
(EGM-2 : Biowhittaker Ltd, Wokingham, Berks., U.K.) 
containing penicillin (100 units /ml), streptomycin 
(100 µg /ml) and amphotericin B (2.5 pg /ml). The cells 
were resuspended in 15 ml of EGM -2 and plated out into 
one 75 cm° flask. This flask was then incubated at 37 °C 
in an atmosphere of 5 % CO2/95 % air. After approx. 5 h 
the HUVEC were washed with 2 x 10 ml of EGM -2 to 
remove any blood, contaminant cells and cell debris. The 
medium was replaced with a further 15 ml of EGM -2, 
which was replenished on alternate days during the 
culture period. 
When the cells were approx. 90 % confluent, they were 
passaged into 12 -well plates (for cellular integrity studies) 
or 75 cm° flasks (for enzyme measurements) containing 
Se- deficient medium to which had been added sodium 
selenite at concentrations ranging from 0 to 160 nM. The 
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Se- deficient medium comprised M199 (Biowhittaker 
Ltd) supplemented with EGM -2 supplements [foetal 
bovine serum (2 %), hydrocortisone (0.04 %), ascorbic 
acid (0.1 %), long R insulin -like growth factor -1 (0.1 %), 
heparin (0.1 %), human fibroblast growth factor (0.4 %), 
human recombinant vascular endothelial growth fac- 
tor (0.1 %), human recombinant epidermal growth 
factor (0.1 %) and gentamicin sulphate /amphotericin B 
(0.1 %)]. The Se content of the M199 culture medium 
containing the EGM -2 supplements was 4.7 nM, as 
determined by acid digestion followed by fluorimetric 
analysis [16]. The low but detectable Se content in the 
complete medium is likely to be due to selenoproteins 
present in the foetal bovine serum, since no Se could be 
detected in the M199 culture medium in the absence of 
EGM -2 supplements. 
The cells showed the morphology characteristic of EC 
in culture, as described previously by Jaffe et al. [15]. 
Under the light microscope, cells were non -overlapping, 
large and polygonal. After 3 -7 days in culture, a confluent 
single monolayer of contact -inhibited cells with a cobble- 
stone appearance was apparent. Cells also synthesized 
von Willebrand factor, as determined by an indirect 
immunofluorescent detection system, characteristic of 
EC in culture [15,17]. 
Culture of HCAEC 
HCAEC were purchased from Biowhittaker UK Ltd, 
and tested positive for the presence of von Willebrand 
factor and the uptake of acetylated low- density lipo- 
protein (an alternative method for the specific charac- 
terization of EC in culture) [18]. The HCAEC also 
displayed the characteristic morphology of EC, as de- 
scribed above. 
HCAEC were initially maintained in EGM -2 con- 
taining penicillin (100 units /ml), streptomycin (100 
pg /ml) and amphotericin B (2.5 pg /ml), and were 
cultured at 37 °C in an atmosphere of 5 % CO2/95 % air. 
Subculture of cells with various concentrations of sodium 
selenite (0-160 nM) was carried out in M199 with EGM - 
2 supplement additions, as described above for HUVEC. 
Culture of BAEC 
BAEC were purchased from Biowhittaker UK Ltd. The 
certificate of analysis supplied with this product stated 
that the BAEC tested positive for acetylated low - 
density lipoprotein. The cells were maintained in EGM -2 
containing penicillin (100 units /ml), streptomycin 
(100 pg /ml) and amphotericin B (2.5 pg /ml), and were 
incubated at 37 °C in an atmosphere of 5 % CO2/95 % 
air. Subculture of cells with various concentrations of 
sodium selenite was carried out in M199 with EGM -2 
supplement additions. 
Determination of cellular integrity by 
measurement of lactate dehydrogenase 
(LDH) retention 
Cell integrity was assessed as the percentage retention 
of LDH by the cell layer. Intracellular LDH activity 
and LDH in the culture medium was determined using an 
LDH kit method (Sigma Diagnostics Ltd, Poole, Dorset, 
U.K.) adapted for use on the Cobas Fara centrifugal 
analyser (Roche Diagnostics, Welwyn Garden City, 
U.K.). 
All EC for cell integrity studies were plated into 12- 
well plates at a density of 10000 cells /cm2 and cultured 
for 5 -7 days until confluent, using two changes of M199- 
based culture medium containing specified concen- 
trations of selenite as described above. At confluence, the 
culture medium was replaced with fresh medium (1 ml) 
containing 100 pM t -BuOOH (and specified concen- 
trations of selenite) and incubated for 20 h. The culture 
medium was then removed and kept, and the cells were 
washed with 2 x I ml of PBS, pH 7.4. The cells 
were lysed in 0.5 ml of 0.5 % Triton X -100 (in PBS). 
After 15 min the cell lysates were collected and the wells 
were washed with a further 0.5 ml of PBS; the washings 
were combined with the respective lysates. Cell debris in 
the culture medium and cell lysates was removed by 
centrifugation of all samples at 11500 g for 10 min prior 
to assay for LDH activity. 
LDH activity was also measured in culture media that 
had not been in contact with cells, as a measure of 
endogenous LDH in the culture medium (blank). 
Protection of EC from t -Bu00H toxicity 
by Se 
The protective effects of sodium selenite against oxidative 
damage caused by exposure to 100 pM t -BuOOH for 
20 h was determined by measurement of LDH retention, 
as described above. Cells grown in M199 containing 
added concentrations of selenite ranging from 0 to 
160 nM were used for these experiments. 
To examine the importance of a preincubation period 
with selenite, LDH retention in response to 100 pM t- 
BuOOH for 20 h was also studied using cells grown in 
Se- deficient medium, but where selenite (at the specified 
concentration) and 100 pM t -BuOOH were added sim- 
ultaneously. This protocol ensured that cells were not 
preincubated with selenite, as was the case for all other 
experiments. 
All determinations were carried out in triplicate wells. 
Effects of Se on selenoenzyme levels in EC 
The effects of sodium selenite on the concentration and 
activity of TR and the activities of GPX -1 and GPX -4 
were investigated in parallel cultures of EC (grown in 
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triplicate 75 cm' flasks) used for the toxicity studies 
described above. After culture, cells were harvested by 
scraping and lysed in 0.125 M potassium phosphate 
buffer (pH 7.4) by sonication on ice. The levels of the 
selenoenzymes were then determined as described below. 
Measurement of selenoenzymes 
TR concentration 
The TR concentration was measured by an `in- house' 
RIA using a primary antibody raised in rabbits to 
human placental TR. Second -antibody precipitation 
was employed, using pre -precipitated donkey anti - 
rabbit reagent, prepared by mixing 25 ml of donkey 
anti -rabbit serum with 1.5 ml of normal rabbit serum 
(Scottish Antibody Production Unit, Carluke, Scotland, 
U.K.) for 12 h at room temperature. After washing, the 
precipitate was made up to a final volume of 100 ml with 
assay diluent of 50 mM potassium phosphate buffer, 
pH 7.4, containing 0.1 % BSA, 0.02 % sodium azide and 
10 mM dithiothreitol. 
The tracer was 125I- labelled human placental TR, 
prepared using Bolton -Hunter reagent (Amersham In- 
ternational plc). Standards were prepared using purified 
placental human TR diluted in foetal bovine serum 
(Gibco, Paisley, Scotland, U.K.) 
The RIA was performed using duplicates of samples 
and standards as follows. Standard or sample (100 pl) was 
added with 100µl of 1251 -TR tracer (10000 d.p.m.; 50 pg 
per tube) and primary antibody (100 pl). After an 
overnight incubation at 4 °C, donkey anti- rabbit reagent 
(100 pl) was added. After a further 1 h at room tem- 
perature with shaking, wash solution (0.05 % Brij sol- 
ution) was added to each tube, followed by centrifugation 
for 30 min at 1800 g (4 °C). The supernatant was decanted 
and the precipitate was washed with a further 1.5 ml of 
wash solution. The 125I radioactivity in the precipitate 
was counted in a multi -well y- radiation counter, and 
results were interpolated using the LKB 1224- RIACaIc 
RIA evaluation program. 
TR activity 
TR activity was measured using a method adapted from 
that described previously by Hill et al. [19], based on the 
ability of TR to perform the NADPH- dependent re- 
duction of the substrate 5,5'- dithiobis -(2- nitrobenzoic 
acid) (DTNB) to produce 5'- thionitrobenzoic acid. TR 
activity was determined by following the rate of DTNB 
reduction, measured as an increase in absorbance at 
412 nm, using a Cobas Fara Centrifugal Analyser (Roche 
Diagnostics). To correct for the reduction of DTNB by 
substances other than TR, the assay was performed in the 
presence and absence of 720 nM aurothioglucose, a 
concentration that inhibits TR activity. 
© 2001 The Biochemical Society and the Medical Research Society 
GPX -I and GPX -4 activities 
GPX -1 activity was determined by following the rate of 
NADPH oxidation at 340 nm in the presence of the 
substrate hydrogen peroxide, using a Unicam UV4 
spectrometer with Vision software [20]. GPX -4 activity 
was measured using the same system as for GPX -1, but 
with phosphatidylcholine hydroperoxide as substrate 
[20]. 
Statistical analysis 
One -way ANOVA was used to test for significant 
differences in LDH retention in response to t- BuOOH. 
A Tukey- Kramer multiple- comparison post -hoc test was 
used to test for significant differences in LDH retention 
in response to t -BuOOH toxicity between cells with 
differing Se status. These statistical tests were also used to 
test for significant differences between levels of seleno- 
proteins in EC cultured in different concentrations of 
sodium selenite. 
RESULTS 
Protection by Se of EC from t -Bu00H 
toxicity 
Preliminary experiments demonstrated that exposure to 
100 pM t -BuOOH for 20 h consistently produced a 
significant (P < 0.001) decrease in LDH retention by EC, 
to values that were < 20 % of those in control cells not 
exposed to t- BuOOH. HCAEC (Table 1) and HUVEC 
(Table 2) had a similar sensitivity to 100 pM t- BuOOH, 
with approx. 13 % retention of LDH found in both of 
these cell types at the end of the 20 h incubation. In 
contrast, BAEC (Table 3) were significantly (P < 0.01) 
more sensitive to 100 pM t -BuOOH than human EC, 
retaining only approx. 3 % of LDH after exposure to the 
hydroperoxide. 
In each of the three HUVEC and two HCAEC 
cultures, preincubation with 40 nM sodium selenite 
achieved complete protection against the damaging ef- 
fects of t -BuOOH (Tables 1 and 2). In three of the five 
experiments, significant but not optimal protection by Se 
was achieved at a sodium selenite concentration of 
10 nM; in one experiment using HCAEC, significant 
protection was observed with 5 nM sodium selenite 
(Table 2). In each of the two experiments using BAEC, 
selenite afforded significant protection against the toxic 
effects of 100 pM t -BuOOH (Table 3). However, 
although 40 nM selenite afforded optimal protection to 
BAEC, this was by no means complete; increasing the 
concentration of selenite to 160 nM provided no ad- 
ditional protection. 
Preincubation with sodium selenite was required for 
protection against t -BuOOH toxicity. No protective 
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Table I Changes in selenoenzyme expression and resistance to oxidative damage caused byt -BuOOH in HCAEC supplemented 
with sodium selenite 
HCAEC were cultured in Se- deficient medium or the same medium supplemented with specified concentrations of sodium selenite until confluent in 12 -well plates (LDH 
retention studies) or 75 cmt flasks (enzyme studies). LDH retention was measured in response to exposure to 100 uM t -BuOOH for 20 h. TR, GPX -I and GPX -4 were 
determined as specified in the Methods section. All incubations were carried out in triplicate. Significant differences from Se- deficient cells: P< 0.05; ***P< 0.001. 
Sodium selenite 
(nM) 
LDH retention ( %) 
TR TR activity 
(m- units /mg) 
GPX -I activity 
(units /mg) 
GPX -4 activity 




0 96.8 ± 13 12.8 ± 1.3 913 ± 30 6.4 ±0.04 0.037 ± 0.011 8.36 ±0.01 
I 97.1 ± 1.0 1.9 ±0.9 828 ±35 6.3 ±0.44 0.049 ±0.005 5.98 ±4.11 
5 94.6 ±0.5 8.7 ±0.8 1111 +10 " "" 11.1 ±0.08 "' 0.057 ±0.004 9.65 ±2.91 
10 97.6 ±0.6 40.4 ±.9.2 " "' 1620 +37 " "" 17.1 ±0.63 "" 0.090 ±0.020' 9.78 ±3.52 
40 99.2 ± 1.0 94.6 ±0.4 " "" 1716 ±15 "" 24.4 ±0.34 " "" 0.121 ±0.013' "" 18.05 ±1.26 
160 99.2 ±1.0 95.1 ±0.8' "" 1059 ±110 " "" 25.9 ±0.08' "" 0.148 ±0.033' "" 16.54 ± 1.56 
Prep. 2 
0 93.0 ±0.6 12.6± 1.1 823 ±41 1.2 ±0.06 0.088 ±0.031 5.89 ±2.72 
I 92.9 ± 0.3 9.9 ± 1.9 956 ±35 9.9 ± 0.41 0.010 ± 0.001 3.61 ± 4.46 
5 93.9 +0.4 8.9 +3.5 1437 +128 "" 20.6 +2.9*'* 0.120 +0.011 10.84 +4.64 
10 93.4 +0.6 92.2 +0.5 - 1659 +_ 131' "" 24.4 +1.4' "" 0.138 +0.037 15.48 +2.58 
40 93.2 +0.9 90.6 +0.4' "" 1756 +96 - 26.3 +2.3' "" 0.118 +_0.012 16.84 +_4.09 
160 94.1 +0.2 89.6 +2.1 " "' 
Table 2 Changes in selenoenzyme expression and resistance to oxidative damage caused byt -BuOOH in HUVEC supplemented 
with sodium selenite 
HUVEC were cultured in Se- deficient medium or the same medium supplemented with specified concentrations of sodium selenite until confluent in 12 -well plates (LOH 
retention studies) or 75 cmz flasks (enzyme studies). LDH retention was measured in response to exposure to 100 pM tBuOOH for 20 h. TR, GPX -I and GPX -4 was 
determined as specified in the Methods section. All incubations were carried out in triplicate. Significant differences from Se- deficient cells: *P< 0.05; "P < 0.01; 
***P< 0.001. 
LDH retention ( %) 
Sodium selenite TR mass TR activity GPX -I activity GPX -4 activity 
(nM) 0 uM t-BOOH 100 pM t-BOOH (ng /mg) (m- units /mg) (units /mg) (m- units /mg) 
Prep. I 
0 91.3 ± 1.3 16.9 ± 1.6 523 ± 64 3.6 ± 0.9 0.032 ±0.093 4.18 ± 2.09 
10 91.4± 1.2 25.6 ±8.0 662 ±43 " "" 7.4 ±0.4 " "" 0.111 ±0.021 " "" 15.26 ±3.85 "" 
40 91.5 ±0.6 91.4 ±1.3' "" 805 ±71 " "" 8.9 ±0.6 " "" 0.170 ±0.021' "' 11.90 ±3.81 
160 93.2 ±0.8 91.9 ±0.8 " "" 790 ±36""" 8.1 ±0.2 "'" 0.164 ±0.010' "" 13.46 ±2.28' 
Prep. 2 
0 94.5 ±0.5 11.3 ±0.7 441 ±34 2.4 ±0.1 
1 94.5 ±0.5 8.2 ±0.6 412 ±30 3.2 ±0.2' 
5 93.1 ± 1.1 80.1 ± 2.0" 642 ±41 - 5.1 ±0.2 "" 
10 92.6 ±1.9 84.0 ±4.8' "' 801 ±22' "" 7.9 ±0.4"" 
40 93.8 ±0.7 93.4 ±0.3 "" 895 ±92 "" 9.5 ±0.3 "' 
Prep. 3 
0 93.1 ± 0.7 22.1 ± 2.2 345 ± 59 1.4 ± 0.1 
I 92.8 ±0.4 19.8± 2.7 390 ± 120 1.8 ±0.1 
5 91.3 ± 0.7 11.6 ±0.8 489 ±40 3.2 ± 0.5' 
10 91.2 ±0.1 89.1 ±0.9"' 644 ±38'" 3.7 ±0.8 "" 
40 89.8 ±0.9 86.3 ±2.3' "" 1277 ±62 "' 7.2 ±0.6 "" 
160 90.6 ±0.5 89.2 ±0.4"' 1059 ±110 "' 8.1 ±1.2 "' 
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Table 3 Changes in TR activity and resistance to oxidative damage caused byt -Bu00H in BAEC 
supplemented with sodium selenite 
BAEC were cultured in Se- deficient medium or the same medium supplemented with specified concentrations of sodium selenite 
until confluent in 12 -well plates (LDH retention studies) or 75 cmz flasks (enzyme studies). LDH retention was measured in 
response to exposure to 100 µM t-BuOOH for 20 h. TR was determined as specified in the Methods section. All incubations 
were carried out in triplicate. Significant differences from Se- deficient cells: `P < 0.05; -P< 0.01; " "'P < 0.001. ND, 
not detectable. 
LDH retention ( %) 













100.7 ± 1.3 
100.3 ± 0.5 
99.3 + 0.5 
99.2 ± 0.3 
100.6 ±0.1 
99.3 + 0.8 
98.0 + 0.6 
98.1 ±0.5 
97.6 + 0.4 
96.5 + 0.9 
97.5 + 0.9 
99.1 + 0.7 
4.4 + 0.8 
4.0 + 1.2 
8.4 + 3.2 
3.9 ± 0.2 
65.8 + 7.5 '- 
65.9 + 9.8` "" 
2.6 + 0.9 
1.5 ± 0.9 
1.7 +0.7 
3.8 ± 0.6 
46.9 + 26.9 "" 
35.8 + 5.4" 
ND 
0.11±0.20 
0.98 ± 0.22 








0.48 ± 0.11" 
Table 4 Importance of preincubation with sodium selenite in conferring resistance of HUVEC 
to oxidative damage induced by 100 ttM t -BuOOH 
HUVEC were cultured in Se- deficient medium or the same medium supplemented with specified concentrations of sodium selenite 
until confluent in 12 -well plates. LDH retention was measured in response to exposure to 100 µM t -BuOOH for 20 h. In parallel, 
HUVEC cultured in Se- deficient medium for the same time period were treated for 20 h with a solution of 100 uM t -Bu00H 
containing the specified concentrations of sodium selenite (no preincubation). All incubations were carried out in triplicate. 
Significant differences from Se- deficient cells: -*P< 0.001. 
Sodium selenite 
(nM) 
LDH retention ( %) 
Preincubation No preincubation 
0 µM t-B000H 100 pM t-B000H 0 µM t-B000H 100 µM tBUOOH 
0 90.6± 1.4 8.1 ±0.7 90.2 + 1.4 8.0 ± 1.0 
91.7 +1.5 6.9 + 0.8 92.9+ 1.1 1.6 ± 1.0 
10 91.9 ± 0.8 8.4 ± 0.3 92.3 ± 0.4 11.1 ±0.8 
40 97.6 + 0.9 89.7 + 0.6"" 91.4 + 0.22 9.1 ± 0.3 
160 99.1 + 0.7 81.2 + I.I' "" 91.9± 0.9 1.1 ± 0.7 
effect was observed when selenite and t -BuOOH were 
added simultaneously to cells grown in Se- deficient 
medium (Table 4). 
Selenoprotein expression in EC in response 
to sodium selenite 
In all of the EC preparations, selenite added at 5 -10 nM 
produced a significant (P < 0.05) increase in the activity 
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of TR, and 40 nM selenite resulted in maximal induc- 
tion of TR activity (Tables 1 -3). The concentration of TR 
was also increased maximally in the presence of 40 nM 
selenite in the human EC (Tables 1 and 2). It was not 
possible to determine TR concentration in the BAEC, 
because bovine TR showed no cross -reactivity with 
the anti -(human TR) antibody. In BAEC grown in Se- 
deficient medium, we were unable to detect TR activity. 
In the presence of > 10 nM selenite, TR activity was 
measurable, with maximal activity found in the presence 
of 40 nM selenite. The TR activity in Se- supplemented 
BAEC was > 25 -fold lower than the activity in HUVEC 
or HCAEC. 
Due to the limited number of cells, it was not possible 
to measure GPX -1 and GPX -4 activities in each of the 
preparations. In those preparations where these activities 
were determined, maximal induction was produced by 
40 nM selenite. The mean inductions of TR activity, TR 
concentration, GPX -1 activity and GPX -4 activity in the 
five human EC preparations, expressed as multiples of 
the basal value, were (means ±S.D.) 3.76 ±1.01, 
2.18 ± 0.87, 3.38 ± 1.86 and 2.54 ± 0.36 respectively. The 
induction of TR activity in response to selenite was 
significantly (P < 0.05) greater than the induction found 
in TR concentration. The activities of GPX -1 and GPX - 
4 in HUVEC grown in medium containing 40 nM Se (as 
selenite) were 0.086 ± 0.024 units /mg of protein and 
7.147 ±2.93 m- units /mg of protein respectively; these 
values were not significantly different from the activities 
of these selenoperoxidases found in BAEC (GPX -1, 
0.115 ± 0.007 units /mg of protein; GPX -4, 4.54 ± 0.76 m- 
units/mg of protein). 
DISCUSSION 
The numbers of experiments reported here are small. 
However, the results establish clearly that HUVEC and 
HCAEC cultured in Se- deficient medium can be com- 
pletely protected from the toxic effects of 100 µM t- 
BuOOH by the addition of Se (as selenite) at concen- 
trations as low as 5-40 nM (Tables 1 and 2). Selenite 
added in the absence of t -BuOOH had no significant 
effect on LDH retention (Tables 1 and 2). The results also 
indicate that HCAEC and HUVEC have similar 
sensitivities to the harmful effects of t- BuOOH, and that 
the two cell types show similar responses to Se, in terms 
of the trace element's ability to confer an antioxidant 
action. 
There were small differences in the sensitivity of the 
various human EC preparations to t -BuOOH toxicity. 
These differences probably reflect variability in endogen- 
ous antioxidant defence mechanisms, such as seleno- 
proteins, catalase and superoxide dismutase, which all 
work in concert to maintain the cell's redox potential 
[21,22]. Variable susceptibility to toxic agents between 
different isolates of HUVEC, and between passage 
numbers within the same isolate, has been reported in 
other studies [23]. 
The ability of EC treated with 40 nM selenite to resist 
t -BuOOH toxicity is likely to be due to increased 
selenoprotein expression, since a preincubation period of 
EC with sodium selenite was necessary to confer pro- 
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tection. Similarly, skin cells in culture can only be 
protected from the lethal effects of UVB radiation by 
selenite if a preincubation step is performed [24]. 
The modification of selenoprotein activity in response 
to Se supplementation in cultured cells has been widely 
reported. For example, Se supplementation has been 
shown to induce GPX -1 and GPX -4 activities in human 
and bovine EC [7,25]. In the present study, we have now 
shown that the activities of GPX -1, GPX -4 and TR are 
increased in HCAEC and HUVEC by approx. 3 -fold in 
response to selenite supplementation. The increase in TR 
activity in response to sodium selenite was greater than 
the corresponding increase in TR concentration, as 
determined by our RIA that is specific for the cyto- 
plasmic TR isoenzyme. This discrepancy might arise if Se 
supplementation induces both the cytoplasmic and mito- 
chondrial forms of TR in human EC [26]. 
The concentration of sodium selenite (40 nM) that led 
to maximal induction of TR and the GPXs was identical 
with the selenite concentration that conferred complete 
protection against t -BuOOH toxicity. It was not possible 
to consistently find a concentration of selenite that 
conferred optimal resistance to toxicity and yet produced 
an increase in the activity of one particular selenoprotein. 
Thus our results in HUVEC and HCAEC indicate that 
TR, GPX -1 and GPX -4 are all likely to be involved to 
some extent in protecting the endothelium from oxidative 
damage. However, our data suggest that, in human EC 
(but possibly not BAEC), TR may be a particularly 
important selenoprotein as regards antioxidant action. 
This is because (i) human EC contain, on a molar basis, 
more TR than GPX -4 and GPX -1 [14]; (ii) human EC 
contain quantitatively more TR than other tissues [14]; 
(iii) TR is able to detoxify some damaging lipid hydro - 
peroxides more efficiently than GPXs [27]; (iv) TR 
expression is increased by doses of Se that confer 
protection from oxidative damage on the EC (Tables 
1 -3); and (v) BAEC are more sensitive to t -BuOOH than 
are human EC; these cells have similar activities of GPX - 
1 and GPX -4, but much lower TR activity (Tables 1 -3). 
In conclusion, we have shown that small increases in 
sodium selenite concentration can confer highly 
significant protection against oxidative damage induced 
by t -BuOOH in HCAEC and HUVEC. Such protection 
appears to be related to the increased expression of 
selenoproteins, rather than to a direct antioxidant effect 
of sodium selenite. The concentrations of Se required to 
elicit optimal antioxidant protection are similar to the 
concentrations required to maximally induce the ac- 
tivities of TR, GPX -1 and GPX -4 in human EC, 
suggesting that each of these selenoproteins has im- 
portant antioxidant actions. However, the very high 
expression of TR in HUVEC and HCAEC, but not in 
bovine EC, might indicate that TR may be a particularly 
effective antioxidant selenoprotein in humans. Our data 
are also consistent with epidemiological evidence indi- 
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cating that low Se status predisposes to endothelial injury 
and atherosclerosis. 
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SELENIUM PROTECTS KERATINOCYTES FROM BY ULTRAVIOLET 
RADIATION- INDUCED LIPID PEROXIDATION AND CELL DEATH BY 
OXIDATIVE STRESS R.C. McKenzie' M. Lewin2, T. Rafferty' A.F. Howie2, J.R. 
Arthur3, G.J. Beckett2, Epidermal Inflammation and Protection Group', Department of 
Clinical Biochemistry2, University of Edinburgh and the Rowett Research Institute, 
Bucksburn, Aberdeen3 
Selenium has been shown to be a photoprotectant for skin, protecting skin cells from 
cell death, oxidative DNA damage, ultraviolet radiation B (UVB)- induced cytokine 
induction and from skin cancer in mice. We sought to determine whether inorganic 
selenium as selenite (SS) or as the organic form selenomethionine (SM) could protect 
the keratinocyte cell line HaCaT from lipid peroxidation and oxidative stress. 
HaCaTs were irradiated with 1000J /m2 of UVB from Philips TL12 lamps and the 
cells collected and homogenised at various times after UVB. Malondiadehyde (MDA) 
is a product of lipid peroxidation brought about by reaction of membrane lipids with 
reactive oxygen species (ROS). The MDA content of cell homogenates was assayed 
spectrophotometrically and found to increase 2 -4 -fold, 24 h after irradiation. Cells 
were pre- incubated for 24 h before UVB with 1 nM- 50 nM SS or with 50 nM -200 
nM SM. The MDA content in unirradiated cells was 0.31± 0.1 µM; this increased to 
1.56 ±0.301.1M. 24 h after UVB. Pre -incubation with all concentrations of SS or SM 
decreased the UVB- induced MDA content by 49 %- 69 % (p <0.05, 2 experiments). 
Menadione (ME) kills cells by causing lipid peroxidation, DNA strand breaks and 
other ROS mediated damage,. Both SS and SM dose -dependently protected HaCaTs 
against cell damage measured by lactate dehydrogenase release) after treatment with 
ME. ME toxicity was cell density- dependent: cells 50 % confluent showed an ID50 of 
10.5 µM, cells 100 % confluent had an ID50 of 45 µM and cells 2 days post confluent, 
ID50= 68 µM. Thus selenium protects keratinocytes from damage by reactive oxygen 
species. 
Lewin M, McKenzie RC., Howie AF, Nicol F, Arthur JR, Beckett GJ Mechanisms 
of selenium- induced protection of keratinocytes from ultraviolet radiation and 
chemical induced cell death. (2002). Brit. J. Dermatol. 146:723. 
MECHANISMS OF SELENIUM -INDUCED PROTECTION OF 
KERATINOCYTES FROM CHEMICAL AND ULTRAVIOLET RADIATION - 
INDUCED CELL DEATH. M. Lewin', R.C. McKenzie2, A.F. Howie', F. Nico13, 
J.R. Arthur3, G.J. Beckett', Departments of Clinical Biochemistry' and Dermatology2, 
University of Edinburgh and the 3Rowett Research Institute, Bucksburn, Aberdeen 
Selenium (Se) protect keratinocytes (KC) from death induced by 960 J /m2 of 
ultraviolet radiation B (UVB) or from chemical agents that induce oxidative stress 
such as menadione (ME). In both KC and HaCaT cells, Se is protective at 1 nM- 
100nM. At higher levels protection from UVB damage is lost, although protection 
from ME- induced damage is maintained. Se exerts its actions through modification of 
selenoprotein expression. Although the function of many of these Se- containing 
proteins is unknown, the thioredoxin reductase (TR) and the glutathione peroxidase 
(GPx) families have important antioxidant roles. We have investigated the role of 
these selenoproteins in the protection of HaCaTs from UVB- and oxidative- induced 
cell death. 
HaCaTs in culture were supplemented with 0 nM to 1000 nM selenite and TR, 
cytoplasmic GPx (cGPx) and phospholipid GPx (PLGPx) activity measured as a 
function of [Se]. TR and PLGPx activities increased 2.2 -fold and 1.5 -fold 
respectively with increasing [Se] up to 50 nM, (p <0.05,n =6) thereafter they 
plateaued. However cGPx activity increased 5 -fold to a maximum at 50 nM [and 
decreased thereafter to basal, at 1000 nM (p <0.001, n =6). This corresponds to the [Se] 
at which protection is lost in cell survival assays, suggesting an important role for 
cGPx in Se- mediated protection. In contrast TR appears to mediate protection from 
ME- induced cell death. Pre -incubation of HaCaTs with gold thioglucose (GT), (10 µ 
M for 48 h) diminished TR activity by 82% (p <0.001, n =6) and PLGPx by 29% 
(n =6), but did not inhibit cGPx. Cells were more susceptible to ME (20µM- 60µM) 
than control cells (p <0.001) suggesting a role for TR also in protection of HaCaTs 
from ME- induced oxidative stress. TR inhibition with GT however, did not affect 
cell survival following UVB. Thus, different selenoenzymes mediate protection of 
keratinocytes from UVB and oxidative -induced cell death. 
